Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Mycoplasma synoviae 53, 53

>MS53_0035 hypothetical protein
MWYFVIFKIKIMQNYKKNSTKMFYRIFFKKMSVPIAYSLIAIFIYYFFFT
LSYYYVSQQFSVQNFYERLKDENSFDSKWIFFWINLSFKFFRYEDFNFFV
LLFFYFLPILIWSYYLRLFYKSDYYKRIILLNGNKKTFRYIGLYLVIFWF
LIFLIINLVSLKPIDYLYKYLAWKEGGDGNYKNYVKWIPWLNPFILYDSK
FKGENFPYNEFKIGETNFFYLENKFYTHIFLMFLSFFTAIAFVSVSFYIN
KWILYLIYFLTLVSLILDSSKILMVFFPYDEAYQYIGSELKFKKFLVKIP
FSFFNPYSLLDVFASFHFLSKKITINWLFPVILISIFNFSVLAFSAWTMR
RNFKYSFL
>MS53_0395 conserved hypothetical protein
MAQRKIYNKQDYTVDLENKIVVLSDSYYEKLSNFSNKWTSFKKIGGSSIG
DVLEVDSFKSSFSAYCHIARLKMPILQTKYIDAGVALEPKIFEFFKNLVH
KKNPELEVNHYDAAEYNYDYFSGIDVIGGVPDGAINNLKMILEIKTANAK
KRSEWDKEIPKAYLKQAQLYAHLMGYTRIKFLTLFLNDSDYLNPENAEIS
NSTFKVYDASALNKSEIVEDIDFVKNWYNQYTNTKVSPQFKPLIDKDQID
YLLCENREQWKELFNRWKAQKKVDENIDFESV
>MS53_0081 conserved hypothetical protein
MHRFFCYKKLDSNYFELSDELLKHLKVLRIGSEEFLVNYQNEFYKCKLEN
NLAKIISKQEINNELDYKIYLAIGLIKFERFEWLIEKATELGVFEIVPFY
SQFTQKHKLLNQFQNKKNRFEKIIKFAAEQSFRNIIPNLKDPISFEDLLN
FYVNQKLVAHEISDNQNFDLNLLTKNDLLLTIGSEGGFSSDEIAKFKEAN
FKVIHLGKTILRSETAAISLISKVK
>MS53_0334 conserved hypothetical protein
MMKNKKIVLAASGALSVFALSSVISCGDKTDGGSGGNTGSEFNIKQNEVS
PEEWKRINNSSVGVNPSARDKKFDQDASDRIVLGAPWSEGEERFRVLQRF
AEVYNADAEVKASPFYKQLVVQNAGNGYSDGDKQVANYLRARNTSSFYNL
TLNYSNVAARLAEYNMLLNFNSLDKRLNVDLSSFSPQFTGENTRTSFVVN
AGSYILPFLKSGTTLAVNAPVLSYILDKMQENGATLKMSDSDFKSFYDDL
KAKGAADREAVKELWGEVSNDGKAALSGYEVSMDTFRAFSPLTDFAKKAQ
DLFTKTRNNPSGQLHIIGIDDPAGTYQSQVLAANGGDDSLGVEAPTKTNG
VPGASYTGLTTKGSPTQDKGKEIYDKFVETSKNGGLVFQNNAGSVRTTTL
MITHRFAMGIVSTSHWGRSYIDSTKVTNSKEYVNSEVPSYSTSTLNSGVV
EAATKTANYKVDYTLKKRATDKKPSYEVYLSISDVQESALGRNGYKLDKK
VDDTAFKAGVAAKTETSKVLVLFQNTGQDSKADLDKMVKKVQSAASASNS
NFVYMGTGKSSRGLSAVFVLVKDGMTDGTALSSLGYTVKSITTANQLNEN
EIIALNVPGKWKNENPKNVVYVQGPSLIGIHSNEAGNNATRLFLKWLLSN
KKLNFDATDATKMETAIEYFQRKVGYVTPTTEFSKPATKQIFEGLKNPYA
LSAYNQFLLVSTDPDKNIAYYSPGTTLQNEFRSGINSQFSTVQNSSQNGT
DAPTFDQFAESVVSTVRATNN
>MS53_0241 putative phase-variable hemagglutinin
MQFTSGSVTAAKAVKEDAEYSKVTDTIKTTLEEKYTAAAGFLTEDSKLAN
LNADGTLATTQSDLESAKTALDAAVAAVKPELDFQKTKTSAAAKVTELES
LVNSALKAELQRQVNELTKEQAAQATTMLANLTSLKESLESLQTLVSNGL
KMQVDYPRNYYDADNKSAFDDALLKASSVFPAFQWTAQSIMVPAPEEGAL
PNPRAWTKAREKSEFKLQNFVIAPAQAAPATQSDSTAAESATVRVANGEA
TPAEGAASREAPTPAADLASTVSYLKSLSDSLKAETDKLNGDTTENKTAY
YKADTTRTLYWDGFMPKIILESFTASQTNVEDNKSKLQTWFDTKANWSNL
EDQLVKKLGSEKFKNVKLTNPQVDWDIVNSNQYRPKVTFDVTQKEGYELQ
SGSEFSQSLTMVIRVLYTTQSPNANVLQMQGASSSAAPAGSTPSNNAAVI
RNVNVYMNYTGPAIMLNADLPTVGGQENTSINGTSNVDGDFNTKFKNLLV
NVVGGSFTQTSLLQAIINYVNKFDPKFRAAFVTEKNGVALTSVQSGTQLR
IGSLNDFLYNNKGFLQQVNGDSSAVYFAVNGVTSQGWLNTFLIRIPLTKF
VKPLSVFTAPVVTPPAEEATEGSQTQASIPQTIPNSSQ
>MS53_0547 conserved hypothetical protein
MKKLKKLFLFSLAPITASVAAFSLSATVASNTSESELSSLKFLSNSDKDV
YRKLIDQAQSDNDKKSILNEAKSVNTELLALSQITSEASLLTANVSNLIK
TISESKVSSKYADLLSALYLINNANSAYNSIKGNKTTYNASNIARFTVEQ
TSFLSNLLELSNFELFETLQSDNASLNDSVAFLNTFKNKILLEHKFYANM
LLGIATGQKAVFDLSIAVLKDQFPNLKENLEKTTYFIDSKKQLNSNADVE
NRLKVYDSLNVEDNGILNSINFNTSMAILNNKTLFDQAVRSSNSQNRYFL
IITAVLLVSLVGFAIFINAKKRKMMQKREQETLQQLKADAQNLNKETSEE
TFLDETEVLPEEKAEKSLKTKSEEKSDKTTEKKKNKARKS
>MS53_0152 putative mercuric reductase
MKKYDVIIIGWGKGGKTLANKLGLSNKKVAIIEKDPKMVGGTCINVGCLP
TKSYTHYSHVFVESSKLGYKTSYETGKKAYVKTLKHKLEFVKKLNQKNFE
LLNKNKNVDIYMGSAKFLSDYEVEVNLNSNKKKVKLTAKNIIIGTGSVSR
KLNIEGAAKSRFVKYSNDILNLRTLPKKLLVVGAGFIGLEFASYFANFGT
QVTVAQYNNDFMPNEDKEDSKFILDTLKKQGIKFEFNTTCEKFKDLKSQV
QVSLSNKTKKYKEKFDAVLISAGRIPNTLNLGLENTKIKVLDNKAIEVNK
YLQTNVKGIYAIGDVKGGPMFTYISLDDYRIVSDQLLKTKKNRNLDNRPL
VPTNVFIRPSFARVGLNLKQAKELNLQGCYAKTILTSSIPKAHVINELEG
FNKLIFNKQNQLIGVSLFSYVAHEIVNVFSLMIQNKMTFEEIKDYIYSHP
VYTEMLNDL
>MS53_0211 putative phase-variable hemagglutinin
MKPKTCPKMLIKFWDGFMPKIVIDDYVADGYDVANNAENNRAQHEAANRP
LLEQWFKVNQDKLSLVAEQLTKKLGEEKFKNMTLSNPTISWDEVEFSNKV
SNKGYLTPKVTFNLTPKEDYKKASDSSEKVTLTIRNLYKEANSDTNVFAT
QGAYYTATPSDNATTIKKVNVYLNYTGPSIVLDADLPRVGEQENTSLNGT
SNVTDDFNNKFNKLLIRYKAETSLFQTIINYVNKFDPKFPAKFVTNSING
VTITKVEKTKELRPGTLDDLLKNKNNVFLQQIKGDKEAVYFAVTAIASNN
WLNTVLVRIPLTKFVKPLSVFTAPVVTPPAEEATGGSQTQEARLQPAGYS
NSDSFGSTEQTPPSTT
>MS53_0209 putative phase-variable hemagglutinin
MPKIVLDNFDKTWEQNSEENERKIREWFDNAANWVGLSDQLTKKLGAERF
KNVKLTFKEASFSGDDIKTPTVKFTVAAKEGYTLTTGDNASATEISLVVR
VLYNRGSENVIQLPTQGASASAVPSNSSVNDAKVKAKVNVYLNYTGPSIV
LDETHPTVGATPNTSLNGTSNVTDEDFNAAFRGLLFTDRYVNPLMQSVIN
YVNKFDPKYRAMFVTNAIDGVALTKVQNKKELRPGNLEDLLYNNNVFLQQ
VQDDSSAVYFAITALTNDKWLNTVLVRIPLTKFVKPLTAFTATPASAPTQ
TDSGTGAQTQPEEQS
>MS53_0594 conserved hypothetical protein
MFLDKNKILNYSDENKLWNDYNKVFFHYVMWFIAGLFSLFLVEAIQLLLL
VVYKNDILLSFYKLAQQQNLSNQESFAIQSFNQQLGIQIFTALLYLGIAV
YFAYTTFASRKLKSYYHLSSFVINTLAILIIVKVIMLVVFTTNSSVGPIT
GTEVPALIAIYVVSVVASVLVGLVFLRPVSLIKKSFVFARRRNEFMKMQE
MFKNSQSNPNGFDLNAFFNHVNNQNKDPYMKSQDEQAYQDNPYTGQNDKA
QNVKSEKDLKIEKLLSLPKEQLHEIAKILNIFGYEKLDKKELAEKIYNYT
KDKK
>MS53_0207 putative phase-variable hemagglutinin
MTIRNLYKEANPDTNVFATQGASSSATPNNASQANDATTIEKVNVYLNYT
GPNIELDADLPTVGGQENTSINGTSNVDGAFNTAFRGNPTKGLLFTNRYA
NPLLKSVINYVNKFDPKYRATFVTEKNGVALTSVQSGTQLRIGSLNDFLY
NNKGFLQQVNTDTKAVYFAVNGVTSQGWLNTFLIRIPLTKFVKPLSVLQA
ATDSSQNAEQTGETQGSQPEAQSQ
>MS53_0020 conserved hypothetical protein
MYIIYNIILGMEIFLSIAINILIFWIGYLIGSLNASIIVGKLFYKKDVRE
FHSKNAGATNSLRVFGYKVAIVILFIDIFKVVFATYFVRIVFPFVFSPKL
YFYIPLIAGLAAQIGQAYPIYFKFRGGKGVAATVGLLISINVLLWPIAGV
FFFLLLFKTKYVSLSSLLTTLIMIGFISIPWMSQGVLSYATSGFGQFWVN
IIIYLFAAALIFWKHRENIKRLLSKTENKMKFKK
>MS53_0293 conserved hypothetical protein
MIYRKILKFIDDLISEFNLLFSSNISLILKGSYILAKNNILKRSINDLDF
CFISDIRETDKQKFLQWIANRLPNSKFDDNLLITYIFDFKIEIVSLETIN
LSFVNKNNYLKNIYDISVNYAILQKILSFAYLFSDDFKHDRNRKISELVN
DLESVYKFNSNLIKEITSWALLRNAINLNLFNTFFIYKHYNYDKYHIRYF
KFKSIEKYLNTYIYSDIKKIYKFMNKESKKIIIFLDLLLKNNSLIIKKII
SSYEKPTLPGFEINFLTNDIDVRKDKKNSIFFNILNNKKAVFISHLDEVG
GIIVNGNIYNLGTMNWIDGIYNVYDKKSNFIFDINCNKKDNNIFSAEKNR
KINRPTLFFSDKKSNSLNKNDIYQIFPSTKTIVDKVFIKSRNSDNRMSVA
CILSLNSFSSINYIFTTREEILLQSSKENKNWIQKKKNKSIINIESSESD
QWNIEGILIRVSDTFTAVNLSLLEKLKKLCNKYSLPYHLYFGSGSTDITE
LQYENSIAIALPADKIHSYESNVLSKNMYYMLIFMELINEEIL
>MS53_0111 putative tRNA (Uracil-5-)-methyltransferase
MMVGQLIEVTCQSISYEGYGQVQLYSKVLIASNFFPSEKAIVRIEKIFSK
YVFAKVIEIKVKSKYRNETQLDSNSAQLVNLNYDQQIKFKKSYLNFLFLR
NFQLTQDVFQDFLTSAKQFNYRNKITYWMNKDFDNRWNFCESIQNTNKFQ
KEKNSFLASKAIVDFKNSFLKFINSNSGFFDKLKPTKIMINSSRDSQIFV
ILICDNLVKRDLWKFDFKKLFPSLTNLIINYNNTFFEVYKGKTFVQRIGV
NKFNVLNDSFFQVNGPVAKYLFDDLAELISKVNSKSLIDFYCGVGAITIY
LATKFPELDFYGYEKNRFAIKIANENVLINKLNPEKIKFLKFDLDKKLND
KVFQDSVIFDPPRAGLSQNLKLLVLNSENVKNIFYISCNPRTLVRDVKEI
TEKSNFKIKFIKGYDMFPQTHHIETLVWLSREN
>MS53_0174 putative P60-like lipoprotein
MKNKFKKLLTLSAIMPVSAIAISCGTTFDDPEKVAQDKLLNSNNAKLAAE
KFWLDQSIASLYGSTSAELTSNEKYKQEALNAYKVYVASQNLKDPFYLWN
QVNSWNLKGLFNESAELNSLKKYKSSVDETSYWLAYNKDETDVKFNTQKL
LLVLKYFELNDAKSLQKVNQNYALQKDNYDNNQFNLIDYVLNKKLVQSWS
YDNQSDKNDVFSTLTRSIQNVSDYNNLLKNTPALLNVASQELLFNANNSA
AEVTMGGFANLKALPAEVKLSYDLQSLLQVTEAKKLSGFYNYQNNTLVPL
SNTSLEAPVFVSRDGQLLKVSYFNQVAPIKDTIDGKDVLSFNKTAYASKL
FNLEVNLAAYDDKLYNTAKSAFVALGYLLEVNNETLKEKLAGEDFVAK
>MS53_0199 conserved hypothetical protein
MILRKVITMKKTKAQKDQQKKSQFKKRFWFTFTFLVGNLTIISSSLIPLS
LKWIWAPLNIEEDLEINIKDDLNGSRFISEINSDNLPEFVNAFFNNKQYS
IDDLNLKLAGVNYITGWVYVQASVKPNVKVAKKYQDAVKLFKLEFKNSQV
KLFDPNVTTFLIKPENNTKEFTSEFQTREDLESFLNNADNISLSELQDKL
NLTFFDKNNVPLNLYTGAVVTLSNPVKFTTTSYVMDYKITWQIPVANDVF
YGNLYSFSLNGKLNLRLKEINSISGLYSDVDDIDFKKLQSKEIFKNLEEV
QNFSTSIETLDQFYNVPDDLIVKGQDFKLGYYVNKTAQIFDDVESFLDNS
NLISSGYLTRMTYDDKYKVVISKPNLDTFTKASSETQRKYLQSFKQNKAS
VKVTIANTVDRTVEIFYTDLWFNKSPLFNGKYLFFNMSPPGDKFVYYTKD
VNTWRIPGVIKTHDNKLIFNADKRVNDKDDRGHLEQDMRVSEDGGKTWSN
PQTIVRISAKNTKDGANKGQVIDGTMLEVFDKSINKHKLLYVFGVSSYLH
TVHHERTIRDDGNTSGLVNNNKWMLFIDKENLNQKFVAKPITVDGDSNWF
KVFKVKNSSSVQWKDIDDRTELDEANIIIDNSLKNGTITGNVYDNVPSNI
FSTFGEPGRNSRSSAISKYISKYSIWDQRLPYYFTGNIMQKNVYFANSRY
YFDNILWTFQVESIDGGKTWTNLKNVSPFLNRKDQRWYINGVGNGIQLNH
QRNSNGDVIAVFPFYLASKTRQERPKLMATKDGGKTWYELADYPFKLLPP
GASESSISEDSKGNLWWLARRSDGKTFTLIKSEDGGKNWKVIFNDKRGIF
TKQFIGSTIFNIKALGEKLIFSANDNGGGKIYLVDINNPTTIEPIYTINR
GSYGYSTTVTFNENDNYFDVLTFYEVNSPQKGRDINLKRLRVFVVS
>MS53_0134 conserved hypothetical protein
MKNKFKFLILFSTLPLSASLISCSSNIQDTKKDYLDQNFQVPINNENQTE
LAAILSLDKNDSLENSSIYKNDQDYFRNFFNTYDKNFQSLLETVNESKKK
EIAETLMSEITKNWYYVFNNLLLFQPYFYKWFNLPDTKEAKHSPFYKDQT
LVSHKHIAIPRFTTYQNGKVLENFTDYNIDKNEIHFYLLLSQNTFARFLG
KKDPNSEKFNFEVKLFTTTNNAQKINLQEIYNDIETNLKTPNQKSYEDFE
IKYSRSGKYGYLAELVLKPSLI
>MS53_0618 conserved hypothetical protein
MQNNKNRFLFAIDLDGTTLQSSRTGEIHEVTIKAVQRAVKEGHIVCILTG
RPWRSTQEIYKTLNLNTVVVNYNGAHIHHPLDKTFIPHIKYLNLNEALYI
LGDDYVKNEISNLVIEGPDWVQLQRKDVNLEAVFSLHNTPKKRIGLDFFK
IPLQPTGVLFDVKETTDPEKLRKYLKTKFSDLAEFSYWSKGEGLTPVFDI
TSLKASKGKALSMLMRYYDISIENTIAIGDSFNDVSMFKIANLSVAMQNA
DKHVKKYATIKINHNNKNGGVGHWINAFLDNPEKEIERSNKRKEKILSVQ
ESDD
>MS53_0228 putative phase-variable hemagglutinin
MALYWDGFMPKIVVEGYQPAGHGSNKEANETTNQEKLQNWFNAPANWEKL
SEQLTKKLGADKFKNVTLTNSQVSYEKSNC
>MS53_0080 putative ABC transporter ATP-binding protein
MIQVLGLKKAFSDKTLFENVNLKFTEGNTYGIIGANGAGKSTFLKILSGE
VEATSGNIVVEKNKRISVLNQNHAMYDEFNVTEVVIMGNTDLYKIKEQKD
AIYANPDATIEDYTLAGELEDKYGELGGWTAENDAQKLLSDLSIPEEKWN
LTLKELTANEKIKVLLAKALFGNPDILIMDEPTNHLDLKSIKWLENFLIE
YPHVVIVVSHDSDFLDAICTHTVDIDYNQATIYTGNYSFWKQSSELAREL
QKQSNLKKEAQMEKLKEFIARFSANASKSKQATSRKKSLEKIVLDEIKPS
NRKYPFIRWEMHRDHGKQILNVENLSYKNEAGVYLFKDVTFTLMPGEKMV
VLSNDDIAKTKLLEIISGVTKPTEGTVTWGQTIKHTYFPNENSNYFKGDE
TILEWISKWPLENSTEETKDASDARMRSFLGRMLFSSDSVFKKVNVTSGG
EKARLMFSRMMLLESNFLIFDQPLDHLDTESIDSVIEGIQAYKGGVVFTT
YNRAFVNKCANVIFEMKPNFESFIFRGSLQDYEETMGY
>MS53_0525 conserved hypothetical protein
MTIGNKIMDQQKIIKEEKNNLLKNKYIAKKVAELNITDDEIIENALNFIV
MENSIKDSDSAFLFDVYRDENNKIKFYWKVRKNEAARQWKIERNLILTSI
SSPYNTNFIDKNFFEKYKDIASKRILKYAKTFAENLKENKEIPSIFFTSQ
GTGQISDFMSSFALHSSLYVRTAYININDLNVFYKNSFSSNSQNNYSEVD
KLDEVIKELSEVPVLVLNELGISKFTINFLNAVLMKILENRYKNNKTTLV
SSYQSIDKLSKKLVNNETDNLFLETCFNKFLFILDNLCTQKEALKWQK
>MS53_0292 conserved hypothetical protein
MVDSGQRCITYKETYDSILKHKNNPKHYDWYLKMKLESELETSGFGLGLE
RLVLFIIDEKDIRNVQLLPRETDRELLP
>MS53_0430 conserved hypothetical protein
MLKIQKLFKLMPIAGALTTAAVIATSCGSASSQPETSYETKKANVVSQFY
SDSLKTIDELEKFYSSDVMTKVNAFLAMQAQEKNQTTTAAVKVDFSELKN
NDGESGSGTTSSDGTSTDPDSPTSSDGESSSVPGSSGDAVTGVDSSEPNS
GTPETSAPENHANPSTPVTPSNPGSGDSTRKSQQAAAPGLTAEQREFLTT
FTSAESISAHTQKMRDELAKFKSLLERNSQLKYLEATYKLVTNQMNSELQ
SLLSLVGALRNELTTFYNDIFPKYFLSYSLNQNYLTVLNYLVDVDKLLKT
GGKADLTSKKEKWSNFKTKAEKLYSLYQSTYELSLSENIASAQKRN
>MS53_0256 putative phase-variable hemagglutinin
MRDVNVYMNYTGPAIMLNADLPTVGGQENTSINGTSNVDGDFNTKFKKLL
VRDNAQTSLLQAIINYVNKFDPKFPASFVLNTNGVALTSVQSGTQLRIGS
LNDFLWNKKGFLQQVNGDSSAVYFAVTALTNDRWLNTVLIRIPLTKFVRP
ISVLEEQSAQDQTPEASQQAGGDQSTSSSPQGTAQTQSNQGS
>MS53_0490 conserved hypothetical protein
MRLYCYNFEVFITKELIVKKSRFVSHLIDLSHMKIENVNAEVKSIINNFK
IKNKKASHVVYGFIYNKNNTEIIGFSDDKEPKNTAGKPIYELLKLKNKNN
LLIVIVRFYGGIKLGSGGLIKAYRQSANLLFSE
>MS53_0051 putative DNA polymerase III delta subunit
MIDLKILSSLKEKAMQNTLHHFFLLNGNHQEVSKEDILEFLNSINNNQSL
NSLEDLPENIIYFDNSDEILKKEDFLSAIEKFSFKNSDEKSFLIINNLEK
TSNVVLNAILKTIEEPSDNIYFIFTSKYLFKLLPTIISRAFVINVSKISQ
DQILSHLSSDKKFDEFEFFISYLAKSFYQADEFNSKSYKDFTQEFIEVLD
FALDENIYKLASFLNEHIEKNSIKSEFVIEFLILFAKIEIFQNKKTEENK
YFKSLFGLFENYKDAEISFYLVITYIDTYLNNNLRNSNYYLNKQNLILNI
LSLYE
>MS53_0300 putative neutrophil activating protein NapA
MKKLEYLLTLQASFMLLTLKAKNYHWNVSGEHFFETHEELDTFFDGCQEQ
MDAVAEKVVMFDGLALGSYSEASKASLVKEVKAKNFTSKDAFVELSKDLE
KLLDFVSKLKSVDFRVQPVLDEVVLFCHEWAWKFKKASK
>MS53_0336 putative MgpA like-protein
MKINSSKIAREAIEKYQNIIIFHHIRPDGDCLGSQFGLAELIRDNYPDKK
VYCVGNNYNSFEFMDFKFDKFEDIDFSNSLAIVNDASSGDRIEEAQLLYE
NKTTAKLRIDHHPNDSDIKYDYLWVDSSYVAAAEMIAKLAYDSKWKVSQR
ASSFIYLGINTDSGRFLYPATSRRTYNLVSFLMKNKFHPSFILKNLSKRS
LKGLKFTGHLLSNFQKDGRVLYYYASQETQKQFDLNSYEIAMFVNELANI
EDNLIWVLFIELENKKVRGRLRSSGPQVNLIAKEFNGGGHENASGITLDS
IDEIPKVLAKLNAEILKYENGN
>MS53_0468 conserved hypothetical protein
MNKKSIETRYNSLKKIYKIVESNKNITLVNLLKLSRSISFYLDRMNYSKY
IIEEVLKKFSVDQSTLNKKNNLISFTKLKTLWVYISEEEKYSTNSYQKHE
KHLVNVIDKNNDQIIVIGEKAIRFAQKHNYHILFSYKQNEITYLSQILPK
IIINSFQTQDFVNLNVVINSSKIKQKHIQLLPIYENNFVLEHHQSSSLFK
SNLSSHKIGQNLDEFINSELESYLIFALYTLLTESALIYEKYKLVAQNST
LNDLEEKIKFQKRTLLKAKREKEIEEISILSKKKDLLHENGGQK
>MS53_0144 hypothetical protein
MLNNIVMSNFKPSNKTYLLKNLTKLALFESLNNLNQKTGEFFEEFATLKN
ELKYLKFQNPEFLNDEFKFSDMDFSFQNDSASNFAFSSDLIEFNNQVRQS
KLNIAKNNLNFWNEFDFNLNLNDEHIMEIQALTLEENSSSLEETIEIITE
KIRI
>MS53_0557 putative lipoprotein signal peptidase
MLSSIEVYKQKTNTYFKKNKKQILLNYLVFFIVLIVFTSIDQIIKTFVFK
HGNALEIIKEGQHAGKILSPDGYSYINPESIWPINQIDWNDYGIIGIRSI
WHRGVTFLSTRNIALIQTLSMFIFVLLVLFPLFNTKNGIFNSFFIGLIAA
GDLGNMLDRFIFDGHVKDMFYTPFLENWLDRQLGTFNFADACVFVGMILI
FLSTFIFFIVELVSKNKKKKTGKIIDDDTSDDIPTIINL
>MS53_0349 putative lipoprotein
MKRLTKKLIIPLVAVSTLPTLALVSCGRSDSENSTVSRLSLSSDVKDNQT
ITIRQKAYTASSNSVYTPVAFLTTGVNGFGVLDSDASSKKLKPLEVRVFS
SPTFETKVVRGENNTFTRSVKRSSFGTFAYKLGSAKKFIVTVFEDGQKVD
KVFDKDDYNAYSSARDDEREQQGYVHLLSDDVRSVNSPEFEKALKNAVHL
KIQVNTDISYVDNKGEIAKDKNGNAYKLQAKDFFLGYQHTFLDVNTTYRY
RNGGSSALDKAIFGTFNTATAGSINSFNEHLSNDVNRYLWDLYNIDANKI
LDEESFLTTDSDGNQYLNLYEKDSEENATSKKDATDFLTFFQYLNQSYDF
QPIPTKYIEDHSSDEKLFTPLTADKYQAFKSEYDKLSKDSLVYKTGQYWY
GYEPRNTLFLGQYLPEGFDSTSNQYITIKNKNYYDQSWVNNPQTFNYFVV
KYQNNPLDPQVYSDNSYNELTAGYLSSTSWHSLQSNQQSNILRNLDRYNL
SYLLNYNPLTLVTTTWWNLNPTKFSNDSSGVNPWANETASKLLYNVTNAE
VKGGDAVNLVKNSTSNYSNSFRSILQASVNWNEWVNTAWNTASLPWIATY
GMDARLDGKDADLQHPKTVRNEYYKNNSIFVVDKDGNKVTFTNLPQNRKG
FSEDNTYLGPLDSIQFSLTTDQRLKSVVFDQLKGEMKKLLDAFFQDNPTL
EQKVKITIPEPRAWTALVKNRIPDLKKVLNELDPRLDISWTEVPNPQYVS
NWYSNPNSLAEHIGWTYDYDGVTSGLNGFTTSRLGVDSMLFNLVADDQYK
TRMQKSFPMLVKVSEDFLKYLTDNKIVFRVKKDKNYEQKSLNEARAKEGF
DDLFLETSDTVTHKQVLTEYLKLPQKYLGIARDYLVKPSAKSPDLTFEVL
SSLFWLSEGRTLTMEELTKLGVELTTLLGTIPAFALFPVAQRFTAPESGL
PTEFAFVPNLYGRGVENATFKNGWSIKGNNADFLIKKEALK
>MS53_0043 conserved hypothetical protein
MKKITKYLLWSIGSISASATLAGLTYYLLNRKKDSMYKIPVKDVSNLEKI
NVLSNELSKKQAEILNNHLYSDEKMTIFYNRKIPKNIESHYYIVNLYKKS
LFQKNSIEKEMFKLFTFSDLSKVPIVIFDNYLYTFSFNENMKKESFINDI
KSYLSKNLDDKNNFFTIKNFGGITINDIANMNIKIYVALKELGLKNILNE
FDFLNKLNYLKNYLLKWIRETKDEYEIKRSLEFILKIKLILNDKSLNSEE
EKYLSEIENEILKEIESVENLSVSQLEFIWEFLKIFKFYDFKTKEDIVVI
IKNKYSNIFNNILNKMEPRNIFMFYTFFKEEFNSIDNENKRMFFEKYLEK
INVFYDWDFFIAYSYTLFKESDISLVEKSIDNYLDFILNKNDMFWDLNKL
INLFFILKIKIENNLLFNKKDIIRNVLLNNLKQDKNIFNILLNVANLFLL
KKIDSNLKIEVSQSLIREIEKIINRNDIIEDIKFLILFKDLATFLDVEVN
WKELSKKFNFINKYNFLFNIISEEKDVLLNDIDNLFDLYSLIINKWNQNL
KNF
>MS53_0120 putative ATP/GTP-binding protein
MKKLKITPKVGDIVEVENDLITDIKPRKNELIRPKVANIDQVLVFLSVKE
PDFSSFLLDKYLAIVESKNIDLIIFLTKSDLDLELANHWKQKYEMQNYKV
FLLSSNDNNYDEIKKLFDKKFSIVMGQSGVGKTTFINNISNNNYKTQQIS
KSLSRGKHTTTSAKIISFLNGFLIDSPGFSSLDVEKEINLNKSYLNFKEL
AKLCEFKDCMHNFEKNCNVKLNLNSNLVPEFRYKNYLKLLKEQNERK
>MS53_0435 conserved hypothetical protein
MKKSWQDAKANIKRNNFLLLAVAFLLGAVTNAMISSFANDVVLSYIANAF
GIKNLQEWKLENGILIGKFLGTVIQFAIVMVLLFFVLFLFFVIKNNYVEH
KNRKNPPQPVVKPLTVDELILKELQQLNSNITKNQLSQDMQTSLSALETS
ARKTSSRSASSKKLNKK
>MS53_0651 putative pantetheine-phosphate adenylyltransferase
MKKAIYPGSFDPIHKGHINIIEKAVKLFDYVYVIVSINPDKNNLTGIKTR
FLNTKKKLSKFENVEVLLNEDDFIANIAKKHDCNYLIRSARNIKDYSYEI
ELAAGNKFLNSNLETILIMPDYENINYSSTLLRHGKKLNKNSV
>MS53_0238 putative phase-variable hemagglutinin
MPKIVVDGYVADGAGANKAQHETKNTRLLQQWFDTPANWEKLSEHLTKKL
GANKFKNVTLTNPQVSYEEITVNSNTWKKPKVTFNIQAKPGYQLTEPTTD
SKQISLTIKVLYENQAYTQNLLTIQGAYPFAAPSNSSVNDANVKAKVNVY
LNYTEI
>MS53_0323 hypothetical protein
MQKLFIDSKTELEIFLIQYHKKIISCSNIFLHLESLSKKEFSKKIIKGGL
KLNDYKHNEIINYLTFNKVHNKISKEVFVEIIENFFQFLHWHTLELAANH
KLEKFVNMFFENNIPSNFSKQSCIDNKLKYYYNFLERFQEVENYNYLLIK
ILKIVL
>MS53_0537 putative coenzyme A transferase
MFKEIYNQKLIPSSEVKKFIKPNTNLAFSMHFMQPRKILEEIANIARSDK
DFKINAYYFSAKQNAADTILDFDLNKQIVPNTFFMQDTERKILKRQKEES
LDEKRVFFIPAHFSDSPRIFSENLKIDSFVTMVSPMNEYGYMSMGLSNDY
SSTAVRLAKTVIVEVNKNIPFVIGENNLIHVSDVSAIVEHDSPLQEVVDL
PPTPEEETIAKIVSEFIPDRACIQMGIGGLPNSICNELYNKKDLGIHTEV
LTTGMIGLIKAGVVTNKYKKINKNISVFTFAIGNKQMYEELHLNPTIQSF
PVNYVNDPYVISKIDNLVSINSTIEIDLTGACNSEYLNGHQFSATGGQVD
FVRGAYMSQGGKSIIALTSTTKNKKFSKIVARLSGPTTTLRNDVHWVVTE
YGAVNLKGLNTVQRARALINLAHPDFREDLEKQAKELNLL
>MS53_0237 putative phase-variable hemagglutinin
MSGSVTKAKEAKDDAEYSKVTDTIKTTLEEKYTAATALLEDGTKLKNLDA
SSNLDTTKATLESAKSALDAAVAAVKPDLDFQKTKTIAAAKVTELESLVN
TALKTELQRQVNALTKDHATEATTMLENLTSLKDSLTSLQDLVSKGLAMQ
VDYPQKYYDADNKSAFDNALLKASSVFPAFKWTAESIMVPAPEGAALPNP
RAWTKAREKSEFKLQNFVMAPAQAAPTTAPTESESRDGSGGGTSAAASAT
VRAAMSGEAEGAQEEDSEAASPTAEASTPTADLASTVSYLKTLETELKTQ
SEALNGDTTTNKTAYYKADTTRTLYWDGFMPKIVLDNFDSSWAQNSENER
KIREWFGDATNWEGLSDQLTKKLGAERFKNVKLTFKSARFSTDPAKVPTV
AFTVAAKDGYTLTTGDNASATEISLVVRVLYNRGSESTIQLPTQGASASA
VPNKTTKVNDENVLRTVNVYLNYTGPSIVLDQAVPAVGITANTSLNGTSN
VTGDFNTKFKKLLVRVLNGGHAESSLFQAIINYVNKFDPKFRAAFVTNGT
NGVTITKVQSNTQLRIGTLDDLVKNDRNNVFLQQIQGDTEAVYFAVTAIA
SNNWLNTFLIRIPLTKFVKPLTEFRPTTPTSTSSDTQQQGTAQTQSNQGS
>MS53_0541 conserved hypothetical protein
MNKKEIMLNQRPNIALIIDYENYKSEKSIISLIKGLKFRGNLAIAKLITS
DKSQINNKFHELEIVYQQKYIDGKSTADPRLIIETMQILYEKDIDIFCIA
TSDSDFVYLLQKLKSKNKYVILACESVASPWLKENAHEVFEENPIDTNKD
LETNINENYLLDLLEEKIAPEKQLVVQEAQISNNENQAEKKNSRRRKRNR
KKLKKANVNEITSEVQKAVLVENSETQNTETEKVEEVKNKEIIVDDSKKL
FKSRGQFFNFVTQFVKQESEEEKIKLESLENKLKDSKDLLQTFFKTDNLE
KILKTKYKNSFWLRKENKTVFLSAINGKAINNFVINYVKNTTNPKLSRLQ
NSLKTTFKNFDLKKRTSYSRWKTYLESINIIDSGNKLNFKK
>MS53_0542 conserved hypothetical protein
MNPTRIIALGGVEEIGKSTLLVEHLDHIFIIDAGIKFADTYNTGVKGIIP
NYSYLKQKGKKIEGLFITHGHEDHIGGVVYLVKETNLNKIFAPRIAIQYL
KLKFDEHKITKKVEFIEIHKSDVHKFANNCKVDFWTAQHSIPDAFGVRIT
TPNGSIMCTGDFRFDYTPIGNYTDFKRLYEIGNQKLTALLSDSTNAMRPN
HSPSEKDILADISYYMKQAKRKTIITTFASNLTRVKVIIELAAKLNKKVI
TFGRSMIQGVKVGRKLGYINVPDDVFIDKKQLKSIPDNKVVILTTGSQGE
QLAALARMSYGKHASIKIMKNDLIIFSSSPIPGNKMVIELLINRLYKLGA
IIKENGVDGYLHTSGHAYRHEHDKIFKLTRPKYFLPYHGEYRMSVVHGKT
AIENGVNPENVIVIQKGIVYNMLSEKITATNEKVEFGPVYIDGKKVLENS
AKVIAERNQLKNSGFVNMVFLINKKTKSIVARPTFISKGTIVMKNSKDEV
EEIKRITHGAVLHYIKNTPEFKEKDLEYIVKDRIYSFFHRKKRRDPVTVI
KFFYVDELKEPEFKNLRISFLNDKTELKNLVSKVNILDNKNKKISKNQKK
KIDSLQKLMDLDDFDLLDSDDDDEDDDGE
>MS53_0378 conserved hypothetical protein
MIFSENVRKWLSISIGIAFFIALLSIIITWIIIRRTRNRYFAKAQQEAWN
QINKLREDVGQLDFSLIELFKTKANAFDIEGILNTIYQNNFENSLIISYK
DHFPFYSINNKNKKNTLYLETEFDSYSWDYIKEKVPNKFEKDIKKYDEKS
PLNMLAIFSSKNNPIEIFNKLKDKFTNDSLVIIKHSILTKREVKELIAYA
KDHKFLYEISPFGTKYFFMVIKK
>MS53_0546 conserved hypothetical protein
MKYLALNLVKFKKWSLMKITLISLNNFSVKKVSNYLQDLSNQLDQNFEVV
FCLQRLSKSFEVMKEINSFAADDLKNKIKIVYFSKSVTCSEMYLQALNVA
SGNYSVVLNSDASFKKDFVTKVLSIIKKTKADLIEYRPRLFGVSKYKPNS
RLQTKVPLDIAQHKLIFAYSFPFLFNKIVKTDLAKEVKVRKFKDDLDNKF
LIELNYFLLLLSKKYYYYDETLTKEYVSEHYIFDFQKFRLSFKNIKAYLK
EFNLDFEEEFQYAKYFFYKLFSIALVSDIHPYYKLKNKAFDTDLKISHSM
EQFNKLFKFLEALEKSKNFDKFLEENKYMLHPIQETKNLKKKLHKLKIHK
LFQEI
>MS53_0324 hypothetical protein
MTQNKPKTQRQKRIEKIQILYQVELLNLQKDFDFVLNMEPYLDAKQTKEV
FVVLKNYDYFKNFLESLLDPSWNWQRLSYMLRAILLNACAEFEFIDARIV
INEAVEITKIFFQLTSDTSAKEYNSIDYNLFKFTNALLETYYKTKVKIEA
IKSNVK
>MS53_0258 putative phase-variable hemagglutinin
MLYWDGFMPKIVVKDYQPAGHGNNKDTNENTNQQKLQNWFNTSSNWEKLS
EQLTKKLGADKFKNVVLTAPTVSYDDVSTAISTDSEVRIPKVTFTLQGKE
GYKLQTTDGASTTLSLSIRVLYTSENQTENALKYQGASSSAVPNRASSPN
DETTIKTVNVYLNYTDI
>MS53_0438 conserved hypothetical protein
MQKNNLIDSWKRLYTQHYLDVEFFKEQSALEKNLSLPKINFYSLEFNSDA
ENNLSNLNLFTLLGILKSFCELKNVKNKHIFMHFDENISPFLVRKAISLI
NYNVENIYLFNSENNAYKLDLANDFVVYQVSKAFNLDYVIFLQKNKVNNK
YYLKIYKKNFLLSTLEYEEILEHFKNSNHDFVFKENIDNNKKIDINKIIE
SAILPSEINLLKKSQWTNDSLIVSMLVASNLDEKILTQALEKANYKVIKY
TWNLHKKLSKWKKYSLQKFLNNSLNKSDVLVILDANHKLKLVIRTKKGFR
LLSDDEIIFIYVSYFYLSLKKLNLLNQNFIYIPYNAGPIVHKILTNYKIN
YKYIDQANFTNVLLAYENGFYSSGQSFNNLQSNYAFLINFCSILNAYKDS
NNLINLKYKTVKKFASLFWQTTKKTKFSEDGVETLIKNTKQFEKVGKYLK
LEKIETINYLSKNYHYLFDIYYQYKYKKTTHKIKINLTYNLISKKLEIKM
TSEKNDNFWIKIKEFFINKYMLMIFNFLIKKYKNNIKKTETYYEISKS
>MS53_0283 putative transposase,undefined
MMASVQIIKKNKTQYVRIVESYWDKEVKKPKIREVKFLGKLEDLTKDNPN
FIEELKESVSSKKNKKQKDRNEQILQIMNSLKLDKFKGTQIKGYGNLVYE
EIMNYLELPSFLTDLQKKNSRSKYDLASITKMLILTRILEPSSKRSSVEK
IKKYWYEFNDSLKDVYRSLEFLQDKKVEILNYLNEQFIEKINRNLTFCFY
DVTTVYFESFLPYELRKFGFSKDNKVNQTQVVLGLLIDDMGIPIYYDLFP
RNTSDFLTLKPVLENIKKDLAIEKITIVADRALNSKSNLLAIKEAGYDYI
MAYKIKDKENKIEGIYDLETYKMMYEEFGVKKQDHKEFFKSNNTFYEIDN
KLILTFSRKRQRKDKKDRERLIKKAEKLLNLSAIKSEMKKGDKKYLKFAT
NEVELDHQAILKDEAADGFYGILTSHKDMDEKEIIKQYSKLWKIEESFRV
MKTNFELRPIFLSAEKTIKGHFLICFLALTIQRYLEFVLDCCGYPMPTNK
IIDAIKNQKLSIIPGINTYIKTEESEDFKTILKVLGIKPIETIGKYEDIK
FTI
>MS53_0481 conserved hypothetical protein
MKYMRLYKRVKELLLPTQLIDKNLNIKLGFIMWSLLIFSYALFVVNWGFV
TGLNGQGGNDPGILSSFFKDGDKPSSFEVQATNWAITLGRGFGSILIGWM
IVKFTHKNSVVIALSLCLFAIPAPYMPSYALFVIFRTIFAIGGSTLMILF
QPLVTAYFKQKTKGMLSSFSTWGYPIGAIIVLVPFAFNIESAKVVRSHWQ
LILLISSSLYLIPLILYLILGQRFDLYRSYVISLKEKHLKELVAKGLNYQ
RPTIKMFLSKKSTYKWAIFYGSWLIAVTLPFVTIRDQLPNLVLQIYNHKD
VSIKEIRALALPIIALWLILFNGAIILAPYTVGLWNRLNARRKPFIITIL
LIGILLWIISILCFIFLVGPNLDKNAINKNIIPWSVSIPFLVLGFFAGLL
LWGIQGVFLNNPHEIPENTSEKIAMQFGFIWGFGYFFFTMLLIIISLLED
FTNHNLAPWLWFSLTIIFTIIAPITWYFISETKPDAPLIPKRKNQ
>MS53_0658 putative ABC transporter
MMETFNYLLKRNIKLFLRNRAKLFFLFLGPMITLFVFFFFVKRNFNVGTV
NTAFLNIENLPRNVKGVVYPEKFTDNISNFLFNATLISGLISITAFTTAT
QLAQNIVHDKETRTLDDFFITPTKTTTIRLSYVVFNLIFNILITLFTLSV
IYIYLFAAFKNSIIVQPKIFFSVLGVTLISCVISSMFFVFIFSYVKTTAI
FMTLNGMISSIGGFLIGGYFPISFLPKGLAGVLSLIPQTQAGLLLRNVAL
NHDFITESMNHLDYNNLKFMVENLADNTTSQMSVLEYFKSVIPNETAAIK
QANDFVSQLTSGINSGIKNNAQLQIATQEISPTFSLVYTLMGAATFATIL
FIFKVSKRK
>MS53_0432 conserved hypothetical protein
MNLKEIFLRQKALDEKILQKSNSLRSEKLDSNYRFKLASIALLVELAEFA
NEIESFKYWKANKKDNSAKIREEFADALHFLVSFANEYKICYNVSTKIIS
DDINIQLIEILKSVVDFFNDLNKEKLTKAFELILGIYQMLGYTEADLLSD
YIKVNEKNLKRLENNY
>MS53_0380 putative deoxyguanosine kinase
MLIGISGMISSGKSTLSKNLNKHYKKSMLLNEFQEEDVVFNTMLDWFYKN
RPHLNIAFQAYVVEKHINEVQSIIREFNSKNLDKNSDIIFLDRFGAEHYV
FAKVILEKLPKKILKAYEAIFKELVSKDDFPELAIFLDVSFKNFKERLFK
RGREIEINTWSQNEEYFKKLHGVYKKTFIDIVNRYEIKYEIIDTNNLTPK
QVELKAIEIINKYKEEKYENTSMN
>MS53_0569 putative tRNA/rRNA methyltransferase
MKSKQNPLIKEYKKLQNKKYRKEKQQFLLEGFNLISEAKKYTNVITLESS
KDLIYKDSIRVDYEIIKHLSETKSPQSIIGVASFLKPTNKINKTVILNNV
SDPGNIGTILRSALAFEFDTVIIENIDIYNPKIIRSSLGAIFSNLNIIST
SNLEEILKDLKAQNFKLYYTLLDVNAKKLNEVSFDNEKIAVVVGNEANGI
DKNLIKYASEKVYIPIAFESLNVASALAIILNKIRNK
>MS53_0220 putative phase-variable hemagglutinin
MGADKFKNVVLTAPTVSYEKVTVGKYTWKNPKVTFNIQAKPGYQLTEPTT
NSKQISLTIRVLYENQASTQNLLTIQGASSSAAPSGSSVDDANVKANVNV
YLNYTGPSIVLDADLPTVGGQENTSINGTSNVTGEFNTAFRGNPSKGLLF
TNRYANPLLKSVINYVNKFDPKYRAKFVTNSINGVTITKVEKTKELRPGT
LDDLNGNNVFLQQIQGDTEAVYFAVTAIASNNWLNTVLVRIPLTKFVRPL
TEFQAQSATTPTQEGQTTQGQENSAGSGALGSTTGTQTPSGGSSQASGS
>MS53_0661 putative ABC transporter permease protein
MNNSFGRYLPGKGFIYNFDPRAKIVVAILYLVLIFFVHHFIDMAVITIPI
IFVYIFTYKKVIPLLSLMRFPALIAGIIFLVNIYVIRENDVHESKYHADL
FLAFTKFKENNFGISILSLNKSIAIFWRIYIMILITTILTNSTRPVLLTK
AIEDIIWPLKFVFVPVHIIAMIITIALRFIPTMLDEAKRIMKAQSSRGID
FKNGHFNEKTTAFTTLVIPLFVSSFAKAEDLSNAMETRGYDPYGKRTKYR
ELKFKFLDFVILFALLLLFTFVIVNMFNPGGYLPSWYLSTIIK
>MS53_0530 conserved hypothetical protein
MILMKVSLKIFKKILLISTLTLTSIVSFFAYSSVNINSKQNVSAVDLNKV
QLNSETAAQNSQDKVTKEKLKSLYDEVVKLDKSNLETNPLNSILLVLYNE
ADKNTYVNLLTEVKTLLSNESATEEQLNSAYERLNAFKKKLDENYKDALA
FLNTLSYLLSDKRLYFINQVNAAKNNPNQVAHFAQYASALNSQVKDAIDQ
IATLKALNESQVSRFNVSLIANAKTQDERNKVVQEARELNEQITALANLV
NTSNLNNLNIEQIEAKLKKMQTKGIDTSIYSYLLDNQKKLKSLQDLYSNL
NNYSYESSEFDSLREEVLNNFSNGVLVKSIAFEYLNKITNLQQYQAQVIA
QKSYDYIQFVQAIFNGNEEIFNQYYETEFNKDYPDLGEFLKSNSFFELKE
KESLPLSYFEKFDKLNFKNSNPLVDSAIQKRVINFKENQPINYNYFYFLF
LAFPIAFLPAGFLILKLTKPKFTKKK
>MS53_0267 putative phase-variable hemagglutinin
MNWDGFMPKIVLDNFDSGWTQNTANQDKIKAWFREASNWAGLSDQLIKKL
GADKFKNVVLSNPQIIFEYVRLLTSESVKFPKVTFRVAAKDGYQLASGEG
TSTTLELKIRVLYSSSNPKRSFTSISRSFIFSSAR
>MS53_0310 conserved hypothetical protein
MIFEIALASIFLSLGIMMNYLSSFVKFPIAPFLSFHFLLIVSFVCLYTLG
YKWSITILLLYFLIVPLIWSQNDLAISYLGNLIVLLSNFFFIGIYILFYR
LFIKFFKSKFNSNNLNLENLTESEIAELNLKRLHKNEFYSFFSAAIISII
ISTFLLSTLNTFLFNVLYFKLFRTLDTFTLSELVSKYDVSFKAFFLGMNN
YYGGSYTLYIIFNLINYSINLVPIAILFSLEVKIKLFSRVRKQKEKNRY
>MS53_0229 putative phase-variable hemagglutinin
MSGSVTAAKTLQAEEQYTNVSQDLRTTLEEKYTAATALLEGETKLKNLDA
SSNLDTTKATLESAKTALDTAVNALMPELTFVKTKASAVKTASELESLVN
PALKAELERQVNELTKDHATEATTMLANLTSLKESLESLQTLVSDGLKMQ
VDYPRNYYDADNKANFDAALLKASSVFPAFQWTTNSIMVPAPEGDALPNP
RAWTKAREKSEFKLQNFVIAPAQAATEESSDSTAAESTAAESTAATVRLA
TGEAAAEAETQPAASTADLASTVSYLKTLDTDLKAQTAALNGDTTTNKTA
YYKPINGRTLYWDGFMPKIVLTDFDKTWEQNSENERKIRAWFREASNWAG
LSEQLTKKLGVDKFKNVVLSQPNVTFEIINWNGQTWRVPTVTFNLAAKEG
YELTGSTNTIALKIRVVYDSNDANAILFPVQGASSSATPNNASQANDATT
IEKVNVYLNYTGPNIELDADLPTVGGQENTSINGTSNVDGAFNTAFRGNP
TKGLLFTNRYPNPLLKSVINYVNKFDPKYRATFVTNSKNGVTITKVEKTK
ELRPGTLDDLVKNRNNVFLQQIKGDKEAVYFAVTALTNDKWLNTVLVRIP
LTKFIRSVAPFAAAAPAEPNSDTQEQAGETGETQGSQPARQS
>MS53_0036 conserved hypothetical protein
MPERVYFSKYADNFNSNRFTLEDRNKIHEELNSQNLVEGNPRITFLESTI
NNNYWESLVDFNNKKYFDKNITFVGSSTQNTGTIHRNWWFYGPTPSNHAT
LVGSIAAGLDGVNPYLDKFSLVLNSTNGTWQEYNWVEAKKTDILNMSYGL
KAKLGRYKYDSDSHDVTKLAYENKELIIVRSAGNDGAETDPNKRYINGGS
LASNIIVVGSNNRYGHRSFTSNYGSYTGRQVTLLANGEYYFNNNEDGYNS
GTSFSAPFISGILSLMLRKYRNVYDLGHNNLIALSTLSASTYNSGSNINE
NGAGTFDYKKIGQAHENLKYFEIKHSSNYSRGRLYSYADYGNWIQVKSFY
AKKRPSSKSCFILTWRACW
>MS53_0669 conserved hypothetical protein
MLDNLNVYSFLKEIPYGSMLPNEEFKSLSVKNLTLGFGHMQVFKDFNLEV
LPNQKVLIQSESGCGKSTLAKIIVNLNNDDYLGEIFYNKNKYNTDTVTVN
KISFLS
>MS53_0603 putative trigger factor
MKEKIMSDFKFTNTETELVVSLFVSKEQVDKEYQKLETEALKKIKVNGYR
AGKAPKEALRARLNSKDLLDRVLQNLSKENLNEVYKQLMERKEPVTFAYT
IDLKEKENGFTFDYKFAKVPTVSDLDVKSAKTELKLEKVTDKDVLESIET
RLNEGRSRVKVEDEAKKGDEVLFDFKGYIDGEAFEGGEAEDYSLVLGSAQ
FIAGFEEQLLGKKAGWKGEIKATFPSTYYVKNYRDKEATFEINLKEVRRV
NSLKLDSKEFKDSPLGSEEYLGQYKVFVKKDLVVSRFIQSQRDFLDELVK
ELSQSVKFHISDLLLKEKIAQLDKQFNDQLKQYKVKRKEYLEVIKATEED
IQVELKTSAVNEYKLSYIYQELLKEFKKEFTEEEKKQYQEVFDALKFTSP
SNDLLDQLAVLEGLLEKTSRTKELKAWNDYKVYLVEELKKLDKEIQSMQE
KQTQEPAEEKVETKEEK
>MS53_0344 hypothetical protein
MKREIKSKYFISVFLTYLICYALALGFFLLINEFSLKQKNSLIDVFTTVS
VIFTAVLLLILIFRFGFLKNLFTFFKKNHENTKKLRQEYKSKKLSYEEKQ
AYKYLNQQKETKKAAKKPKVKTSNFPFVFIALLSLIITIIVAIISFNL
>MS53_0162 conserved hypothetical protein
MLINKNLKIGIVVEYNPFHNGHIYQLNWIKNNYPNSKIIIVMSHKYSQRG
EIICMPFWKRKLWAKKYDVSKVLKLSTRKTIQAAHIFAQNAIQKLNKEKI
DILVFGSESTNDSLMLKIATFIKENKEIYNQTLKKNLKGGNSFPKANFLT
LKELTNEDFSLPNDILGFEYIKQIVENNYKIQPIAIKRSVGFHSEEPSDE
FASASLIRKMLKDGRDVSKYTPVDLKQIPTKLLIENTFLKFKKYILKTPA
SKLKKYLLVDEGIENLFKKNILLFDNYHDFIDACVSRRYTRSKIMRTYLC
ILLKIKK
>MS53_0664 putative GTP-binding protein
MMKLISTDKEIQNLINWYPGHMAKSFKELKELASLANLFIIVLDARCPIS
SYNSDFDLISPQKPRLYIINKSDLMDKAKKDQINNFYKDKNLLWVSLRKQ
SSKKIIFNKINEIFKDKIKKDKEKGLLQTRIKAFVVGIPNSGKSTLINFL
SSKNSLKVANMPGVTKANKWTTKDNYFFLDTPGILLPKFKDQEIAIKLIA
INSIRNEIFSSKFLASQLFRLLSKYYPNVLTDLNLKPCYSEEEILANFEE
YARMHNFYLKEKNLDLNKAYIKFINFVQNLSGVTYD
>MS53_0219 putative phase-variable hemagglutinin
MALYWDGFMPKIVTTALPTTVAPMNREYNESPTGGHEFWKGRNKQVLDAW
FAANQDKLSLIADQLTKKLGKDKFKNMVLSTLTITWDEVRFSKGNVTKLY
LTPKVTFNLAAKEGYALAQDSATSVTLTIRVLYKDSNPEVNVFQTQGSSP
AAAPSGSSVDDDNVKAKVNVYMNYTGPAIVLDQDLPTVGSANNTSLNGTS
NVTGEFNTAFRGNPTKGLLFTNRYPNPLLQFVINYVNKFDPKYRLHL
>MS53_0006 conserved hypothetical protein
MKLVIDVGNSYLKIGVFHDLELIELKKFKTKYFKISYFENFYKKVFAKYK
FNLFIVFGSVVPSIEQKFLDFVKENNLENNFFLINNYLKLSFKVPQEKLG
LIGNDLLGAMEYASKETSNALIFLFGTASVALLLEKLNFSGAIIAPGMNF
SFNNLLSKAKKLKGFKLHKENVSLWNLNTQDALESGYENLKNGFIKQIIC
KSNSNYPVYISGGDISNLSPEISHQFVDNIVLKGYLLIYLKNC
>MS53_0359 hypothetical protein
MNKINIKKWNSEIKSFFNINLGATTIRKNKIINLFLNKNLNRIHGLKIQI
INLIGNKIHSADEIYNIILSCVIDSVNNYIKQNISYKFEAFFWTDLKFKT
LTKLNKFANSQQKFEYKISNSQVNLKNLKSKITLANSEVFLDSQISQKLE
KIRPTLTENETRFLTLYKQNKAHLYYSGFMQNRLISQLKAKLESS
>MS53_0588 putative transposase
MLILTRILEPSFKRSSVEKIKKYWYEFNDSLKDVYRSLEFLQDKKVEILN
YLNEQFVEKINRNLTFCFYDITTVYFESFLPDELRKFGFSKDNKINQTQV
VLGLLIDDMGIPIYYDLFPRNTSDFLTLKPVLENIKKGFRYRENHYCCR
>MS53_0279 putative MGPA-like protein
MALEKIKNYDSIVIFHHIQPDGDCLGSQFGLKTLIKDNFPNKKVYCVGDS
KNNFSFLDFQMDNEKITPEIMKNSLAIIVDANYKERIENRNLLDLNLFKE
TLRIDHHPNEDDLDKCTRWVDSSYVAADEMIAHMAILENWKISQTAAEYL
YLGINTDSGRFLFSNTSSRTFFIVSKLYETNFNADKLLKNLSKVNFKDLN
YNATLLANIKTYQNIVYIKTTKEQMAKFSKNADNGVKVNLISNIENYPIW
VQFLERDDNKIRVEARSNGPIVRNACVDFNGGGHQRACGCVLEDFSKVDD
FLKRLQKEI
>MS53_0039 conserved hypothetical protein
MQKGLEEKMAVGILAGYPMIDVKVTLFDGSYHDVDSSELAYKIAASKALT
KAKDLIGTVLLEPIMDVSVVVPSDHMGVM
>MS53_0212 putative phase-variable hemagglutinin
MDDLVVKNKNNVFLQQIQGDTEAVYLPVTAIANNRWLNTVLVRIPLTKFV
RPLTEFQAQREAAPTEEASGDQAQADPQATQMGTQARS
>MS53_0314 hypothetical protein
MTKLPKEKILEALTSFIGYKNKGISIYQLELLKLIKNKKVIANKLSIERD
FIFRWWYFLNIDLDIVSKKFENNKITENTRKLAKSIASIDVSKYSLKEEL
NYILDNYILVNSYDNVSEIKNIFHLIIHSI
>MS53_0287 hypothetical protein
MGQIIKTIQPLVSDTADIVNELDLPGDFEIVKLGALALESTNLVLTVLSK
IQIDGTYIYTYVSAINYELNKQDDMVLLSRLFSQLKQDADNLSWWRKYLL
GGWIISEKANELAQKTTDYYQEAINKYNNSIQAQQQYSDYENQIYQSYNS
Y
>MS53_0018 hypothetical protein
MNDISFLMRFKDAIHGRIDIFVIALIFFILLVSFAIGFWLRWKFTVANIV
IILATVGVSFLVSLVYTNHLNSSNLSEQEKTNYELFKPYFITLAASGFYL
AVSFLNFIVMIIFHYVLIAKRKKKGKYKKSKIKFRFLFGWSALCTAFPAA
FLYANLASSLTNVKEEEKTKQEKENWNLDVLYRLSDISVKLFTGNNGKSL
SGAYDNSLKLIKLNEINTDFSNIFKEVENGDKSATEKLNEFSDILVSGLN
NEDVRSFIFNAIENNDSLKQIISEVAAQVEDLNKSLPTYIENSDRYRDAY
NEAIKNNNTEKQKEIEKEYLSNYANNQLNTNDFLITVRKNLNSLSNDARG
QLTDTLINIVNKEKPKLNTLVDTNLLISMFLAKK
>MS53_0013 conserved hypothetical protein
MKKEFVINSQDEINLILDEIFSEIKIKKIVLLEGELGAGKTTFVKYLAKR
LNIKENINSPSFNFMKTYNGLIHLDLYNYKGHIDEFIPYFEDNVVVLEWS
NLFKLPFKHFVLIKIQSFNDEINKRKFLVTVK
>MS53_0493 hypothetical protein
MNKNNERENNLNSASQETSQNFSNEFDNKTQLIDLEKIETVPLKSKKEIV
KLIIEKNQFTEEDKLAFKKQKRIYWMAITSISAIALLALFLLLSVWFQFF
>MS53_0384 putative glycerol transporter subunit B
MFLKKIKLNSKSLIGFLYLIPLLVMIILFNIVPLIQSIEASFTIRPYSNN
FLITQRSLNNYKEVLNDSYFWEAIKNSTAILFIATFISFIIAFVLAYVIE
SLILKSSKNIFLTLIYSQFFLSSFAIGFSFLVLFGEKNIFFRILNLNDLN
FRFGKINIIWYYILFQIWRSLPFNTILFAAAINKANQKYYKLIKLDNLSF
FNKVKDIYFVELKNTIFVIMLTNFVFAFLLYPGAILDTNFDLKLYHGHTV
ASYILERLGIPRAVQINQGQIYSSSILVLIYIFFLAIVWNLLRPKFIKKL
YLIFKKVFGVFYAKKNI
>MS53_0620 conserved hypothetical protein
MQLVTIMFSKKIAIVVDSSCGLTKEQAEKLNWHYLPLVVEIDSNEYLDGV
DLTSDNLFDVFKADSKTARTSASKIGQAHELLDKLSQEYDKIIVYTISMY
LSSQYSFFKTIENDFPKIVVVNSKSIAFLTVMQLLNFENKLKDVKSEEEF
EALLVDLEKTDQYSVSLVPKYNNFLVKGGRLSPQAALLAKLLNIVPIIKF
ENGELKKEGKGRIFERVVTKVIQDKLSEDFNPNKNDVVLLHSNNLQINSF
KNKLTKKYNVNCYVFNIPSVVAIHTGPEALVVIKMPKMNAHLVKKLKSLN
LIS
>MS53_0141 conserved hypothetical protein
MKIAISGMVASGKSTLTKKLHTEYFKNSFMLKEYEEDDEVFEKLLKWKLE
KKPNVVLPFEVYIMDNHIEKMKKLYKEYLAKDNYYIFSDRFSIEHQIFAI
TAFEKEPHKHKTYLDVVNSIIVPEVLPDYIFYLDVTYETFEKRFLKRQYK
SEMDTYHKNKEAFKKLHTIYKENFVNLCKEFNLKYHIVDVNNLDENEVAQ
KVASLIQNLK
>MS53_0612 putative ABC transporter ATP-binding protein
MNKKELGVKVTKKNIFELLDKDGGKNKVLVDAKIAKILKKASSKKRAKDE
QKALTNSKDAIIEVRNVSKYYLSGNVVTRVLKDISVTINKGEFVLIYGKS
GGGKSTLLNLISGLDRPNNGHIIVCDTNLPYYSDSQLTYFRRKHVSFIFQ
NYNLLNNLNGYDNVLTGAYLQKDKSKKLDIDELFKEFDLLDIKDKYPSQM
SGGQQQRVSILRALAKNAEIIFADEPTGALDEKTSQIVLSYLVDINQKLK
TTIVMVTHDPKATEIANKVITVSKGKIESVKINKSPKHPKEIYLH
>MS53_0443 conserved hypothetical protein
MFVLSFSILIGILLYPRQSGLIQFFEYIKDFKYDQWSFWFSLSISINGFI
AGILLIFINQYSKSRLINCNYYTCWNFLINRW
>MS53_0205 putative phase-variable hemagglutinin
MASTVSYLKTLETELKTQLEALNGDTTANKTAYYKPVEGRTLYWDGFMPK
IVVPTYEPDTTGDSKATHQTTNQQKLQQWFATESNWEKLSEQLTKKLGSS
KFKNVVLTSPMVSYEDTSSNTRVPKVTFTLQGKEGYELQTTDGASATLSL
SIRVLYTSESSTQNVLRYQGASSSAAPSGSTPSNNAAVIRDVNVYMNYTG
PALILNAALPTVGNAANTSLNETSNVTDEDFNAAFRGLLFTDRYVNPLMQ
SVINYVNKFDPKYKAAFVTEKNGVALTSVQSGTQLRIGSLNDFLYNNKGF
LQQVNTDTKAVYFAVNGVTSQGWLNTFLIRIPLTKFVKPLSVLQAATDSS
QNAEQTGETQGSQPEAQSQ
>MS53_0360 conserved hypothetical protein
MMKKFPLFEKIKNRQKKYYLRKVAKEVKRVKWPTAKTNWTTFFQIIVFTI
LFSTFVFVVTLIFTAIWRAGGLNI
>MS53_0482 putative amino acid permease
MISKNKKYLSAKYFAFFTINFVVGFGFIATIFNVLEKKVYGFVVLAAASF
IAFGVLLVFSRLSDTYKETYGGSYAYSKDLMYEIDSKGNRVLGTKKSHQV
YKHLTFFTGWTQFIQGPILSATSPIFLVAILEPFFRNSDGTSNEVTINII
RGVSFLVYIILILITTFGLRINRWVVLAAASVKWLILLFSLILGVYLISQ
GNIYSSNLTLTKSDEEKISFYLVISSVLTFMYAYGGIEGVSAISKDVKAK
SFRKILMYSFVFIFVFYVVFYLILLGIKTEYNGQKIDQIRNIFSAVWGLS
GAVFFAVGIFFQQVSSKISGTVTIARSVAPMAEDKFLPVSLAKTNSKNEF
KNAIWFSTAITIFSLVIFYVIPLVLKANGYEEPSSYLSQVVNIGTIPFLV
QYLLTFIIAFILEHKKRITKIPLWEKIIYVLASIAIIVVLAVYIFPVIAN
ERWSASNTITLVSYSGFTLLGYVFYFATRKYYKNKKLKNN
>MS53_0329 conserved hypothetical protein
MKQKIFISLSAIASIGLGLSAIACSGANQSGNSGSNNPVNGQGELQERRA
NSLLGANPEGRNNAFQQDKKEKIVLAANFLGSTAQANALVELANAYNSDP
DVKTKYAGFFKPVEVEQIGSTYSDGAKKVAQYLKAKNKSAFYNLVLNHPS
VAAEIAKSNMLLSFNDSLGRENLDTDVSLFSSLFTDANTNTENIKNPSTY
ILPVMKSTMVSSVNGPVLYYILKTMVDNGATLSQDKDTQDFYNALMKTSS
SDLEFIKQKWGNPVDNARTLVTSANLTISKDMFNKYEDLLNFAMVAQKLF
TNSANNQNDLHIVGMDFPTVTLKTSVFSIVGNDYSKSLEAPSKVAGTNKV
SYNSLSTTGSPAQVAARTVYKKLKDAAGSGAVVLQPLGQYSSGKQIYHNF
ALSIGSTAGYLYNFIDDTAASALRFTFDSSLDKFSFDDNDNPAASNYNNR
YFVSFKQGSEYLSASAKDKNKTNEVLLSFGKNNNALIASGGKTASGSDFH
MVDAKSDQALKTALAEVTKDGNQENYKLLILRQSSNDNNQLATMKAKVMN
LASKDTKKELVYAGVAKGGSSSRPRNAVLVFVKTSNNNFVKTDLEKYGKQ
LGASVSQLTSANSLNKSELVVMNAPGKWNKNSTKNVAFLRGPSLIGIKAN
EEDDNATKAFVHWLVTNKKTYTFFSGKNNEVSASPSEFFQRQMSYLMPIA
GFETSTTKFNNGFLDNALEVFSSAAKDPQNWTTYEPPGSELGDLFDQALD
SAFRNLGNQALVNTSADKLQSFEAFVNSFTEIFGSSN
>MS53_0442 conserved hypothetical protein
MLLQKYIKWNLVKYFNSISISLIGSEDFKLASSLYIFKITGSFWLVTILY
LLIQLPSIIIYSFSNKLIKILKDKNAHVLCDISSAIFLGIVFGISFWYLQ
EELFFVVLITLSTILGTIHAYRFIHLKNFYII
>MS53_0313 hypothetical protein
MTIFSLIDKDTNQEIAKIENFFTYKDHKIYVFLQVNIPQGYQLDSDPNLD
EINLFEENTLKVSKSKNNYVTTLNFRQDNYGLVKKITLNLDYSFILPLGY
YIPDGYELVNKRSLILFNWTNDFIVQKIKTRENDNSDIANENEIEIDQSK
TQLGKFTINDPAYIFENLLLYSNLNADPFASDFKLISNFSSNWYNFLTSI
KSYDDDLDTLIFKAIVTKNNNSKAKKEFEFNLKGLRKIYQLKDFNYSFDP
NFYIVKE
>MS53_0496 hypothetical protein
MNDNQSEKKVVDLDEVKFNANKYVEAKREASEYNKTLKEMFKDTESEVTQ
YLDNGGQLTYKYVEAKPGFDYKGYSAFLQMQVSRGVKLDEAQLEEYKAQF
IKPAASKWKLTIKAK
>MS53_0217 putative phase-variable hemagglutinin
MALYWDGFMPKIVLEGFDSRWTNVEDNKSKLQTWFNTKANWSNLEDQLTK
KLGAERFKNVKLTYKEVTFSGDDIKTPTVTFTVAAKEGYTLVDSGENASA
TEISLVVRVLYNRDNESTIQMPIQGASSSAAPGNTKTPNNATVIKNVNVY
LNYTDI
>MS53_0133 conserved hypothetical protein
MKIKKILPAVFLTMAALPAISCASNSNANTNSNNAKSLFEKITKENVTIN
QRWNDFIESKAINSLLNLAFPKKENREKYIKEQNELNYDSKYKKDLKYWL
SYGNNIQSALGSDSNFFFGDLPYPYENSRARVGQLFDNNWLWFLFNLDKF
TFVNYPSVNLFEKTSTQYSIQSQENSLVLGTFYTPNSNKIIDFSTQIYES
DDEILTANVWLLIEAGFLIRIEVRHYLQDELSDISLLGYLFTYPDLISSN
NKLRDFNIKKYIEDNEDFDSKSVDELKSLLFTERYGGSKIRYTVVDINNE
K
>MS53_0253 putative phase-variable hemagglutinin
MREWFATASNWAGLSDQLTKKLGAERFKNVKLTYKEVTFSTNAVKTPTVK
FTVKAKEGYTLVDSGENASATEISLVVRVLYNRDDESTIQLPTQGASASA
VPNNTTMVSDPNVLRTVNVYLNYTGPSIILDEALPTVGSQDNTSLNGTSN
VTGDFNTKFKNLLVNVVRGGHAESSLFQAVINYVNKFDPKFRAQFVTNSI
DGVTITKVQNTKELRPGTLDDLVKNDRNNVFLQQIQGDTEAVYIPVTALT
NDKWLNTVLVRIPLTKFVRPITPFTASAVMIPTTEDSQEESGENSSQADN
TEQNAENQEDGQSGGEATETQEAQGDSASQSSPQT
>MS53_0326 conserved hypothetical protein
MKKLGIIIDSFSSLSKKEAQDLGFEFLSLQLEADGKLYQDGILDAKEMLE
TVRDAKVVATSLPTLESMENAIKTQSEKYEKVLYLGINHEISSTGKYMKT
FSQDFENVYVFDNHFSGYQLVYAALLAQEEYEKHQNFDLVLEKLNFLNEN
SQTYILPESLDYLIKGGRLKGFKKFILKTGKLIPLIEYKLSGHVMVAKLN
KTVTGALKKVFNKVLELKETFKNLEVHLISGLSEKLNSEVLELAKEFNVI
VSKVCIASSVTVAHTGPNAVAIAFMPSIEEFKK
>MS53_0470 conserved hypothetical protein
MNNSKVLRFNWEKENILRVIALSTLFIFVVIFGFLFEFAMKHLSVNLLSY
EYLFNTSYTLHKGSNFYVFYTVILFGLLIIISTMKSYFLVNKNNLKFSKY
ITWYVLYNFYALALLVLFAFSLNVNSNTQANTLLRNSFVIIPLLIIDLSY
DFFSLSMQKKYFTLDLKKIILEISYLLIKIVLIVIGFYVLQVFLADKQIT
AIFINNSFINHLQRIFVVTPIYKNLIIFALIFVFALMIAHKFFANKNKIF
NSVIRNKILKHLVQNFLMLFLASIIFAFYALFKTKTKELIFKIENNNELI
IFVLVISLIILSSLSFIFLTIFLQKWFNNFDQKKYFILNLLINSFLLLIA
NLLLNFQNRLIINITCLTLVFMNYLTLLLKNKYKLNSFENLLLSFYLIAG
SAILIFSNLLYLTTNENNYYLLVWTHIFDIATVFVLASLVISLLMVISPI
IYAILTKIVNNIINKENIKKGKEHVQKASKKSN
>MS53_0459 conserved hypothetical protein
MLLDKVFDSLDKIDSTNSYLDLLKLIFGDDDFNTKFVTAFKKALVDFSQD
PQFKTQVASVLTSIVSSDSKLSTLLDKITDKEGFLSSLVGLVKPLDENLD
LVSSTLNLVLAKLKNASSLNLNMLTSEVLSNLKSLLDLGSQEKVVNLLKA
VLSDPEIQKQKDNYVQFVKNAAKFALNNLDVTNLVWDSLPQGLKNALTSA
FVSEGTLKDALEKVLKNEAVVDLVANATKYFLDNPTSLSDAKTYVDVLKT
YLKNNKNTLKADLSKLVNVSLNSTEVKKAVNEFLWNLLNKNNLTNGITKE
QLEKLTNDVLAWSGSYSKFETLFDSLVDGFVNGHFTGAGSSVDLVSLVTN
SLSTSFGNLPDFAAEVLSSLAGSSALTENKDVLKKLLSNVADNLSTFNLE
SLLSILVKNTLVNDFVSNSDLNKLLNIVLGTEQSKTLLKSLLGSVVDNLD
SLKGATSANDLFTKLLKVVDFDTLKTQSENFFSNLLSDTKMQDALFDLVK
GFLKPAKLENYKDALKTLRVLVKQLPELVKHFSLDKEFIDLAFNTLKDAK
DKNLNLDQTWAELSKKLSEKVNSLLGTKFKDIAKWLLNNAEVNKNKTGLN
NLLYSLFTFAKDKNLLNSLLLSQLEKLKQSNPLFNNVSSSALSGALTTLL
NSSEFNVALKSALALLTKDSSWVDKLDKPLDLINHFVSDDKFVNTLKTQS
LNLVKTLLSNANFKSVLSQILTNLLKQYKLNLDASKVKALVDSLSTDLYA
FLQSNWILEKVNTFFFTDLAKTKNLLTTLNNLTSQFSSFFDLTNYNLFKK
LVTSKFFKSQKETLKDLVKQASTILLKDANFVKTNLLNFEPVKNLVSSLG
LSNDSAAKVLNLVVSDSKFAEATKLLIDRVFTSLGQVDKTKSYLDLLKEV
FNDSTFKTNFVSKFKDALLSLTQNSGFKSEVSKVVLSIINKDPKLSTLLN
NVTNKEQFLSSVIGLFKPLDQNLNLVSNVVNLLLGKLSNPQKLNLNSILA
SVTNDLKSVVDLSNEKTLINLLKTVLKDSEVKKQRNNYVQFVKNAVDYAV
KNLNLPELVWNNLPQNAKNLLNREFVSKKEFKDLLSAVLRNNSTATLVTN
FATYFLNNPNSLDNANSLVDVLKTYLKAQNSKFKTDLNNLVKSSLNLTEF
KNAVNDVLWKLLTKHQLTTNLTKEKVGKLSGDLLAWAGSYDKVGEILNSA
INKFLDLYANDRNNNKNWDIWHLVNNAVTSKFGNVTSFATDALSSFAKSN
AVENNKDTLKTLFTNVIDKLESFDYNALLNVLLKDNPVNKFVSSSDLNTL
LKAVFSNGAAKELLKKLANNLVDNFKEFKNVKNLNDLLTSLLKALDFNQL
KVNAHTLFDSLLGNEKVQNALVNVAKNFLAPAKLNSDTKVINHLKVIIGE
LPRLLTKFRLNVDVAVKSLENSKNKKTTLDQTWNSMLSDVSVQVEVMFKT
QFKPLIKWVLDNKEISKDKKSLSKLVYGIYVFAKDNHVLNNAISSQVDNL
TKNLDLLKNVSKDSLVKMLNTLLNNSDFDSIVKSAFDVLTKDSSWVDLLD
DPVKLFNYFVKDSTFLTKLKTPALNLVKTLVSDNNLKAVLKVVLNNFLNK
YGVKVEQNKVDKLVDSLAKDFYPFIESNGILTKVTDFFFKDLQTTKNVLT
TFNNLSSKLVELANLNDYTVFKNFISSNFFAGQKDTIKDIVKKLITNLSN
NPEFIKSSLLNFGFIKQLVSQFNLSQDTLATTLQLALKNESMQKVVNTLV
DRVFAATDSIKSTSSYNDLLKLIFNDKSVNATLVKDIKEALLGLTQDSSF
RDLLSNLLVSYVDNDPKLKPLFKGINDKKGLVGALLSVLKPVDKQLNLIS
PFLNKSLEELSKASAQTDLNKVVQVSLTALQNVFSKDNETKVVNLLKTLI
NERELFLNRIQLSTLMKNMIKQMQSTFDLGTMLWNGLDSNLRNQVQDKAL
DQGAFVKFVNTVFQNVKLGDQADRIFNYVFNTRKSNPLKDVTTYFGVFKK
YVKDNQHALVIDLQNFILDAVKNPKVQGALNDSLWSVLTKWGINKSKALT
DAILKTTSNLSSFLESTQIPVLLGKMIRDAVLKSSNFTEVANQVNATMKD
YLPFNDFSFVAKILRNATFSNNKALYKNAVNDLLQQILRSRDSVKRIATK
LNVARILGFKDETRVNELVAGALSDSHVRNLATTFSNYILDRITDFSNAN
SFGEAINKLFRENSQVSNYVKNEIIAWVRDLMTSKDKKIYDGIAAILVQK
LNENRWKLRNSDIPVISNFVQGFLAGVAKNSPNNDYASRIIDSVYQAVKN
VDYTKSENIMQTMTSSLKEGLVALFLTSDKKSISLNSILRKKDWVQTIIS
SIGNQNYVAFINLLFDRSDSRRNTGIFPELRRILTPEEYASPHQGGSNSG
GAAAAQGYGLSLDTNLIWAASQGFKEFIGAFFIPMWEGLFNDYIKLSYNA
RKSFDYKNNANYKAMFRLSTLFLWFLRTQPGISNYMYWSYANAFTVSNFV
AYGLWWAQDEVLKRKYSNGRSYRDNILRSRPSDRQLKTIGMEYWYNHARY
HWYYIFGYTENVNIYNYRPSQMLAYVYYENKKRFDRNWRSFKVSYILYLA
LELGRMPENANDFKLKNW
>MS53_0450 hypothetical protein
MSNVNIKNNNYDKNYLIENERFLSRQISKIVSLDFDRSENIAFNDIANSF
SKKNSGIKHIVNFCDNIYNLNLDYLLILTPSDLKISILACLDFVLGKQDF
NEDKKIKFIFIDESESSSSIDEKIDYFFEKVRDNRVGLLFIDEIVKNEKL
KKVGQNLIIKFNKFSSHFIVKKYLFYVGKRSLFSQNYENLNLLKENILFS
SEDIHNDYNIFSENVLIFLALKGINISKLIDGYEIEVNKIFFKTSEMPKS
LDLAVSLYEARNELFVEEDTQKIFFVAYDDFLINISKLFSIKYQKLLSKY
RAFCDYLHFPRQIYSVGQIVLNGAKNIFMIYLTINNKIFDFQFSSNLNDN
YGQDFENYTLNEMKRHSKDVFDNNFLSLNPNSKSIEINLENNKEQTLGEL
LAILYWSKIFYSMISSQKAF
>MS53_0158 conserved hypothetical protein
MKIKLKKKLLTSSLLASSTALSIVAISADTDSNTNTNNNGTGGGTTPKTP
ATPPKNADDFDSFKGELDKKVKENVEKLVDDTVTALNNKAKELIEATKSE
PNIARDLIAKALYYQKVATYLQTNKAKLVSDKTFDPTYLNALANDKKYSL
GNITYEGKEFSNVIIGSNPNDYASALAKDSNSKKEVTEKDKVNDISKDDL
NSKINDYFKNITDNENENAGDNIFVNKDDLPKLNTDTELTFDKTFDLTTP
KNYSSWDDYIKEKLQKRFTIYDISQNQDQNQEQKKQQDNTQQNQNPIPGL
PKENEDDLNKNIASQNVPRIAPFINYKYSGFTDYNDILARTGNSAQLFSF
DNPINPRFEYRVTEISNFNLDPGYSEFIKQNPTFFDDRGNFPIKVKVEIR
DLNDPTKTATYAIGYVKNYGNSTLAREIANQIVQDTYSKFYTALGMKPDQ
LNFTNVGNAEIAAAAFDLMGVTTGIINEPKYNASYIDLLVRLGSGVKLEE
NEDLKTAAKRYENTSFGKAVQTLFLSAIKTSNLNNSAYWTFFSTRLESVF
AQLSFNINNSNSGSTNRDKIREFFAKNPNYSVETFDKAMQSLNSRIQYFK
GLAGNPTFDESAQYNTMMEQLTIIMEQIRNMTTILTDVLQSQAPSDQKKF
QAAYEKLNILPIESGQNNKIVLASIGSILMLISIGLFILSIFLQNFKRRK
WLSNKTNKIALTWSITSVTFIIAIALIVFAILGGI
>MS53_0288 conserved hypothetical protein
MIVALGDSITAGFDWTFPDDFPGKLENNQITGSSYPAFLAKIFNKQNRIA
SFNNYAKSGATISQWLKLFDINYPGQNDASLNIFGNSPQEIKDFQTKVLS
DLKKQI
>MS53_0621 conserved hypothetical protein
MFVIKKFKSNFENIAIAFINMNVNVTKQLKFENFIVFCDDNYNINSVNIL
DLSKLKLEKNELFFSADSKLKTALEKELKKLDKNLKLGENLVEFFTFAKV
LEVEKHPKSDSLFVLKLDAKRDKEVQIVTNSTLVKKDMIILIANPGSVTA
KGDVILKSSVMGIESQGMIMSYKNAAVDKDGVFTTKDEKLIGTEYLINA
>MS53_0543 conserved hypothetical protein
MMNSIYILIPFIVISMTIFLFIVIKFIYLTKKMERGVILFKIDYLNKRVL
RLNKKSKFFNTVFDSKKLNFTTSNYLSLNTFYDLINKEDLTKIKDYLDFQ
VNQKEKIDFRISKSASKHLTFKEKIIWKIKNTKNNSISFVLTINPSQDAI
YYCTLKWEFNNQNKTKKIIEDNSESYVRAIKTNKNIAVLAFSLKTYYYIN
SINLFDIYKIVFFLNIPKKSLRFFQKDGLLFFVFPDVKSSKYRKLLSYAK
NIQSLSLANKYFINGTIFKNKNYKTLDDKALIIKKAQFCIFNLFNLNICK
KTNNLLKLNSKTTEEIEVKNKESLNVFYNLDLHAEDTNSFLDFHRNLEEY
IHENAVAKNFQIKKSYLYKYGSEPKQEFSPKDVGYADVEMTNIRESDQRF
FRNIPYLNFVFEPIWFDFIRKKQIELLKEENLKKDYVKKTMVKVSQESYL
NNPNNYIESSPSVVIYSYKNNFERQKLSKIISQNKQNKVTTFLYIKEIDR
STLHTVSVCDFSAVIIAKEISEKIHHNETLLNCISLISLCEKKNIGIIYE
NAPEKLSKALTNMAKMNFLIDKI
>MS53_0249 putative phase-variable hemagglutinin
METSRSVTAAKAVKDDAQYNSVDETLKTTLEEKYTAATALLEDGTKLKNL
DASSNLDTTKTTLESAKTALNAAVDAVKPELDFQKTKTSAAAKVTELESL
VNTALKAELQRQVNALTKDHATEATTMLENLTSLKDSLTSLQDLVSKGLA
MQVDYPQKYYDADNKSAFDNALLKASSVFPAFKWTAQSIMVPAPTNGALP
NPRAWTKAREKSEFKLQNFVMAPAQAAATTPTQPAAVESTSATVIVAMGE
DSAEEGAQEEDSEAASPTAEASTPTADLASTVSYLKTLETELKTQSEALN
GDTTTNKTAYYKADTTRTLYWDGFMPKIVLDNFDSSWAQNSENERKIREW
FGDATNWEGLSDQLTKKLGAERFKNVKLTFKSARFSTDPAKVPTVAFTVA
AKDGYTLTTGDNASATEISLVVRVLYNRGSESTIQLPTQGASASAVPNKT
TKVNDENVLRTVNVYLNYTGPSIVLDQAVPAVGITANTSLNGTSNVTGDF
NTKFKKLLVRVLNGGHAESSLFQAIINYVNKFDPKFRAAFVTNGTNGVTI
TKVEKTKELRPGTLDDLEKNRNNVFLQQIKGDKEAVYFAVTALTNDKWLN
TVLVRIPLTKFVKPLTEFQAQSPTAPTQEASGDQVQADPQETQMGTQAQS
>MS53_0113 putative methlytransferase
MRLRNDKFALSELNEFKFFIKNYPFNIKEDDILEIGSGKGEMISQMALLN
PNQRFIAIEKYPTVAKKIMQKIKELNLENLYISCIDASKLSENFIGKTNT
IWLTFSDPWPKKRHEKRRLTYKSFLDQYKFLLKDKNSNFYLKTDNDLFFN
YSLESLQENNWNLKFVTGDLHNSIYNETNIKTGYEIKWMDKTKINFLIAS
KGENA
>MS53_0109 conserved hypothetical protein
MGFIIFNMLSDKNKTEQILEYLMELIQTGQMPPNKIMPSQHQLMKRFECS
RNIIAAAYKKLEFLGAVYSISKRGYFVSENFHNLIKPLSFLLGVSRQDGY
EIKNVDTLPDWATKKHIIFTNGFRTFFKNYFKEDKLIAESEIFLSLKCVS
KKENINLNIPITDLLIRRKILTNVVYQIEFEKIIKFGANPSVAVIFYGYD
ADSICIDGKFYVDPENFKFYHQEFSLN
>MS53_0517 putative lipoprotein
MSCGAPQEEKKPTNPKDGNNDGGIVDLPPAIGGPGEGGGSPRTYGSIDPV
QSKLVGSWADYTKLSIAKRYEVDNKAYLNGLKSQYDIDPRQEFVPSDIKN
GFGTVQAYDDKATKLGLPDFVTSYLKGFTTYSGSGLEISPNVSGPALGFW
NSEQSGFDGRSRFLPNDLYKNTALQTYSISYVNEIKGDYVNEVKGDIEDT
GVNTVKTNKGTAWILDYVKPNDSSYPTKWYIATNIHVIGDLTFTKSQTDS
FGSDFTSIYNEEREKPLIKEARNVKAQIDKLQNEYNEVYAKLQTKEHEND
QALKARADKLNFELAPPLQKKLKDLNAQISGLTQNVTLAILDSDVPLQTT
LNTVFSADSRMKFVTLPASAVNIVYTANDFLNTSPKNYLDTTSTHNKDYL
NNEEMADFAVLEIDFSKVTGGFKYTKNSVGDEPAKEITVNSAQELAKIMT
NAYASTENQDKQIKFAKNSLFYQYKDLTNEKVTVTNDANKQKLQVSRIVA
NFVSLGYPISKDDLGNLRAEFPAKYAGPEGKLLAENDSSLWTNKPQKGRN
FYQEFGNRLNRSMILRNFVQYPGIYDLFITNPVINKGVGFNIKQIKDKTS
SYQQGNYLNYGLAYSLESWRPAPGASGSSLRDLNNEVLGINFAIRAGAGS
GTSLIQAFRSEGANYGGVYGSYNLPQYDLIYGGGKDQRTSYREALAKILK
NGETTNLFTSGVNVIPEEYKFRTNALINFTNSSNPEEAGLITNTGGGAQA
LTDQNKKYGSTITNPVVLPEGTS
>MS53_0089 conserved hypothetical protein
MIDNFDDVFLLSTDTVCGLGVKLENKDSLHKLYALKNRPVDKKIMILAGS
FNDIFKLTKFTKKQRVMAYKLLPGSNSIIVNNIGMRIPNCLKLRKFLIKN
GPMYVTSANISGEKPLSIEEAQVKFEKIRYIVDYCSPSGSPSKIYNLDTG
EILVRDK
>MS53_0112 putative methyltransferase
MLRVIAGKYRNRKVNQPSKETTRSTIEKIREAIFSSIAFKLPDKSFLDLF
SGSGIWSIEASSRGASQVVGIEKDRKAYKIILENINSIKMENISIKNMDA
MEFIKNNTMVFDFIFIDPPFIRYDYINDSLKFIQENKSLSEDGEIILHTD
DYRQVVVPEKLKIYKEKRYGKKFIYFIVWK
>MS53_0189 hypothetical protein
MNLKNTNYADAYKVPSTKSDNVKIAEARLNLEQRDPKQGFVCNCTILLSQ
HYGWQHIKNQEQLIKSVLDKAILGETLSRTEQELLDSLAKDWKTT
>MS53_0555 hypothetical protein
MMVSRDMRIIPESLEILAVPQNSKQPASDFDKYAWKLKDQKDQWKYQTQN
DWTYIDYNVGFKNSTVSSMSMWHKSYFGRNKFSSEANRWEVASWAESRKH
LQEHNGLGLFFLNRMYNLNKAWQENVYKRWKAKDMLPTPKLSWRSKNRER
YSKYTGVGNGDAWAAKAQQLNDFYYRSFNSVDLAGVGETLTLRLKQHTDR
YKKEQGWKYVLRFKTEFSHKYYTEETARYYDKFKAGSSGQSFVALGYSTN
DWNYQTKYQYKALFLQKADRTGNEKFDVNVKEMVDSKYKGFKLPKASFKL
VNETLKALAAKDPYVPEMNKNNFNWDFTSQRGQKVYQTQALSARRAQSSN
FNARFEMM
>MS53_0568 putative tRNA/rRNA methyltransferase
MLNIVLYQPEISPNTANIIRSCYALGAKLHIIKPLGFDLHPKYFKRAAAG
RLLSDIRHEVHDSYLDFYNKYKNANVFYITRYGLKSYDKVDFKNEYSKDK
NIFFMFGRESTGIDKEILKNNIDKCLRIPMVSKMRSINLANTVCIVGFEF
MRQMNWEGLSLYEVQKGKEYLLEDDNQV
>MS53_0602 conserved hypothetical protein
MKKTKIKLIPLIASLSLIPTIAISCGAPAKSEPVKEDENKQSQQPQPKQP
IENGPQSVEDIQTMLTNVTFAKSLTENTVFTELQKSLSQLDPQAKSEKLT
KFTSVLNEVKELIRDLDLVELSARSYTQDDLTNRELVVTKLKYPSLDPKL
KELRSALNDLLSDLIGFSEQIPGYLNLTENLNQKVFNALKNDTLNNLKDT
TQASAVNISQSTIDNILNKYIEEKAKAQQWFTKMNLPKELQIKYFNLALG
NTKAELDKEIAKNIQFQNAFTPSVEATQPSSLFASETNVVSNEASTNPPM
ISLEDFQRLISQSRSSRDIAANTYPKYTNKFWTLKSETLYKEIYDRTFSL
AYGFNEYDPKAENGGNKDWVGTLGGTAWLLDYHKNTQNPNKYKLFLATNL
HVIGYLSNTLTEEQDKHLNYFDPTGFKANGIALGKQVQTPSFAAVANNTR
NNQGPIYYGNMAGFSTVIKPTGSYKNLDSVISNAKLIFAAVDFVKRSNVE
RYQESLLKAFDDDSKNSFEAKNTSIQKDRNVFDAKVEYQKQQNFVPFYQD
FGVFAVDVDLTNADATFKSWITNATAAVDKQVSRKYTNLSPNNLDLLSPT
PSMDYVSASKYLSDDKSTFKWKELILPNAKNLYIAGYPAVQGKAQWMKNN
PTERSSRELTSAQNSSLKNNNLFSLQNGTWTSRSINDASNSPSLYKDLWH
RYFAQDYGYNLDVNFSSLYFGASGSMVLDEFGQTVGIYNLVSQNATFGDL
LKPAKFTQLTLANPVLDEGGKLLMPAYNLLDGSDQSKFPEQTRSFRQNLR
YLYQNGFEDGDNKTALFPDGF
>MS53_0570 hypothetical protein
MNNMENSKYKKLLSLLENASFSKSLVGVSPSEIALFINNLKSELLLLESS
YNELSAQNKELKEQNENLVLENLKLKADLKLK
>MS53_0647 conserved hypothetical protein
MAHINLFALGGQDENGKNCYVLEHQADIFIINVGVKIPINSTNGVDALIP
NFEYLTQRKNRIQGVFITNVKNDNFSAIPWLVMKIPNLKIYTSSYNKTIV
INRLNKYNISPSQYKVIAFDKDLEFKNLKIQAIPVSGSIPGNLAFLFKLE
FGSFLFMFNYVEGDLKYFGNLNYKNLLAKLDNKPLVGLITNSGQSNYPAT
AMSRLNLPDYIENVFKESIDSNYQIVVGSYDEEMVNLDQIINLCKKYNKK
IVIYGRTYANLLNLLSKTNLEFGSSLPEILDHKTIKKHKDCVILFTGKLT
RLYKRFQRVLDNEDAYLKLKSDHRVIMMAPPINGTESLYASLLDQIAKVT
PYIWDVSDLELFRSNPTKEDLSNLLFALRPKYFLPVAGLYRYLIDSSNYL
KDSAKQNKFNFDSLVLQNGAIARFEDDKLINSNAKIKEVGETIIDGFGVG
DISSEIVSERETLGREGAIIINVLYSSKPNKPKMILDEIQIDFTGVTSEE
NFDDIKKLIKATIVKIISKEKFKSIKELNKRLRKSVRKKIFKTTDKDSVV
ALSFISV
>MS53_0372 conserved hypothetical protein
MNTINLRSIFPENTDVNIVKFAGVLIFAAILLVVPLIIALVFPLIKKKLN
SDKKIYLYAFSSGFFIMLATIGFIKEGLENAIDGADRYIEINRINNHNVS
FGIVIPIMTGGIILGIAISYLVKYVFISRFNKVLSKDKKASILVHDHGHG
DHKHKDKHPDFIFNQSDNIEVASKVINSEKTSQKVKIVALVLLLTHRVFV
GLLFGWSINQLIEGSTSNLTWAFIISFWLHLIPEELVFYYRLREAGYSRW
KSFTFSVLGLSILIPFMIIGVYGANFIESLWWLRSLLYTAIGGIFLFNSL
VEFFPEFYHVHFIKQKKWHYTLLFLFAGIILGVFILSFHMH
>MS53_0191 conserved hypothetical protein
MKEIVKPSLATADYVVIALYLTAVLGIGLFFFIQQIKRKKQNSVNNFFTG
EGKNPIWVVGFSIWATILSSNFFLAATGNAIATRWMWAGANISLVGITPF
IALFVVPFYRRLKESTAYSYLENRFNYATRVLASGLFIVFQIFRVAIVLY
VPTLAMTTVSDVNPEFILLGLGIVVILITMFGGFKAVVWTDALQGLILGM
GMVLVLFFALGKTNWSSSHVLLQKPLTIESWKVTLASGGIGFIFVYNIIN
SLYAFTSSQDVTQRYKGTKTIGEIRKTLYIAAGLGIFTVLIFFGAGAAIY
TYVSSQESVTVKELKEIAKNADGKLPANLVGLQDSDLVGQLAGQKTIGQI
DNVKAVPFFAKGGIEQGDKVFAYFVVKVLPQGVVGIIIAAVLAAAQSTIS
SGLSAVSNSIIVDFVDKTQWGKGLSAKYKANLSRLLVLLFGSVSLGGGLF
LLATKQQQIFNYITGTVGLLNAPVVGVFVLGVFTKRVNGKGSVAGIVLGF
LVAFPLWVFTQGFVPKELRIEFAGVWLTITSFLTAIITALVVSKLTGDAA
AMNKSIANKSYWTRTKEFKYLTELEENLEQVSKLVKKGKLSKEFETRYHA
VFEKMQHVVDAQ
>MS53_0203 putative phase-variable hemagglutinin
MSDQLTKKLGAERFKNVKLTFKEASFSGDDIKTPTVKFTVAAKEGYTLTT
GDNASATEISLVVRVLYNRGSENVIQLPTQGASASAVPSNSSVNDAKVKA
KVNVYLNYTGPSIVLDETHPTVGATPNTSLNGTSNVTDDFNNKFNKLLIR
YKAETSLFKAVINYVNKFDPKFRAQFVTNAIDGVTITKVQNTRELRPGTL
DDLVVKNKNNVFLQQIQGDTEAVYLPVTAVTNDKWLNTVLVRIPLTKFVR
PISVLEAPQQEETQEDGEEMQQGNEDGTQAGQTDETAGSGTPQASTPQTM
PNSSQ
>MS53_0068 conserved hypothetical protein
MYRYKAKLASTNEVIAQSNTIEDLEHNIVTFRRLQKYAVHTRANDKIQIY
HIEQNHKIGKRASKEVLIKVV
>MS53_0176 hypothetical protein
MIIKNMHLESLLNSLILFNKMAKKNKIVFSVCGQSLNQLYFSKELQAPFE
IALSFENYNKLLFDKNFKTSDYKLNVNDNPLPRFFLDNNEFWINLLIPSE
TDLVLSSKTKKLIYKINQSSKHQKIISLVDYLNSNNPNTWAYLYFDSASQ
KLKVKAVYKINPNFYKVIKLNKNLSLPYLNYFEENLK
>MS53_0261 putative phase-variable hemagglutinin
MADLASTVSYLKSLNDTLKAATDALNGDNPTEKTAYYKPVNGRTLYWDGF
MPKIVLTDFDKTWEQNSENERKIRKWFDNAANWVGLSDQLTKKLGAERFK
NVKLTYKEVTFSTNAVKTPTVTFTVEAQDGYTLDNSANEISLVVRVLYNR
GSESTIQLPT
>MS53_0007 putative pantothenate metabolism flavoprotein
MKILLLVTSSIAIVKLGDFLNLLKKDSKNQITIVLSKNASKYKLNFPKED
ENLKYLYSESYIKKDPQHVYLARDNDLTILFAATYNTITKFARGIADNFL
TSILAVNKKPVVILPAMNSNMWENPINLEHVSKLKKYGHIFIGPDCGTLY
CNDFGIGKMAKVSDIYERLFGKNKPKLLLSFGYTKSPIDSVRSLMVPSSG
KMGLALISELAFDFDLTVINASLQHLNSKIPANVKVINVNYINEYKEAVF
SEIKNSDGFISVAAVSDFIFEKIDNKISKNNSSGVLKYHIGSDVLKEVSN
KYPNKIMVGFSLGDSNNYKEKAKEKLINKKLSLIVANSISSLNNKNINAS
LLDKNLNEIYFENVSKYDFAKEIKNQLWKIIKAK
>MS53_0365 hypothetical protein
MKPKKSQQDLSQETNFELLREITEKQQIILKKHRVSYGVWVFLNFLSVFI
TSAIIILNLYAIRYNPRPDETMSFFVAIAILSATITFLVSIRTFFAISDK
KEKLNYIIAENQNYIEQLKKSIKRKKNKTSGEPEENQNNTIEIKFNLDK
>MS53_0034 putative ABC transporter ATP binding protein
MMDKILTVQNLNKTYSNFWGRRKKQVLKDLSFDLYKSEKLAIVAKNGAGK
TTLAKIISGYIGYESGEIKYNYEFTWSPYEEILLEFQESHNIPFHFVGEL
INDYKVRGKERLISKDYESYLYEKLNIKRFKGRRFSKLSGGEKQILKLYL
SLIVKTKILILDEFTSALDFENKKFVREILMEYLENFDVTLILISHDAGE
IRRIADRIIVLRDGKVFNELKDIKSKFKNDDEIEEVLKENIEDIAATNLN
KSNTFLNFKRKNK
>MS53_0070 conserved hypothetical protein
MIKVKKNKIILLFGIASVALVSTAAISATVVKINSSYLSNQNAFAFNRSR
SLELIDRGRAESRFNSNTDNNLEVPQPKKDDPIKPTIVENPPIVEEKPLV
VLKPEPPKEEPIVVVAPPVQTPPQSNSSYDGSIINIQTITSTVSEKSDWN
KPTGKRLSAALQKQAREAIEKAQKAFNDVFSKLKPNADGTVKFTDEQKEE
LAKSLGVSTTNTKEYWYFNRFLKNFEEGSIAKDIMVHRDPSTAQANRDMF
LHAINNVDYDFYFSINNIPYIKWEYGDDITIGGKPPSDAENVVVQHQINL
NKKRFLSSDSKWRRYSPQMIADNDYFGWKQEDITSKAAQDIGISDTSGIK
ISKYTPDQNNATVTDKSTVRYALTLDASNPNAYAAVIRNLNLMNQHNYKV
EVFNVKHLGVDKSQDFAAVFRAMPDTIKLLNLFFDDTNTDALSGLKDKKI
QSLGLWTTKNQLDENWGIDPYVLKNVENIEYDYQNSQSGDYPRGAEIAGS
IIFRKLRFHKDDTIPQIQEGLKIALIEKADQRAFQGYWGSGSWPSELDFS
NVIAVKSLKGFTFGPANDLVFKKLTLFNDTFNYVLSASDLADSGFEHMLF
RDTKPSEIDFSNQGSTFNSYQIYIPGNTSDLKPNWVPQLQGLLYGGGRTF
KKTIYVDNQDMVQRLSKSGVPGLYGFSVQVKPNGYDPNKNEASLDFSS
>MS53_0559 hypothetical protein
MKIKFFVETKEVKLDQEPRIKEYTKLIKKSRPKVINFELWRLIEAMLEED
ERDKLFKFVDNDMQKFYVYIKTKIESRLKNKIVIFSRHYIKVDYDFRSGL
DAAKVYMIDQWYKKFKTMQENIYLVRKDSWKYNSYLYEKSLFHKVDKVNQ
DNCPVAKYPKNFFWKLEQEPYKHKKKYDQYPKTIFTLEKQLRHAPEIVSY
GHFLDNLWKFLNATYSLKFDKAFEDKLLFSYLQRKHENLILNYDVRVPES
LHKIKFTSKSAKNKFQRVLLAAKENMKVEYLFVIITNVLYSSKTQQKENI
SFEVGGNLPFSVFDFKFFQFIDHKVVYDAFAKLKSILRSSAYLPSTNWKE
IKD
>MS53_0673 conserved hypothetical protein
MNNFLNGYDLAKAVISGANSLKNKKNEIDALNVFPVPDGDTGSNMASTIF
SCVDNLEKLLAQNPNPSISEVAQEISHSMIYAARGNSGVILSQIFKGFSL
GCQNKEKVSSLELVDVFVAAKTRAYKAVFSPVEGTILTVIREVSEGLEKN
INGSESILDFFKAVVSLARKSTDETPNKLKILREVGVNDSGAEGLYLIFL
GMLSYLEGFPIELSETEEKSVNNFISDLEIYDGEFGYCTELLIDLNDPEN
FKKEKFQNKVEKMAASLVLIQDDNLLKIHGHTEKPGSLISYCHKYGELIK
IKSENMSLQAKESKKTAQSAQSNFAANKSSEEELCGLVSCNFGSGIIKKM
KEYGCHNIVEGGNTQNPSASDIIAAINEVNAKNVFVLPNNSNIILAAQQA
AQMIKNKNVIIIPSKTQVQGISAALNFNAELSPEDNEEMMLDSIKSVVSG
SVTKAVRTTEINGIKIKENDFIAVKDGNIISSHKDDFTVIKKLIKKMVTA
QHEVVSIYYGENSSFQDAQKIEAFIKSQWDIEVEIFEGNQPNYYFLIGVE
>MS53_0214 putative phase-variable hemagglutinin
MTIRNLYKEANPDTNVFATQGASSSATPNNASQANDATTIEKVNVYLNYT
GPSIVLDADLPQVGTAANTSINGTSSVTGDFNDKLKKLLVSVLRGARSIF
IITSNN
>MS53_0613 putative ABC transporter permease protein
MALLIILFSKDIMWNLFKETFLSLFKNKITIIGLTILVFLSTAVFVLLND
ASSSIKKEYSRYTKQSKLHDITVDLNIPNSGSAYNDGYYINSLDRNLGGS
FYDRPIHYIKSDYKTTSNILDINNIKDEYINLSSFVDDSNYVNKYLAKDD
FLRFYNIYDPNSTSALKLQLNFNQPQKTFTLPEDYSFQVYNKVNNAYQVD
FNNFVINLNDEIHFDKTYKLSDIATITFDNSKAIVSQLSTLFINVVSKQA
TFDILKGRQWVEEKSGYRVTMNDLVKFLKLTKTSQNNFIYNLNLANASDA
YSNLNSSSETNDIFNAALKDTFTFNLLSSKRLDFKNPTSIIFRKATSYKV
PNVIAAQRENIEYFERKHYTTTYDKDNADKWLGSYKIVIDNLKDQNNGEI
PKEFSDFSYWYKNVSVYFIRYDNNGRLDEQNKEKVLDFNSFVSLDEVKNT
KLSIGPLDDQYPNTFFYNYLLKEPQTIEQIEKFSNITTQQYNNLINPDIL
SNTFNYIKNQAKKVTQNSIVKYVEKKFGKDNLGLRQTVTVESVDNSGNKS
VFNFINLGNANNEINGVKLNVDKPFYESQDSTALSTLNNQDLASYFKTRE
LDPYVVQTLLLNAKHNFSSDRDYIIPEFDYWNVTYTKNTSNTVENLSNVK
IYKLANFIGDNPKPNSEYNKFNGYGIFSYGDDFVLVKAVYDDDGKITHWV
NADVVPSFNDVVRGGDIERFFRQRNLTLELQYINPNGWVKVDNLFSNIVY
LPFYFRAPKPDLIAEALNNNSIEKGMQEIQKALLNTDLYKKGFITTNEIF
VLIASATKVANDNNFAKIYAEGNINLNIVPKMVYQLIYELSHNPTGEYVS
KILTSFLTTAKQYVNTKEGLAKEIKNLSSIFSIFGFNEILQFLSLDALTK
IIENPSKVIDGLLQIVSSIDFRNFADKIKEFLDTEYDKVTTINEIDYTRK
FSLYEIGTWLLESIDQKRFKDGVNTIIDSINPSGIIEYVKQIFGPILGNS
FGELLNKLDAFKNTDTQYKNLTTGIKELVSLLDFNTLRSSLAEATEIHTF
QIENSLIDPITKKPFTKIENFTAGVINNADVVKSLLRALFSVPGSDKTFK
DIIIKMLNISSKGQVIQISNDQSLIIPADDPDKLGLFDLINLLGNSQQSF
SESKVEEKNGFTYGSDLFSNIITFLILHEKDSVLNFRNLNNTEKFIAANV
FRWDSKSRVTQKDIAAEIQKWAKIVKLFEYRPNANRYSKELSLSNLATYS
LNFTSTNNNNLFWQTTSNLIRQLVPIAEPTKFNYVKDGYQSMILWWDILF
SDEKISYQRKLDFAKDLLKLANEPSVIDSFNSFDLFQPSAENIIQHKKTN
FGVSRSIANPERMRELFFTKSGSRYTNIYLQKLADKYPEFREFIENNELL
ITQEFSYLASSDMYVRQGEDSNLDNQVPLKYKGLRSNLADNFLNGIASNN
LIRDNLDVIQYILKVGYSNNIGGINPVFLSLLGISNILIDPVLRYSNPQY
LIWALADTSSVNLNQDSVISNLAYFIQNKLVNFYNLINGNSNTLNVLLNN
LFKDYPSINPINEYDSYQTIAIDNDFFEKLKEKTDADLENNLFLGINFTD
FLLNVINSITSLNAANNVLVFNQNSSYVAKANYAWLQQNNKKIYSGEIPD
NPIKMLALLNSLPEDNILNVNGVKFIIIGQEITADYLYPVIDEENLQVDT
KSQGIIYVNQNGFDRIRNSYRNNVVKEYVVSKIPGETTDEQKSEIRNNIE
NYVQETIDDSAKIQRTYLTNELDGINPERSLRVRIIDSIISSINKSLIAL
TGILIFFVTVSVIFIIKRYIFNKNKVIGILISQGYSPWEIVFSMTTFSIF
IIFFGGILGYVVGFTSQAAVIHVIKNYWTLPIVTLNFSWVSLLVTLMIPF
LAITVLIYSITISSLRFKSIDLMSGVYEVKLGRVQRIFSSLFKSKKITTK
FSASLIFNSFWKLFSFGTSIFLTSIVTIFAFTATTVFDKAINETYKNRLY
NYKYDLKTPTVESNAYKTFNGSTLDNQLYVPLGHSSEINSYAGDYFRPGF
SNSINTNFANGNPEYNDPHVLTQFSLNIRINGGVSVDPFNLIFNSLPDSQ
KNKIIVIRNIIGKELEKTQDNLVYNSNNEIDISKTSKINKVGFFGYIPDN
LVIQNGKFWYFQYNDAKNEYERVQITTGAYRNEYRQFLINGYKKLYEDPK
KTQDFLISFGGIYLDNRFDETYTYAQAIFNDNSINLYGYRPDSKQIQVYD
NNVNILKKINDEFDANPDLNEPIPLIINEVARYKYLLQRNQIITLKIENT
TDRFKEKFDKEINPNRELSDNTYKFKIVDISKTYINTEFIIPHQAANLIT
KLDKLNFGEDTGPFNGILSKNEIPSLLLSSASLYSYSNFWGVVAAIDTNS
MSRIDKVALFNSLFGSKLTNPNDFTEGVLKTNGYSDFEIAKFINPNFNQN
DRNAIYDNYHQTINNPDGAINKFLAAYNDMPYVIVASNLDAKNIELSFTT
ITANTVKVIITFVSIIFFITSIVILIIFSTILINENTKNIAIWSILGYSN
KEKVKMFFGIFIPFILVAFLLAIPLAIAIMQIFSITLTYVASIAIPSMIN
AVNIFATLGVVLGVFSITSVILWINMNKIKAVDLLKGK
>MS53_0390 hypothetical protein
MFLFAIFLFFISFVRIDFYKPALINFDNDEIYISNFSSEKLQPNQYIKFS
YLSNEEVFQFETKIEKILDSKIYIKDARIASELKSKNINLLNISMFFEEK
VLWKYILKI
>MS53_0657 putative ABC transporter ATP-binding protein
MVLNVKSLTKTFKKYKALDNLSFKVYKKQLYGFLGINGAGKSTTLNIIMG
LLSKDSGEIELFGENIKGDFTKIRNNIGIVFQSSILDSNLTVYENLYSRL
LLYKNNFKGKKIKEVVSEIISEFKLEDLVNQKYGTLSGGQKRRVDIARAL
AHKPSILFLDEPTTGLDPVSKKLVWDILSQLQKEKGLTIILTTHYMQEAD
NCDYAIVIKKGVKLDEGTPSDLKTRLTKAKILIQAPKDDFEINYLLKKHN
LAFEFKTDLYKVEFDSYQKALEFTKKNINHLKNFELIKGDMEEAFINSTK
KHLEGSK
>MS53_0587 conserved hypothetical protein
MKKQYHKEFFKSNNTFYEIDNKLILTFSRKRQRKDKKDRERLIKKAKKLL
NLSAIKSEMKRGGKKYLKFAANEVELDHQAILKDEAADGFYVILTSHEDM
DEKEIIKQYSKLWKIEESFRLMKTNFELRPIFLSTEKTIKGHFLICFLAL
TIQRYLEFVLDCCGYPMPTNKIIDAIKNQKLSIIPEINTYIKTEESEDFK
TILKVLGIKPIETIGKYEDIKFTI
>MS53_0286 hypothetical protein
MDQKEQINYFKENLQSKLRSQFGDEILNQINFQKDLSDNTSFTNSDLQTL
QEKVSGLKDLSNNLKTIINTYNNNYFSNSDQYPSQSLLSESKEQLQEEEK
YSKFITQAQWDQIKGDFNLWIKQVSNFF
>MS53_0304 hypothetical protein
MNMIFIKATLYKVASEKIKGFIDYLYVFVKKSQMQELNLSFEYAITKKDQ
EVVSVLLVQRWTNKQAYEAFVTKEEFKKEFFTLKSFAKETSLVFEVTTAK
>MS53_0129 conserved hypothetical protein
MYNFIFHLFHIYRKSLMKQFYVYCAFLHKLLFKKVNSIVIPLFVFSVSLI
AGIVIWNQNIKNINSTTIIYAFLFLELLFTTLYASIKALNLFKEQESDAL
DILVFSKPISRKKMFISKQATFISFGLMWSLVVFTSNISAFFIMNLENAL
VVSFISFASLFFSYLIFGNIAALIAYKLSSKLALTISLVISTPLVIGGVV
INSNSTSTANNFAYYLNTPYQFNRSNTAVNTNQFYLNNNKDNYYILANGY
KSDKFSDLQKEFINNAYGYAENSSKSWQVYSWLSLPYQLIDAANVNNKNP
LSFTENNSENNLKDYIFYNHLDSIAYNYNLVKDPKIATSGVNDDKSKYYI
VPGLLKVDSKIDNLINTKIVYARENASTFDVTFPEDNFIYSSPNNLVGEI
SWQYTSELLNSDVFKNYARSFYANLFNKLKQVNSTDLFTNKKLLLDEVSS
KLNEISSDSSEAKLVDPSTTVLDENAIKNNKIKNLTEKKVYLAVGLLYYL
YFAHNDSFLTKALLSNEDPLEKDNASKIVLEIDGYKYEIGGYSSFTAKQE
VKNDKVVIRYELEPSDNYLFQKVNELYSLERGSQIVDKNYYYLIWVVIAM
MVVFLNTYLYMKKDYK
>MS53_0474 conserved hypothetical protein
MIDKRNKMKRKFKLLLALNASSIFVLTPLLTACVNREAINEELKRLNANN
FDFNYPNKNQTYALDVKAEQFTTNSNDQIELVEPKIIEQVNQEAKATLQY
RLKSLKTNLNAEIISDILTKEISGFKQGLSLEELITNEKEKLNKTNFTFD
YPYKENTFTEEAKLEKIQIKTNNNYQNEELKNFTHDLKTNSISFEYQIFI
ENFYGQKISSNVKKVTISGFKNKQTFENQNSVDTFLASYKIAENPSINQD
LNIKLYSTSISEQNAPYFLNLVNDKEINLKIKNIKIDDNNLNQISFTLVA
QKGDYTKEEQRTFTFKNDVASLTNGLSFNSIEELYDVDYAFLNSLAGNDL
RNKTNLLNSAFSKKVEKLNNLFDYEINWQKSKNDITQVEKKVRDVNRQVK
NAKAFVLKWNLVVDVKLNGKTIKSFNNLKTADNRNQHDYFGGNYLYTYLL
NDDFNVTYKPSQYYLTNAKFNNNKTDEVLLTYINNTAEEIKKTNEKYKNI
TTTGRYPTLNQNDALSRELFKEIVLKSFDFNLNGWQIEEVVSYLNNDTDK
FNYFYFQPNNLVKLLLKLTKNNQVVYLPLIFNNFNYDINQLEDAFFVNLV
TGNNISKILSQVKIKKNNDTHQNYLASKIYDNLNDFYELPANGRYQIKFL
TKDQTRLGLPNKPIQHFNDIKGEAIVQFGLFENGKYTGISTLGYTLKYFK
TIEESDFYPARNWFSANDFNDATKYTKPQANIINEIGKINSTNFIYNFVQ
GSPNNQNDLRTRRTLDPKLLVEQKAFAQLNHLLTMVNNNSSQKQHDLIKN
STDLVNNVNITNLLKDYYVYYYDVNNPKENSLSFKLGFINKTNSNIRYSA
NKDITLENLYNDYQLEAYPEALINSITLKNFNVKVDVLKNQTSATLLNYF
KTNKNINNNYFNLTEISYNNWKLPNWNDLKIAEVKNIENRIFVRLKYSKY
IFPQYVNRPKDILGDTWYEIGHFSDWTDDNLTDEQILNFLSAQYNMKKVF
LANGKILRQRKIKLNYKDNYFDLSNNKKEITWLFKKDYYNPLLKQDKVTN
AKINFEFFTNILYLDENRYKRVLDSQQNLNITLDWNELVKQKTLIFKKET
QSVNNIKIDFTLTFTLNEEGIHFSYRLSDDNDYLIVANNIAETLYYHQKT
LPEVKFDKNKAIYFNQNFGANINIQYQNEIENETFSKYQSNKFDYQNLSI
TPENMPFYIYNEAYNHGELFKYNPNENLIYKWHEGYKPSVEFMHLSYDDQ
RIKDINNRVLAFNNGSSLMLGKVNKDKQDGKYYFITNNHVVNNNNTIETP
WENAWKTNANFTLNGTNKHVISADAKKGVDNENATSTPIFTFWTGYKQYN
DDGEIHVDSKDKNKLAVLPDLSTYMIDVNNIINNLKKQGKFSAALWFENL
KKLPNLGISDYNKDNITYFLEMHKAVNKSPSFENKLNFSTNRLITGFPGY
KQIGYIYNDSTIGRARESYQRTSVETSYAPIFFRGGLSGTGVVDDRGNYI
TSLNAASFYNFATSYYNYSVAWNNDKNKYEKFNWFGFAPNIEQLYKLANK
NSLASTFLKLSSWDSTIEIPEWVFNPKQLHKN
>MS53_0670 conserved hypothetical protein
MFEFSKLENLEKEKLLEMFQIDFWNENQEFKDLSLRQKQRLLVLKSYIEN
KDIKIYDESFANIDAKTRNKIIKSLLKSDKTMIIISHHMPKNLVSLFDQV
INL
>MS53_0385 putative glycerol transporter subunit C
MLKKISKEFLKINFIILFCIIILFPLYYLLVLAFTKSSDIDTGVINFWFN
NTSSEAFKMVLNNNFIKALAVTFASIFTLIIIRILIYSLAIAGMLKINNK
KINSILIYFFIFISFVPEYVLYFQNKLNLNNWNLSSARAFSLITNSIFSF
FIFTYSFKIAYKTFQEKNKIIMVDNLKWYEKIFYVYFSELKLSYLLLIIF
TTTSVWNDFLWPRFLLNNTNTLTISIWFSFPKTQFVPLANVFAAGSVIAI
SIPLGIYLVFSKFINKTIT
>MS53_0615 conserved hypothetical protein
MIAVSGGADSMFLLDKYKHKNIIVAHVNYNQRNDSNFDEELVRNYCEKNN
IKLEILSLNKQDFLKGNFQDWARKARYSFFEKVYKKHNCNKLLIAHHKLD
FLETYYMQKESNKMNFFYGIKKRSFIFDMHVYRPFLYKYTKKQICKFCRK
NKIPYRDDYSNFESKYTRNIVRKSLLQKNLFLLNLTFLKVVLINFFKLFK
YKKVTKKFENLKQHNFQIKDFKGRYLNELIYLYLSELNLDLNINKHKILS
VKSFILSDKTNKEYLLEKKYYLQKKQNKIALINKEN
>MS53_0589 hypothetical protein
MMASVQIIKKNKTQYVRIVESYWDKEVKKPKIREVKFLGKLEDFTKDNPN
FIEELKESVSSKKNKKQKDRNEQILQIMNSLKLDKFKGTQIKGYGNLVYE
EIMNYLELPSFLTDLQKKNSRSKYDLASITKYWF
>MS53_0475 putative transposase,ISMHp1-like
MELIYKVIKELDLFKGLPKTKHKSLEEVLEFIVATRIIQPRSYICQYKNK
NDFLHKIDIKKSSIYNYFDTFLEYKNAILVNIYNKMQELTTRNAKLMHFD
NTTVYFQSFSRDALKQRGFSKDRKHDEDQIVVAMAVDNSGIAFHYKVLKG
NTADSKTLVKFLIEMQRIYRIKDIIIVADKGIIQNANLRYLKQKGYKYII
QKRIDILGKEDKAFIVNEQGFVQENKYFTKSRFVESIWAKNKNKKRDSDT
FRKQFVYFSPSKQTLDKIKRQNLINKLEKKSIKGELPLSALASEYKKKYM
DVDGKTVGRLNIEKIKKVANEDGFYMIETNITNLNSKEANEIYKGQWKVE
ESFRTLKSAIEVRPICVYKDKHIQSHVFLCFLSLIVLKYCIYKLKKFYKD
NGEIQKLTMNMFIDALKLITITTKTVNGKVVSKIKNNLDPGHKELNKIYS
DFQYAVDGLSL
>MS53_0069 conserved hypothetical protein
MRVKFNLLRFIMNKVKKKKLIILFGFSSAILTSAAGISFGVTQLSQAYNS
NQQIIAINRSRSFNLITAKAIKNSTEFNTDLNLEELKEEDKVPIQEIEEV
PKPIEEVKKEEPPKVVAPKVELPQSENPPLLSSAGSIVDLNSIKPTVSEK
SDWNKPTGQRLSAALQQQAREAIGKAQKAFNDVFSKLKVNTDGTAEFTKA
QKEELADSLGVPADKKEWFFKMFLKNFEEGNQITDMYGMLRRDSSTAKTN
REMFLHAINNVDFDFYFSINNIPYIKWEYGNDITIGGKPPSDAENVVVQH
QINLNKKRFLSSDSKWRRYSPQMIADNDYFGWTQTDITSEVTSRVTLPST
DGIKISKYVANSDNAVATDKTTPRYALTLDASNTRGYSDVIRNLQTLNAA
GYKIEVFNVKRIGHQKNQDFSAVFRAMPDTIKLLNLFFDDTNTDSLVGLK
GKRIESLGLWTTKNQLDENWGIDPFLLKDVEEIEFDYQNSQSGDYPRGAE
VAGSIIFSRLRFDKSDTLPEIQKGLNVALIEKADQRAFQGYFGAGSWPSE
LDFTNHPNIKTLQGLKFGPKNDLVFKKLYLYNNSFNFNLTADQLSKSGFH
HLLFRTEPSKHAEIHFSNETRVNQYQLYISGDASQMTGKWIPEFQGLLYA
GQKTFIKTIYVDNQEMVNRLNDSGVPSLYGFSVVVKPAGYTGNESSADLD
FSS
>MS53_0262 putative phase-variable hemagglutinin
MKTSGSVTKAKEAKDDAEYSKVTDTLKTTLEEKYTAATALLEDGTKLKNL
DADGTLATTQASLESAKTALDAAVSTLMPELTFVKTKASAVKTASELGPL
VNEALLAELRKQANDLPKNDQSKADKLDSELKSLKESLESLQTLVSDGLK
MQVDYPQKYYDADNKEAFDAALLKASSVFPAFQWTEDSIVVPAPIDGALP
NPRAWTKARDKSEFKLQNFVISPAQAAAPTTAQTSPSAAATATVRVAMSE
EAAAEAETQTPAAPMADLASTASYLKTLETELKTQSEALNGETPATKTAY
YKADTTRTLYWDGFMPKIVVDGYVADGAGANKAQHETANRPLLQQWFEAN
QDKLSLVADQLTKKLGSDKFKNVTLTNPVVTYEEITVNSNTWKNPKVTFN
IQAKPGYQLTEPTTEESQISLSIRVLYENQTSTQNLLTIQEASPSAAPRR
ATVNDENVKSKVNVYLNYTGPSIVLDADLPTVGEQENTSINGTSNVEGTF
NTKFKNLLVNVVGESITQTSLLQAIINYVNKFDPKFPAEFVLKTNGVTVA
SVQNNTQLRIGSLNDFLWNNKGFLQQVNGDSSAVYFAVNGVTSEGWLNTF
LIRIPLTKFVRPISVLEEQTTEEETQESQEGQENQEQGSTTQTNTESSGT
GQSSDLTEVSA
>MS53_0132 conserved hypothetical protein
MKIKKRFLAISLLIPIALPLFAISCANYSERSSLNKLIDTSQVVTNKDID
NNEAKSELILNNLLSRTFKNEIDRVNFLNQQNDSNYQNTLLDQLNSLKQD
FLKAKQDNNQTQMDLTANKLADLYSQNWYFFFKNLSKFSGTFNDFVIINK
TKDNFHSAQYLNQVKNKTPYRDFRYLTNYIDSIKVGEESAELGDSSVLYI
AKDKSVFRVTIRNESLDKPTLSIRPYIWYFGDFGARNISLSIISRIWHSA
VIHNYQEGYELFEKSLIKDQNYGIPAKFVLLPKINAIQEESPASQTSNTQ
ESKTQENEN
>MS53_0363 conserved hypothetical protein
MAKKRSNFVDAHAHISYDFYSKAKVLEIVNNSKKLNIEFIINNGGEAKGN
LEVLELSKEYDIFKPAIGFHPENAYFDKNDINQLKDLLEKHKDQIVAIGE
IGLDYYYENAASKKDQLVFFEKQIQIALEYNLPAIIHLRDKDDQYNAYID
CYNIVKKYPKLNFMLHSFAGSLDIAKMFLNLNSYFSFSGVATFGSSKIAK
EVIEFLPMDKLLVETDSPYLRPHPYKDLKNVPQNVVFTHYYIAGIKKLGM
DAFVNKINSNLRKLFNLK
>MS53_0646 hypothetical protein
MNMTKTLNKKEFFKLQKYKRIEKDFNTKSSYSIWHLLFYLVVFFLNSILL
GFSLLFLLRSDFLPAIFFEIYIYSINSWLGNLVFPLCLLVYLLLMMVLLN
KLFENKALSWFSSRDVKIPWKVVSKKIVKFLFYWFFILALCDYLYFHYIV
YENSSLFFNPTLVRIQELFANGWWKYFNNSQIPLGSFLHVGVIFDSLGNA
LVVASLSWILTLFLLVFLGATSFAELIVVDLSKNNASIFKRENNLQEYKD
YLRYSSYHYSYTTSVEKYLNFLMKAAIYFKLDYIHSTVEDLEKEVFEQLK
KEKIQEIEAVKLFEFSKADEARANSLYLENQTLKDQIEKLTVENRNLRNQ
EKQLDFFDENHSAWQNNETPFATNLRLARPNQGFTQEVKVTQAVPIPKPQ
VKTQVVDTGPKPNDGIFANSKPAPVVKKAKIEEFDLDEFLKQEATQSIKL
EPEFEEVRPLFAPKPVKETKKTVEELNREALEKQEFYNWLEEKNSSKVGL
FKPRKLGDTSLGMVHESDGILRDDINPKNFQPKNQRMQTKQKGHYTYSDE
KLQKITNEIDVSDFLVDDN
>MS53_0343 conserved hypothetical protein
MVFGQQLRNLDEKNRIALPPAFKNKLVEPLYLTIGFDGQADLRSEKEFEK
FSAFLDQKNPFDAKIRQIKRQINSNTFEITLDKQGRITIPARIMQWIFAG
EELGKEIYFVGAKDYVEIWSKSKFEALNEKVTPVGLEKLVEQAYNEK
>MS53_0063 hypothetical protein
MTFLFLLILAGASGSAIYFLYQNDWKLKKDKASDSDKRFEFTSQENVFPD
LDAEYFQKYIKLNSQNKEEIKQEIVLPIVSDVLSRLKSAEGKVEFDYTVK
NTKNIEIYFKYKNGSNYQTKAYLVYLD
>MS53_0061 conserved hypothetical protein
MNKFVFEDLNINYQYEEKSQQNPSENLILFLHGFGDSLKTSYSFSKEKNK
NFRLAAFDFISCGASDYKQNLKLETYGKLTEFFINNILKNENNIYIVSHS
LGAFSALYVNKNSKVKYTFLASPFSPWNKENLEHKKFLINHLLPENNEDK
KISYFDLFYNPSNLAIVNSAKIFDKLNSNFYTKRKTAFEKMVNDQIVNFD
FLSNDLYALYKDAKNYCAISGEDDKYVKIESLEELASKLNFKLYKLSKTG
HAIFFDSFQKVLEIILSQIKE
>MS53_0545 conserved hypothetical protein
MMYQNANFSRRFFASIFDFLLVLLICFLCFYLTSIRFLALNKNFNDFVIY
LPFILCLVFIWQYYFIVPIITEGYTLFFIIFKIKIINQETKKFSALALTL
RNIFGVFYWSILIVLFLIFLKPSDLMIQDKKLFFVDNENTKLIQGLFKYL
SGLWGMLTSFNFLFILFSKKKLSLFDLMSKSRVVINKKIIPITEEKIIFK
PKVYIYRKYIYFSDLQL
>MS53_0582 conserved hypothetical protein
MLRLYCANNLVLNNVQNLWKYLLLLIFDKKIIFLFKIKVILIRRYMENNN
KEKIVIGFDLGVASVGWSIVNAETKEVIDLGVRLFSEPEKADYRRAKRTT
RRLLRRKKFKREKFHKLILKNAEIFGLQSRNEILNVYKDQSSKYRNILKL
KINALKEEIKPSELVWILRDYLQNRGYFYKNEKLTDEFVSNSFPSKKLHE
HYEKYGFFRGSVKLDNKLDNKKDKAKEKDEEEESDAKKESEELIFSNKQW
INEIVKVFENQSYLTESFKEEYLKLFNYVRPFNKGPGSKNSRTAYGVFST
DIDPETNKFKDYSNIWDKTIGKCSLFEEEIRAPKNLPSALIFNLQNEICT
IKNEFTEFKNWWLNAEQKSEILKFVFTELFNWKDKKYSDKKFNKNLQDKI
KKYLLNFALENFNLNEEILKNRDLENDTVLGLKGVKYYEKSNATADAALE
FSSLKPLYVFIKFLKEKKLDLNYLLGLENTEILYFLDSIYLAISYSSDLK
ERNEWFKKLLKELYPKIKNNNLEIIENVEDIFEITDQEKFESFSKTHSLS
REAFNHIIPLLLSNNEGKNYESLKHSNEELKKRTEKAELKAQQNQKYLKD
NFLKEALVPLSVKTSVLQAIKIFNQIIKNFGKKYEISQVVIEMARELTKP
NLEKLLNNATNSNIKILKEKLDQTEKFDDFTKKKFIDKIENSVVFRNKLF
LWFEQDRKDPYTQLDIKINEIEDETEIDHVIPYSKSADDSWFNKLLVKKS
TNQLKKNKTVWEYYQNESDPEAKWNKFVAWAKRIYLVQKSDKESKDNSEK
NSIFKNKKPNLKFKNITKKLFDPYKDLGFLARNLNDTRYATKVFRDQLNN
YSKHHSKDDENKLFKVVCMNGSITSFLRKSMWRKNEEQVYRFNFWKKDRD
QFFHHAVDASIIAIFSLLTKTLYNKLRVYESYDVQRREDGVYLINKETGE
VKKADKDYWKDQHNFLKIRENAIEIKNVLNNVDFQNQVRYSRKANTKLNT
QLFNETLYGVKEFENNFYKLEKVNLFSRKDLRKFILEDLNEESEKNKKNE
NGSRKRILTEKYIVDEILQILENEEFKDSKSDINALNKYMDSLPSKFSEF
FSQDFINKCKKENSLILTFDAIKHNDPKKVIKIKNLKFFREDATLKNKQA
VHKDSKNQIKSFYESYKCVGFIWLKNKNDLEESIFVPINSRVIHFGDKDK
DIFDFDSYNKEKLLNEINLKRPENKKFNSINEIEFVKFVKPGALLLNFEN
QQIYYISTLESSSLRAKIKLLNKMDKGKAVSMKKITNPDEYKIIEHVNPL
GINLNWTKKLENNN
>MS53_0458 conserved hypothetical protein
MEKKKLVKSTALALLSTGGVAGLIAIAVTEAPGSSKPILKVDPGSREEHK
IEYETIVQKPGSDKDDKEKNGRSYEDLLNSDANRLFNGDNDQRTEKQISK
KLVLANDKINYIALGDSIAAGFDGSLDKDYQGQKEESGAISGVGYPAFLA
RLLNGDNNRVTDFKNYAVSGSRILDWINLLGINYGTQDASQVATQLSQYF
GKDYQSVAEDLKARLKNANLVTISLGGNDLFSLVFESLKSLNLSSLVESL
LGDNPTYSDVIGAVNNLYKAIVPEIKKRYVTLLANLRVLAPKANINIIGY
TMPFLRLKKTIDSILGNFSGMNISVSDTLLSYINGLLKSLAQPNNDIYYV
DTWNSDFYSQNARLLSDTFLDIHGNINSYKRMAMDIYLKLTTADTNLSSY
GNSSYDFTEKFIKSDLTTLNYQIQVNNKNLNSIFGANSLAYLNNKSIYEL
QALSKRNVGNYPNRIFEIGRQLNYVFIDFLTSLIYTNKAGSSSKENADLI
KLLMQKDEFGNYKIASLIESIARSNGVQNILNNIQNELDELDKQNKLDLN
SLIRVLLKSVSRESDVVSLVKAVVSSDFVDQNSDELSQKIGAWLTAFARD
FKGLAINIATNFVARSQVGDFVSVEDLKLLIQQFFDSPSFNSLLKNVVSA
VFTNKALFKDAQTYDDLARAIFGNKEINQKIANDLYELLKATLNNSSFSK
LVSEFVFKFLQSQKLDNNLTQEKVTKLVADLLKWTNSYNKLNDLLKGVVA
TYLDSVATKGLNTSLEAVSNLALTSLRKEFNSVEESITGVVSSLAESNLV
TENKETLKTLVANLVNGLNNVSLNKLLSLFLKDEGKLNSFLTNKDLKNLF
SVVADNDQTKKILVQVVSDLIDNFDKFKNAKTTDDLFKAVLGSLNLDKLQ
EESKDFISNLLKNPSFQSSVSGLLSNALGSTLAEDLKVKTLLDSLVKNLP
TLLEGINLDEKFLETTFGVLKEAKQSSWGLEQTWNKLLENANSQVTKVLE
GNLSNLVTKLLTDSEISKEKDSLNKVIFGLYKNLKDSDSLTNLIVSQVEN
LSKTTPLLNGLSKEALEKVVTLILNSPQTDSLVKKVIESLTKDTEWTSLL
DNPLKLVEHLLKDKDFVTALKDPSLELLKTLVTNSNFNSLASTLLTNLLT
QYGFTLDPVKLNSLSLSLTNDLFPFLKDSGILDKATKFFFNDLAKTQNLL
KTVNNLTSNLASLVDFSDYSVFKSLVKSDFFKNQKSTIKDIAKQVATSLL
ANEDFVKNNLLSLDVVKKLTTSFGLLNDATLKLLKAIFRYTKL
>MS53_0222 putative phase-variable hemagglutinin
MSLKNKLAFIFKLIFLWFTSGSVTKAKEAKDDAEYSKVTDTLKTTLEEKY
TAATALLEDGTKLKNLDASSNLDTTKASLESAKTALDAAVTAIKPELDFQ
KTKTSATAKVTELESLVNIALKDELQRQVNELTKDHATEATTMLANLTSL
KESLESLQTLVSDGLKMQVDYPRNYYDADNKANFDAALLKASSVFPAFQW
TTNSIIVPAPEGDALPNPRAWTKAREKSEFKLQNFVMAPAQAATEESSDS
TAAESTAAESTAATVRLATEEAAAEAETQTPAADLASTASYLKSLSDSLK
TETDKLNGDTTENKTAYYKADADRTLYWDGFMPKIVLEGFDSRWTNVEDN
KSKLQTWFNTKANWSNLEDQLTKKLGAERFKNVKLTFKEASFSGDDIKTP
TVNFTVAAQDGYTLDNSTNEISLVVRVLYNRDNESTIQMPKQGASPSAAP
SNSSVNDAKVKAKVNVYLNYTRPNIELDADLPTVGGQENTSINGTSNVDG
AFNTAFRGNPTKGLLFTNRYANPLLKSVINYVNKFDPKYRATFVTNSKNG
VTITKVEKTKELRPGTLDDLVVKNKNNVFLQQIKGDKEAVYFAVTALTND
KWLNTVLVRIPLTKFVRPLTEFQAQSEAAPTEEASGDQAQADPQATQMGT
QARS
>MS53_0554 hypothetical protein
MHLDECQKYLKDLFVAKAKGANYYAVEALKEKAKDLNWKLGKSWEKWRQV
ESWIKSDEFTSSTDTSGKSKATDALAKAKKFLESGENGLTLENFETKLNS
VSSTLDLSSLKLKPEPSQKTVSQKSYDQLVSEVSKLSYLSSLEKSTYLQN
>MS53_0223 putative phase-variable hemagglutinin
MYWDGFMSKIVLDNFDKTWEQNSENERKIREWFREASNWAGLSDQLTKKL
GAERFKNVKLTYKEVTFSGDDIKTPTVTFTVAAKEGYTLVDSGENASATE
ISLVVRVLYNRGSESTIQMPIQGASSSAAPGNTKTPNNATVIKNVNVYLN
YTDI
>MS53_0302 putative DNA methylase
MLNKPEVKKNSLGFDSNLYVYQDKTMFNYSVDTILLGNFINLTNKTRSAL
EIGTNNGALSIFVASRSKKLKIDALEIQAKALELAEINVKLNNLENQINL
IHGDFNDFYKNHCNKTLPKYDVIFCNPPFYIYEKQKVKKEITEEQLIANY
EVKLNLEQIIAGSAKIIQQKGELSIVLPIERLVDLFTTLRKYNFEPKKVQ
FVYTRKSARAKFVLCNAKFNSPYFTEFLPALFLHADDEQNHEYLPEIKQI
YKPIKIDN
>MS53_0333 conserved hypothetical protein
MRKKLKFFLAGAAVLTLPAISVSCLYENDKTIKFARTFLNENAILEKQKS
MPKHQNLVVQKFLDTLYSSNLLTYTFSDFDYRIKANISGFSLTQKINGSS
VSATEDEIRKALEEFLKDTPFYASYLVNKNTKNDYLKFSNDTVKRVNFSV
PQGIFNTIPTFIFNPIEEKYKSEFLTLSDFQNNIEKAYQMARSIFREFSF
FINKEEDNKVAAEPEKFQSVLGINSGFGATYLIDGVNPSTRGKDDGFKVL
DSDTLDDPELQKLFLSDYQRFVSLYPHLLFFESITSIRNRITSAQASIEA
IEKTISSTSNSAQRQSLSQSLKSFQDIKDAAEKQIEKFNSDRQEMKNLSD
ELVALNNSTNADENLKKQKQDELDKLVAFYQEDIDKIKSKFARNSRNSFT
DIYHLNELFAKILFTFGAYKTQIIRGSYQEDDPANPGETKKQTIWWLEVF
DYKDSKWKIIDVYKDYLMIDKLGEENSSNNVLNNLNYKVQLYISLPSNYK
IDSEFKDIAHIKSNIQ
>MS53_0233 putative phase-variable hemagglutinin
MWFTSGSVTKAKEAKDDAEYSKVTDTIKTTLEEKYTAVAGFLTEGSKLAN
LNADGTLATTQSDLESAKSALDAAVAAVKPDLDFQKTKTIAAAKVTELDA
LVNTALKDELQRQVNELTKEQADQATTMLANLTSLKESLESLQDLVSKGL
AMQVDYPQKYYDADNKADFDAALLKASSVFPAFQWTAESIMVPALEEDAL
PNPRAWTKAREKSEFKLQNFVMAPAQAAPATQSDSIAAESTSATVRLATG
TEEAAEDSESSEAQTAPTADLASTVSYLKTLDTDLKAQTAALNGDTTTNK
TAYYKPINGRTLYWDGFMPKIVTTALPTTVAPMNREYNESPTGGHEFWKG
RNKQVLDAWFAANQDKLSLVAEQLTKKLGKDKFKNMVLSTLTITWDEVQF
SNRLYLTPKVTFTLTPKEGYEKATGSLETVTLTIRNLYKEANPDTNVFAT
QGASPSAAPGNPTEPNNAIVIKNVNVYLNYTYI
>MS53_0239 putative phase-variable hemagglutinin
MYWDGFMPKIVVPGYQADGAGANKAQHETANRPLLQQWFEANQDKLSLVA
DQLTKKLGSDKFKNVTLTNPVVTYEEITVNSNTWKNPKVTFNIQAKPGYQ
LTEPTTEESQISLSIRVLYENQTSTQNLLTIQGAYPFAAPRNATVNDENV
KSKVNVYLNYTGPSIVLDADLPTVGGQENTSINGTSNVTGDFNNAFRGNP
SSGLLFTNRYANPLLKSVINYVNKFDPKYRATFVTDSRDGVTITKVENTK
ELRPGTLDDLLSNKNKVFLQQIKGDKEAVYFAVTAIASNNWLNTFLIRIP
LTKFVRPLTEFQAQSEAAPTEETSGEQDSAPTGTGS
>MS53_0096 conserved hypothetical protein
MQTKLNYEFNLQNYSGPLDLLLELVKDKKISILDINVLELANQYLKIINE
IKNTNLDIAAEYLNYATIFIYMKAKYLSNKPEDIEIVTQEKQKLINDLIE
YKQFKEIKDALSTFQKSRQEIYIKKPSNVDEFIIESDSSRLDGHSSITTL
ISTLRKMFERVFAQELRKANFSTVKINSADQIKFIKNVFGQRSEVKFEEI
FIQSSLTHFVITLIALLDLARQQFLTLKQDSQYGEIKILRNFDNNEE
>MS53_0264 putative phase-variable hemagglutinin
MALYWDGFMLKIVVDDGYVEDIEENNKENNKNTNQQKLEAWFKANQDKFT
LVADQLTRKLGEEKFKNMTLSNPTISWDEVKFSNRGSNKGYLTPKVTFNL
VAKDGYTLAEESAATVTLTIRVLYKDSNLTRNVLSTQGAYYTATPSDNAT
TIKKVNVYLNYTGPSIVLDQAVPAVGTANNTSLNGTSNVDNDFNNKFKKL
LVSGTTQTPLLQTIINYVNNLTLNFQLHLY
>MS53_0269 putative phase-variable hemagglutinin
MRDVNVYMNYTGPAIMLNADLPTVGGQENTSINGTSNVDGDFNTKFKKLL
VNVVGGSFTQTSLLQAIINYVNKFDPKYRAAFVTEKNGVALTSVQNNTQL
RIGSLNDFLWNNKGFLQQVNGDSSAVYFAVMGVTSEGWLNTFLIRIPLTK
FVRPISVLEEQSAQDQTQESQEGQENQEQGSTTQTNTESSGTGQSSDLTE
VSA
>MS53_0110 putative DNase/RNase endonuclease
MKMKKKNFWKKLILSISSLFVTATVVTSCSFGFSQKKDEKQNEQSSPRTS
SGQTQNQDQKVAASNLPKAKVTKYTDGDTVNIVYDTIGVTAKIRFYGIDT
PETLKGSNRNLIAKYENVYAQKAKDYVKDLITKNNHVVYVKKITTDKYNR
TVAILYLTDDETSKSVNELIVENGYGAVRYISLTNKTYKVKDDFQRDFYF
RLLNLQEEAKSKSLNIWEHDLKDVYYKYPFNND
>MS53_0041 putative ABC transporter ATP-binding protein
MNDKKIFSNINLEIPINKLTFIIGPSGVGKSTLLNVLGGIDKEYDGTIEY
NFNNISIDPSTLLKNNYVDFIFQDYNLFEDLSVEDNLVFPLNFLGHNLSK
EEIIKVINELGIKEIQLNEKVKNLSGGEKQRIAIARAILRKSEFILADEP
TGNLDTKNSENIFKILSSLSKKRSIIVVSHDLEAAKKYGDYIYDLKNNEL
LENKPTCNEYLFNDIKNNLGKNNFWNKYKPLLKFSWAGIKRKIISFILMI
FLISSTSALLSNTYSLHNNSQFVSTKYFKETNSDFIELKYQTYSTNLIDI
KKIDELNNRIGNLSSTSYYSYYPEWRIVALTNSDKILELNFDEIDNSSFW
TNKLANMNIIGKASLDVNEVIVWKKDAEKYNLDLYTNNELKIDNGIILKI
VGIVDYDDMIDLSNYYSYIKNNEKINIFVSTETTKKISLEINKNSKFSFS
ILKYIDDENAIQIANSSMIDYDENLNDNEFTLISPVKKQLNIGEKYKIHS
DFHIDMDLTLNNFLIDKNSENTKIKFSKKTFENLKKIHSEYISGYPNSLL
IYFNNAENLKKSLNLLNDLAKEDSKIVIHTNFASLGKMIVENSKDTTKII
FIFAIFIFMISIIAVAIFSHLIVSSKSKEIALLKLLGLNSRQSLIYHLFS
FIFVALVSIVFSLLIMYPIYLIFTLLINNLALLKFNWLLNVTTLFIFWSA
ISFVSFLIYFFVSLRKFYAKTNRLLKEK
>MS53_0032 conserved hypothetical protein
MFNKIHAFIFDMDGTLLNDKNQISESNLNAINFLHLNNKKVIIATGRPNY
MNHQYYDALNLKDAIIGINGAMVDLNWRNLNQTKVMGYLPKESFKKIASY
LNENKIDFLTYHKNSMYGFNYNNPPWFENRIYPKIQSDNKYKWNYKEIAL
EKLYDFLEKKPGEFVFLKILVISQKQSEQTLLKLKEFLNKFNDLYYLRSQ
SDVIDIMPLNISKGQTLLDISKDINLSLENALAIGDQENDIEMLKNVAYP
VAMLNAKKELKKIAWKVTNLDNNNSGIADFIYSLTNVTFEEKIKKYKLNV
MDNGWWYQPSIWTMSLTKWTYRPFKNYQDFLKYIKKTNDPIYLSLNGDYQ
FKVFNQIQKYYNNNLRLDYKSLLNKREIYLKLTDEIYIYLNQKTLKQMQV
GKVFGFPSIYFETKVKELNYKIDKNLVYVFKYKKFSFELQIMDKNLIKNK
>MS53_0668 hypothetical protein
MKYNFKESSFALFKIFKKYIFIFVLFSCFIFTFDFLAVRFYAHLIDNLSE
NKEKISLENKDICFYFLVLFLSIILTFVYKKFNCVFWK
>MS53_0056 conserved hypothetical protein
MIMVNFSFPLSKVEDLSNYKPGFFSWFGTKAYWDSNLPAFIKNGNFFFIF
AIVVLFLLFVGMWVLKRQIIAKYKLSLQNNSNFYKYFHMTLGITILLWMI
GRSLIIYFVMGYPRYWETIPVHFCRLMGIMLGVLLITNKLKYIKYVAPLA
VLGTLMALLSPDLTMEVYFDKNVSQSDLDALSAQKIFLSGRDQYINFKVE
EVFKLRWGIFNFIFWDYFFFHTFLLAAFVTINFLNPGKLGLKEISKTLLV
CFMFVGAMASINHLLDNSPAVSINWKSNYWYLGTNEINNLSTLVPPFTEF
PFSIFTFVLVGVVYLLFVSFMLALQDKVYINVFAKGKQVKFKIIESENYL
YWKSSFKLAFSSLLKTMKKLFRKA
>MS53_0236 putative phase-variable hemagglutinin
MSNAFFYLKVNQKLTWKYKKAPAQAAPATQSDSIAAESTSATVRVAMSEE
AAAEAKTQTPAPTPAADLASTVSYLKSLNDTLKAATDALNGDNPTTKTAY
YKADAGRTLYWDGFMPKIVVSLLTTKLANQEYDASVRQGGVVFWKTRNGE
ILDVWFAANQDKFTLVANQLTRKLGKDKFKNMVLSNPRITWDELTIPEGT
ILTPKVTFNLTPKEGYEKATGSLETVTLTIRNLYKAAAPNTNLFATQGAS
SPAAPRGATVNDANVKAKVNVYLNYTGPNIELDAEAPTVGSQDNTSINGT
SNVDDAFNTAFRGNPSRGLLFTNRYANPLLKSVINYVNKFDPKYRAEFVT
NSKNGVTITKVESDTQLRPGTLDDLNKNNVFLQQIQGDTEAVYLPVTALT
SDKWLNTVLVRIPLTKFVRPISVLEEQSVQD
>MS53_0583 conserved hypothetical protein
MMAKKVVEIKETEYLFFHLNSLIVKKENNKIVLPLSDIDTILISNPYCTI
SVPLINAIVSNNINLIICNKDFEPNVQLLSISGYYSNKNFLSQINWTQEF
KDKTWEKIIKLKTTNYVNLIYFFGLLNKEDVEKFNFYYKKIIPGDKNSME
GHIAKLTFKNLYGSTFNRTDKENEINKFLNYGYTILMTYVSRNLVKKGYD
NRIGVFHKSFNNHFALATDLMEPFRFLIDKLVYELLIIEKNYDFINFKKK
VFLIFEEKILLNKSPISVNEYICKLIENFINKDFNFESLEIDWNKK
>MS53_0192 hypothetical protein
MHKYRKDGLSQSKAFFYCLGLGLIGGEYFYLKLKKLALIKLALAFVGATI
IFVTLVVLANTQSPVLSDETKKAIDLKTANVFNQFTDKHQNTQALLPAYV
VGGLLIASNVVWTIYNAVLIHNGEFKDNKKQKISQWTETQESYLEHLLTK
SENWRH
>MS53_0504 conserved hypothetical protein
MGKKVNLNHESINKKFSTLEILLMRSEKFNERNTVEKINLNRANFYLNKA
RESKELYSEQKQNVLFIFKKWNVYKSFKQHNLIHKNYLEFMNSYELFLNV
VSNYLKLSNFITEVQLKANKKLEILDQIYKENNYFDKHFKNYFKNKQNEF
RKLIASIGFQNDKANLLEALENWDLSRDLFISYLRHVNYFLKVKNIFLNP
KEFNIKSEAQLKKLKNIAKNFFNLSVDNINYILLEILSSEFKKNAKQLNL
EELSVLNSKYKILNKKVFDLYLDKSSEYKFIEQNLNTLIELGLRETSNSN
LDEKFNEFDLFIETWKKLEVYDNKVSTQNINLKEINENNNFDFQKSIKIF
YQIANSQFINLKDENIKNKYYHFIYLFDKTNKILETKKEIDDRLKTEYFE
YLKYFINMIAINEFYFKMHNFIKINFAKNLNSNDELDKQKAKEKEKQFLA
SLKQSENDINNFLYKEAYLKIKKYI
>MS53_0503 conserved hypothetical protein
MIMKKWAVFSDVDGTIYPFPSKNLTETVKKRCQLLKEENVSFFINTGNPP
LDKIKKLATKLNSRYLICSNGALIYDNEAKSALHVEYMDKDQAKKIFDLS
DKLNQTLYYFGIDQYYLKNASKEVYDFLSDFCEYSDWITDGRLNDDLYKI
EVYGTRDEIQAFYKEAVKLDTNLNIVNLNTHIEITNKGVSKASGMKWVCD
NLIHADLKDVMAIGDSPNDISMLDAAGYSYAMENSDDLTRSHAKFYTSSV
EQSGLAEAIDDYLYRSDYHIHHKK
>MS53_0064 hypothetical protein
MNNTNFKVNIVGDLSQKDFKFQLELSRVWTNNLFSISIFNTLDKNKYALD
LALNSKDVLKDVQRDLNQIEMPFNLIQLSYNKLNNIFVTIYNKNYPNERI
QYQILLSTFKKVKLNLKSNKENIDYKIPYQYLFNFNSNKTWYLDKTFTNI
KWKFHNPSKQRSLGEIAQILFENDDAFYFETRRNKLITELPVVNSASLLA
KPLFDTQFELAIESNLNNLGFIQDANDIKFKKLFLNFDDYISIDNLNQRV
EINGDIAPTKKFTVPRFFIGTLRYSLIFENSNFEIITEKILKFEQDEFID
YSRPKIKIKDITDDVNFSLLRLKYKINLSKIINFISLEDDQLNFNYLLRN
NLIYKKDENE
>MS53_0235 putative phase-variable hemagglutinin
MPKIVVQGYQADGYVADGQGNNRAAHEDANKTKLQNWFNAPANWEKLSEQ
LTKKLGADKFKNVTLSSPTVTYETISTGRDVRIPKVTFTVTAKNGYNLTA
PTGNTKQISLSIRVLYTSASSTENALRYQGVSFSATPKDASVENPATAIK
NVNVYLNYTGPSIVLDQAVPAVGTANNTSLNGTSNVDGDFNTKFKKLLVR
VLNGGHAESSLFQAVINYVNKFDPKFRAQFVTNSINGVTITKVESGTQLR
PGTLDDLVKNDRNNVFLQQMKNDTEAVYLPVTALTSDKWLNTVLVRIPLT
KFVKPLTEFQAQSATAPTQEGQTTQGQENSAGSGALGSTTGTQTPSGGSS
QASGS
>MS53_0118 hypothetical protein
MVMNFEQKNNLNSLHVDVDKDYKFLISSKKTQGQFYGLVFMFFSLAFSVF
VALTISIYHSVFNAIVNGVDNAFTRFMKEKPFVVYGLVLGLFVAYFIVIW
FLRKFSWKSLIFSYPVVVLFFSVMISMALVVYSINPDWNRETTSYKNPPI
TVPLVLMFAPMLVLFFLGVFSYYGLFDLTKLMRVSGFLLAVFLILTVIGI
FAVGPVYGTINVAISIIGIAIISISTIYTFNRILTDSKNLAFFSKHEFIA
RAAGYGIELFISYANILWFLIRIMMKFKK
>MS53_0095 conserved hypothetical protein
MIEALLYIQGDEGLNLEQVKEVFNLNNTHEAKKIMQDFQKDFNNLDRGLK
VVVFDEIFKLATRESVRAYVSKLVTTTGKQRLTSAAIEVAGIIAYKGPIT
RGQISKIRGAVSDHIVNNLLKKGIIHEVGVSHTQGNPVLYEVSSQFYDHF
KISSKQDLPKMRDFDYSDGFEDESEFDIFQSQREI
>MS53_0038 conserved hypothetical protein
MGDLSRRRGLISDQEQRNDGAVIVRAKVPLSEMFGYSTELRSMTSGRGTY
QMQFDHYEKCPNSIADPVIKRRNIQDKDEE
>MS53_0017 conserved hypothetical protein
MMNNLENKENTNLEVAQRPVYKKEGNFNSKLDKKYKDPKNQLNSLTYSVF
KKERFLYSVYVIFWSIIFVASLIGGVVNYFLNTTLDYQNGLVWYFLLAPL
ALVSLFFMIKYGLDIKAWKRSEKIYRANVANGQVDGLVHFNEKYKKLILA
NLRRAWLFAIFVTYFLLFNLVVFGLWKAGNIDIVSNNADSPFQLNLHLDL
TQLMDQIFKDTKILLIVNSVVLFAAFALYFAIFLYNKNRIENIKTLLGPE
ANEIVNTVYLIKQRENRSWIIAYTIMFALIVLLPLTILIVLLFKKTIRRK
K
>MS53_0536 putative transcription regulatory protein
MQDATNVSRYKKVGENRYRETTGLYYEDFNVGDVFEHRPGKTILDVDNVW
FTLLTLNPQQVHFDQHYASQTEWKKLLVDSTYTLALVTGMSVNTVSGKVV
ANLGWDKVRLTAPVFAGDTIYAESTVLSKRESKSRPDQGIVTVLTKGINQ
KNEVVISFERTVLVYKRDNNKIESQTNY
>MS53_0201 putative phase-variable hemagglutinin
MWFTSGSVTKAKEAKDDAEYSKVTDTLKTTLEEKYTAATALLEDGTKLKN
LDASSNLDTTKASLESAKTALDAAVTAIKPELDFQKTKTSATAKVTELES
LVNPALKAELQRQVNELTKEQAAQATTMLANLTSLKESLESLQTLVSDGL
KMQVDYPQKYYDADNKTAFDDALLKASSVFPAFVWTTNSIMVETPEGQLP
NPRAWTKAREKSEFKLQNFVMAPAQAAAPTTAQTSPSAAASAIVRLAMSE
EAAAEAETQTPAADLASTASYLKSLSDSLKTETDKLNGDTTENKTAYYKA
DADRTLYWDGFMPKIVLEGFDSRWTNVEDNKSKLQTWFNTKANWSNLEDQ
LTKKLGAERFKNVKLTFKEASFSGDDIKTPTVTFTVAAQDGYTLDNSTNE
ISLVVRVLYNRDNESTIQMPKQGASPSAAPSNSSVNDAKVKAKVNVYLNY
TGPNIELDAEAPTVGSQDNTSLNGTSNVTDDFNNKFNKLLIRYKAETSLF
KAVINYVNKFDPKFRAQFVTNAIDGVALTKVQNKKELRPGTLDDLVVKNK
NNVFLQQIQGDTEAVYLPVTAIASNRWLNTFLIRIPLTKFVRPLTEFQAQ
SEAAPTEEASGDQAQADPQATQMGTQARS
>MS53_0177 putative transposase ISMHp1-like
MEKKSIKGELPLSALASEYKKKYMDVDGKTVARLNIEKIKKVANEDGFYI
IETNITNLNSKEANEIYNRQWKVEESFRSLKSAIEVRPICVYKDKHIQSH
VFLCFLSLIVLKYCIYKLKKFYKDNAEIQKLTMNMFIDALKLITITTKTV
NGKVVSEIKNNLDPKHKELNKIYSDFQYAVDSLSL
>MS53_0419 hypothetical protein
MDFNNKLNQRINSTSDMSYVNYENLQVLKRRLTHTKNLIITGLVFTLVGV
IILVVGGSMLAADTSGFASISIMFLGGLLATVVPIVFKVYYTGRVWSLRW
EVENKYLTNDQETYHQKADAVSALITAKVLVSISWIALWLILDFVAIFNL
LKARNILDTLSKN
>MS53_0251 putative phase-variable hemagglutinin
MALHWDGFMPKIVVEGYVEDIEENNKNTNQQKLETWFKANQDKFTLVADQ
LTRKLGEEKFKNMTLSNPTISWDEVKFSNKVSNKGYLTPKVTFNLTPKED
YKKASDSSEKVTLTIRNLYKEANSDTNVFATQGAYYTATPSDNATTIEKV
NVYLNYTGPNIELDADLPTAGNKNNTSINGTSNVTGDFNNAFRGNPSKGL
LFTNRYANPLLKSVINYVNKFDPKYRATFVTDSRDGVTITKVENTKELRP
GTLDDLVKNRNKVFLQQIKGDKEAVYFAVTAIASNNWLNIFLIRIPLTKF
VRPLTEFQAQSPATPTQEASGDQAQASTPQTIPNSSQ
>MS53_0605 putative endoglucanase
MKKEFKNRLKEFLEISAMSRYEEPVVDELKKTLNKLDFSLSRDNFGSLIA
YKKAKSAKAPKVMIAAHMDEVGFLVRSIDSKGQLLLSPVGGIWPTTVVGT
KAVLITSENKKYNGVFGHTSIHIMEREKVTKALTNKELYADFGFSNDKEA
LEHGVQVGDRVEMTGESVELFNDDLVAGKAMDNRAGVAVLEQVAKEVSDL
KLDVNLYLVWTVQEEVGTRGAITSTSLVDPDIAIALDTTSSHDTINTIPG
TTSLGKGAALRVFDNGMMADPKLISFLLKVAKKHKVKAYKFVSMGGGTDA
SSMQYAKGGAATTTLSLPQRYLHSPIGICSVSDLLETKKLLVNFVKELTT
QKYEKEIKYS
>MS53_0371 conserved hypothetical protein
MKNSNKELNKIKFLQEGIKLTKNLIKNYKNSESKNSESNEKVLDLKNIKK
QKSKNFISKDSEIRYLAFGDSITAGFDASLPYDFESKLDEAGQITGISYP
ANLARLLNFNNKLKDFENFAISGSTIQDWLEFLENKNYSSERMQNELKEN
FDAKRNLFLAKLKNANLITLTLGANDFFFLITKKINKEDIALGPKFIYKL
FTEKNFGEIVNSLTEDIFPTIKSRLETLLEKVLEINPKANINVVSYPMPQ
IRLLEYTNEFWAKLFMDRIGQKPSNDFLDYLNNIIKSATLKFKEVNFVNI
YNEEYWENNLKNVSTFFVDIHPNLNGYKKMAMDLYLKITNPSFELKDYQN
YDYEFTKKFLLSDSDKVQYQIEKVADDKYLFGTSTNSYLQKFGDNEKEIA
SHIDFKNFGRRINEFSPLFNLFLSKIPQISVKNLSTEGFVSHLTQTFSYL
LQSYRQKNEKVIKILIKMNLLPEIFENVQLELESVLSKKPKDFSFFKILQ
IVRSNFFNEKNILLLLDHFTNNKFSLKEKEQFLISLSLFISNYLADQLDS
SFGLNLHIDEKNKLKKQGVFGSISDQLANLIFNNRDKFQDFSSFKKLLFE
IWMFDDFVTNKNLLNDFEKLFEKFVYSNNFYDKIKESAIEFVSKNNLSKK
EFLKSYQNIYRLFVTAFFKNKEDVDSRFFYLLDFVLKKSEFNLPNSFNYL
EEEFLNFISLNFESWDWNENINNLKTLIKEDEFFASNVVKLKNNFLNKLT
EKDLTESIFRFTKLIYGFSDILSDKKELKNNFGFIYKNKLFSEIAKSNFE
VLVQKIKENNKATNKQILKSIYSDFYKKYNKKILDLISNEISVEKLKNIF
FKTFETIAKASTNKAEIDLLKIKNISEKIFDFNSWIKELKDNLFEFFKNH
KDTIFKFDRKFLEYLYSFVEEKVKALLYFDLSKLNKNNDSEDFNELKDLQ
KSINDKLEKNQSKVEEQLRKVKEEIANFNSNFKKFKEGISKNEFDVDFLL
KSLENVSSLDADEIRNWALSNLNLDDKKVEQMLWYFDKDGFAELFKSFTK
DFKKNENKYKEFNDFYNLFKKFANENSEDNKVLNKLILWFKNNSKDFSKL
ISLFFFEYLKHIKINIKNIENNFNVISKFLSKYLDYLLSENKLNLKELFN
SKNLKNKFTFLENLFKEIMLNGKLNFFNLFFNFSKFVNKKNIKSIFEFLN
LTFENSYFNNENDFSGIYEQVSEFLKSKIDLNVFESNNYQILFNGVFKNI
FENYFQEVFKKNLDLDDEKWVNYYKSFFRIIVLFLWYVIKNFAKNHDDVI
KLLSEFSNLYNKAFSKLISSPKNNYTFANFNKKQELLLGYENGIFSLDFL
IGDTNIDLIKKKYFKNKNVFSLLYKAFDENKNFLKTNKNEKQLWNLLFEG
SLNKKEAFKHLDKLIKKY
>MS53_0564 conserved hypothetical protein
MAAFDVDGTLLVPGDLVFSKNIKNMFLELKKNNVITTLATAREFASINNF
LEQLNPDYFIGANGSFVWDVKNKKFIFTNVCNKEDVIKLYDEFATKVEGF
QISHFDKVFKSPTTNTNTWYSKPFEHKFEDYSADKLIDDQIHLITLNQPD
PKKVQELVKNVTKFIKQNKLDLEISSLWSRGIFIAPPMSNKIHALEKLAS
YLNLGLENIIAFGDGENDYEMIKNVGYGVAIDDSSNELKAIAKDICFSCE
VDGPYHKLKELEII
>MS53_0599 conserved hypothetical protein
MKKVFKWLKILFYTFFFGLTLTGCIQNFVVASSNTVGNGIEFYNSKKDVV
PRVNTLDAKETITSYVDANGETQSFTTKELKGNALDTVLLNDRNVLEKLR
EQSQKNGGNFGEYNSLTSSFYLNVSEEEFSNPDAKIFVNNGKYLFATNGN
KTYEFVNEIKPIYVLAPLNNNIVAQISKVTETTTDENGTQSVKDKLYTDE
QSQEKRFGIKYVSGLARINDYSSDAYVAKPTLKYSRDVLQLYYNYEFGPS
SEFYKQLGSDVSEFLKSKIDSIQDKTIVGTGNNSPLFYLTPKQYSLVNYY
SNRMKVILSNLGWYKKETVENFAIDFSSSKNFLVDDALKYNADSNILDTR
TDEKELLGSGGTVQNPVTDWGQSWQYGPFYGLIVYPFSALINAITNSLPS
LDGWSSIIAILVLVLLTRLFSLFITFKATIVQSAQEDLRVKKAAIENKYK
GFENNKQMKMRKQKEIADLYKKNNINVLDGFLPQLVAMPIFFAMWRAIQA
VPSIKATTWLGINFGATSWREVIAGNFIYLWIIIVVVIIQFTSQLIPHWL
NKKRLKERTTVAEVQALKKSERYQTIFIIVFTFMAIIFTAGVQVYWLFTG
IWQTFQVIGLHKLRKTQWFKNKYSRKKPA
>MS53_0358 putative tRNA/rRNA methyltransferase
MAKLFIGGKNSTLDAIESKLNLKRIYLSKKENLKYFKNTNFKVEILSNLE
LSKLTNNANHQGFVAELDFTYSDINKIYESKPKIVLVLDHIMDTYNLGAI
IRSANAAGIKDIVMPKENCADITSNVLKVSSGGFIGINFYKVSSLNAFLN
KLKKHSYWIYGSMLDKNSTSYYSAKYNFPMAFILGNEEKGISKSALVEVD
EKIHIPQSGSVESLNVSVAAGILLFDIKHKVNE
>MS53_0471 conserved hypothetical protein
MIKAKKIKLLINFGAISILGVAGAVTAKVIIDNSSDKARDLNVIIVSRGD
KSVLNLKNVETDDINSSNKDNNLKEIKEETITPVVNDKEENQVESPVEPE
PDPEESNKYFSDVTKPIENPQPEPPVESKPPVKPKPEPDPEPIPEPEPKK
PTIEDMLPQSSEGIVNINNLPDLDFSTLKPVETPKGQLSETEKRTIKTAI
NNLVRISQNIPTKFTQEQIDEINKSINDIRKLNAYTKNEKDNDWSSLLNG
LIVNDGRTTEEKANAIGWPYKDNRHNYSLSFKLMWENYQRDLDAMLAKGM
VPSLQWGSFGNVWGFADHSDNVVRNKLIADNNRRYFPYNTEYKRTSGVIR
NLDYEGFSKTDVTNSYRNYGAESNKGITVLEYTPTSDYAKSQVGTKRVMA
VLDATNREGYNSFLKFLQDATKAGKKIDGIVIRNMGLIDKTQDFSQILAQ
MPDSIQKLTLFFEGKDTSSLIGLKDKKIQEIDLYNSSNTIADDWAINPYA
LKGVKNITFDYNYDIGFPGIPGNNRDMPGSIVFNTLKFDKGMSLNQINEG
LKIALNDRFGERIFQGQFGDGSWPTYLDFSNIPEIRSLQDMNFYDRVFKK
LTLFNKTNVFTVDAKTLHLQQWSALLIKGPDRPKLMFVSPQKVDTLYIKG
NAVDLGNNWGPELYGLIESGKAVFNTVYVDNEVMANTLNNSQAFTTFGKR
AIVKPSNFDTNGGNSEIISFE
>MS53_0242 putative phase-variable hemagglutinin
MASTASYLKSLSDSLKAETDKLNGDTTENKTAYYKADTTRTLYWDGFMPK
IVVKDYQPAGHGNNKDTNETANKTKLQEWFATSSNWEKLSEQLTRKLGSD
KFKNVTLTNPVITYEKVTVNTYTWKNPKVTFNIQAKPGYQLTEPTTDSKQ
ISLTIKVLYENQAYTQNLLTIQGAYPFAAPSNSSVNDANVKAKVNVYLNY
TDI
>MS53_0260 putative phase-variable hemagglutinin
MNYTGPNIVLDADLPTVSGKENTSINGTSNVEGTFNDKFKELLVDNNRVP
REFLSTVINYVNKFDPKFRAQLVTDTNGVAITSVQSKKELRIGNLNDLLY
NKKVFLQQVHGDSSAVYFAVNGVTSEGWLNTFLIRIPLTKFVRPLTAFTA
TPASAPTQTDSGTGAQTQPEAQS
>MS53_0449 hypothetical protein
MFVLNLNNGFTTLDENIKAIVPNVKKFLLENKDDSDIYFVNDLYTNLDME
FETNKNLYYCNENTDESNIDSSLLEFVNLQNKFQKNSTNAFWDLDPNLYL
KYNKFTLVGACTDLDILEFALTLQTYLLKLKLKKNIVVYSDLVATFDNEN
HSYKKYQELSLELLSQKGILVKKHG
>MS53_0679 conserved hypothetical protein
MVVNACWNYFVKWFVKHTIESNMKQWKIDLINDYKKKIDEISKASLNKEQ
KELIIETLEHYSLKENCTEAKLKNLYSLLIQRVKVGFTFDTTPEIINKTY
KFYWKKFIKNKSKNVIFISWSVNIATHFICCVSYCWSNFLFCHLFNPYVL
LNKK
>MS53_0650 putative GTP-binding protein
MFKFVKSSSDYTNWYFHKNSEIAFWGRSNVGKSSLLNALTSKGLAKVSKT
PGRTQLINFFENELNQVYVDLPGYGYAKLSKDLKDKMMAMIEEYLLNRSN
LKMLYLLIDSRLGFTKIDLEILSFLKENNLNYFIVFTKIDKLNTKEKNEL
NKKIKTYLEKESFNYLIVSSETKYQIDKLKENINSNF
>MS53_0178 putative transposase ISMHp1-like
MRYWEEIKEKFSLQNIDNLKQIARLVPVGENKIEVKTKFFQLLNLTSVET
NIKNVGIELIYKVIKELDLFKGLPKTKHKSLEEVLEFIVATRIIQPRSYI
CQYKNKNDFLHKIDIKKSSIYNYFDTFLEYKNAILVNIYNKMQELTTRNA
KLMHFDNTTVYFQSFSRDPLRQRGFSKDGKHDEDQMVVAMAVDNSGIAFH
YKVLKGNTADSKTLVKFLMKMQRIYRIKDIIIVADKGISQNANLRYLKQK
GYKYIIQKRIDILGKEDKAFIVNKQGFVQENEYFTKSRFVESIWAKNKNK
KRDSDTFRKQFVYFSPSKQTLDKIKRQNLINKLKKSLLKVNCH
>MS53_0014 conserved hypothetical protein
MMNVFLDTTSKDFLLVLFDNNYKVIWKSYYENEVKKVNLIVDEFQKMLQE
NNLQVSQIQKLYTNVGPGYFTGVRSAIVLLKTLALSLNIDFYIANTFDLL
MIQNKTRKTFKVDAQGNKIYFFSKNKFLETGDILKSATVKYLSKNTKLDF
LNYLDMANNLKKYIPSFKKTNPNDVNALYIKDPQIGNKKW
>MS53_0204 putative phase-variable hemagglutinin
MSDQLTKKLGAERFKNVKLTFKEASFSGDDIKTPTVKFTVAAKEGYTLTT
GDNASATEISLVVRVLYNRGSENVIQLPTQGASASAVPSNSSVNDAKVKA
KVNVYLNYTGPSIVLDETHPTVGATPNTSLNGTSNVTDDFNNKFNKLLIR
YKAETSLFKAVINYVNKFDPKFRAQFVTNAIDGVTITKVQNTRELRPGTL
DDLVVKNKNNVFLQQIQGDTEAVYLPVTAVTNDKWLNTVLVRIPLTKFVR
PISVLEAPQQEETQEDGEEMQQGNEDGTQAGQTDETAGSGTPQASTPQTM
PNSSQ
>MS53_0548 conserved hypothetical protein
MVAKELNITVSQVETVLNYFKEGATVPFIARYRQSQTNNLNEEQIYAIQS
LYLYASELSKRKEKIIEKLKELNLLNNDLEQKINSCTKKSELESIYEPYK
SGKITKAKMAIELGLMPLALKIWNNKNSRFDLNFEARKFLSDKLKTLDEV
ILNVNYILSQKISEDFDLREKLKENILAYGKLICKKTKEQDENDRFKNYY
QYSTPIKYVKNHNIMAINRGSNLKKIKWDVYLNFEILERISLRKITKFKF
NEALLKDAVNDALKRLILPSLKNKIFSDLFDEAEKKSIEIFSNNVETLLS
APAVSGHNILAIDPGYVSGCKLAALSEKGSVLEIATIYPNEPRSNVSQAK
TKVLELIKKHNITIIVIGNGTASRETEQFINNLIQENNLDNIYFCIVSEA
GASVYSASEIAIEEFPNLSVEKRSAINIGRKFLDPLNELVKIDPKSIGVG
QYQHDVNQKELQNYLNFKVQKVVNNYGVDLNSASREILSYISGLDKKTSQ
NIINYRNKNKSFKSRDEVLKVDGIGPKTFEQSIGFLRVFNSSNFLDKTAI
HPESYSLANKIISEYKLIPSEEGIKNLELNAKELSEKYSSSIEEINLILS
SLKNPTKIIRSSKQGYLLKKNLINLENLKIGDIVDATIDNITDFGLFCYI
GLKESLFVHISNLAKKGNIYESYNLNNLIKVEITEINKENKKISGKEI
>MS53_0389 conserved hypothetical protein
MIKLMVKNTNLINISTYKNDVIYFEKEMHEILNNFAKYFKINKQIILDVS
IVSSYTSRKLNFEYRQKDKTTDILSFGYDDFDLYDKMPFLNLGELVICNN
KIKKQAIIFNHSIKREFLYLFTHGLVHLYGYDHQSEKEKKEMDFIVDSIF
NPLKITRND
>MS53_0116 conserved hypothetical protein
MLVQQYKSLIADEVKIYSILANTSAFIYQNFKNLNWAGFYLAEGEVLYLS
SFQGKIACTQIPFSRGVCGKAAREQKTIVVDDVHEFKDHIACDSASNSEI
VIPIIVNSKLYGVLDLDSPLKSNFKDKEIVLTLEKIATELANKIKELL
>MS53_0042 hypothetical protein
MLSTMIVAPSAIIASTVNKKEANAFFGKKTEIIWIQKGEKHVDGNDYKTS
HDGRVWARDYFWSSDEVFWRGVAEARVERVLFDSTLPNRVVLGVETWVEG
SGRPSVSSSISISQSSGLEASLGISSNPTEKGRSFSYVFEDTNTSSVHYS
YSGRIWSWSYVGISTNPFLKKRIK
>MS53_0210 putative phase-variable hemagglutinin
MSDQLTKKLGAERFKNVKLTYKEVTFSTNAVKTPTVNFTVAAQDGYTLDN
STNEISLVVRVLYNRDNESTIQMPKQGASPSAAPSNSSVNDAKVKAKVNV
YLNYTRPNIELDAEAPTVGSQDNTSLNGTSNVTDEDFNAAFRGLLFTDRY
VNPLMQSVINYVNKFDPKYKAAFVTEKNGVALTSVQSGTQLRIGSLNDFL
YNNKGFLQQVNTDTKAVYFAVNGVTSQGWLNTFLIRIPLTKFVKPLSVLQ
AATDSSQNAEQTGETQGSQPEAQSQ
>MS53_0179 putative chromate transport protein
MMCVISLSVFGSGQVFIPLFRWFWMFLEKTFNANISNDTINEVISISNLT
PGLVSTKFAFFSGYLISNGYWYGYLAAILTYVVFALCAIMVLVFVMKNLK
KFESSKTIQRIFVILKPVIAGIIFSLAIQLFISITFPFVTFNSSISSYFK
IDLGKTNAIFFSGWRRYVLFAFVPVSISFSIIMLKKTKIHLLVLILLNIA
LALLFFQPWI
>MS53_0440 putative cytosine-specific methyltransferase
MDENKIDLLTYSFPCQGLSVANMGRDKGISAIDSSSHLVWEISRILKKTN
NKPKYLLLENVKNLVNKYKLEYESWKKELSKLGYKTYTALLNARDHGSLQ
KRERVFAISVLKKTKVPFKNDVDFKKYINNIGQKRILENNKKEFFAIFDL
KNKKYLEADKCLIKDTPSRRKIIEKCKNISDINKSIKNNFVINTLTTKQD
RIPNGGYIEFANSKQNYLNYRFITPREAYKIMGFTDKDFDKLKIPIEEGI
LNNNVLWRQAGNSIDVNVLESVFQTIYEIDNMNGEKNEKK
>MS53_0008 conserved hypothetical protein
MIYLIMSIKRIAYFGMYLGIILGLSLIPYIGLITIGPVSINIITIVIIIA
SFHLGFFGGLASGAFVGLGSFLAALLYGRILFIYFDIAFLPRLLVGALIG
VIVIKIKKITIWKALFLGLLAALANTVLVTAFLFLHNAISTIAFIGESLK
GFVFWVSLISVNALVELLVLGALSMFLFKFYIYLCNKTNQEKAEKLLKY
>MS53_0416 conserved hypothetical protein
MTNHFPFFQWKKYRKISLFSGILILLIALFVTLSNWVLDVRGLNNSLSKL
SASARQEIIYADAAPSVLATLWKNTLTFTHMSNYALGIIWILFALYPTKW
HSQRAAYLITVYITITFLVYWGLIFPQIFKGGIGPFKTFLTTLVHAINPI
IGFSLITYNRKRITISKGTFFGLIPIMVIYYGFALVSFLIGQNTADNFAG
LKKSPDSDVLINHQNGQKLVDNVIYEFLNILHPFFYQGDNLAIVVAINFG
LVVGGILFTLLLGFIWKVSLRLKWDRENKAHLVY
>MS53_0487 conserved hypothetical protein
MTNKNRGMFLETIINKSISFFWENNLAFIEKKGLPITFASIKKQNNKFIL
ENSIISRKSTVDYIGMLNGKFICFEAKTSNEDKFILKNIKQHQLEYLILM
QSHGAIAFFVFYFSKQNEFYKVDPMYIDSELKKNKKSLHFKEIKENSIKI
ELNFPGVLNLLQ
>MS53_0243 putative phase-variable hemagglutinin
MVVNGYVADTTGDNEAAHEEANKTNQKKLEAWFTNSANWVGLEDQLTKKL
GADKFKNVTLTNPVITYEKVTVNTYTWKNPKVTFTVEAKPDYQLTEPTTN
PKQISLTIRVLYENQTSTQNLLTIQGASPSAAPSNSSVDDANVKAKVNVY
LNYTGPAIVLDQAVPAVGTANNTSLNRTSNITGDFNTKFKELLINNLMPR
EFLSTVINYVNKFDPKFRAQLVQI
>MS53_0101 conserved hypothetical protein
MTEDNNKDVNKESSKIVEPVDYRTQDLKYDDVPKRKIKKVNTTFRRTQMS
NFGLFFSKLYQPLSIQKIMLITIAMAIFFGALSVFFVKNVGIYNFGLAAI
GQSVAKIVAVNTTELPHFISNLIDQIIFWLAYIILSIPIFIFGYKKIGKF
FIFVTVVFLLVSSMVSIGIGLIPGANDVFIIGDFSNPVVKEALPENQKHL
SSIIPLMWSDGGNIAALLVYATFYGVVLAFIFAIIQIIGGTAGVTGIVGE
WYANVKQKSFGTISGYMNIIIVIFSVLVGSWLPGSILLQNAKQNFLTTNN
IDTAFIPKEMAAVFNKAWNFELYLSPNFVATVFINVLYIVVLNKIYPKFK
LVRLEIYSPLWEEIQNKIRNDRKIVAGSTVFRARGGYKGKKINVLVSVIL
FRHVLRIIHDVRKIDKDAFISISNVRSIDGWIYLPDKNF
>MS53_0255 putative phase-variable hemagglutinin
MLIYWDGFMPKIVVSLLTTKLANQEYDASVRQGGVVFWKTRNGEILDVWF
AANQDKFTLVADQLTRKLGKDKFKNMVLSNPRITWDELTIPEGTILTPKV
TFNLTPKEGYEKATCSLETVTLTIRNLYKAAAPNTNLFATQGASPSAAPR
NATVNDANVKSKVNVYLNYTGPSIVLDADLPTVGGQENTSINGTSNVEGT
FNNAFRGNPSSGLLFTNRYANPLLKSVINYVNKFDPKYRATFVTDSKNGV
TISNVTNNVQLRPGTLDDLDKDNVFLQQIKGDTEAVYFAVTAIASNNWLN
TFLIRIPLTKFVRPISVFTAPVVTPPAAETTETQEAQGDSASQSSPQTML
NSSQ
>MS53_0451 hypothetical protein
MKMKTKKEQKLVTGSLIERTALYITIQSHNQLYRVYKNNLGKDVTLQNCY
NSFEKDQKVEILVEIGVKKTKYILANLNKANCKITISDETENGFLNLKKF
TDLEIENYT
>MS53_0514 putative ABC transporter, ATP-binding protein
MNSKNIKNKKPLNNFQSLIRISKYIMKENKFKLFLVFLLVLITASGVVYW
QFFIGNLIIKNLFEQPDNLFLINGKYNPDFKFDDNYFILIMTLSFFIILL
VPSCQYLYQRIMISIAFKTIGKLRRELYAHMQRLPLEFFNSESKGEILAN
FTANVDVMRQFLTGAFPNVINTIFITFSLFFTLLFINWFFALITIFFLLI
ILLISGFFTFHSSKNFIKKQNYINKSTGFAEEYFSGIREVKIFSQEKNVI
QNYQKINTELRSADRKATTYSNLLFPIAINIANFAFILIAILGAFMILDK
NFPISVKGLTLGVVISSAQAARGISRPITDVFQQINLWINAVSGARKIFT
LFDVAEESNSGKVTLVKIVFDENTWKETNAKNKFGISAWKITKENDEVEY
KPVSGEIVFENVYFNYKNTKDNSNQINGVSFRVSPGEQVALVGPTGAGKS
TIINLLNRFYEINSGNIFIDGINIKDIEKNSLRKSIGMIMQESSIFTDTI
INNMTYGSEHYDENLVFSIAESYGINNFSNLSENKYQNFLKDLGSSLSEG
QKQLLSIIRASYLNTNILVLDEATSNIDTKTEEIIQKSFNKLMRSKTIIT
IAHRLSTIKNVDKILFLENGKIIESGSHKELIKQKGKYYQLWARVINE
>MS53_0428 conserved hypothetical protein
MFIMKFTGKKFFVLTAGSVTIGAVFTTGIALIQTNKTLTQKRIELAQEAT
KDLKKNNVEFQAVLKESINEFKNSYQQFLEKLSKFIKQKVKPEVQATVLK
VYSGKVYIPKENFTFLNYFVSDETINAYLNALMEQIQKYSSLFSNNNSIK
LINTWIKLITNVFSNTLITIVRYVPELAQDVLDFNTKNFSALGSNFSFTW
YKIHYQNFINDSKLVLKTFSESDKQNPESNYEKVLDFKNKSQSYLSELET
KYNSLINLPKTIANNKLLDDLFDENSAQLKALLPLYEQYVLSQAAEQMQS
LHSTPKQFINYFVNNGEVLSKAQAASKATSDAGEFKNKLNSLSENGFKFL
SNDFTNDLTPTKEVKASANYLNENEELTVSFYKANENGIFQVENSTETNL
LSSKLKNAKPNSYVVKFSFLLNESFPESIFANSLNSYLQEDKNDLFVKNN
FEIYSVLPFVISRIDIQNSSVNLNFNFNYLDSQFILNEFQSNYGNSKNLF
LVDPNNKEKSQAKVDIYLYLDNTKIIEKLNKLIQNDKININVKF
>MS53_0604 conserved hypothetical protein
MVEMQTYAFVLMMIFVVIGVGFAVAIVTFIYVKKLFEKQMRENPPISEKM
IKVMFEQMGRPASQKQIKQVMNSMKAAKDSK
>MS53_0117 hypothetical protein
MMKNVSEFTNFKNFYEKLHSNIKAHYNKEINDLYKRLNLKKKLKIFYSLM
GVFIAIAVALLITVIVLYKKEGFSFVIVFLALAMFAFGGLAYLMFFFADK
YKERFNITVAKMLNKRVIYKEAFALLDEQFSYDEEYPKQYRDTLNEVTVV
ELKKLIRPILFKLKADLETIGDEEKITLSPSHDAYFVNMDIKVEVQKNRN
NSPMYKFLKTTLLKIDTKNLGDKGFAFAAAFENSKLIKEYNDLFKSFRLQ
KVKLESDAFNKTFNAYTNDELKLRMMYTPLAMENMVKLHQNSKSVQKISN
LVMISDGSAIYFVFTADMGFMEINWEKDYSNPDQLLRAIINDVALDIYNL
YILISYAYIPYYLK
>MS53_0463 conserved hypothetical protein
MVACVDTSSKKQIDDKINPTTPSDEEKRASDKHGGLVEVQPERPSINLPG
TNPTNPTIPTNIPGKPQLAIDNIEAYRKLSTTEKNKVDLEGYVNALSRLH
GGLENVQNIISQRYNIPALNETQIQTYNQKAAAANQPDYASALLRNFSIV
NDNNYLYVNPIRDSSKAAYWNSTPGNRGLPRYLPNEIYKKAAMQTYAIEF
FNRNSELEKNPKGISKAYLTYRGTAWILDYELDSNGYPTKWYLATNAHVA
AGFMKAKSDGSRFTNIVDLNAEKKRFEKAQKTFDEGQTKWEKISKNYLDK
IERLHAEVNRYHGLKQQAETNGNAAKVSEYENLIKKIQDNDLPAAYQEKD
SKTLEEWNKLPFEYRKAWSDSQETLKGGFLGETTSIVISHFNQNTPLNQW
LRTNAVAPTVEKFTFKPEQVKLVYAGVDFLKTSPKDYIDPSSPISQIEES
ADFAVLEIDFNHPSGVNDTYKYTTRNTLQPTSDQENVVENAKELAKIATS
NYANWEKKDQISFISKSLKATYEEDQKAIINDVTLTNGQKTNAKKASLNF
ISVGFPISSTDNHLEKTYDTVVDQLEEGSQSLWINKPIYIAEGKENSIIG
TKEYGGSLNPTLSIRNFLNMPGITDFTISNPLIQAEKNVGYVYNFIKDTE
SKYQGNQYTNYGLGYSLNSWQPLGGASGSSVRTIDNKLIGINFATADGAG
VSLTAFTQAFRSEGESYNGFYGKYQLEEYDLIYGGGKNQRTSYRQALESL
NANIKTALFPNGINKIPEEFKFKN
>MS53_0341 conserved hypothetical protein
MKKLFLWEIHSDKVSLSESIYIDNLNYSNIANYMYNLYGQEMHNNLAKMS
QKVSEIKAEENQKINFVVFDSSFFAQNLNSKKFQVSLSKREVLNSYQEFS
SENILDLVDKKIYAFLEENKINYVGKANIFSYVTLGHSQEDSLFQVEKSY
DNFPKNTDFETINIFFSVAICEDQVFYNKYKKILEFLSFDNNFVFYKESL
LASYKAGQKSKKQNYFLLKLNQNSSEIVLRNKNNVIRHKNLFSKLSSKVN
LKAKNQQLKFLNNNLNLDLNSSDLTFLKNNLSDFAKNLVDELSYLPIENL
EISSENVHLANIMATLLKAQKTSYSVESIFNLNQENSFEKFLLNQAILNS
SIINSNELKVENQTVTTNIKPNLNKRWFSFNLFKYFSNK
>MS53_0172 conserved hypothetical protein
METLFIVLIAMVAVLIVTAFATIAFFVFNKKKAATTQSEAPVVSAPDLNN
NNELLQKLVELTANLKNSDENLKSFQTQTNLKNQEVNNTIINVVDKINKA
IAQQNETVADKIFNQSQNLIKTLDKNKNETHKILFDQNQNFSQSVQNQSQ
HLNKEIRFLSENVNQKVTNSYKELKEEFNNYSKTLKDEMSKKINEEISKF
GEKVNLISSDVNQLVSLRNDLSEIRKIFEDNKTRGIFGEKLLENYLNDAM
PNGYKSQFQLSNKKQDKVDIAIPINVSDNNQIYIPIDSKFNLESYRSLLD
YIDANKNELDFPEQQKAINNLWKNIKAEIMANAKSISEKYIIEGITTNVA
FMFIPSESIYLELVKYEKGSLVDEIRKKYNIELISPSLVMVLVSIIKDLY
SKFNIGIHNKDIVHLIKKFDDNADKVIKSTAALLKKQSSYLQELEKWVKT
VNDAFSTYKKEKTKITSKKRLSEFERIEKTLTGETPESLIVEGEILEIE
>MS53_0252 putative phase-variable hemagglutinin
MASTASYLKSLSDSLKAETDKLNGDTTENKTAYYKADTTRTLYWDGFMPK
IVVEGYVADTTGSSKDTNETANKTKLEAWFTNSANWAGLEDQLTKKLGSD
KFKNVTLTNPVVTYEEITVNSNTWKNPKVTFNIQAKPGYQLTEPATNPKQ
ISLTIRVLYSSQESNQNLLTIKGASSSAAPRRATVNDPNVKLKVNVYLNY
TGPSIVLDADLPQVGTATNTSLNGTSNVEGTFNTAFRGKPSSGLLFTNRY
ANPLLKSVINYVNKFKPKYRATFVTDSRDGVTISNVTNNVQLRPGTLDDL
VKNKNKVFLQQIQGDTEAVYFAVTAIASNNWLNTFLIRIPLTKFVKSLTA
FTTIPASAPTQTDSGTGAQTQPETQS
>MS53_0335 hypothetical protein
MIMKKPFKKLFILSLSLPAALAASSCSSFSFHPYKNTYNEAFSKVEAKHN
KLENSSNKYLKAAFDNYYENAKKINQDSIDNPDHFNDNIYIQLGASINAI
LKSVEIIEKDVLRGRQPNSPEFLEIYELIWGKISEHQSQLETLIINSLNS
IASNITSTNLSQETLDKLKKVSDSFNNYISYYYQIIKTHKSSFYETLKFS
QSFDDKKSLEIINDINSKFLLYTNYVNEIMTNPNYNYIENENDFKITILG
D
>MS53_0294 conserved hypothetical protein
MSLIGSEAFKISSAIYIYKISGDFWLVTLLYLLIQLPSIIIYIFSNKLVK
ILKDKTALLLTDILSAFFLLILFIISIWFLTYNIFSIILIVLSTILGTIH
SYRFIHLKNVLYYLATDEKTLKSFNIGNSLATSIGFVLSPLMSFYLYNYL
QFYWLIVFNIITYLISGILYWSLKLNINSIEFSKKTISQEIKKTKLLSWI
FIFSFSILIGILLYPKQAGLIQFFAYIKDYSYNEWSFWFTLTMSISGLIA
TILLMILNHFNKSKIKLHILMIVMLILATSWIFIEKLTTSSYVIFIYYFL
INTIQQFIFSITLPTFYSESYKLFNKKDFHKQNGWSLATRVIVSNLLIIL
FTFFNNKFSYYWAYLSYSLIILILSTLIITTSLIIFKTNNINKFYSSKKT
FKDYEEYTKNGLWNSEKNIIEKYFFDNTKELKIYDIGCGLGRTTFELKKM
FPNSKIEAIDINKIFINNCKKRNSDNSILFKHKNIIEKINEKEKYDLILF
SFNGLTNILEEEEVRMALNNIYNLLKKGGKFIFTIHDMFSTEEYKNYWLE
KVKVYDLELFSEKKVLSNKENDIWVKNRFYTQEDMKKILSDEFNFKILEV
SKRDEKLEEEWVKKLSKPLLFYVTQK
>MS53_0208 putative phase-variable hemagglutinin
MPKIVVSLLTTKPANQEYDANPRTTSVTFWKQRNGEILDVWFAANQDKFT
LVADQLTRKLGEEKFKNMTLSNPTITWDEVKFSKGNVTKLYLTPKVTFNL
AAKEGYGKATGSLETVTLNY
>MS53_0054 conserved hypothetical protein
MRKIQAEYEVKQKEIEKKEFVVEKQGITLVMLGTFKLKSLKIDEALIDPE
DKELLEDLISLTLNEAIDLVNEEIDKLSPQLPGGLSV
>MS53_0059 hypothetical protein
MAISYKQATSKDLNLSFDFEITYFEMSKFVIDIKNTLRPLEFNEKYCEWF
IEDLIYFLKSNGYNFRFDLGLLELVNGKNLKKLVNKKPVDLNDLEFEEIK
YFLEKKITNFDVRITK
>MS53_0319 conserved hypothetical protein
MKIGIFGGTFNPVHKGHMKLAQYAIEELKLDKLLLVPNHISPYKLKQKTI
SGKDKLNMLSLVLEDKMEVCDFEIKRKNISYTIDTIKYLKNKYKNDELFF
LLGSDNLPKLHKWEGIDEIASSVKIAVFKREKVINKKNIKKFNCLLLDNN
LFYESSTKYRKGNLEEVDPRVAKYIAQNYLYLDQLIFQVQSARLSKHSVF
TAQMAAELARNLKLNPKDAYYAGLMHDFAKEWSEKKSREYIKKYDPSAEL
EFHELHEYCAYLWLKHEYHLDNDDILHAVRIHTNLDDRSEQKISLFDKVI
FVSDKICQGRKFAGVQKLRKIVFENFEEGFKEVIKHVIKFNEDKGVVFSD
RQIKIYEGLLK
>MS53_0126 putative potassium channel protein
MFLLKYIKNNKALIFKNLSIIVWSDSIVNGLEKRVTDQRIRFLRKLYAFV
IVFISLSSFLTFINPNDNFRTAFNAVIAITQVVSFFVFLFDYASHWVTFY
TRKNTQNWSRLKTLLRYPISFPGIVILICLLSSLNVLQILNNSIEIPPYL
NFFKSLNFAKIFRILFCLKLIAGIAYIFDAFKEQKKVLLYLFWLSIIFIL
LFGLVILNNEVQELNLAQMNWLKENNIDPSDTAKYLNDPSYKALSNGYIT
NFFDAIYFMTITLTTIGYGDLTPHSPVSKFVVMLAAILGVAIIAIPSGVI
AGSFLNLLQSHFKDKKKEKQEAEKQALKAKEALEAKATKAEKNTEETHFD
ENNLWLS
>MS53_0466 conserved hypothetical protein
MKIKKLLSFAPIISTIPIVFVLSAETDNNSDNNNENAPKEKTDFVAAKEK
QKQIISERLPEILDNAIKNIDLEIAELERKNEVEPNIENLVKIAYQKKVI
QYLNNNKEKMVADPLANGLNFIFDDLLFSPSYYFANVKYLGNPYDNVMIG
ENNPLDYAKTKDIDKNSKIDYGEEKKLTENNLTQEKILLQHGTYLTNFAN
DWKTIFVNENDFPNYENNQKRFEVKADGSIELLPPEGYENFDSFIANNIN
KRSLEFDLKQNKEFNEPEEMPQPPIPPILPIDPEPVEGIEIDVAQENVPR
LSPILRADYLLNSNQNLINLLNTNSTIFNQDAIFFFNPILQNISYRVIEL
REDQNGNLLAKIQLTNNTNNTQTTYERTVTKYNDSKYVQSLEVASNVINQ
MMQYYYNALNIKADLDLSVLGNRNLSIAVFNQIFLAIQTINSSQFKILQD
ALIQDQKNNTTIKANNETFTNELTNKNLISLMADLFTNSIHNQTISRLSY
FSYLTSTYREIYNNYLKQLKDVQLNELITKNFALLNLNIENLNKAINSLP
LLILDLDRINSENNFDQEQFKAFNTKLALLQQQFLNLAVLTQNKTLDQDN
LEQESSQYLKAYNDLIVKQNLTSNATSTTTLITLGVVIAVLIVSVITLSI
MNSTTKKQKIKELNNGK
>MS53_0556 hypothetical protein
MKTKKLNLLKVVAFGVLPVASGAALVSATSSVNSINARSNNFWSSGEDFE
NRVGFTFKDDRWGVGSFNYTGGKNALIMMQNVLNTIV
>MS53_0429 hypothetical protein
MWNSMQSLNSALQQEYSADVLNDAIAENSFSSNISSFFSVSFPDNLVPNS
FSALKENQSVAETAQVNATLKSIKDSDLKLYNDTFKGVFDNLKALKTYEF
SSTNLLGDSKVRATFYKAGSDAKFEVDATKVNATFNLTSLSETSLVKEVN
KTGNYLVKVSMNAFSIPLSILKAFQARNLDLGPVQSLGSGYRFVGLIPFF
VRNFDFTSSQNQYTLKLDLDYKFGSQEKFLTENQSNLTEANTLILLSNNF
LQQNVDTSNVNLDLYFVVTDSSQISKFDSFLNNQEKTNLNVSFSF
>MS53_0386 putative lipoprotein
MKKLKFLFLSGSVILSAAPLAVSCGADEVKPADKQIIFATAQGDTWPLMV
ALKPMIEYYNRTFFEDPDFVPVYLHTQTQTQTYSELRLITDTITNIDANS
ENIPNIILSNQTGAYLMKSRGKLLDLKENGLNIRFSQKIQDSHSILAGQS
LDTKQLFNVPFDIADTDSVVFNLDIMNKLFELIKSNGGKVDDFDLVQKAK
AASETGSDIPKRSPFYALKAKSSSAFDGYHVTEDTFKTFKGIRDFAKKVY
DATDFDQEKTGELKLSANVLSIDYQEDVFRKELQSLTKDSQRLWNLETTS
DANQPTKINFENLKNSESEASKTFVKLWNEWKAALAERKVKEGGTNDIRF
QSIQFKKNENADWGSYDIRKYSSAISYAASVGSNATQQSYLSVAQFLSGV
QEPEETEEYKSWASHDDVFMKSQLLLAKENANKAYWEGGSSIVAIQSSDE
DLNKGTSKFLNWLYTGTVIGRKTFEEDEEVPNWMKIAELSGYILPSESAV
TQENLDKMIASRDQLISDWRKQLKAFKERIASGESFISGKRESIKLSIDE
KLVKANRLNSAIVTLESLLKYTNNDDVKEANNVGDYNTAVLVDILKDDLL
NLNTPTKESNVFESSTTGEEQLAKFQRLVRKL
>MS53_0131 conserved hypothetical protein
MNKLLSFSLLSLVPIVTSSCGTSSVKNSVDSNEQASTSLSRESIASFDGL
LNYVFNNNQVAVENFKNSQDQILPAKFNEVKQALVWAPPFYVNVLEQNSE
LKKQTSDSINILKDTFKNDWYWMVKNISKFIYQFNPYGQLYDDEAAQKQD
FDLIEHLYGRLDKKINWNEIFYILSYKIQVDPDANETFKDLTAHFYFLDD
GFVKFYTYENQGKQNLFFVPDYFKIALSDDDIALVDLTANQENSNGNTTT
KNYKAISLQKEADQEKYKNIALDFENKIWEKWTQKIDSLIEEAKEFGSKT
EEEVRKENTYEKFFQYFSNVSYVGMQFKAINELNASNPKTKLFKYTLRWI
DEN
>MS53_0139 putative sugar ABC transporter permease protein
MNTIAFVIINVGVFIFCILLLGSISGIFSEKAGIINIAINGMIVFGALVY
TVINYLIRVFGNSNEISMYYQLLLVPLCGIITALFALVFGYATIRLKSNQ
TITGYAINILVFGITAIAFLIIKQRSGNISFATKELALESDITSSLKNLV
SLKVFLTLLIIVLSFIALKYTRWGLRFKAIGENPQAADVAGINIYKYKWH
AVFISGLIAGIAGTFFGQIRLGQLQQSYDIQGLGYLALAIMITSQWKIAI
SVLISLMFSIVYSFSFYGVQYFPASYKNYSELFNILPFITTLIVMIAFSK
KTNAPAALGVIYDKSKR
>MS53_0315 hypothetical protein
MVFYLIADRYNNNQDLYQPTQGPYNESNSSKWVEFKITGLNKINVEDSKN
DLLEKFNLSIKENVNHSLIANLIKEKSNDQSWFEDKTSEDSLFNALSFQF
LETLLCLFKNFWFL
>MS53_0476 hypothetical protein
MITMIIIYNINMSNYILYKRKNPKQIYIALGISKGYGKGIGNLVGLGYWE
EIKEKYSLQNIDDLKQIARLVPVGENKIEVKTNFFNYLTRHLLKQI
>MS53_0316 conserved hypothetical protein
MKKRKKFLNHLITAPLIITSTSLIAISCTGGSNQGQEITAEVTFKDGETE
VSKTTFKGREEFSINLENHVPFGYDFKENQTLLYDVKQNTSVTVQVQQKL
TKFSLVDRATRQELAKVEGFFTDRDEKLTAFLQVNLPTNYQLDSRFTLDG
VHLFEDNTVFLSKSTTNYTTTLNFKLQDNTVVKTVTLNLDSNSLLSLSNY
VPAGYELVDKSQRITFNQSNDFVVKKVEASQSTPRKSDVINQDKVVLDQS
NNTRNSITINGPAYILDTLNLSRTTFPSDVVFNSSFSVNGYTFLNVVVKS
YDDALGTLSFSSTVVNSSNPSVTGEFDFNLSGLQQTKRIFSVGTDFNENS
LYSKKLTNATADQLSKEEILSGLKSFTGVDQEFTVNYDLLDLIRKNRVSV
NTMQIQDNGTMLNLNLDLLSKRLENGEVTETKVRLIDKEVSFNTGYSLNG
ELSYILNNKVSVASLTGSSVQNQYPSYYWGRIKKGIELANTLLQFDPTFV
NNQQVKTTNDKVIQVKYENLVPNDLTGELTFDAYLVALDSTANDGNIQSS
RRRFTVGGLNKLNTKMSLTDPVLSKFDLSIKSSGNKSIIANLVKNNSTDT
NFTNKDTGSLFKALSFTFLLSEADEAEQKNNSFWDLKFNNVDLQSAYDSE
TKLLKQNENELFAPYKIEVEPISFSNYSFNGTTVKFTLNVNLKVTLFAGD
DKYEFTKSFRFDNQTLSTSSSSSSSSSSSR
>MS53_0682 putative PTS system, IIB component
MKILCICGSGMGTSMIIKMKANQALKELNLEGSVESIGLGQGKTVAINFD
VIFCTQNFVDEIPKGKTLVYGINNVMDLNEIKSKILEAKDKLNA
>MS53_0206 putative phase-variable hemagglutinin
MPKIVVPGYEADGAGDNKAQHETENTRLLQQWFATESNWEKLSEQLTKKL
GANKFKNVVLTAPTVSYEDGGSNTRIPKVTFTLQGKDGYTLQTDNGATSS
LTLSIRVLYTSASSTQNALRYQGASSSAAPSGSTPSNNAAVIRNVNVYMN
YIGPNIELNAELPTVGSQDNTSINGTSNVDGDFNTKFKNLLVNVVGGSFT
QTSLLQAIINYVNKFDPKYRAAFVTEKNGVALTSVQSGTQLRIGSLNDFL
YNNKGFLQQVNGDSSAVYFAVTAVTNDKWLNTVLVRIPLTKFVRPISVLE
EQSAQDQTPEASQQAGGDQSTSSSPQGTAQTQSNQGS
>MS53_0025 conserved hypothetical protein
MENKFARTVLGDIPVEKLGITDCHDHFIKNGGPEVEEHIDFLMLNVDASI
KEFKEFIDRGGSTIVTMDPPNVGRDVLKTLEIANAVKNLGGNVIMSTGFH
KAKFYDKYSSWLAVVPTEEIVKMCVAEIEEGMDEYNYNGPVVKRSKAKAG
IIKAGTGYGAIDRLELKALEVAARTSILTGCPILVHTQLGTMALEVAKHL
IGFGANPDKIQISHLNKNPDKYYYEKVIKETGVTLCFDGPDRVKYYPDSL
LAENIKYLVDKGLQKHITLSLDAGRILYQRNYGLTKGKQTFGLAYLFDRF
LPLLKQVGVSKEAIFDILVNNPKRVLAFDEKRNFDPLKVSKEVLELKKEL
NLN
>MS53_0085 putative transport system permease protein p69
MVFLSNLFFYKVESKNSQTQNKLKPIWFHILILFFLAVIIFTFSKFDYKL
NSYFGFQNFYKNVFKFFQIKNESTYLGKTNLALDSLSYLWVSIKYAIVGT
FIGFVIAIFTAFLSSSKLNNFWLALIIKNLILLIRSIPELLFITLFNQTF
FREFALILIYLWFSWLWLHKYFLETIECLDLTAFYVSKYQGNSSFYAFRK
EILSRLWNKFIVLFLYSFESNIRWVSILSALGAPGIGVLIDYAAISSNNI
DQLAIPLIFLFLFIVFIELFNYFFNKYILEWNSKTLKTNDYQKLAKTFNY
KSVIKLLFFSVIAIFSIYQLITINKDYLLNGFFSSYLNNFFKPDWSVFDI
SSNSISLNPFLQIFQIYGFALATLVICLFITFWFLPFISKNNNNVWSSLF
VKFLNIFLRIFPSLVLFYVFSNIVFSPATLLVFVIGITASSSLNKQLSEV
IDNLDNEVIQNLKYQGYSKFKIFFSYILPSIKVEFFLLAMFYFEIFFRSS
ITYSFLANDGLALGSNMYFHLQEKSFNPNKAFAYMWVIVLNIFFINNAAR
ILKLVI
>MS53_0218 putative phase-variable hemagglutinin
MTKVQNTRELKPGTLDDLKGNNVFLQQVNGNSSAVYFAVNGVTSQGWLNT
FLIRIPLTKFVRPLTEFQAQSPAAPTEEASGDQAQADPQATQMGTQAQSQ
>MS53_0224 putative phase-variable hemagglutinin
MLYWDGFMPRIVIERFDTTWTENTRNRNDLVAWFQNTANWSQVSEQLTKK
LGVEKLRNVNLVYKNITWVNSPAGAQHKIPTVTFTVEARDGYTLADDSTR
ELSLVVRNLYNSSAVDATTLFPYQGASSSAVPSGSSVDDANVKANVNVYL
NYTGSSIVLYEALPTVGGKENTSLNGTSNITDDFNNKFNKLLIRYKAETS
LLQAIINYVNKFDPKFRAQFVTKTNGVALTSVQNGTQLKIGSLNDFLWNN
KGFLQQVNGDSSAAYFAVNGVTSQGWLNTFLIRIPLNKFVKAIL
>MS53_0467 conserved hypothetical protein
MIQLNLLSAKNIQTTVKATDFKVNFNLNDKWNKIENNALLSFQNVLCSLT
YNKKEYFIFFDSLLIQSNKGQINLYYNQEYFVYEQNDKNKNELKKLNQEY
SKLKKNILLKTFQINDNNNASNIANLLILKQKAYRLKAQIYFSLFACEEP
WK
>MS53_0540 hypothetical protein
MFSYFWFFVFLIINLVSLWPIDYLYQYNSWGYKGNSSNIYEIPWQKEFSE
SDLEFFGHERPPITLVPSNLSSSLNNDNFIDNGFFYNELLDQYFFRPKQL
FGSYIKKWNNIYFKYKPFDGILIDNFFYLNNKYFSHIILSFLSFFTAIVF
VSASFVLNKWILSLIWIFIFISLILDFSGLLNRIDFDREGLYSISYKEAH
DFIGSELNFKKFLVKIPFSLFNPYSLLDVFTNFHFLTKKISMAWAFPIIF
ISIFNFWFLNFIIRTMKRNSEYSFL
>MS53_0659 putative ABC transporter atp-binding protein
MIKLNNVTFRYRPSDENPAINNVSLEIKKGQYVAILGHNGSGKSTLSKIL
VALLKPQKGELFIDGIQYSKENLKEIRKKIGIIFQNPDNQFIGSTVEDDI
AFGLENKNISRDEMRTKVVEYAKVVDMEKHLSREPEYLSGGQKQRVAIAS
VLALDPEVIIFDEVTSMLDPKGKSKVIQIIKQIQADKDKTLISITHDMDE
AILADTVLVFAKGKLVAAGSPKDILNEEKIIEIAKIASPFIYKISKHING
IEPTYVEEELISQICK
>MS53_0180 putative chromate transport protein
MSKPSFWQAFLFVLKITFISFGGGNALMPIIEKEAIIKNNWASKKEFEKV
IIVTNMIPGASVIQAISFLCIKWFGPLKGSILTLISVLPHLFFALLLFVF
SRYIPKKYLYIFALAIICVVIAILINFTISFLKTSHKTLKLPLWIFLFIF
SSLFSLFVPAPINVSILNISIVISGTLLYQLIVYLKQKKALNKNKGGKK
>MS53_0103 putative ABC transporter, permease protein
MKKYLANKHWKKATIISSTLIVFAIALFWVSPFVFTLINSFKPLRESIDS
SNFFKLPINSTQNNYSKSFSDINYFHAFLLTLGITIASNLSIIIFGSLAA
WQLARTKKWYAKVIFYTFLVALIIPFQSIMFPLINDVAVKFNLRNVMGLI
VLYTGFGISLSVFMIHGFIATIPLSLEEVAKVEGLGPIKTFFKVVIPLLR
QILTTILILNTMWIWNDFLLPNLIKNAGSYNSFTLIVNLYSNIGVHALNP
GQIMAGVTSIIIPVVVFFIVMQKNIVSGITNGAIK
>MS53_0232 putative phase-variable hemagglutinin
MTAAAGFLTEDLKLANLDVDGTLATTQASLESAKTALDAAVAAVKPDLDF
QKTKTSAAAKVTELDALVNTAFKAELQRQVNELTKDHAAQATTMLENLTS
LKDSLTSLQDLVSKGLAMQVDYPQKYYDADNKEAFDAALLEASSVFPAFK
WTAQSIIVETPEGQLPNPRAWTAPRAKTEFVLQNFVMASAPAQAAPATQS
DSDAAPAASATVRLATGTEEAAEDSESSETQTPAPTPAADLASTVSYLKS
LNDTLKAATDALNGDNPTTKTAYYKADAGRTLYWDGFMPKITLESFTASQ
TNVEDNKSKLQTWFNTKANWSNLEDQLVKKLGSEKFKNVKLTNPQVDWDI
VNSNQYRPKVTFDVTQKEGYELQSGSEFSQSLTMVIRVLYTTQSPNANVL
QMQGASSSAAPNNTRNANDETTKRTVNVYLNYTGPSIVLDEAHPTVGATP
NTSINGTSNVTGDFNTKFKNLLVNVVGGEFHSNSIITNNN
>MS53_0501 conserved hypothetical protein
MMKNFTEKVGKFFKSSFPGKWTTRKIVFVAILIAVSVTFTIISVQIAPFA
GISTYKVAFIGLPVKISGFIFGPVIGIFIGLVSDLISLIYIPPTTYNPLY
TLVVVMNGFIPGLFSWFFFRFINYAFGADFRTKLYKSKIQLYSTSYLVAV
ANPDSEKEANYYASKIIYYNNKKEYIKRFGTINLIKNINLIIALMILSII
ILFEIITIGFLIPDAYLVKSPVKNRWIIVALITTGLIMMMSLCIYGKFKI
KSSRYLVMVPIIIFSAVLEIVNLPILSFADLFALGNSSIKDIFLWIFQHV
FLAPVKIWFNIIIIYYSFSIISKLVNKTLIYLEILAVKNETK
>MS53_0553 putative ABC transporter permease protein
MAKTLAARRGPFTFKKFCKNYWKKLFLIFLGALIFNLGIQVFLSRSETIP
SGLTGVASLLQFSVPETKPYFAIIYFATNIPLFLIFWRKIQKKNFLYLTL
IFMVFQILINFGLTLPQVEKFIHTVINFVSFDWTSTKAYEMNLTFLILLN
CTIGAIFVAIGISLIWKAGGSTGGTDIIVYYYTTKYKKSIGNISVLVNII
SGIIFVTIFNFLRPNVTQGEYPYPIVFGLREFSTFLYIFIVGQTINILYP
KYKKVTLLIIPSDIHKVIAYFRLINYWHSYRIIKFRSGFTGNISYKIETT
VLLLESKELIQDLKIVDPKVWITATTIHSQSGNFLTSYVEE
>MS53_0044 conserved hypothetical protein
MFAKPINSDVLDNISKQFRASGAVVLINFKDTEISYCSNEEIKKQANFFY
NLQFANNDFEIESKVFRMLIWHFKSNVSRKLFKTWSEKYQSQIHITKSGP
NDNFIEITDAKVSKGITKKLFATLINNSKVKTVHIGDSMNDSTAVGQLDE
VISMKNGSEEFKKLANIVSEFNNKDEGIINTIKKYCF
>MS53_0535 putative citrate lyase beta chain
MMSKVSYKLNSWMFCPSDKAKLIEKSLEVSPSVVIYDLEDGIEYGKEDIA
LENLKSYWNQIKEKDFKKALRVSKESYESSLFFLFKNGLDFDFIIFPKFE
DKAELWTLKDILAKYNSKAKLVLMLESKKAIKDLNNLIALLKPEDKFFGF
MIGKADLASDYNVEIYSELIESISLKVIQKCLENDFNYIEAPTFELNSEF
ALIANLNYLKRNGVYCKAIITPKQIAEVNSTLEISSEQIMQAREIISLSK
EGAARYNGKMVDEAMAKKARKLLEALGE
>MS53_0383 putative glycerol transporter subunit A
MNNKNKSLIEIKNLEFKYHKKNILEINNLTINQNTTTVILGPSGSGKSTL
LDLISGFNKATKGEIKILNNPKIYEIGYIMQSNNVYPNISVLKNVYLSAK
NYPQWVKSNLVDEMKLLSNSFNNSKKQNLDFLIEKYYKDSKLSFWYLLLF
KLKIFFYSKNLKKAYQNLKRLLFKNIFYKKWKEVAQKLDILSLEKQKASN
LSGGQKQRVAFAKAIIKKNKFIILDEPFSALDAKIKESTINWILDLKKEF
NLSLIVVTHDQQDAMKLGDKIILINEGRIIQHSSPQELYEKPLNLFAAKF
IGYPEINLIKQDQNYSYYIRHNKIKIDEKSLKPNAIVVNKKHLGENINYT
LEFNNFKINLLSKNNYEISSKLHISFDDKDILKYNQKGELVS
>MS53_0284 conserved hypothetical protein
MMKKIKKIALVSPILILTSISAISCGNANTENNGQTTASFKTGSNSDINL
TTSYNYQLVLPKSFQTQYLLRLNENYYKNNINKLTQDSIDFNSKVKSALE
SALESKFTNQNKTSFTGNITVEPTDYILIPKENIKNYPQVFNLKFNNDNF
QLKYIGTNSSLELGNLGEKRSDGETVSINSVSNKLSIIYGLFYNNLPVNG
FQNIFLSINKQNVVNPDLKTKLESITSVDTSKFQKVNIDWVKQEGNYFDA
KIVSQQDGDTFTVQPVKATTASSIPLTTDQKIRIRLKGIDTPEKAVGKKS
DSIVASPFEYDFAYMSTNFGKAALVDPNKTVRIAFTEGLDAFGRMVGDIF
FGDDFQYSYSVEITRAGYTLPYGDDGWKAQLNNPNSYSSLVYQKISDAMY
QAQNEKVGYYHYFKNFEDIQINIYRLKENSKWIIFTDEMLRGNKKIKHET
IK
>MS53_0330 putative ABC transporter ATP-binding protein
MNKQKMLNTIKKLLKQVNLNKLQVTDEDMAALKKYREIYDKQHEKDISSI
ELKNLNIDFGETLAVDNVSFKIPEGKLITLLGPSGCGKTTTLNAIAGLLT
PTSGKILFRGKDVTHFTPQKRKLGFVFQNYALYPHLSVYSNITFPLKNDE
NWKNKTFMKRIKARMDIDLLYLEDMNVPKTELEELKNSFLRWRFIKNELE
YQNSVLYAKLSDDLEKAHSEYKLESVKYNAKKTLSAKKTLEEQKKAKEEY
NFASKKVADDYKLAKQNNIVETSWKDASFLSDSKFDFKLDLKTDLETKKT
QVKELKNLLKELRSKELKEYSYWDREKLLKLVLKLTQDLLKLNFALENQQ
LSTVDKQNLALKLEAYKKAKEDFKKILDENQEYKTLKIHLKRLPLVAEKV
FFDKWRELRKHLEGKNLKEFQNSWSEEKHEKLKEYSKDNVSLKKAIHNEV
MEVAKRVEITKILQKKPTRLSGGQQQRVSIARAIVKKPDILLMDEPLSNL
DAKLRISTRQWIRQIQQSLKITTVFVTHDQEEAMSISDIVICMDFGKVKQ
IGSPIELYNKPNNLFVAKFLGMPEMGLFPATFEKNKIKVNNLTLKNKFKV
ANKDFADLQIGVRAEDFVLHRYKKDADFSGRIIVKENFGKESKLVVEIEN
VGNVNFLVSNDANYKLYDEIHFSLPVNKLHVFDSLTSERLEYEVAS
>MS53_0552 hypothetical protein
MEAEVFVRRLVLLELHLKETILSFISPYGERLVLISPTTGEIDWTISGML
VSIPNAIGPSPGSISDNWLLSNFCNWFILIITSHNIK
>MS53_0247 putative phase-variable hemagglutinin
METSRSVTAAKAVKDDAQYNSVDATLKTTLEEKYTAATALLEDGTKLKNL
DASSNLDTTKATLESAKTALDAAVAAVKPELEFQKTKTSAAAKVTELESL
VNTALKTELQRQVNALTKDHATEATTMLANLTSLKDSLTSLQDLVSKGLA
MQVNYPRNYYDADNKSAFDNALLKASSVFPAFVWTTNSIMVETPEGQLPN
PRAWTKAREKSEFKLQNFVMAPAQAAAPTTAQTSPSAAASAIVRLAMSEE
AAAEAETQTPAADLASTASYLKSLSDSLKTETDKLNGDTTENKTAYYKAD
ADRTLYWDGFMPKIVLEGFDSSWAQNSENERKIREWFREASNWAGLSDQL
TKKLGAERFKNVVLLNPQIIFEDVRLLTRGSVKFPKVTFRVAAKDGYQLA
NGEGKTTTLELKIRVLYSSSNPNALLLPYQGASSSAAPREATVNDANVKS
KVNVYLNYTGPNIELDADLPTVGGQKILQLMEHQM
>MS53_0230 putative phase-variable hemagglutinin
MPKIVVPTYEPDTTDDNKAAHEEANKTKLEAWFTNSANWVGLEDQLTKRL
GSDKFKNVKLTYKSITLTDFTADKSKGVTRWYPTVKFNVKANEGYTLDTN
SAKEIDLVVRVLYNSAEANAANVFTHEGASSSAAPGNPTEPNNATVIKNV
NVYLNYTDI
>MS53_0226 putative phase-variable hemagglutinin
MPKIVVNDYKIVADGYVANTDEVKKEADKTTNQEKLQNWFNDPANWEKLA
EQLTKKLGKEKFKNMTLSNPRITWDEVEFSNKLYLTPKVTFNLAAKNGYA
LAEEQDASAKEISLVVRVLYNRDDESTIQLPTQGAYYTAAPSDANADNPA
SAIKNVNVYLNYTGPAIMLNADLPKVGNQANTTINGTSSVDSDFNTQFRT
LVFNNNNNVTSLMNAVVNYVNRFDPKYRAMFVTNATDGVTWAKVQIQKVK
GQKDREELRPGNLEDLLYNNKVFLQQVQDDSNAVYFAVNGVTSKGWLNTF
LIRIPLTKFVRPISVLEAPQQEETQEDGEEMQQGNEDGTQAGQTDETAGS
GTPQASTPQTMPNSSQ
>MS53_0240 putative phase-variable hemagglutinin
MALYWDGFMPKIVLEGFDSRWTNVNDNKSKLQTWFNTKANWSNLEDQLVK
KLGSEKFKNVVLSQPNVTLETFTWNRQTWGVPTVTFNLATKEGYEKAKNS
TNTIALKIRVVYNSNNTNEILFPIQGASSSAAPSGANTANHTKTIKDVNV
YLNYTGPAIVLDATLPEVGKVDNTTTNGTSNVTDDLNTKFKDLVTSDQRT
NCITIFPSNSKICKYLWS
>MS53_0250 putative phase-variable hemagglutinin
MPKIVVDGYVADGAGANKAQHETENTRLLQQWFDTPANWEKLSEHLTKKL
GANKFKNVTLTNPQVSYEEITVNSNTWKKPKVTFNIQAKPGYQLTEPTTD
SKQISLTIKVLYENQAYTQNLLTIQGASPVAAPNTASADNPASVIKNVNV
YLNYINQFKLTN
>MS53_0662 conserved hypothetical protein
MKDFMKLKWLKKLIVPTSLVTLTTAIAISCGAPVADDKKDGEKKQGQQDN
PKAPTNPSSSLVDQKAFDAYVKEHNSLIYNPAEKGSDKDNYPTNFDALKA
IADRSFSLYVGMPNPQASYVGTMWLLDYQKISDTQYKMFFGTNFHVAAGI
VTAQNVNENVAQNDVAAENRPIGFTIRAAVGTNPNDRNATTGRNYYETSV
LSETNKFKVFWHARNFVKRSEELNQVIAPDKDLYTDFSVLEWDVDFNDIQ
NNPNFFFNPNLRAEISTSTNGSNTVVQTVSDEVAAKRKANNDRFIEKLKN
AVAAVDNQIALGKKTTLYNHLAGTPFNFDFSTSLNVKDKYEATNLIYKRP
TTPEQLQSFASSLTQQEKDFLETKYVDTPRWVNLYGFPLIQQNEGFGIYA
SIWQEAGEPNKLQEKGWDVYPKFQSLFRFDRTQLGKESAITLQDGRKIIQ
ASFNNKTLYFYGYQYKVTTPVDVSGGVSGALVTDTQGLSLGIFNSKDNSF
VTASDSERPELGEWRIFNIFVIPFTQMEKIGRVEAYNLIDGTDKTKFPNQ
TSSYRDQLRLVYNSGSTKFKTALFPEGA
>MS53_0245 putative phase-variable hemagglutinin
MLIYWDGFMPKIVVQGYEADGEEKGKATHKEANQKKLEDWFAANQDKLSL
VADQLTRKLGKDKFKNMVLSTPTITWDEVEFSNKGSNKVYLTPKVTFNLA
AKDGYALAEGSTTTVTLTIRVLYKDSNLTRNVLSTQGAYYTAAPKNAIVD
DANVKAKVNVYMNYTGPNIELDADLPRVGEQENTSINGTSNVEGTFNDKF
KKLLVNVVGESITQTSLLQAIINYVNKFDPKFPAAFVTEKNGVTVASVQN
NTQLRIGSLNDFLYNNKGFLQQVNTDTKAVYFAVMGVTSNGWVNTFLIRI
PLTKFVRPISVLEEQTTEEETQESQEGQENQEQGSTTQTNTESSGTGQSS
DLTEVSA
>MS53_0355 hypothetical protein
MMRTMLEIAIEVISKDTTRHFTFEEIFQRVESELAEVWATKFVDEKNSYN
DVRVRKMGELYRILTVDRHFKHLQDETWKSSTYKIKN
>MS53_0161 putative type III restriction-modification system: methylase
MYIDPPYNTESAFADGNSISNNNELISASKFIYRDKFSRNGWLNMMYERL
QLAKKLLKETGIIFVSIDDNEQAYLKVLMDQIFGEENFIANISWIKKRGP
GSNTSFINKVVKNCEYILMYAKNYNEDTQIGYKIHDLEKLKKLGYTNKDE
FFEERGFYKLADLHHPSSSGAFRYSKSLDYLIEAPDGTKFELYSNILKPE
SACYTWSEDSFNVGNKLGFIEIKKNPKGYWQAYRKQYQFVKFDPKEKSIV
KVVAGQEFENYIENIYSQNGGKEIIEIFENKNVFDFPKPPDLIKYLLSFS
NNKNARVLDFFAGGGTTGHAVEDLNKQDGGNRTYTLVTNNENNIGYSVTY
ERLFRVNFGKSTDGNSFKWVENNNAYKSNLDVFEVKYESTNINDSRNVDQ
IVNKVSKMLFDFGINKTVEYKKILNGLSSLKKLKSD
>MS53_0046 conserved hypothetical protein
MELIKKGYTNISYKNDAEFVQEKILNGFNHNVNYDLLNKLNFVPKFLGSD
EKFIRWEFIANNKFKFNDSIIKEVANNLKQLHSSDLKFQENFMHKRLKAF
LENIKKLDRLNDIVQKSWILLSNRLKNFRFKHTHS
>MS53_0175 putative membrane protein P80
MHENKKIKKVSNSQATRKKAAIATLSLLSVGVILAIAVPLGVTTNSVTVI
SPVDDSSTAFTFKGPNSSDGSQKLTVGSVTKSVQGSEAQVKEEISDVTKK
LVFYLYDQEYKASVEQQRVYNASLALGQSARNDIALSSLEEIKQKQTKVV
EDLKRNYISVYGFQNWQKQFTETLSTDPKYSGAKDEAEAIENLTYNEIKT
YAEARFKPEFVNTTRSEINKLASRDIYKVDANGNEISSNGQRQVLIKSGE
RVNSFYQDGSNYFLNAANNNLATAFLTKSFVSSQKDPSEILKSYFDANDL
HVVTSVDLPGKLSSPVTNAITLDADAKAKFINLAKYWSVKNTNSQRQILS
GSEILKQLKSATSYFPTPTEALSQSQITVNQGNYQTFLNTLTLTKGDSYG
TSGLQSIESVFQNGTEQGLSSIWSKVLGSTLNASNLPQVDLSKVFDFENI
RTNDPSAYSRFSTLLTAAKNATSDQDAFNKTKELNQFIESYLTNMSNAEF
SSLLVRQYTNQLVKNVGGNNLVSFIYAIKDMPNAYLVVSKDKISIQQYTN
FTSFDNFKEFVKNTLYSVAQGNKNIFNLPQAVSQSQNDNVILAHMLNDAD
FVSYLKTKENPFSKDKSNYSDEDIAKIKQENASIIAGNKSKMQIQNFTSV
SNLINNSLVSQNSYNFGVKDGVARIISGFNGSTPTYLGNSESAQDLIVKV
LISK
>MS53_0027 putative PTS system, IIB component
MGTSMIIKLKVTQAMKELNIQGNVEALGLGQGKSIVPNFDVVLCTQNFVS
EIKNDKVLVYGLKNVMDVNEIKAALSDAKEKGR
>MS53_0244 putative phase-variable hemagglutinin
MQTAPAAETPAADLASTVSYLKSLNDTLKAATDALNGDNPTEKTAYYKPV
NGRTLYWDGFMPKIVLTDFDKTWEQNSENERKIRKWFDNAANWVGLSDQL
TKKLGAERFKNVKLTYKEVTFSTNAVKTPTVTFTVEAQDGYTLAEGQDAS
AQEISLVVIVLYNPDNESTIQMPTQGAYYTAAPSDANADNPASAIKNVNV
YLNYTGPSIVLDEALPTVGKQENTSLNGTSNVTDDFNNKFNKLLIRYKAE
TSLFQTIINYVNKFDPKFRAEFVTNSINGVTITKVQKDKQKRDRELRPGT
LNDLKGNNLFLQQIKGDKEAVYFAVTAIASNNWLNTFLIRIPLTKFVKPV
SVFQATTAAPTQEASEDQAQADPQATQMGTQTQS
>MS53_0473 conserved hypothetical protein
MHCRKIYFKPEQVKLVYAGVDFLKTSPKDYIDPPSPISQIEESADFAVLE
IDFNHPSGVNDTYKYTTRNTLQPTSDQENVVENARELAKIATSNYANWEK
KDQISFISKSLKATYEEDQKAIINDVTLTNGQKTNAKKASLNFISVGFPI
SSTDNHLEKTYDTVVDQLEEGSQSLWINKPIYIAEGKENSIIGTKEYGGI
>MS53_0074 conserved hypothetical protein
MNQILIYGSENYLINKKIEEIKKKFANYKVTNIYYKKDFAFFYEVYSQND
LFQEKELIFVNDFDFKDKKQVEKLINTLSDDNEKIVLFVNYQDFIPKNNL
LEKLQSKNKVFEFKKLTKKEKVDYIVDYLKSKNAQVKSLDIYYLIEKSTE
NLEILIKELDKVLIKENKITKEVIDENIFNYSESVEFAFVNALTVRNFYN
LYSKYLKEVAQNKSVITILAQIANFLHLSCSVYYLFQQGKNNFEIAKDLK
IHEFRVQKIIEFLNIYNLYNINKLKDIVSELLEIDNKYKSTGDLVNDIFE
VFLIKKFGQA
>MS53_0234 putative phase-variable hemagglutinin
MALYWDGFMPKIVVDDGYVENTEENNKENNKNTNQQKLEAWFKANQDKFT
LVADQLTRKLGEEKFKNMTLSNPTISWDEVKFSKGNVTKLYLTPKVTFNL
AAKEGYEKASDSSETVTLTIRNLYKEANPDTNVFATQGASSSAAPRGATV
NDANVKAKVNVYLNYTEI
>MS53_0457 hypothetical protein
MLSKIAPKISEIPKKNMKYFRNFFIPLSLETLNNSKSLEPTNAPENELES
GDINSETIITQTPIKTKNITRVNIRLILLFF
>MS53_0402 hypothetical protein
MKKFEFLLLGSATLPLMAVAAACGAQQEKVEEPDFVHETLTDAEKIAFQS
AAGSNLRTMGRMRLVVRAALVNNDKTLVSRFTTLAGEDATKKAAVETFKT
EWTGKWGALFGTLSDGDKNVFSGENKYANGTATLAEYQTLKTAFTEKAKD
LLASVAKVIKALGLGDLSDDYKTYLDSANVSALQTRFNYTGALVPDSSTL
NDFERFLESIVGEDTSKDQSNPTPTGNMVTVLSGLEDNAVFSKTVMSLVA
LLTDRMVRLVEGAEAAKVLVSTGTATAEAAKETYLALRKYDKWPASTLKT
RGTALSTPVQALEPVLKNVETVLSPLFAEGGKGKSLVDTLKAKESKTDKE
TMLLSRLESLANLAKANSELEKLSLLVYKDGVALDYEAAVLKSVKTYADF
YAKVGLSWQWALNVLLWANPAKDLVTYFTASGLADKFADKKADLEAVVAE
VTKLNVAATLANFDKFKAAGDTLNLGLFNQKARALTSHLQAMLAATKK
>MS53_0367 conserved hypothetical protein
MDLILETLQKRLNSDKRKLKFYEFLDRFIGLFITFINIVILIIASLALDK
LTSDSEFNKNNLFSQNTSLLLLIAFTIVLIVSFFLNIVIEIYKINQRYDE
YKKVSNTFSYLIVKYRTKFINEKDLIAQTNKLWEKASKKTKIQIKRYLIN
MVKGTN
>MS53_0412 hypothetical protein
MSIKNNSKTKLKIFIKRNFDEIFYLSALFLVSTILLITIVFNYSSIIFGY
LLSGLMIYLWNKYNKLFYYVFFQKVNFKYSKWVKIMIFLFLKKALVFITL
GALIYFIVTIDVNAVINSEISGNKVIKFMHPINIFAFIVGIIINMFIYFL
ALYLHAKKNSK
>MS53_0248 putative phase-variable hemagglutinin
MADLASTASYLKSLSDSLKAETDKLNGDTTENKTAYYKADTTRTLYWDGF
MPKIVIDNYVADGYDVANNAENNRAQHEAANLEKLRTWFATPANWEKLSE
QLTKKLGANKFKNVTLTNPQVSYEEVTINTYTWKNPKVTFNIQAKPGYQL
TEPTTEPTTDSKQISLTIRVLYENQVSTQNLLTIQGASPSAAPNGANTAD
HPQTIKDINVYLNYINQFKLTN
>MS53_0506 putative ABC transporter, ATP-binding protein
MKTLFKYVLYYKKELYIAIVYSLLQTVFYTIGAFLVGKIIGIFFEPIIYG
QKAISDFGDLNFFFYLLGLSLCFILYAIFRYLELRSYIDISYKTTQNLRK
EIYHKLQNAPLYYLDTKKDGDLITLLIIDINNVSNSLFQTISGFFNSLLS
LIFAIVAMNLVSSLLSLIVMPTAFLIYFSVFLYIRRSQKHFHTNTQAFAR
LNSFVKEMLNNAKVTNVFHKQKFVYKNLKKITNDIQNISYKGDVISRSFD
IFYSWISNLLILLISALCIIFYLNKTNVYGVYGFGVDDEGKATVSLIVTY
IAINWSFMVPFQGFLSMSFTIQNGIASGNRIFKILDIPQMENQDSKINIK
DVVGEIVFDNVYFKYQNSNKHQLLGVSFTAKPNTITAIVGPTGAGKSTII
GLISQFYNYEKGHIYLDGIELKDISNKSLIENTTMILQDCFLFNESVYEN
LKIVNPEANKEDVVSAAKITNANEFILNMEDSYKSIIKNNGQNISHGQKQ
LLNITRALVSNKKIVIFDEATSNIDTKTEEIIQKSFNKLMKNKTVFIIAH
RLSTVKNADNILVVNDGKIIESGPHKALLKQKGFYFNLYYSQFNK
>MS53_0491 conserved hypothetical protein
MKFELKEDAKAGDYFILNKSLDQNEHEKIASFVLEFKNNLDKKIKEQWEN
EFEETIENNVRFVRKYQQKEKELLKEFAQKFESEIEKVKGQIEASYKNKE
KEIFLEIDNLKKSNKSLENQIFQEKEKFQNDIFNARKLALSEAQKEAEEK
LKQLKEQNEKFNDILKQENQTNQNLNKQIITLNDEIKKMNASFLVRQNEL
MNKIEKEKKALSDDLIKQKNEEINKLNQKNSEFNNELKNQIELLKSENKN
LESENKKLEGYIDGFKDQRRIFTANVKQAGEEYEMWVNNILSKKYSFDQL
TEVKKATKVMEKDDGSKGKPDFYVTYNNSGINNKKQMIGKVVIEVKSLVK
NTGQKNEKFLKKLEEERKKSNSDFAILVTELEPEKTFFIEKDKNIEYRNI
FIVRDQFLELVLDIIHEFIKKKAEVNKLQKVFKDKKIIIEEFEKFKENML
NNSLKHIESNLEIILKKASDISKASKAMQDSINIILNTHLSTVRNKIISY
DILKVTNNIEQAQRLQDFTYEEEDPQLELEFKDETQEE
>MS53_0221 putative phase-variable hemagglutinin
MALYWDGFMPKIVLTDFDKTWGQNTANQDKIKAWFGDASNWADLSEQLTK
KLGVDKFKNVVLSQPNVTFEIINWNGQTWRVPTVTFNLAAKEGYELTGST
NTIALKIRVVYDSNDANAILFPVQGASSSATPNNASQANDATTIEKVNVY
LNYTGPAIMLNADLPTVGEQENTSINGTSNVDGDFNTKFKNLLVNVVGGS
FTQTSLLQAIINYVNKFDPKFPASFVLNTNGVALTSVQNNTQLRIGSLND
FLYNNKGFLQQVNGDSSAVYFAVNGVTSQGWLNTFLIRIPLTKFVKPLIE
FRPTTPTNTSSDTQQQDTQQQGTAQTQSNQGS
>MS53_0391 putative ABC transporter ATP-binding
MYLMEKQFDSRDCSLYVLKYFYNHFYSHNVNINDLKINAIYSDSGIKLTD
LHNIAINFNLNFDAFNCNKTELLRLEKNLFPLGIIFKENNEYHMVVLEKI
KNDKYYIYDPLYGKQKLNEFDFYSKFSEKVIYFSKLKNEVKENKIKKFDL
NFKNLFLYKIIYFIFLLLEVFLTFMLPFFNKFVFDQIIPNFLKKELFLSF
IVIAWIVLIKIIFKYSANLIINKKITSTICEIKSLFINNLKSKNFKKINL
INENEMQTRLNAFDEIIKFKMSFTSEVVVNLITLLFSFILLWNINLMLLI
ILLSYSFIVFVINFLNKRYNENNYVQIYNLSLDDARNFSNYFNSIKNIYH
PKIEKQIYSNWNLKHFNLHKKVLDYEVKNSLFESFLNFSEILAPILILIF
GSIEIWNSKLTLINLIFFITGASLFTNPIKSILPLTHQYVSYKKQKNILN
FFDLNLEEKTEKSNISKIQKIQLSYIDFKFTNNKRYDLNIDRLIIDKNII
LQGNNGSGKTTLCSIIAGKNKIDNGEILINDSVVNLFDDYDLKSKILYLG
FDKHPVNIPVLDYLDINEESYFNILKILNLEKAFSNLLSKNLTSLSTGEL
QVIKLFKIFTSKYDVIIFDEAFENVYLEIFEKFKTVIKKYFVETMFIEIS
HSQRYVFENSEVYNLQAINLR
>MS53_0246 putative phase-variable hemagglutinin
MNGTSNVDGTFNTKFKDLVTSDQRTASLFFQAIQKYVNTFDPKYPAKPIS
DQKNGVTWARVVGNALKIGELSETNTVFVQQMQNDTKAVYFAVSAIASNG
WLNTFLIRIPLTKFVRPLTEFQAQSATAPTQEGQTTQGQENSAGSGALGS
TTGTQTPSGGSSQASGS
>MS53_0590 conserved hypothetical protein
MYMRLKNKKILASLLVSPGLLIPFSTINATTSVNSNAPKLDFFKNKSAEE
IAKMEFFDARDYNLVTSVKHQGTESLCWAYTIASILETNMLKNNIGNYTK
NSLDIDEHAIDYVSNSWNHNADKLNLNSDAQQWRGFFGEGNYLSHAFTGL
MRNTSPIFQTNQTEFPKFDNPTIAKIKNAVKVNPTVEDIKLAIAKYGSVG
FAYAFNAMNLHPNTIWYNEPNSSIVNKPADQKNIKNHASVIVGWDDNYYE
SNFGPERPTRRGGFIVKNSWGTKMHSQGYFILSYDSLDLIHEVMAVEVEK
NDAYKNTYYYDTKNSFSLFATLNTKERTMANIFPVKKANDEVVEKLKSIN
FALRGLNITAEIKIYVKDSLMSNPEDGELKLTQTVQIPNSGEKGFYTIDL
DKEIILNKGQYFSIIVDVTNEGEKVVDLMASGETREILSFYKYKNEWVNS
KNSYVVFGIKAHTLEMPITELNKDIAADEENNPISKESNTSESQTNNSVK
TGKQTNSNTTTDESSVTENNNSNNENELEDVLINSKKPKTNKTNVILWSI
FGALAGIATFGMATFFIVKLMKKKS
>MS53_0050 conserved hypothetical protein
MSKLYLIGTPIGNLEDITLRALNKLKEVSIIACEDTRVTYKLLKHYQIEG
KKLFSHNKFNEKSSAKGLVDLILQGNDIALVSDAGMPLISDPGFDLIKLC
KENNIQIELIPGVSAVTSAFVLSNFSDTFTFCGFIKDKTNQRVNYLKNLT
QGTYIFFVSPHKIEKTLEDINLVFNGNEKISLSRELTKKFEKTYHGSAIE
VLNTLKTNSEILGEFTLVLHIPKVKKVKISKY
>MS53_0291 conserved hypothetical protein
MVNLPITTQSVTSPMGLGSDSKPYKVISKSNLNYEFYLTDSMQFHLELML
RAKDISSVGYITNTFRGEQVDNRHLHQFNHFEIEMLGNLNNCKEKIIDYI
KFIVNELIKKHKNLIDFLILIIQID
>MS53_0171 hypothetical protein
MNKAAVKKSKLLWIKNRQFIIGFWFFTILLSVANLLWSSRVIPLYYWLDF
EIDRTLRIFLALLFLANIFAVGFIFCIYSKITINTLYSVMFFACFISSLS
FFPQVLINSETNKTQLLFIYFKFDTALFFVLHGAVWLLMLVFLKPKYIIN
LRVKIKNKKITKN
>MS53_0108 putative oligo-alpha-glucosidase
MNKKVLENKIIYQIFPRSFYDANDDGDGDLQGIIKKIPYLANLGINAIWL
CPIYSTKFVDAGYDVLDYKNVWKQFGTLADFKKLQKVAQKNGIDIIMDIV
INHVSSDHVWFKKALESKNNKEHEYFIWRDNLSEEEKKAESLFGGSAWEY
VPHLNRYYFHLFSKEQVDLNWNNPKMIDAMVDVVDFWYKLGVKGFRIDAI
KHIAKDFKTLESNPAFAWCSGAVKFLKEFNKKAFADKPDAYTFGEASSIT
ADEVLKYASGKQKVADNYYNFAWWWIGWGKLGRNEYNPNWEIKAFADSQK
PFQENLKIKPYMITNFLSNHDTSRSISRWGDTDFFFEESAKSHAMLLFML
KGIPCIYYGEEIGLLNTKFSDISEFRDRDSFNFYDKYVKQDKVFSDKEFL
RNSNINSRDAGRSLMQWDNSINAGFNLGFETWFNLGSNQEKINAKDQIKD
KNSIFNFYKKLIYLRKNELNSILIHGTSEINCDSKTNLITIKRVYKTKKL
TVLINMTNREIKLNKLPQGSVILSTYNLENVVIDSKLRPYESIAILK
>MS53_0285 conserved hypothetical protein
MSISASCGSSNGSINESNNNIGGVTDNSSIKDRRLNALLGANPEASSNAF
QQVEKDKIVLAMTFSQGGAQAKALNELVNAYNNDAELKAKLGNIFKEVTV
NNVGSGYGEGAKKVSQYLEAKNTDNFFNLILNYSPVGAILANSNMLLSFN
DPNGNPDLDTDISLFNKDFVNSNATTENIKNPSTYILPIMKSTLVSTINA
PVMSYILDTMKAKGVTFSDDVDTKNFVAEIDSKGQPDRSQIQKQWGDPVD
NATELLKGFQFSKKIFNNYEDLIKFAELAQKLFKNTQDNQNDLHVLGIDS
PTSTFQNSVYSLTGYRYANSLEATSKKNGVNTVNYNSLTTTGSPANVAAK
TVYETFRSAVATQGVVLQGPGQFTSNKQIYHKFAMSIGSTAGYTHNYIES
VEGTINFNFSQYSGFNFKASTNKSDRNNYNRSGFLTFGLGLNGLGRKYRT
NYTSDQIFLGFGSFKNGLAKSNVTLKSRFDIKSIDTTNDASIQAAIDKIK
NDTSNWKLLLLQQSDSSKTQEFTDFQTVVKNAASQNSSEIIYGGVAESSN
SKNPQKSLVVFVKSSNSNPVKADWEKYIKLLGGTAEEQTSSNTLNKNELV
VINAPTKWNENSAKNSIYLQGPSLIGIKANEVDDAATRAFVHWLVTSKKE
YTFFKDDSKSTVTATPSLFFQKQMSYVMPTSDFQNSVSDKTFDSGKNSRT
DNPFLENALQVFKNAAKDQANWTTYESPGSEKGDAFRNSVESAFKNLINQ
AANGTQVSQLQTFDQFVQSFRDTFGSNNN
>MS53_0266 putative phase-variable hemagglutinin
MKPNDATVIKNVNVYLNYTGPAIVLDEALPTVGEKENTSINGTSNVDGDF
NTKFKKLLVNVVKGGSRWIFIIPSGN
>MS53_0373 conserved hypothetical protein
MAGHSHSANIAHRKNAQDAARGKIFQKLSKEIFVAAQKGFDPEMNSALKL
AISKAKAKNMPKDNIERAISKAKGDKNSNSFTETIFNATLSGGVSFIVTT
LSDNLNRTRSNMTALFNKQNASLGKTGQIPFVFDHKGIIEFSKGELSEDD
LMMVALENGAQEIETTDETFVLISNPEDFSQLKKALEDSFKIEEFLQCEI
LYLPNTYAEVSEEKQQKLLEFIDKLKDDDDVQDVYHNLDI
>MS53_0073 conserved hypothetical protein
MGFLLLFFENKNLYFLVSGLILFLISLFFLKKKYWKIIAITFVILICILV
KNLVQNFYLYENKEIANLNLKVISKNNNYLIAKDLFFNKYLLKTKENLNL
YQSFQVSGVLEKIESNYSQYYLSENVKFQILNLKINEWKSYDLRYFFFNY
LSQKHVYKNYVIPIIFGYSTEDKNDLFKNLNDIGVIHLVVISGFHFSLIY
LSIAKITKKIDNSKIIAFSLIFIYFLFVKKSPSVYRSILMIFFGFVFEKF
QKFKKWNNNYLEIYLAFLFVILINKYYVLKLGFWFSFVVVIFIHLINDFL
KSFILSDIWKKVITFFLIWIISQILIIIFNKNNSLLSMLSLIIMAPVIEV
LIISSLILIPFKFLLNYLYLGFEEIVNLISKVSVLAKIEFIYQSEILWTL
LLFLIFIFGKKVKYC
>MS53_0138 putative sugar ABC transporter permease protein
MMKFLTFDEQKSTRRKVYSSLYAIIFGLLITSIIFYIRGVSQFSRESSRI
NFFSLISFIFKNGFSSSNTYLFLNYFIVFGFSGLGVAFAFKSGLFNIGAS
GQMLLPAVIFYSMLILARFRAGEEISFTILALGFLIFVIGGFFLGALVGI
LKSFFRIHEVITTIFFNWIVIYIAQWMFNSGHDSILLGSGVSTEFRDKFI
SNFSFGTAIYSIELSLTHNFIIFGVALFILLAIGTWFVLSKTMLGYKIKV
LGLNKTNAKYIGLNEKFLSILVFGFSGSLCAIGGFFYIVINQNSINSLSN
GPIAIAFESIAIALLALNAPLGVIFTSLFYSMLYTSAPVLQLQNGIQKVN
VEFQTLITGLVLFMSALSVMFYKFKPFEWIYKQMHLLFNKKYWQSYIKYK
QDKVHNSLYYQRQIYRHYLEHLKIKKQISKEKKQLENALFDKVLSTKNQN
SKEILETYADIFKERSEFNLKVKALGFDNLQNFKQSHKLKKVNLKNQYHF
DKNQLYQAAHKKLKLKGIFS
>MS53_0087 putative P37-like ABC transporter substrate-binding lipoprotein
MEVFIFNFKKLKLLLLIILFSSFVASSCGFASQNEQKLQWDATLTLYGPN
SGNLFSENLKSAWIKKVQDKFNELKNSNPETKNYPDVVFDLKFLDDKNLI
FQNLNNNLENYDFGILNATTILKNKNSDLISHPLLQTKTLKFLWSLDDSK
TYVDGSENDPLITAASEANKIQFENELYGPYSSWNDENKKILLKWDGSKY
NVFYKDFHDSNNFSSVFRGSILISGTKEIRDEIIKAWNDKNWEKFLSFGI
VIRNFESLSRYNAQVEILAKQFNKNVSEIKTELQNPNNKNVLIGRASNSL
GVLSNQGKVFNIAFDYEGVFNWTPPYYGSGNLIYNFKPSDNNSSVRYLTF
TNPIIYDQVFARRGLSEIQKELFAKALASLSFEDNTYGNYTGYNQFSLVG
NNEK
>MS53_0084 conserved hypothetical protein
MYLVSIIIFYYQNLNNIITLMSKLFIKNQLLNKHKSNLSESSIIHLNKIC
EKFNITNAKLHYEGFHNITYKVLINDSWYQLKIPIDFTVVNRKIEEKIYK
HSKESIYYKNGFLIKKWFDGKDLNKVNLTNKIQIKVLEKLKEFSKLKIKT
ENFDWNLYKTNNKKYLSLVDKYKNEKLVLQHGDLSFKNILVNKNFEVNFI
DYEWVRNNYLSFDLFYLHKNGFSKENILKVFNITEKYLKDIFYISSHFDY
LSYKHEYSKKYLTYIKNKNKVIQDNFLPNLYALNDKKVKLKSQSFKGLNL
KSNYQKLNKFDLFVNVSYEDNKMIIFENLNEINHLQFNASSFIKNFQSLK
IKPKKYFLKLIVEKLFLKHKEKLLNYLDLKLMLKIIKDFKSVDADTLSHN
KLFYFSLIETNNKKAKLQFNELLSKNNKYFDIATYISSLNLSKNKEINLL
KEFDKNLNLDEYYKIKVLANFYLLLIYIDENILNFDLNIFVKNITKYKKS
K
>MS53_0127 conserved hypothetical protein
MKNKKLTYSEISQISGISIASISRYYRDGYLSKEKKLILEKIISDYGLET
KDHFKLTKTVNYNLIFALIPQWQNHKFSPIISGLVNEANKVKQKVFNLYY
NTDKNDFIENIYLALKHNPIGIVVFFNKKNEEQLEFLKKLSDQCNIFIYG
YTYDGLNSIKIDFTKAFYKLAYFMDLYFLSKKNIAKKLVYVFNNKTEKAI
QNEKIAGIENYAKKNNIETAFYNLNLYSKKDVASFFEFCKKGSYKYIVSS
TREIFASLMAGNSDNLYITDIGYISIYDQIRNYLLKIHIDYPNIGIEFHR
MISSYLLESESGTINKNMEVEIIK
>MS53_0277 hypothetical protein
MSFRALSNHFGISFSKSKKLTDSIAIADNLILINKNQNSNQEIINLNNAF
NNYLSYYKKIIFKNDLNFYKNEVFSQTFSDKLSQEIADDINKKTNLYSDF
LSKIKNKTNQFTAKDFQETFAIKIKGI
>MS53_0680 conserved hypothetical protein
MKNVNINEIESFIFDMDGTILDDKKQLSQENISAIKFLQDNNKKVIIATG
RPIFINKEYFEKLNISDFVIGINGAIVSLNWRKNKNEIISYLPKDTFQKL
VLYLHENKIDFLTYTEKFLYGFNFNNPIWFENRIYSQIQKDNPYKFKYYE
NNLEKLFSYLEKEKFLKILILKDKTSQEKLDNFLNYLLSFDDIYCLQSQS
DVIDIMAKGTSKGKTIIEFFSKYNLDLNKTMAFGDENNDIEMLQNVKYGI
AMLNAHNNLKKVTKYITEKDNNSSGIADFIWNLTKTNIEDKNKKFKVNHI
NNKWWFEPSICSLSFTNWAYRPFNTFDEFLKSIKMQDRPIYISLNSDKEF
LLFNQVQRQYNKTLRLNKNLVLSKKEIYLKLTENIYIYLDEKAIKDIKKG
YQFAFPTKYFEEKTKKLNLKLNQNLVYVFKYSKFDFKLFVKRKNNFI
>MS53_0155 conserved hypothetical protein
MKTKIHFVLEKYPLSQIFSLISYFLIFSVSLILLFMFPTIFKETNATAKQ
DADFSILFLYNNTEFQGLNFLLVFNYLYAFFTVLMTYFFAYRNSNKFLAP
SYKYIPYFLAYNLYALIVLIIAFVIKVDSPTMVFKKSFSFIGLLIINQIF
EIHDFRLNNYTKKEQALYAFNKTLKYITFAGLYAMFFIFTQETTYQSLFV
ENKLQNWMLANIFKNELASVMQLAAIILFVIVTVLSSFWAFLVRPNSLSQ
SKIFLKNVITVLIVISLAIALWYLVSIFLVADPNFKFVEIDPRSTMPAYE
VKFVDSYLVNQQINYYIFPAYIGTFFLLTLFVLVISNIKKVARENTRLIL
YSNVFAIALICAGAVGTNLYVEQKLTTTAVTIAMVVFVLAIVINWMFFTR
KPNFSQLLYIAAVLFLVGFIAAYQILSLNLSSIDNFSLATIAFRIKVPEI
AMILVTFISIVFMISKIAFWVFNTVNIYRYSKKYSQS
>MS53_0099 conserved hypothetical protein
MKINFKSTILQNGETKEFDFTASVDIDRYEDMDTFSFTEPTQNVANRIEI
SHKKINIFAGATTLFIEKDKNLASPFILNTPDGKVMEVNFYTRLLNLEID
PLNKYKFEYILYRLNDYQEDVIGNFKIELTIS
>MS53_0215 putative phase-variable hemagglutinin
MHKIVVSLLTTKPANQEYDANPRTTSVTFWKQRNGEILDVWFAANQDKFT
LVADQLTRKLGEEKFKNMTLSNPTITWDEVKFSKGNVTKLYLTPKVTFNL
AAKEGYGKATGSLETVTLNY
>MS53_0090 conserved hypothetical protein
MNNILNPKPKKLTYKKLTRLKYKKKVFNSFSFNIVWPFRKDYISIAYVVG
LKAVISFFVWILIRNKDDNRKIKNKKVINRIFDNFNTKEYNFIWLSTAFL
ILISFIPVIYIVYFFNSVLTPNIAGLTPADFEELFLSSILGKIIPGTDNT
FLKLNARDIFNSADFSSIVGSFLLFVVAIYISSGGYARLITSSNYIYDHK
KLGTYIGNRFKGLFVVFMVAFWLWIMSTIQILIEIGIMNNKEIDSDISKG
ILIQFTFGVNTLIFFFGLTFGIYKFVPSFTSKFKNIYRGAIIATIPSSIM
SYIFSSINQNSSYGKFGSTVGFFLLVALFVNWFIYFVFLGFTFNEAYFKN
YVARKTDDRKFWKLITFWW
>MS53_0196 conserved hypothetical protein
MIYDKLENISRYQNLNKNFDKAIKWLSNLDLNHLPEGVFEIDGKKVYGFH
VDVEGYDDLNKQYEVHQVYADLHIVVDEREKFYYLYESELTHKKNDYSQK
NDVQLFELPNERNLLAPIKHEFLLFLPKEGHVPKYISSRDKFKKFVLKIQ
W
>MS53_0672 hypothetical protein
MLTLKGLMELTKIKQIFFEVISTIPGIVNINNINGGDKSARLLDRINVKK
ENEYLSFYVDIDILLGVNVSSLVQEVSQSLHFKFKSSKYKIKEISLFVSG
VIYE
>MS53_0528 putative DNA polymerase I
MMEKALIIDGNYLMFQSFYATYRGDINVILRTSNGTPTNAITLFLKQLVK
YLVFYKPDYLFIAFDAKERTKRHELLDRYKANRIKAPQELFIQFDLIKEI
LKEMKVFYYESAGDEADDLIATFCKNFESLEKFIFSRDKDLLQLVNKNTR
VFFKDEEVTYLNFFEKYQINPDQIIDFKALKGDPSDNLPGIKGIGDKTAI
KLLNEFKTFENIYQNLDSKLISEKVKNNLLKGKENGMLCYQLAKLNYEVE
VLPKNLDLFKLNIDLKASEKILDELELNTTKKMLLDKRWLQ
>MS53_0290 conserved hypothetical protein
MKIIIFCFNKLKIVKLYDRINQLFDLKKEVYMYEDFRKNFIKTIKNERYS
NLLKLFSVINKLTYIWMENNNV
>MS53_0104 putative multiple sugar ABC transporter permease
MYKKRFFFGMILPSIIVFIIVILVPTILALGYSFTDWNGRSGKDLKASWI
GFKNYVDIFKDSYFAFRIGYTFVFSIASLLLVNIIAFALAYVLNSKLIKG
RNIFRSFFFIPNIIGGLVIAYIWQSILQGVYYSIYKQEGSFATLNKWSGL
LSMTVVYTWQMAGYIMIIYLAALQNVSKTLDEAAQIEGVSKFKRFKSVVI
PAVLPALTVSFFLVLSGSFRMFDLNFILTNERPDSSLLAYDIYTTGDINT
QYGLAEAKSVIFVILVSIISISQVAISKKFEVQA
>MS53_0566 hypothetical protein
MKMATKVTAFCNTCTLKWEYFFGETQELSMINLALNYIEQNQKNLFVKEN
FFEFINKSFSGKKDFESMPQETKNKSMELFYNQFVGMFSDEERTMLESNI
LLKHNLEIYPIYLSSLPEDERKVMNIPLLSLWFLNQEEYKRRYNPEIIYI
QFTKEQDYLVCPKCQSMSAAVIAQDQV
>MS53_0188 hypothetical protein
MAKVKHVYKYLIAAVSFLVAGGVSLGAVKLYSDNSSQTKGALNPAENELV
NVFLAKDSSPELKFLLQDKKTSVASFGKYQDGQDNLDRVTYSGRSYEYED
FFNVFYLQNGFLPVLEISYGSFKFYNEYLEAVPPHEFLKFAQWFVKNVSW
GPDMLTLKSFSIVKGVQRDGNSITLGQHLNANKELQTIKFYPDAFFGSLS
LYSFLAGEGNLQDSLLYRLNSVSITEEELNFFLKNAKKLNILANEPRNTQ
QSNIKFRNLLAAQRLQNRKLYVYSDSEAGVKQVVFLKEYDPESASSQSEA
QARLRDLLKDPSFVFDSSKLKEYYVSGLGMANADLLSKTYPELASLDLTP
SEEKETNLKNLPVTRNGRMALYLRFVDAAKGDGAIEAAKKAEEALEAKVL
EDLQTNANDTDAKAKVAAELDAIKKALYTPDETLLVTDYDYSAQALSNLD
ELEKYEFSQPTVDFLDYYDLKSLIGKTFNLYQSPQPQQDQSESQEQSETQ
EQGSTENTENTAPAVAPGFPGATQPAAPQTSLMVPEAPVKSDATDAMAAT
VVDLNDKKNLTLFSPNGKEVEFAKNYASLVDERNFKDPETGKVDFPAFDT
NLLSQARVSDISVENGVLTVDLLTHNAKYRYSVDAKSMSDRDWDFVQELF
SKAGYVKYLDPYLVNLDSDIVTPEGKRERTFTLYYSAYQNLLDNISRKMP
YLLSDRTGPHVVKKVNDQGVVEYKLEDGPYKGFSSDDNIGLWAVLKLSDP
KFKGMSSDFLRFVGAHEYGHHITLTGAQDLGDKQYDPVLASAQSPRGATN
IQNFISKENLDLYLRARTHLEAKTTNLYAQGEKEINSLPESNTGNFVNYG
FQKKDGSYAYETQSDVWGAPKADPSIVRALTNPKRRFLQNFEGLQKALQE
RKKDYNLSDNVDLFDLWLTNAFDEQSGTLNPTIEGTAQYFQVDTSSPTGY
TFKDASNDQIKDYLKDGLGQKIEYSNGGFVLFKFVPYDPQNGLFKLTSNK
VRRENGELYVNIPEGSVLTTAQFSELKRIEREFNENVNNFIVKRFSSNGW
NTGTAITDTNVQITNAVPYSLRYTSQDELVNGEYSKATEFYKNFVNKRSW
TNGLFGNDEFTFRTAEADDYNITYWPLYFAKTSFYGPENYRNALIFDEGA
LTKTREYAYNFPVRFPGLSIAEVNKTLTEFLTLFPRTLTPQERSAKQNQI
RTEAERRKVFDVFMQTSYAWRGHLPEYNVVDTLGGNKLFLNSTHQYVPNF
AQRRVVYNTNTKETTYKDPYKSSSFLNNTPISISNVVNGLVWFKNLNGRI
YSDYAPWMRPIGAVDNDGQQFATAYFFADENGTEIEAESPDETTKVDLSK
RNAQTLVVNTDFGVSDVQNGVFGAIKLSPGKDKRVLNDLEEMFDFMTVDY
EKAKATYDAATKQQVLNWDIDYVEARLDLETFRSRYLSFLQNYKGRLFTN
KERQDLIDLYSKPLSETKQEVANQAMQRFLRSGYVPFAKDYQLKNFLAKR
DNLWVLDKNVGVDNLKSSFVDLTVTDADDNRNVDRYLKFVKEYFDKHQIM
YDNLTLFDLHLLTGITWFLPDAKTSRGFVNKEAGQLTVRNGVSSDVDLYF
STKISSETGSIFSDYVYSYAEQINRDYLQTTYTPSYDQYGNRPDYISGIT
EVTTGLEYIVDATASNKYQNFQVDSEVTNNMLISNVIPYYVEQNNRNRAA
KNGLPNYESSKRDNYFYWLPKYTNNFFGKIRSFNNGWYKDRFYRTKLNWE
LYDEHGLDKQDNSIRIKDLLGQTVTSRAKAYWQYLIRSQGIGDRTLSGFW
RDSDKDAVAFYGYFDLEKSQDLKYLAFENTATKEVSYLPVHVSHTNNLFY
YTKQAPENGYTDVNRHYIKDEPYLDKKTNTQRVGFASWVSDYALVSQYRN
RLVSPGNTYNVYFANSNKEKLEDVDLGSLVSMAENGKLFNQSPLTVQKVE
NTDGTHSAVLNVKDQFNSN
>MS53_0499 hypothetical protein
MNNNCNNKIKKVIMKKVNNFWKKLTAAKTKAIQKQNEASKSKKQESLIEM
RLEEINNAILAYEHNVVDLDSKEAQMALPWYKRQLFLNLLGAGVTILLMV
FLLVLAYLLGGIV
>MS53_0339 putative PTS system, lichenan-specific IIA component
MEVGYTNISYKKGDLFIQEKTYNGFNHRLDLSELKKLDFVPELISDSEKE
VTWKWIETQQLELSDENIKKIAHNFKKLHNSGCNFPKNNLSERIKKYLKI
INSKNIKIDEINNFYSKVNLILSNMKGNAPLHNDIYQSNLLWGVDDKMYF
VDWEYASMGDKHFDLAYFICAGHLSPEREKLLLETYEDYQEEYILQHKIV
VYYLIILWVNAQPIKHFDDKPYIQKMLKAEEFFQKRKKEKFQ
>MS53_0016 conserved hypothetical protein
MNLLVIVDNNFQDVELTTVVSILKRSQQFNKIAFYNPCSRKATGQFEIVK
FNNLETSVNLKDYQAVFVPGGKACFSFKDNKEIIKKIRHFFDKDKWVFAI
CDAPNALRYNNLIKEQNYTSFPSAWSKELRSNSNYQNKGVVVFEKLITAK
SSYYSQHLAFEIIRTLFGEKEYKLSKKLAKG
>MS53_0325 conserved hypothetical protein
MAFFTKSLKNTSNRWSYSWNIFKNKRIYFSLKEGLVFNLFSFLVLLVGIA
LVITTLPGFFHLTGNIPANASEEQIAALKALWEKNMFTYIWSVRGIAIFL
FALSFGLNLFNLNQINKKVKKSLIWFDVKNNERYGLFVFVSFLLSFFAPL
QYFWNLYHFQKKMHFRSFYDFENNLISLEDQKLSLFEKFSFYLKSPYFKS
LFRFSVFDISIAAVLLGTFLIVSFITSFSALKLTGINLEYIFYITFAFVL
RWFKGSILALLADFLNLLIKGAIGTYHWVYAIVPVFVVLISSAFFYFLEK
WKKTTIVVGNVILLGALIAVIAVFSYQVGIKQVNEIRISTLFGIRNVSIT
IIIVFIVLSGIVFLTSLGISIYYLYISVKKDEDFKLDRKKDFAFRLIISF
IIVTIIVVVARWLWGPYAYIRWFSWINGKPPRNPYELAIIPILLRSVFII
PFYTFLVVALMAPFFVLKKKYLDAKMHHLY
>MS53_0520 conserved hypothetical protein
MVMRKKASFSFEIKKEISNQVKKKKEITTFINGVIYSNSILKNNFYILNF
KNKQALDIILKLLSKAQIKYEFENNLIKISTKDLELNFDSYYENYLTFFF
SGIFFGSGSLNLSVGSFHLEFSSRYYEILMQIQKKLNEYDFNFKLLKRNQ
KYTLYIKKQEQILDFLAAINAKEAWSLVQQQKIDKDMNNASNRINNLDFK
NEKKVTKASSELIKKINFILNKKLNYFFNEKEMLFLQEKLQNKNASLARM
CEIMQKKHNLEITKSGLNHYVRKVNKIYKENKKARL
>MS53_0671 conserved hypothetical protein
MSDFTTGIVLKIKKHSENEFIVYFLCAKGVLKLFAMGLEKPTSKNKTNLV
IGAIVEIEYFKARLKNKIGRLKTVKTLLFPVYNFKSLEEYFEFQKLIKLF
LTINFENNFLSVYKFMLEKLKYINYEYAMTYFYGQLLINYGVCPNFKSCA
ICMQESNLVSFNLEEGGFFCNKHSDGIEILNVEVLNLIYLSYNNFILYVQ
KTNKYVNDFLQNKYKEVLQNAGFAIY
>MS53_0045 conserved hypothetical protein
MYFVDWEYASMGNKYFDLALFVCATDLSVENETELLLQYKDVNLYEYLNE
KLVAYFFICTWAIAKNEIPINIKYFLTKLEDFYNLVVYLNNLNKKQIKQV
LFLDLDGTTLNTHINGRSSSTQKVRDFLGHLINLNTLYVPSTGRGLNWET
KLIVDELGSKIIF
>MS53_0259 putative phase-variable hemagglutinin
MKFWDGFIPKIVVEGYQPAGDGSNKEANKTTNQKKLEAWFGDAANWAGLE
DQLTKRLGSDKFKNVKLTYKSITLTDFTVAGATRWNPTVKFSVKAKDDYA
LDSTSAREIDIVVRVLYKSAEANAANVFTHEGTSSSATPGNTRTVSDTNV
LRNVNVYLNYTGPAILLDADLPAVGGQENTSINGTSNVDGAFNNAFRGNP
SKGLLFTDRYPNPLLKSVINYVNKFDPKYRAEFVTDSKNGVTITKVQNTK
ELRPGTLDDLKGNNVFLQQIQGDTEAVYFAVTAVASNKWLNTFLIRIPLT
KFVRHLTEFQAQSEAAPTQEGQTTQGQEKSAGSGALGSTTGTQTPSGGSS
QASGS
>MS53_0479 conserved hypothetical protein
MISMLKDALLVFQWMTIISVLLLSLPQLIKVVKEKEAKHVNFFSFWVAHI
GIVLWVIYGSLNKSDTWNVIAADGSSLFINGAGMYYLHKYDVNRTSKKFF
WANFSILLTFVVAIVFAALHFAIKEFRVSDKVSLIFSLVAPAFTTLAFVP
QYIYSIRTKQWQGVSYWMYALYVINNFIWISYWSLLIRKEQLDGNFDLIN
LYGALTWQSISLVLFSSQLTFTLHDRYFRQKDKYRKKHENNSN
>MS53_0299 putative endoglucanase
MIAAHMDEVGYLVRSVEENGNVLVKTVGGVWPNVVIGTKAKLKANSNEKV
YTGIFGHTSIHILEREKFTKAILEKELFVDFGFTSKKQVEEAGIEVGDPI
YLSGEYLEFPNDLIAGKAMDNRAGVTALELVGKALAKANLNCDLYLVGTA
QEEVGTRGAKTSVTLINPDVAIALDTGAAHDSFGAPKGTPSLGKGVALLV
QDGGTLPDTNLLRQLMQVAKKHKLLAYKYIAEGGGTDAAELQYAQGGAAT
ITTSIPQRYLHSPLGMASLVDIKHTVDLLVKYAESFSDKHLKELKFK
>MS53_0369 hypothetical protein
MCFQKIFWRKRRKIFRKNIPNIAVRLILNYAVCVIQKLQNEKINVKFTNE
NKLLISRKILEKINNIAYNLEKNKYNQVTSSIIRKLKMNLYWALKVDISV
LFQLLFLR
>MS53_0186 putative oligopeptide ABC transporter ATP-binding protein OppF
MKKYYKETTNFKTTYRPIVEGLDTMLNAYPERDVLVQIRHLDIVYGSGFK
KFRAINDLSLNIYQGEVLGLVGESGSGKSTTGRAIVGLTPYQHGHIKLED
VVVPRKFSRGFKFGKKLQDYKKTLNYMANKVQMIFQDPANSLNPNKNIEK
VVSEGLDNLKNSRLIALATFDLAILKELSTKGYKKELCTFLKVAEKKYYS
TFESSHVFNKKTLYTDVRDYFAKANKPEYKELVKFLNDKSKEREKFEKMS
DKALKKHLIVDILKQVGLDKSVLSRYPLEFSGGQQQRIGISRSIVLRPKM
LVADEPISALDVSIQAQVVNIFNELKEKFNLTILFIAHDLRMVEYISDRI
AVIYKGTLLEVGPTHEVVKNPLHPYTKSLLDAVPSIESKKGSLIGFVYDP
SMHKYTKEVQPVWNDLGNKHYVFATKEEISAWKANKYDQLSTRKDAPKSE
FDVQTHSFGKDAKTKKPLSSSLLAKLKELKESLAKATKPAKAKPMQSKQS
QAKPLDPKAAAPAAKEAPKAKLEANLQDKSNKANSKSQLHSELNNTKTAK
DSVLEEFRNDSKVSSARTAQESRRSWNLDKLDKKK
>MS53_0202 putative phase-variable hemagglutinin
MSDQLTKKLGAERFKNVKLTYKEVTFSGDDIKTPTVTFTVAAKEGYTLVD
SGENASATEISLVVRVLYNRGSESTIQMPIQGASSSAAPGNTKTPNNATV
IKNVNVYLNYTDI
>MS53_0107 conserved hypothetical protein
MNYNTKDKIISQVKFDKNLTAKTESIFSLGNGYLGIRSADEELAWYNKED
FFVNGIFNRDVKEEVSELANLADCLSNPIFINGRIFTASHKDFYNKSLDI
KKGILSRKIIAKRSQSEIEFNFERFVSQDDLNVYGQKIKIKVLKATKENN
FLLKVGINGQVTNQGTQHFSEGHKFRPTNESLQMHQQTTNSKRFVVHNLI
TKLYLNGKLIKGGTDDYVIDIDRRRIVFNINLNLKEKDELVLEKLMSVHT
SVDSKNKTISKEKVLANANEKHNYLLSQSYDNLKEKSIKAFEKNVWEKYF
VKIQGNEESSYDQLALDFALFHLNNFVPKFSTTKNVGAKGLSGEGYQGHT
YWDTEFFINPNYLFNDPSVVKNLLTYRYKGIKGARDKAKEFKQRYEESYL
EGAQFPWEMAWPTEGEVCPYWGQADIISGEQVPIASRRQEIHVSSDIAYA
VEQYYRATNDEKFMEKMGYEMIFDTAWFYTNRAEKQSDNSFEIKDVMGPN
EYKGNIDNNAFINFMAKYNIDLAINYYKDLESKNKDLLKKVLSKIPYKID
LEKMKLVSQNLVQQKPNDQKIIAENDQFLKLPLVDLSSFQMRGDAGKKLF
STKEGTKILSSQVVKQADVVLLLNIFPNLYDYETKSKNFDYYEKITTHDS
SLSPATYCLEAIRLRKLEIAYKLFKYGINIDLGENMKSSNAGIHAGSLAA
IYQMIVFGYGGLNFTDGKLFFDPVLPSNWNQLTYKFKYLNCEFLVNVYKD
KFSIKCLTKDKAREIYIENKKYLITNKEEFFKIKHAN
>MS53_0065 hypothetical protein
MQEIHMKNATKSDENKKLRTECNAFVKQVFLTYEAWNNQLKKQLLNLKFK
ESYLKDKNLSQEVHKLEIKIKASGSMIQSILSVMKPENSWIIEKCFLDKN
TRNNSLWYKDYFSKSTFYKRKNLAVKEFAQIYFDF
>MS53_0086 putative ABC transporter atp-binding protein
MISFDNVTIKYPKSKENVLENISLDLQKGKMIAFIGPSGVGKTTLFKIIV
RAIKPINGNVFLNNENIYNLSKNQWKTKVKKIGFLTQKPNLIESDSVYSN
IKRSINDYQNWFFKLISFLTFDKRVKIFETLDKLGILNKAFSRVSDLSGG
QKQKVEIAKLLIKDVDLILGDEPTSNLDYKSANSVMEILKEINKKLNITI
IINIHDLNLATSYFDQIIMIKDKQIFLNESINLKNKWNLNEKVKRQIV
>MS53_0338 putative aspartate-ammonia ligase
MDKELNFNTYKHQRQDLLLELETNLVKKLNLVKKTPPVKLSGNFGNENNY
VEFFVKDFSQYTSQLYKWNKISLKNFDKYEGLYNMPGPYYLNESGQYSYN
AKLLSWAQVIDYSDRNLVFLKKSANKVFLALKATEKFFVKKYSLSKKLGE
KVFLITTDMLYKQYPNLDASQREDEITKEHKVVFVYKIGYNLPDKKPHSE
KVFDDHDWKLNGDLFFYDEENKKAVKLASLGISVDEINLLKQKVYLKLSD
TTLDRYHHEVLARSLPYSISGEIFQDQLIELLLGTKQESNNGK
>MS53_0105 putative ABC transporter protein, periplasmic component
MKLSKKFLLIGSALSAAAIPVIAISCGGQSESEQDKKVKALVAKMEADAK
AAALKTTLEGYSKDLMIILSNKAEAKEGSELLIKAFNQFYGTNLSIVQVG
GSENYQTTLKNRFAAGPGQILLVGAESQSAFGDINSNLVNTDAKTFLNIT
DTSKTFDDIVLGDKHFMPQSREAYGVIYNKKNFADAKITVFEGKSFSASP
KTGLNLTKPEKYDGTVKMGDDLYVFAADLTVDGYKVIKAQLAEKLPTKQV
FYSTIKAGKSDIWPITNHLLQAAIVSANLGTKGVGSPEYTELVAKMKDKT
KTAEWLNEAVAKSLKDALDVYGYSDPKNSDQNKVVNSSSLIALGTVSMVQ
NGTWALSQISDTLEGEVKDLVGFLPVPTPNKTTGKLPLFAGASQRWAATT
LANDEAKKKTAQLFLRFIYQTNSGVTNLGNLLGSLSPYSVSDLGEIKSNN
ELFDSVFNYGDESVDSWIQAHLVKNFNNDSEELVTLFNQGLPGTDAEVAK
KLQDIYNRLLDQFADRS
>MS53_0502 conserved hypothetical protein
MPYFEVIKNLQTVIYTDNYNQKSLMNYLNKFNYSKNTIVSFYDYQNEKSN
NIVSIDKNKIKKYIEIWNLAKREDIFSKNKNILLFLSNKVLKLLNNTENE
KLENFFSFNKVKNNILKNQFCQVCHEFIEPLTNIFKDINLKYKEFNSSIK
NLENNFDYKLHLYNFWNILISANEELVKTYFKLYEKIESLIESYTSENNI
FLLKEQQKEVNKNKRKKEYLEYLQNNSPESLQNKINIKTKEYDLDFYSKY
KNDILISNYKYINFIKEKIKKEIAVLKIKRKLLLLKNREEILNIKIEILI
KKKIIKTFSYYKNKLNYLFESELASLHKQLNNEGNIFAAKNLIKKDKKHK
KQESLFYLNRLINYEFVLDINEYLEISENRKIQINEKLKNLEKDITNLKN
KIFSKYFPDNFKISKHNLEQDEEKTKAELQWLKDQNEKIATKLNANKQKD
FDEFLRYFRYTEKVLGVEKHIFENTSKKYNLFLDSKEKEFEKYIKEFNNN
FFSLFFVKELNNLFHNLKFPGFKITKDKLNIFFTTFKLNKLIKNNNFEYK
DLIDVFNSSNEDFLIKTKFLTSYIEGKKIIFIDLLEFSPEMNWNLYIEKI
QSYSELFKINTVLITSNLDILKNFGDQIHFFINNSFLEGGDKNEIFRRPI
NPIVKEILKGSNHKFEMLTNYKSWSANKMIDISTTKKHYIFSTITDFQKW
THQIVEHEDNSLKSFRKNKPENIKASSKEQLNIPSIFNDKTILLPKVKTN
ILNLEEPSEMVKELQEDLQSEMFFVEDELENNS
>MS53_0257 putative phase-variable hemagglutinin
MNGSVTAAKAVKEDAEYSKVTDTTHKTTLEEKYTAATALLEDGTKLKNLD
ASSNLDTTKATLESAKTALDAAVDAVKPELDFQKTKTSAAAKVTELDALV
NSALKTELQRQVDALTKDRAAQATTMLENLTSLKDSLTSLQDLVSKGLAM
QVDYPQKYYDADNKEAFDAALLKASSVFPAFQWTEDSIVVPAPIDGALPN
PRAWTKVRDKSEFVLQNFVMAPAPTQAAPAPAPTESGSEDVSGGGTSAAA
SATVRVAMSEDAQAPQAPATPDLASTVSYLKSLSDSLKAETDKLNGDTTE
NKTAYYKADTGRTLYWDGFMPKIVLEGFDKTWGQNSENERKIRKWFDNAA
NWEGLSDQLTKKLGAERFKNVKLTYKEVTFSTNAVKTPTVTFTVAAKEGY
TLDNSVNEISPLLLEFYITVMMKAQSSFLHKELHLQQRQLVQRHLIMPQ
>MS53_0146 conserved hypothetical protein
MSKKNFEDLNLYLMLFDKYSFLLTQNQKQIFQLYFHEDLSYSEIAKILVT
SRTNVYDSINKTLKKLIKLEEKFKKEY
>MS53_0538 conserved hypothetical protein
MYVNSKFFEVKGKELWLKPEGVQSKDGRFLVFDLDWKEMPKAKSYALTLV
DYEASRVIGQPFVHFAAANITSTHLKHGENLEKTQWVMGVNSRVPGAREN
SNGVHVECIPAAFKASSFEEACDYFPPMPPDKKHLYTLKVYGLDTDKLDL
EKGFFLGDLNRAMLDHVVDVYTVNFWYKQ
>MS53_0157 conserved hypothetical protein
MNVKSLVNKRESYTKIKKIVESDKNITLINILRLSKQNVFYFERSLQAKY
YIESLAKRYEIKHFLILQKQLKILSKLSRVKSIWVYITEEEKFATNSYQR
HERNMKKSIDFKRDFLVVIGKRANEFAIKHKAHVIFSHDKNDVEFLVKIL
PKFLQNYLKTNGFHNLNFVINSSKLKEAYLSVLPLNKLNFKIERNLQNKV
ESVDTSKLKIYPEIKEFINSEFESYLTYVSLSLLSESALISEKYKLVALN
KTLNDLDEKLRLLNIRIEREKRELEVEQISILFKKKDLLHSSSIKKEGS
>MS53_0427 putative DHH subfamily 1 protein
MNKKYLFLITFLVIFVSFTVAFVSLVFLNKITDMLMAIFSGVMVFSFAGA
LIIFLFVLSSYSYSKHLVYDSFHHLIDEVMSNNNLGILIYDVDMRIIWMS
KYLKNTFKEDYTSKTLNSYLEFITSDKHSADFLSKLDVNNNSSNLEFEYE
NTFYEAQFWYLNNIVVIRNINVEKNYKTNIFQKRSIVGEIEMDNFQLYKS
IYSDEQIFKLNKVLIDSLNTCVNNYDFIYRQYSDGKFIIFTNEESFQALE
KGNFHEFFKIKNNLDLSSKDDVNLLDAKLTLSVGFARGWENLKEKLESAK
KALVVAQNRGGDQVVVNSFNEPTKYFGSNTEILPTSSKTKINFITNQLKE
KLQDPKIENVIVYGHQHADLDVIGSAFALCELARVKYKKQANLFMKTYDS
TVARMLSLVKYKTKDLKIIEKESTAKKNTDSNTLIIIVDTSNPQRTDYPD
SLANAKKENIFILDHHRVAGSINFCYEKNTYIDTTASSTCEIISEILYFL
EGEHNISQVAAQHLLNGIYLDTSQFTKSMTSRTFQAAAWLEAKGAKAIYA
IDMLKINFETKKLVNEIIKNPIEVKKGYFLAYTKDELDNDIISIAADEML
KVRDRFASFVIAKLKNTNKYKLSARGIETNVQIICEAVGGGGHFNTAAAF
SEEELEVFVDNTIMAITSTGKEIKNESDFN
>MS53_0370 conserved hypothetical protein
MNILIYYNFFVLTFTKYNDKNKNKIINYLYDKSDELNNTFLISDLENFKL
DDQNIILYVGKQNKQIYQIFLVFYDNLVLYSQNQFLDLKMLRKLHLNHKI
KNFIYGQNLIDSIDKYFLEHKISNSILKQELYKLDQNYFEQKYKDFITTS
QQFVLDDIKAIINSRKQIKEFSELAESNFNLELQKENFLNHSYYGFIIKE
ANTVIAHAGTSAITNNTCTIGGVYTLENHRQKGLALDCLVNLIRKSIQDQ
KLPILFFSSSDAKKLYIKLGFVPHSNIFVAIIK
>MS53_0328 conserved hypothetical protein
MKKKKLLILSSLVLGSLILTTSCGIKLALDKDNQKTQVALALGKSSKFID
LNTKVKYVALGDSITAGFDGTLPQDYPGELKNNEVTGSSYAAFLAKILQD
QNRLDDFKNYAISGATTFQFMRLLGVIYSKPNDSNLNIFGKTQAEQQSLA
SELKNKLKDANLVTLTLGANDFFDLLFFEIQNSNLNENSIKQAILDSKGN
NNLIFTNLFKNIIIEIKARLNAFLAALKTLAPRANINLVSYPMPLLRLKK
TLDAYLKQYFGNLDFSVLESLTTSINSLLKSLATPEKEIYYVDVFNSDYW
IKNADELSTIFFDIHPNYKGYKKMAMDIYLKITRSAKVNLDDLSKYDFNF
DYLNDDSKTLKYQLEVRQDSAEIFGESSEEFLNKNDDLTSFVKSKVDTSN
FGKRIVALSQIFSFITNKALDVFLASDIYKNLDPQGKLKALLNKTPESAS
DKSNKEKFLEFLYDSNLIPNSISNLQNNLEKARSEKLKIDFPFLISQVSK
SLFSQNNLFSLLKSLLTSEFLNDNLNELKDIFLTITGNLTKGELTANLAS
FVFDTKDKTVTNLINANLKIALETKGMADAIKLILDRLFNNTELFKTSTD
FKDLLQKMFADETFKDEFTKAVVSITKSLVENSDLIQLDANALIKLLNTN
PEQNLLNGIDSAKQVLLVINLIRFIALDSNFEELVKSSFEIFLNNDLELK
FDSNFILKFFKYYLQDTTKIFELIKNLFKSNLYTQSKTELKQVLINVFDL
LKNNDKFFESVFNSTNLKEKLFRKENLLKDLFKIVLNSDEFELLKTDLIE
NLFETNGDDSRFDSWNDFLKSLFNLDKKDNNLTAKLNNLQKFLTNNEAFK
SKLGELIYAILSNDADTKDLFKGINNPQEFLTKVLSIFLETLQPDFFKNT
LNNLFNSNFWNDLLAGNNLKRIFSSVVRVQGNSNVIRLFAAIASDSKFSE
IKSDLKTFTINLLNVYKTSISKFVVEVFTNNEEEAKTLETSENQQDQITQ
ENQEESPSVLGRFFDDKVLSSLLNQESFKFVASDLFDFFVDNAESLKNAN
GFSDLLVAYFKALSVAKAKAELLNTQVSTALSTFSITSEDKIKSVAKLLN
STSENNSENSQTPSVADKDAAKLYQNLLTWFNDAFSSTNVDLVEFVAKSF
FDLLKEQNINFEDNQRNKDLFKNLSTSLLKSLVSNQLIKQILDSLIDNVT
SEFATKAQDKTSEAQSSSKNNLVLFVDDSEAVGKARETQRLAKFQEVFKK
SLFAIVKNDQGQFSFTKMISLTGFIQSFISDFGALNFAKFVNLLFDSSDF
AKTQGVYEYIAPYFRKYNPSVTENATTAAATSSSLSDFAFDISIFNLKKI
EDSIKALFKSLNSTLLSEYIKQVQDGSITAENQKQNPVFRAMFRINTLIV
WLIARKAPFASLWWYGLLPSIRKSFNELINEEKNRKNIDSLGETKENKKL
KLLGLDSSKTQTDLNFIFGNTGSVYDWNMPSDAIVAYMYYETDSKVDPHN
SKKKIYQTIWNAIVKGYAGELKQYQGQNLKRRR
>MS53_0115 conserved hypothetical protein
MWFALYIFIAPAIFDMVFRNQFNRMQNEINENASLIQIQLAKRADTLTKL
VEQVRSYKDFEKETYAEVAKLRNLTSQPSAVENGAEIERLNNSVFGRLMA
VAENYPELKASSLYKDLMENTAYLEREIAASRRLYNSKVTEFNKLLFTFP
RNSVASRMKLTTFPLFAASEKQLADVSMDRLN
>MS53_0434 putative PTS system glucose-specific enzyme IIB component
MMLKIRLKKILLILFTLGFIYRKWDKALEKKENTVYQSAKLPFDFKELLL
YLGGPENLKSLEKTTSRVLVFFEDKSLIDQNKLMSLKGINGIFFKSDSIA
LVLGEYTQVTYDKLLEQKHESK
>MS53_0337 putative MgpA like-protein
MNSHKLAVEKIKQHNSIVIFHHVIPDGDCLGSQFGLKNLLQDNFPDKKIY
CVGDSKNNFQFLDIKMDNNLVTEEVMKNSLAIVVDTSDKKWVENSYLLDK
NLFLEVLRIDHHPNDEDNLNTKLKWVDSSYVACDEMIAHMALLENWKISK
KAAEFLYLGINTDSGRFLFSNTSARTFHILWKLYETGFDANKLLLNMSLV
SKDDFQYNAFLINSLKTYQNVAYIVTKQTDLKRFNKCSDDAVNVNLIANI
NGHPIWVQFIEMEDGKIKVKARSNGPSVRNICQEYNGGGHERASGCVLDS
FSDIEGFLARCQQEIKTQ
>MS53_0586 hypothetical protein
MMAKKVVEIKETEYLFFYLNSLIVKKENNKIVLPLSNIDTILISNPYCTI
SVPLINAIVSNNINLIICNKDFEPNVQLLSIIPNFDTFKT
>MS53_0079 putative transposase
MITMIIMYNINMSNYILYKRKNPKGIYIALGISKGYGKGIGNLVGLGYWE
EIKEKYSLQNIDDLKQIARLVPVGEDKIEVKTKFFQLLNPTSVETNIKNV
GIELIYKVIKELDLFKGLPKTKHKSLEEVLEFIVATRIIQPRSYICQYKN
KNDFLHKIDIKKSSIYNYFDTFLEYKNAILVNIYNKMQELTTRNAKLMHF
HNTTVYFQSFSRDGLKQRGFSKDGKHDEYQIVVAMAVDNNGIPFHYKVLK
GNTADSKTLVKFLIEMQRIYKTKDIIIVADKGIIQNANLRYLEQKGYKYI
LQKRIDILGKEDKAFIVNEQGFVQENEYFTKSRFVESIWAKNKNKKRDSD
TFRKQFVYFSPSKQTLDKIKRQNLINKLEKKSINGELPLSALVAEYKKKY
MDVDGKTVARLNIKKIKKVANENGFYMIETNITNLNSKEANEIYNRQWKV
EESFRTLKSAIEVRPMYVYKDKHIQSHIFLCFLSLIVLKYCIYKLKKFYK
DNGDIQKLTMNMFIDALKLITITTKTVNGKVVSEIKNNLDPEHKELNKIY
SDFQYAVDGLSL
>MS53_0190 putative lipoprotein
MKYSLGLALSSLMAPAIAISCASNASKEPTPLLSNNKKLDYDLGLSAPSL
NSLNYVLYKSVDLIVPSLVDTVYKFGPVSELQAILGKTPLTFGVYGNNNN
SVSLEKYVNSPDLENNNYQSDRSYPFDNFGIDVGAGSFQALSARGGRGLF
TPNARVITYTITLNDGRSRWSNGDVQTVDDFLDYIHYIADINTGSQKQID
LLSRDIKGLDQFVSLQNEYLKKFGTTYKNPWGYPPYEKVNGKWQYKVDAR
DENGNQLSNKDYLWPSQNEGDEQDVEKIQQAALNVGFWSGRLFFNISNKD
LYNLLKLKDNKDVDPSNGDTITLKDKDGNDLVLRRNPYIDPRQVFQYARI
DSSNFQSYEDARLIGKYIIFARDEHEFRVEYAESNPKSIDDMINDLNRNW
LPINRAFVENELGGIQNFGKDKRSILINGPFLIDSLILGSQGSLTLAKNQ
SYFNVNRTISNKIKIYFNDERNLESAMFSDGYIAFAKIPSVLQKKFWADP
EFRNLMSKTTGYGTLGFMFNLDQETNKDSYINDPDLRNAFYYAINREVML
FNSGWNNSYPVITWTGFGNAHKSDGTAIEFGFQDQWTTPKGSYATDQKVP
LQNYSYGDHLSKNYKFEATNRTDQGYRPEVAKHYMEVFKAKHPGLKQVNL
TYIFNSTEEQRNVGLVLKNSLELLFGNFINLELKALPENVYISKVEEGDF
DIAYKNFDSFGTEIDSYVKAFFVEDGINRENSKTTGFNLNPSGGFTYKKY
FDSLADSKDLVNGSLVAKTEEETRERLGVSQEIWNKIKELSQRRDDEDEF
QYKDRYSNFFSYQFTDKEKTQGYDENKVIEIVAGLEKIIRDAAPVIPLME
VDTLWNISRVGGTRNLFRYDLQYAYDIDRPPVPGLPRVTAGQSS
>MS53_0516 conserved hypothetical protein
MTINLIAVGKLEKDFQKLFDEYAKRIFVFSKFNLIEIKENTLKNLEVKKE
KETLEILSKIPKNSTVFLLSIKGKNYSSEEFSKLITNDANITFVIGGSNG
VIESYFENKISFSKLTFPHQLFRVILIEQIYRAFTIKNNLKYHK
>MS53_0472 conserved hypothetical protein
MPGITDFTISNPLIQAEKNVGYVYNFIKDTESNYQANQYTNYGLGYSLNS
WQPLGGASGSSLRTIDNKIVGTNFATADGAGVSLTAFTQAFRSEGESYNG
FYGKYQLEEYDLIYGGGKNQRTSYRQALESLNANIKTALFPNGINKIPEE
FKFKN
>MS53_0454 hypothetical protein
MLFFCSSFSFFFFFFRSYFFCYASFNWSCFFFYLSSFCRSFSCYFFCCCR
SHFSLWFFFCFYFSFSSWCSFFNSRFYSFFSFNFFNFYFFSSYCFSSSCF
CWFSFSCRFNFFFNYCFFCCFYFCASSWFFNCYFFSLGFANFCFWCCNFF
FYFNCRSFFNCFCFSYRSSFFTRRFFYFFTCNFFNRRSFFNFYFFRSNFS
CFCFWNSL
>MS53_0072 conserved hypothetical protein
MIKKYWKLLSLVFGLAIILLGIILTFNSHQSSLSKKFNDKIYFYNVTGAV
RNGKNIKSLKPLTYRELFFHAQANSYADFSSFNLDEIAPEKSEVYIPFKN
YKLNWKNLKSENQLIAFKISSKQAKAIVKFREKNSVNVTWEKLLNISSVG
IKTIEKLKTFLILN
>MS53_0377 conserved hypothetical protein
MGFAISDESNSFSLALENFDYDGSYEKIIQKIQLFLDEYKIDKFIIGYPL
NSRGEKTKTCLLIDEFIIHLEKNFDQKIKLINESYSSRKASEILHQANIK
NKKQKDKKDMLAAKIILQDYLDLYK
>MS53_0598 hypothetical protein
MKFFSETVKLEKNKWLEAQRDSLAALEEIKKKQPSLTINQSEILDFAFMN
LSLQMTDEHWKQKLDSNPNFVVYKPLLQNHKKTVDSLEVEYKTYYLDDLE
KFSFDDSYKSELKLESNYEELLQDYIEKFVQNYEFHLPKKDAPVAAGDYC
KVVFYEKEEQKASERPVFVYAGKSKDQLAFEILSLELNKPKAIDFYGLKG
YVEVLEAFEVKHMPITEENVKLLNLPFAQTLADLKNVVYKQVRENIVANC
LYYYGNDALNFYTLNNKDIAKIEFEKDLEAATSQMDQSKNPNFANYTLKK
FSVEVMLRQKWNIDVTEEELHAELQIVNSFINPPKNSSVNWPRLYHVVFC
KKLGLRLLKKNFPEVYNEHKEFVRIS
>MS53_0403 hypothetical protein
MKHYIILINGKRRSGKGILSSALKDQIQKFSSNVYIFSFAESIRKAAEDI
IQKLNWEKEPKETTRPLLIAIGDVGRKIDSDFWSIKLFEQIQEKINLAEQ
NNQDSYYIIDDLRITNELNFFKKNEILFNQENSISELNVISIRIQKYLDA
SNFIHGTDDNITETSFDDVVYSSFDYIIEGNVIVQKEGLAEFDQVKIQAK
KIIEKFL
>MS53_0418 conserved hypothetical protein
MNKKAKILLTSFSALGAIACASVYPIYKIISDIKFSKFNSDSQLVNLAPP
NYNLISSENQSKIKNLLSASTNFDDLENKLSANIELLNENVKKLNNENNL
KKLFLLLYTRISSSLNQVELFDEFYENKYLKFTNKILQVKEINNLKFDEI
NKELLELKAQIKAFIDIFIYNANASIDAINEFDLQKSQTKDILKLNLDNA
NGFLAYLNQFKNKLDSFAFSSQNFKTSLALLNEYVAKFKTNLQNYNLYFS
FSETFYQNYSLNLNKSDEINLENLSAKKELDKLAKNFNDLYLQEKTFLSS
SLIEKNNIERKIAEVSLRFNYLINFYFEVFNVYSNEESALKINNLLKDAK
KYVEDNFKYVFNVNSNKFLISGSYINLINKYSSFIQDINLELNSFLLSKF
SSITKNSSEILNLINKENSLYLELNTKNLRLNNLNLTLISLNNNPENNSV
SDEFIDSIEDVNIQNIYKEINAINILKTSIKNQISKNKTHLDKALENLYL
NSLKLEFINKTLTDKNFDYIAKSKILEKLLDKNLSDSEIENYFIQAQILA
NNFSVDNDLIYSYLDEIKRLSLNNLQDQSQLESLRFELNTNKLNKNFNSS
NLEKLILEKEKAIIKNKEEINNLNSLIDSINNQLQEKINEIKLLKIENSN
FKNTINQNNLNLNNLRSQLNQNNSNIAYWERQNQELQNQLNEKTNLIRNA
TEKYNLAKSELDNFKKQNALLSNQYSALRNAAISIKNKLSKFKKWIDEIN
DAIDLAAEPIKTDPIRQLINTYRFNSPLHLESENYQTKAGRINKAAFTIK
NNTKWILDETSEIINVILARVLKN
>MS53_0231 putative phase-variable hemagglutinin
MLQTIINYVNKFDPKFPASFVLNTNGVALTSVQSGTQLRIGSLNDFLYNN
KGFLQQVNGDSSAVYFAVTAVASNGWLNTFLIRIPLTKFVRPLTEFQAQS
PTAPTQEASGDQAQADPQATQMGTQAQN
>MS53_0511 conserved hypothetical protein
MMKLNKKVLLYSGAALAGVATISGLVAGKINFKYKPSIWNYKSYISDENL
RVIDKNFDYKQFDTISQFSNALINNKAVAGIGSDFFAFNLVKNNHIQKID
YSKLFGVPELKDFNTLQKFMQLILKPEIWNHFNNKYYTKALNEISKNKSQ
DQYLWEYMFPYYSQDAVLAYNIKKVNIPEKYKLEDGSANFDLIYSDMNLT
GDKNSMVNLLKMLNFIGYKEIIWTDAVRDNMLYGSAYTRLQNGSSTDKNY
TGNVTFDNYKNQIDSFTNLIKDGTSNDVKDNQKITFEGDGLQIVNTLLDP
TRFDITSSLMYNGDAIDAYYGEDNFESVGDGAIRVVKFKNNLLLVDGLVV
AATNNDETNELIYDTLRNSWIKNVGNIYTQYKDLLSKNLISDSDSVETQQ
KVLTESAVADYWKDFRNIDFESFAEDNDFEQSAATETLDKYYSMLNLALV
ENKDKFNSFYEMQDDPDADFEEKINPYPSIFLSYLKDNKDELLDKIVSSY
KNNSLKDLLEEQDNFEDKYLVNLVNENYEDLTSEDYYPTSTEDSELKESL
SQFLANALSFIDISEDQYSDLLTEKYLNLNNYDHINYDPTQNIDYEFIKR
NYFASALDGQDENALNIYQIVKTDEVDYKGIEPISQDLQSLVDSYYYNRT
KS
>MS53_0456 conserved hypothetical protein
MASFLEYLYPKDNAEEWDPVGFSLSYKNMLVRGVITCLDVTKEIVNFAIE
NNYNFIVSHHPFLFYEDLNEELNTYFYKKEIYELCKKHKISLFSLHTNYD
SDKNGTSYQVAKFLNLFDSPAHKELKTVSKYAYCFKDNLSVSELAKAAKN
SYKIDSLATNVSDLDAKFNSFCIIAGSGASEISQLKRQYKIDLFLSSDFK
WSDYLFYDQSKINFLEIAHLQESVFALDLARLLNQHFPDLKVKAINQISL
PYKLI
>MS53_0441 conserved hypothetical protein
MWKIGTAISTYIDKSIINWFKCKNFLDKFLEDKNQKFYFDKNTNKFKNLF
DSNDTSEENYLFFYNNGKSKSDTTFKQILSVLNCLKFINYSFDLSYIELS
YDFRDFLEKNYNTKNLEKLIYQYASDSVLKISNEIIENLKEYKGWYQNSN
ENCEDIKKKLREPKKELITSIWYSFWEINDDMKIDYSVFFDLKNKNDLVR
YYENFIKKCSENNEKFNNELLSIFKELKEIYDKDLYIKIKIKDYVLLNEN
INEENIYKLNIENYNIEQKKEAEKEDINQFKSKTFNLYNFINEYLLNSQN
NKWPFIIPSYQRNYVWDKYNLETLLSNINEITISEKTYSHFIGSLFFTNN
EETMEFNIVDGQQRITSLILILFAIYNIFCNNIKSNKELKIEKNLLNLFN
KKANPNKDENSNYIISKFPDIKNSESLKYLYSLLNGQDLEEKKTLPLIFE
NYKFIIQYLYKILSDNNKIDKNKLEKFTEKLYKYIEFSVINTKQKNQDFK
IFSYINSTGKKLNVLEIVRADIFGLSEESDSQNTKTNINNYNKYFVENIE
KNNINILEFIYYFHAIEIKANDNFKFEFSSKENREYDFFKNYFYEYKKEI
KLNEKIKILVQHLLFYIATTKIGSTNKNKKDFEIWKAPIEEIIKDNPENL
NINSYFLNNVKNILPKIYIYINLYNEKTTMTTLIYAILNKNELWKSEKEL
SKNDLFKEIKKFHKFLLEIQKFNFVWKIIYFEGQSIRKNIEKIAIDIINQ
EIKDEKQLFKELLKILGVTITNNDEWRNHSKRKIEEYFLNEKLNDNKTSK
NLLIVIDYYLRNKKSMELNNNSDFFDEMVKSYFKMTLEHLLSQDLIKETK
NEKLEKICYQIGNHFIFTQGKNSELKNKHINEKIEKIEKIISDNKRTISI
GKDVNKIELENIKNESEKIDKNWIEDPKKINKMEEIFETRTKILSDYLLE
IFDFKNKK
>MS53_0527 conserved hypothetical protein
MKKLEQEGKKVFIADEFVKSLYENKDFCQKMQKLINFDLLTKNKLDKFKI
KKLFSENKDLFEEFEKQVHLEVFKYLSENKFDFAEIPALNSKHANFCSLI
SKIYVHKVDENTRIKFCKKRNVDSEALKILDALNSYNWTDLKNYNGILVV
DKL
>MS53_0254 putative phase-variable hemagglutinin
MLHWDGFMPKIVIDDYVADGYDVANNSENNRAQHEAANRPLLEQWFKVNQ
DKLSLVADQLTKKLGEEKFKNMTLSNPTISWDEVEFSNKGSNKVYLTPKV
TFNLAAKDGYALAEGSTTTVTLTIRVLYKDSNLTRNVLSTQGAYYTATPS
DNATTIEKVNVYLNYTGPNIELNAELPKVGSQENTSLNGTSNVTDNFNNK
FNKLLIRYKAETSLFQKIINYVNKFDPKFPAKFVTNSINGVTITKVEKNK
KQKREELRPGNLEDLLYNNNVFLQQMHGDSSAVYFAVTALTNDKWLNTVL
VRIPLTKFIRSVAPFAAAAPTEEASGDQAQADPQATQMGTQAQS
>MS53_0197 putative N-acetylmannosamine-6-p epimerase
MKNFNAKFIVSCQALENEPMYGKTTVLKMARSAMQGGAQGIRTSQVSNIN
LILKENFKVPVIGIIKKNYPDSEVFITPTLTELKKLIKTKVDIIALDATL
RERPKQDLKFLVEYFKKNKAKNQKLMADCATLEEMQNAISLGFDIISSTL
RGYTQETKNKSNTEKGFTFLKKAIKLAHDSNKIFIAEGGFNTPELARKAL
LLNSDAVVVGSAITRPQFITKQFKDIIFKDA
>MS53_0660 putative ABC transporter ATP-binding protein
MQIKLKDVKFTFNLKSSWEFQALHGIDFEVNQGEYVGIIGQTGSGKTTLI
EHLNALLMPTTGTVEWIYKDEVFDKATKTKKEVVVTDVIGLKKVRKFKKV
KQIRKRIGVVFQFAEYQLFKATVLEDIIFGPVSYGMDPKEAEEKAKKYIK
LVGLPEEYLKRSPFDLSGGQKRRVALAGILAMEPDVLVVDEPTAGLDPWG
VKEILDILTHLHESGKTIINVTHDLDHVLERAKRVIVLKNGKIIKDGQPY
ETLNDIAFLEENNLQPPKLLNFVNKLRAKGVNVPKVTSEAELVSWINDYM
ETKNKKEVSNE
>MS53_0585 hypothetical protein
MQFLNLKGLVKNYNGIVCIETNNSDLFIRKLFEFEHAENQSSININNNKY
SIKDFIIIDNLTKYHDLYNFNSKGLLNQWINDLDFENQKIANEKLVLEIK
NLLNNKIGFEFVSIEENNSKYLKYLFNLENDKFIDNKSLIKWMENQKYNN
QKINLIIKNFDFVLINELIKFSNNFNIIVLTNDFFKHINNFDYIESVAFT
NEDLNRIVSIEEKDSFEYFLEEIFQDSIRNIEKFDFFSQNNKDLIKKSLK
INFF
>MS53_0156 conserved hypothetical protein
MFKFKKPLNSKSRKTKEAQYSKEQLKYQDFVYKNYFEILSQAKDSDEKFL
SYEQFVNQFYLKLNQKDKISEFNKLWKASYDSFFQKQQVVFDDFVLAWTR
NERFSLHDLVPYVSLSEDSNVLSTDLSAKNNDKTNLVFKHLNNFLKDYLF
EKLKVIEIFPNVILFLDENSKFKLLFDKSVVENER
>MS53_0062 putative acyl carrier protein
MNVQETVFAHLRKLTKKEFHLDSLLSDLKLDSLDIAELIIEAEKKFKIEI
SDEMLQNLKKVSDIVNLITDLVEAE
>MS53_0433 putative ATP-binding protein
MFSSEIKIALDNLLNFRSNDSCIFVKPSELKTLSYFDLAKTLGKKVIHAI
SNSAEMEVDLNSQIYDPIVDKISKAQTYKDMIAAFAEIDIFEITEREKEK
LVINFEIIKEDLIARVKKQIKEWIFAWKDLAQDHEKNYHTNSAHTLYLGF
FFFSYQDIKNKAFAPLFFKQANIDYSRGKIILKVSGNVIVNEKLLLFMEN
KGISLNLDNIVDSKINDLIQTMKVEWKGAFNFPDNFASKIADFDSLEFPN
EEFEIRPGYVVGLFQPQGAYPRRRMKEIIANDELDSMFDISFDKTIYKKS
VSEKIKDPNTKLVKIQNTNLSQDAAIISSLTHDTIIWGPPGTGKSQVISN
IVANNLINGKTTLISSEKKVALEVILNRLGSLGGFCLNFYDYGTSKAQKQ
KFYAPIINVLNKIGNFDNYWENLSEQKLNVFTQTEIEFIELASEFVSKSN
SIKALEAIYYYAENNPTYKVSDIEFILGISENYKIPEKIDELFVKKFLKE
NKISLLSLKRKKAIEVANSIKNTLSSFEGNLALLFDKLFELKLLQSSDIN
ILIEFQKLALTYEKLLKEKAKFKPVSSEDEVANVILTRLKNVISQYDSSK
MNLYKKFIANANAMNLPPDKFVRVFKEIIKDVFPVMITKIDENLSQYNKN
DFDYVLIDEASQIQAERGIPALYLGKIKILSGDDMQMQPYTPFVARKINE
TVLGSIRSLLHYAISLGIYKVFLNKNYRSKWANLINFSSKNFYSSNLDAI
DENSSKHSPSIEVYNVDGVWDNSKNFKEAVFSIKKIIESLPKYKKIIFIS
LNQKQSDYVLSIIYEKNIEVLIKALNSGQLLIRNIENAQGDEGDLIIFSV
SYDRNTMISSTRLGQKNGRFALNVSISRAKEKMIVYKSIYASEVTVNENE
DLKLFREWLNYLDLAEDQKLVYVKSKTHSYSQQKTSEISKFNNSFFIDHV
YSYLKEVTSKHQEYKIYKDYQIGSITLDIAIVKNNSIYKAIKFDSFDYEK
NIKRYGDIYDEVKYLQSKKYDVVILDPISWLEKNREIPSWFKESTMSYE
>MS53_0415 conserved hypothetical protein
MYNFFMQKIININLSLFKRVFLLNPALIFAKSAIEAEFQNLNKEEILLDS
NSDSEQALADDEIDLGDLTLYTEFLESDDGSTKQKYFSLSKSVSDKMFKK
YVELAQKWYSKKYKFKAKEIEYIGIKSTLENKINLTKEAIKDDSKKLIFN
PSFSFSEEEKDLIFNFNSTAFAYDKVNKKIILLNFSKTSKFKFYFDFFYV
SNIVKKWNLDVRNFSVIIIDPFTTIKRNFKQKELLFYEAFGAAFTKTATI
SKNKNFSVNNKEFNYALKLTGDEIYFYESNYKDPNPRYSFFNAVNLYKSL
YTNSYQIETQNFSEFENYDNYLEILNSPKLKLKKLIDTEKQNTKKPLLYN
FLDFDIYINLIKKAYLIFGENLNLDAARHFFTNSQNKYVSQADKFKHLET
KALEWLETKNKFNSRKKDFLNENIELTFEFDYNDSFSKEEISQLTSVFLK
EKYEISANLMRLSKKGLNKLRLNDVIKSKEIFSKFENFVNPISVNLIRNL
HLKDKKIIWYDYEGFSSILPVLTFTNPHQQLVNQVSIIQTINGNETYTKN
LVFDTFEFKYQDLVEIIENIYSDKSDYYIVYNKAYENTRNKEIGNLVTKV
LASNSEEFDEFKLWFNQKYSDVSEFLKKIEHINSNTIDLTDFFTHSRIKF
NNEFLENHLSVDKNLFKFFKVSENEITFYDSVLKEEFLKIEKVFLTDLKY
FYSIKRIEKFITKYKIELKNKIKEYKNLEIQNGYMAMNEAINRHWKTTNN
ATWKRISLYLKEYCENDVRAMMMLYDFLMLLFYKIDANLKNIEFNISLSE
SQNDFLYKYENDGYQIYYQDKLKN
>MS53_0263 putative phase-variable hemagglutinin
MIQKYKPNLGLIINKIYWDGFMPKIVVPGYEADTTGRNKDTNEAANLEKL
KTWFDTPANWEKLAEQLTKKLGSDKFKNVTLTNPQVSYEEVTVNSNTWKN
PKVTFTVEAKPGYELTQPTTDSKQISLTIRVLYSSQESNQNLLTIQGASP
VAAPNTASADNPASAIKNVNVYLNYINQFKLTN
>MS53_0366 conserved hypothetical protein
MFQKHWFVKFLKFFRIIDIEKKPISEREYYSILIKVKFDVYFLGLLYWVL
NIMSVVSVFVLSVLATIFLAGTVKYNNGENPFTSYLNENRSSNYILLTAF
INTIITFVSGTLSFFVINAKYVNSKDQYQKLELEKMLFDSNIDVYKNKDQ
KEKEYILYKRSIQIINYNRYRKDTLISMVKVDKKPEVKTKESKTNDSEK
>MS53_0498 conserved hypothetical protein
MNSQIKNLAKDVSKLSANNNLVLILLGVTLGAFLLFSAIILIVFKNNFKD
FFNKKNRRKKYESLGKSSQIRLINQLRESVTYFSENKIGALITIENSEKL
DNLRTDGIILNANISSALLISIFNKNSPLHDGAVIIRDNKVYYASTFYKI
TSKSLSSEFGSRHRAAMGISEQSDATTIVVSEETGSIKIFKNSTVYTIKL
EFFQESLIKYISEESNAK
>MS53_0666 conserved hypothetical protein
MFKPSAIFIDLDHTSLDARVNNKSVFSEKNRKAIIEINKEIPVVISTGRG
LTSATKEIIDSVNLNSYVLWNGAKVVVDNEEVFLKEIPQEIALEIFDEIA
KFKSVMVLNSDFKNQSYFAWKSLRFVLKLLRFDSLKKYDEFDRESTIFKF
IVFDLRKEKLFKIRKHLEEKFGNFVTITESGNKNNILEISAKGVSKASGN
KIFCEHKNIDVTRAIHLGDAMNDASCVGVLGKTIAFANASDAFKKVADEV
LPYTYENAGLARFLEQFKK
>MS53_0649 hypothetical protein
MKKLKFKYKLILLLLSATATLSATVGVSVLAFSKVQNTKEVNRIYYQEQN
INTIGGSVVTLDNFVFNASARVKNYYANSFSNHRIYNSANSGYDSTPNYW
SKLLTFSKAPTLAELQSKDFTLMTPDGIFLNYYLGAFQISFDSFSDELNG
TLYLQVTLTSKTNPANVITKVFEASGFKKVSEDSGDLNLRNLLSFNSVNL
NFTYLDSFKNLDDFKAQYTSGAATEKLSMIQSAFNFETSTVASVDFLNSS
LVFDDNNDLKFNLRLTANVPMAIPTNLDQKVPLDNIYLDITTQSYSLLKD
YFAAKAVGDKLSFATDGLDKYTIEDIKKSFDLLGANYALLNVNNLPVEYN
LKFIEIPFLNPERNEYEFIYNLYLKSAPSQLVYTAKLSLPKTALKAEEEK
ASEPQQN
>MS53_0539 conserved hypothetical protein
MHKLGNKTQIKSKSVNEHGYLHDVHGAHGKASFRFPDHSFELKWDKMPNA
KSYALLLEDFDAMKVIGFPFIHWVAVNVKENFVSEAASKLAFDHLKENLE
KAMPSNLLWQGYNSSVSKTLVTENKEKGSSLNGILPEMFTSLELEDAAQY
FGPYPPDKDHVYTLTVFGLDVDASELEYKDADGLSHKLDKPYYVGDFLQA
VDTHVVGTYTLNFKYRQAGSN
>MS53_0609 hypothetical protein
MMKKIKFSFKDLNTNYFFLKCLMLVSAHFLYLADWIWNGVGIEHFTTICT
YFFGLILTHLFLFVFYRNKKNEELKFDKFWNSKQKKSTLLFLVFFVFVFL
IFSRLNLIWSDPDTFPYSNSFHRTLYNFWAIFWDGILVFNSFIVIASVLF
LTLLSDYVFKLIYYTKPKYNAVEKSKAKLKNFAVIYLGVVTSLWIQIAML
LKHIYYKETATLAQIVNPVFLLILLVGFALFVFVYFNVNLNNLKITKDEK
SQIFKFSKNLYYWFLWIVLAWFFISWIPYTYYFLVTNYQVIRGFKERNSI
DINPSSWNFVHMSYLAFNSMLIIMPSSLLLTCAFSFLSRKHWSYKLK
>MS53_0003 conserved hypothetical protein
MTIKIYGEYIKLSQLLKKIDEVDSGGTAKFFLQNKINKVLINGKQTTERN
KKVYPGDIIWINNIVHKVEKE
>MS53_0469 conserved hypothetical protein
MSNNQKIILEFNKKAQEYKNKILQEFNNVKNTNNFIDYEQFWNSFSLKFN
YSEEELKNHLFTLLKNFFVSKKNLVLDQFVLTFSRDPRFNLNAFVPKIDF
KANSNVADVDLTSNNDAIKANLNTFLNNLLDNNFKIEFLRDCIIFKSQLG
YKLFIGEKFIDE
>MS53_0227 putative phase-variable hemagglutinin
MKKVTVNSNAWKNPKVTFNIQAKPGYQLTEPTTDPKQISLTIRVLYENQA
STQNLLTIQGAYPTAASSDANADNPASAIKNVNVYLNYTGPAIVLNADLP
TVGNTDNTTINGTSPIRDAYLATKVKALLNKTANQNYSTELMQAIIKYVQ
TFDPKFKTSVDPNASQSTYRAWVSWMETRERDMQRNPALVQVELKNPTNV
FLKQIQKKIKVKNQNKNKVNHKLKNNNKIKVSFKI
>MS53_0265 putative phase-variable hemagglutinin
MFQAVINYVNKFDPKFRVQFVTNSINGVTITKVQNTKELRPGTLDDLDKD
NVFLQQIKGDKEAVYFAVTAIASNNWLNTFLIRIPLTKFVKPLSVFTAPV
VTPPAEEATEGSQTQVSTPQTMPNSSQ
>MS53_0584 conserved hypothetical protein
MMYDIYSVDEKNKEYTNFKKHILSLGYFMIQYSVYCKNISVHTQFDSEIK
KLSSKIPNRANIRILLLTENQYQNMIILSGEKSLNEIYNERDKYIEL
>MS53_0216 putative phase-variable hemagglutinin
MSLKNKLAFIFKLIFLWFTSGSVTKAKEAKEDAEYSKVTDTLRTDLEAKL
TAAAGFLTEDLKLANLDADGTLATTQSDLKSAKTALDAAVAAVKPDLDFQ
KTKTSAAAKVTELDALVNIALKAELQRQVNELTKDRAAQATTMLANLTSL
KESLESLQTLVSDGLKMQVDYPQKYYDADNKEAFDAALLKASSVFPAFVW
TTNSIMVETPEGQLPNPRAWTKAREKSEFKLQNFVMAPAQAAPATQSDST
AATVRLATGEAAAEAETQPAASTADLASTVSYLKTLDTDLKAQTAALNGD
TTTNKTAYYKPVDGRTLYWDGFMPKIVVQGYVADGAGNGKATHEDANKTK
LEAWFAANQDKFTLVADQLTRKLGSDKFKNVVLTSPMVSYEEVTVNSNAW
KNPKVTFNIQAKPGYQLTEPTTNSKQISLTIRVLYENQASTQNLLTIQGA
SPTAAPNTASVGNPATAIKSVNVYLNYTGPAIMLNADLPIVGGQENTSIN
GTSNVTGEFNTAFRGNPSKGLLFTNRYANPLLKSVINYVNKFDPKYRAKF
VTNSINGVTITKVQNKKELRPGNLEDLLYNNNVFLQQVQDDSSAVYFAIT
ALTNDKWLNTVLVRIPLTKFVKPLTAFTATPASAPTQTDSGTGAQTQPEE
QS
>MS53_0665 conserved hypothetical protein
MINFTVMDNKNLTVKKSFQYNENESFNYLYKVSSRMKYLYYKTRIFNRSL
EVISAVNDFDEKYLKKKEILKFFEKYYKYLHKSFYVDNKNNLIKNNYFYL
FGIKYFYQIQNVNKKSFIFIFKNENDLNYYKVINAKNNIQKAIDKFLEDE
LLKLLKEKLLPKAFEKLNAPIALNKIKLEIKTKISAWGINSQNKTKNIYK
LIFNLDLYMFPEEVIYAIVVHEVCHYFQRNHSRDFYKLVTKEVPNYFSLL
KVTYTYDFD
>MS53_0526 conserved hypothetical protein
MEQTKEYSLKYDNLKIYSETDLSEYDLVNLRKLYSPIIGSVAISLYSHFF
DALSSPNNANSISYRDLSLFLFETPEKIHDARKKLEVFNLIEVFEKHDEY
SIIIKLNKPETKERFKNNSLYSKYLRKALGFEKANQLLSSSIFNFNDKSL
TNVTSGWVDFLDQYKDYSFQLDQNLKNNKIEFIKSQMKNYSFEDENIYLN
SNSSSYNLNLVTDEKNNNLYEVIKKEKVDFYLQFQHGIKLSEEKNTLLKN
KISFWKSQIFNEHIINLVLFLTSKLRKFNKVESWYLEVDKLITKICKKEA
YLNFEMAEEFVIKTYLESDLDKTSLNTYISEKNNYFKFKKAV
>MS53_0513 putative ABC transporter, ATP-binding protein
MTILFLFIEGITQILIPFLISKLIDLGLTKLDIEQTKKYALILAGVALIA
LTFGLLRGFFLSKGSTLLAKNLRYKLFSHVQEFSFKEFDKFSTGAILNRL
NNDITNIQNSYNFMMIAFFRAPILIIGPLVLAIISSPTLSIVFAVSIPAF
VVLVLVSLKFVAPLFRMAFKEYDKYNLKIQENIANIKTIKSYATLDFEAN
KVEAINKKVRNFFIKIEKILAFNQPIFFGIVFGALAFIGLYGVNLIRSQS
SDVMFGDILSFSAYIWQITTGLTIFIAVIGVFFASFPSWKRNKEVLSLQS
SLSYNENSKLKINNGSVKFENVSFKYDEADFKYALENINLEIKAGQSLGI
IGETASGKSTLISLIARLYDPTEGQVKIDDNDLKNYSLNEIRDNISLVLQ
KTNLFSGTIKENLKWASKDLTLEQMQKATKIAQINDFINSLDEGFDHKIE
QKGNNFSGGQKQRISIARALLKNPKILILDDATSAIDFKTESQIKKALDS
EINNLTKIIISQKISSLKDLDSIIVLQNGKILAQGSHKYLLENCKWYFNL
NESQKTTWGNLDE
>MS53_0676 putative ABC transporter ATP-binding protein P115-like
MKLIKIEAHGFKSFADPISLKFDGGVIAIIGPNGSGKSNINDAIKWVLGE
QSSKELRGNSMSDVIFSGSKTAKAMDFAYVTLTFDNKDRFSSIDRDYITI
TRKITRAKNVNEYYLNGEPTLHKTIKQLAMETGIGKSSLAIISQGKVSEI
AQSSEENRRGIFEEAAGISKIKYQKEESERRLLKTIAELEKTQISISHYE
KDLNYLEEAAKKALEFKDKKSKLKEVEISYLAHEIGRLQSENEVYVNEIN
SSSDVVFTLENEIEKLNASEAELKLDLRDKTEKLQSLANQIATDIDLLHK
FEKTYNQKDQERSLAASGKLNVSQEEIKSANLSKAKEIKSKLDFLLNKTQ
KTKFELDDLNSEKSQLESQALMLETQLREVKNAVSNAKAGLDFAKREKES
NSSLQKGVRTIVQNRNIFNGYVGLVSELFKIKNEYIHAIDTILSPSMQNI
VVKDDKTAKEAVRFLKNNSAGRAVFMPLSSLRAKSIRQDLYYGLQSYNGF
LCAANEAVECHPQLEVLRDFLLGNVILATDIDKANEISKLVEQKYMVVTK
DGDLIRPGGIIVGGEKKQVSNLLNIDEKIRKSEEFLNKALPSLNVYESKF
EKLKTQIQNISNLISVKKLELSSENESISATENELKQYQMFLDDSIDTSL
SGESELLTLFNKINELKNQIQQNKFSNSLLNQEKEQIVAKLDDISILLKS
KQKDLDKLRQSFSKNEVKFEKNKTYLENHKSRLLEEYGLTFEFARDNFKL
NIEINLAKEIVSTLKKEIQEIGSVDEKAIEKYKAIKKDYDFLVTQRNEIQ
NAIGETKESITILENTMVDKFTSLLRDVNLEFNNIFRSLFGGGSASVSLV
DESLPLTSGINIKVQPPGKIIKNINLLSGGEKSLTAISLLFAILKARPLP
LCILDEAEGALDDSNVVRYADYLQQLKDKTQFLVITHRHGTMTKSDAIIG
ATMQNRGITTFLSLSLAEAKKYVDKFEAQN
>MS53_0507 putative ABC transporter, ATP-binding protein
MWKIFLIAPKKAKIYYFIGLIFAFIWAGIVMMLPVLLSQFLSLIIQSENN
AQLSIKLFAYWTIFQSNNFKDAIVFLIGITFALIVVGFISAFLSLLIVTW
AGEMISANLRNILFAKYQKLSIKDISNLGVENLITRINDDVGVFWDFLMQ
SSNAFVRAPFFIAFGVVFALFTDLELSVSIFIILPFLFFTLTFVYLKTKS
LIVKNKKNLESMTKNANDSVSGIRFIKSYNLQNYQFSKFKNSTKKWTSTE
IKTQKYLNITTPVFFALINLISVIVYVFASKQLKFNPSDLNLIPKINVFI
EYVILISFGVMICSQFLGVFFKAKVASKRIIEIIDMPYENLNVKNGIDLT
DKNKYSITFKDLNYRYHIGLNNALNDLNFSLPGGKVLGIIGPTGSGKSTI
ANLLIYNMKYSDGHIYIDDNEITKINTKSLHEKVGIVYQDSILYSGSLKD
NMLFAVENATDQEIDFALENACAKDFVYKLENNLNYEIEEGAVNLSGGQK
QRISIARALLKNPKILILDDSLSALDNITTQKIISNIKNNYNSTMVIISQ
KINAIKHADLILVLDNGKITEQGNHLELLSKSKLYKEVYENQMEE
>MS53_0423 putative amino acid permease
MKVKTARKIGLLIATSISISSVIGIGIFFKNFTVLGAQTVPETDTFAFWS
FILAWVLGAFISLLTVYSFSELSSSRQSKSGLAGWVEELSGSKKQGMTVK
FLHSGFYYALLTAALPVFGMEAIFKAFEVATGSSVSQEPEFYLVVILLSL
VFLVAMTALNYFSLKWSSRLQVFSTAFKLLPLAIAFILGFVGTKYLGVDP
KATDSASLEIVNKANEAKSYYLFGGLSYGITSGEKSFNFVGMFIALPAVL
FAFDSFLSVGNLAKDVKNPKTVPVAAVLTIVISATVYILISIGAALKGTG
FVGNLFTDIVLSVSKDPATRLTASKVLNSFVFFLIGFGALFVANSTSIVL
LKSSEGLIESRQVMFYKKLGELNKRYKNLGSLVLYSVFVSIYLLVVVLPS
AISLSDSVIDSSTNLPTIMFFFIYAYTMLLGIIDRFKGGKKTKLKVKGFL
PASVLSILLIVAVIGFQFVYKFIVKTTQSPNVADSAGLFFSGTTVFTLAH
NSLTNFGLLALCIILALTNYFVVKKQLKSEGLTIQDTGNASDSEEEISYE
ETSHEKHEGIFCKMMHKFKPKK
>MS53_0225 putative phase-variable hemagglutinin
MPKIVVPGYEADGEGNGKATHETTNQQKLQQWFATESNWEKLSEQLTKKL
GSDKFKNVTLTNPQVSYEEVTVGKYTWKNPKVTFNIQAKPGYQLTEPTTD
PKQISQTIRVLYENQASTQNLLTIQGASSSAAPSGSSVDDANVKANVNVY
LNYTGPNIELDADLPTVGGQENTSINGTSNVTGEFNTAFRGNPSKGLLFT
NRYANPLLKSVINYVNKFDPKYRAEFVTNSINGVTITKVQNTKELRPGTL
DDLNKNNVFLQQIQGDTKAVYFAVSAIASNKWLNTFLIRIPLTKFVRPIS
VFQATTAAPQDAAQTSEGQGSQPDQTA
>MS53_0374 conserved hypothetical protein
MKVRSKLKKILMVTAFLSVSILASSCNIFDTLSSRQKKDEKKDDKLYLNK
NGDPEDQDDQSKKPVVTPPVTFKPENPSKDPISEKPQEPDAPEAPSAENN
FNINTDIKNWDQKLSNVQLQSIYNNNPQLTRFNFTKAPENTKFSSNEEYL
ESIFKRTFSINFNYSTQTIAGTAWVLDYHYDKNNPKEITLYLATNFHVAT
NLRTANDYEFYVQNSPNLERVRSVDLRFAQDWRNPDTSYITKRYTGRNMP
RNIFLAKNFMDQEVSSSYNDGGGYYADFSVIEWKFKISDFYSNSSFFINT
VDPSLDLWVKKIESAAGEVKAAVDKNLGIDGGYLNTKAHEGYTSLDYTTI
QSTYYSDLSKTITNEVRYPQTVNEILEFQKNVNNTFTNYIYAFRPEYWFF
GGYPLIPNDGFVPTFNIDYDNLTNLGFNKNDYNPDFKIIYTLNNTKNTDQ
KISFNNEPTYAFYGTAYETFQKIKIHGGISGSLVLNEQGIPAGVLYGSFV
NDTEKITRKDGSTLTLNNALMIPFAQQKDITYTTFDGQSHTIYAYNLVDG
TDKAKFPHQIDSFREKLIEVYGPNYKTKLFPNGVGVFDGPSNHDINSEKF
KA
>MS53_0067 conserved hypothetical protein
MEFYLLIILKGIMAAIINKPSWNQAKVNSKVTIQAYKYDGSLYRKWKNAS
IILNNSRHIVFYLKNTKVYNEGKTSYSWLYRHDAIWFMPKDSFYNCIISF
DDTGLLYYINVASKPYFEENVLKFIDFDLDIKHSSKKHLQIVDRMEFKTN
FKKMKYPEKLKDIIYKEIHNIFLNYNEYKYFFSGRVLNYYVELLKKQGYI
SEFQAKRLRQIIKDDFVSEEDQYLKNL
>MS53_0075 conserved hypothetical protein
MDFSNIEINLTKTNLENKEVNFSGNQLRSYLKNLLDKILVQSYLNLKIVI
PDLYDFLWNHSIEEKANINLALIIIKYKTFDWFFNACKKNNIDVYFTIDY
KKKEKVLKNIQNFLKIKSSDLYKKSKYMLMDFFLTKEVEINSLFIHDDLY
NLFREIILFYNHWNPKGFFIENSTALFDDNKFKKIVNYQSYEKIDIINKL
LKNIKKEFKCEIYGIESSIIKIKNFYKVSAFDHHFYRGQHLTFRKLIKNF
VDCKKNSVSLIYDAKNILSSKQVKIFKYLNQINTISKLAIMNFDYFSFVY
LYPKNENEFIQTFSHKLLYNHTNNLLFSYSNNGFFRSKLKNKNALKIKAL
YVNILGVKYFKIYLNFENEKYLLFCNLSEKIIKINTSKFKNLFVDDSQKD
NLLLAFESDFFETN
>MS53_0037 hypothetical protein
MTIKNSKMFYRIFFRKFSFPIIYCLIVSIFYFSFILVSFFAIYNNWSTDN
HPGKVDWIIKNQPGTTEGIPTSEQQKVFYSLAFYQQGYFLYFVLIFIYII
PVSMFSHYLKIFYKSDYYKRIILLNGNKKTFRYIGLYLVIFWFLIFLIIN
LLRILGMDYIFKFNIWLQDAKKIRSGIEPYVGIRLDPNEIFHYYSYQIPQ
SHFTENFNNRFLTYIIGCISIFIASILFTLFLTFTSVWIKILFLAMLFVS
YVLGIYYGADFNFYLEKDITVEYAKSVNFLWPISLLNPYVTLPLILKFYI
SSKEFDIWIYFPLIMQFLFFSILLATTLVIRKRLDRHIFL
>MS53_0560 conserved hypothetical protein
MLFVGDIFGEPGILALKKILPKIIFREKIDFIIAQGENVSGRKGLSKKDF
DDLLKLNVNCITMGNHIWSNSEIYEFINNPELIRPLNVEGSYPGKGSRIY
NVKKYNLRVTAILGRAFNVLNKPWDQAQANDFFDAFDSVISSEEKVDFDF
VDFHAETTSEKYVFGLYLDGKVDAFCGTHTHVQTNDAKILPNGTAYITDV
GMTGPQNSAIGANFEEVYKKMRFNGKEKFKVSDNDLQFNAVVITLNKNKK
TNQKRHKIKLINISDIKK
>MS53_0462 conserved hypothetical protein
MIFYGGSMIKAKKIKLLINFGAISILGVAGAVTAKVIIDNSSDKARDLNV
IIASRGDKSVLNLKNVETDDINSSNKDNNLKEIKEETITPVVNDKEENQV
ESPAKPEPDPEESNKYFSDVTKPIENPQPEPPVESKPPAKPEKPDVSKLL
PNSNPGYVNIDSLPDFDFAIDKPKENPIGKLTEEQTKTIKTAVSTLVNLT
KDLPKQFTDEQIEQINDAIYKIRKLGAATKNEGKKDWTLLLKNLYNNDGR
TTSEKSKAIGFQIINDAYNLPKEFKDMWANIERDLDKFLAKGMVPNIQWG
YTGNSWTFIDHSDNVVRNKMISNHQNRYFAYDSEYKRNSKVIRDLDYEGF
KKQDATNRFIQYGAGSNIGITVLQYTPEGKFAKSKVQGNRLIAVLDASNV
AGYNNFLNFLKKTEQAGQKLDGIVIRNMGLIDKYQDFSKILAQMPDSIEK
LTLFFEAKDTSSLIGLKDKKIQELDLYNSSNTVADDWGINPYALRGVKNI
TFDYNHESITTSTVQPNNKNMPGSIVFNTLKFDKGMTLDQINEGLRIALK
DRYGERIFQGAFGDGSWPTYLDFSNLPEIRNLKGMNFNTRVFKKLTLYNR
TNVFETDAKTLHEQQWTALLFKGPERPKLYFVSPQEVNTLYIKGNAIDLG
DNWGRELYCLIEAGKDVFQTVYVDNETMAQVLNNSQAFRQFNKKAIVKPA
GFNNSADNSIVSFE
>MS53_0102 putative ABC transporter protein
MKPQGLPSHIEDLYQKLKVEFLNNRTNSPDLNVLVIDNIDKVYENGFQAV
FGTSLFLKKGEFLSLLGPSGCGKTTTLRAIAGLDTATSGQIYINGADVTY
SEPIDRDITMVFQNYALFPHLSVRKNITFGLDANPSKIGKEAKYYKEEKF
IKNKINNLKQIQNDIVNLLKIKQKNQALLEKIQKHQAIYDKLKNKQSKKA
LSLFFKINGWKSVYQINTKKIAALESDKENAQAYGVEVESWKKKLEEVKL
KKAQAAKEDNKKEIKEAKLKEVSEILGLDYYLDRKPAALSGGQRQRVALG
RSIVSNPTLFLMDEPLSNLDAKLRASMRSEIRKIHERVNAATVYVTHDQI
EAMTMSDKIAIMSDGFIQQIGSPDEVYKNPANLFVAQFIGNPTMNLFEGR
FKDGHFVSNDWKVLIPNWKTKNIMPDVDIVFGIRPQDIYLTNDDYPNSNP
TYFVEVVRSELLGNEIQYIGVIKELQKEIVFITDTYNKFKPGQVTKISII
PDRIHIFDKQTTISLTSEFNYETLSSLKNWVESEDKIKVKRDLLEFSKKQ
KLQIFSVIKLLKNLVKKVLKK
>MS53_0213 putative phase-variable hemagglutinin
MLQAIINYVNKFDPKYRAEFVTDSKNGVTITKVQKDKQKRDRELRL
>MS53_0495 conserved hypothetical protein
MDFLKNGALLYVVLGFLIFGLVGWILFTYIRDKINKKKIHLAGVELDKLT
KKYLAKFDVEINEVIAQNKRYLEKFVVSVGEYKMGELTNFSRKKVIEILE
DSDFKNYVLENPKYAELVKNLSELKDVKSNMWESKALHNLTYFSNELKKL
TSVTLTEEEEREIKEKVALSYGDNLRKKKKTS
>MS53_0652 ackA, acetate kinase
MMKEKILVINAGSSSIKFNLFDKESMQSIASGLAERIGLSEGHISIKYND
EFDRYVDMKNHENAVDVLYKFMQEINLIKDKEEIKYIGFRVVQGADYFSS
STKLDAKVVEIIEKCSIYAPLHNPGAVQSIKAFEKVFPKAKMSADFDTAF
HTTIDRVNSSYAIDNSLVKELKIKRYGAHGISHYYITKKLEEILKKDKVT
FVNLHIGNGGSLCAVKDSKSFDTSMGLTPLAGIMMGTRSGDIDPSIHAFV
KAQKNMSVEEFTDLLNKKSGLLGVSEVSSDMRDVRKAAREGNTQARFALD
LFAKNIVDYIAKYFNSLGGKLDAIVFTAGIGENDIATREEVVNLINFRKV
KIDPEKNLEKYSDYKLISTPDSEIKVYVIRTNEELVIAKNALKLYDQE
>MS53_0088 acpD, acyl carrier protein phosphodiesterase
MAKVLVLSGGLSEKEKSYSSQMLDLFVKTYKEVHPNDELEFVDLNTTKHA
EVFLSRNTFATYWKDVESDKWIDKLKAADKVILSCSMTNFGPTAVVKNFI
DSVAVANKTFSYKYSKKGDAVGLLDHLRVMIVTTQGAPKDWYLWGSHTNW
LIGTWKFLGAKYVDTFELNGTKLSVFADKKPYDVVEEFRQDALEKAKQF
>MS53_0098 acpS, holo-acyl-carrier protein synthase
MVTISRFKNKNKEFIERLLSEEELVEFNKLDNEESKELFLARSWAIKEAI
FKADNSYFKFNKINLIKINNEWNFKNFKISISHENDLLIAFVIKE
>MS53_0580 adk, adenylate kinase
MISKNLILMGMPGSGKGTLAKELIKISKLKHISTGNILRNEIQNKTELGK
LVEEIMAQGKYVSDDILNEMVKKTLLDAKENNELIILDGYPRTINQAKFL
DSLNIEFKIVELVAPLNLITKRLSGRRECPKCKASYNVFFQPPKQENKCD
LDAQELVARKDDNAESIAKRLEIFKKETSPLFEYYKSKNNLIKISSESNP
KLIAIELLKSL
>MS53_0376 alaS, alanyl-tRNA synthetase
MNSKEIRKAWLDFFESKNHFIVPPKSLIPVNDNSLLWINSGVATLKDYFS
GKKNPPSKRMANSQKSIRTNDIENVGITARHHTFFEMLGNFSIGGYFKKE
AIEFATEFVLDVLKLDRSRLYFTYFHDDLETKNLWISQGFKEEQLIPGDR
KTNFWEVGKGPCGPNTEIFYDRGEKYDQRGIELLKNDIENDRYIEIWNIV
FSTYNSDGEGNYTELNQKNIDTGAGLERIVSILQDAPTNFDTDLFLPIIH
EIEKYTSYRYKIENYFIKDKAQKEINSYFKIIADHMRTVVNAIADGEKPS
NLSRGYILRRLIRRSYYKAIQLKITKSPFLYKLVDVIKASLPFEYDSKKV
AEVIKEEEVLFSQTISKGKEILEKFISENSSKDLFPGDLAYKLHETYGFP
FELTEEILLQKDIKINKEEFNLAKEKHIEASRNQKETGMDKVINSLALIK
AKEDEFIGYEHTNSVSKILHLLNEENELSENDGTSYLILDKTPFYATSGG
QKHDRGYIEQNGVKLEILNVFKDKFGNHVHKVVGKLSKNYPVTCQVDLKI
RRGLERNHSGTHLMFCALRNVFGNQIKQLGSDNNEDRLTFDAPFDSKPTN
EEILKVENLVKSYIQKEVDRQYLIMGIDQAKEINAIMTLEEAEYMDSSKL
RIVNFNGITADLCGGTHLENTKLLEDFKITSVEKKAAGVYRIRAISSKET
IEKYLENQKQELMQELLVLVKKLKDMQFDFKVSLDESLELSSQIQEIKNL
TNLASEAIKNKIKENSKKISIDLNEIELENINGNYLYLNDEISKEEIKNL
SGVIREKFPNALVILISKGEAQSAISFASKKYNSINVLKELANHFELRGG
GNAILAMGSIKDYSQLKTFLKEKYKWEN
>MS53_0078 aldA, aldehyde dehydrogenase
MNKSDINLSLEQRIYYLKKLKNLIIEHRQDIYDALHKDLNKNNFEAEVSE
IWPILKELKLYIKNLKKWSKNKVVNHPGKLFSKKFKLFDFLKNKRTYTVF
EPYGQVLIITPWNYPFYLTFVPIINALSAGNTLLVKPSEYSSHSSELIKK
ICEKLFNPKHVKVFLGGKETVDKLWETQKIDFLFFTGNTKVGQILYEKAA
SKMIPVILELSGTNPLIIDESANLKITARKLIWSKYLNSGQTCIAPNYIA
IHSKVKDEFLKVLSEQRQKLFQNSDLISKIITKQHFENVLKKFPDLKHNY
ESQKFDFQILETSFNDPKFDYELFCSALMLVEYSDFKDLIAKIKSRKKPL
ALYLFSNNKANIKYALENVKFGGGCINDVIQQVEEKDFGFGGVGLSGIGK
YHGYDGFAAFSHQKNIVHYKPNKDDSKRYLTLKPSDKILKLIQKISKF
>MS53_0687 apt, adenine phosphoribosyltransferase
MQLKDYVKDVLDFPKKGIVFKDISPLLADKDAFDLIIKEMAKYCQNSDYI
VAADARGFIFGAAIAFHLKKPFVMVRKPKKMPGPSYSVSYELEYGHNVLE
LQEDLIKENASVSIVDDILATGGTLNAMIELLEKAKAKVNNIVVAIDLTK
LSQDFKSSLKTPLDSVIKY
>MS53_0356 argS, arginyl-tRNA synthetase
MTLYSQIKNSILNSLTKLQAKEILPEFDLDEINFNISQPNIPEKFNPNNI
FYHYSTNIAFTLAKSLKTNPIELAKNIQSELLQEDLYERVDFIAPGFINL
VVKDIYFNNAIYEIIKLKNNFGKFKANNQKINIEYVSANPTGFLHVGHVR
GAVVGKVIYNVLKFAGYSVEGEYYVNNAGNQINLLARSVLYWYLKLHKIS
SPKVEDGYNGKDILLCAKKIKKVFGNKFIKLKESHKLFADFKKFSYEILF
EEILKDLWKLKINFDSVFYESSLYENSDIEKVLEKLKNKTYQDGNSLVLK
TSEYGDDKDRVLVKSDKSFTYFLPDIAYHYLKFKKADKLINIWGADHLGY
IQRIKAAMHFLNLNDSNLDILTLQLVRLIKNGQEFKMSKRKGTSVTLKDL
LKVSNKDSIFFGMLLRDSNSKYDFDIDKNNASDINNPVYIVKYSYSRAYS
LSQNLAKHQKTKEAFLSDKAKKLVLELDFFQELISVITKTLKPNLLTQYL
INLANLFNSFYSEKKIKDTSEEKHYSGLIQAYKIVLSNALKLLNIKPPKK
M
>MS53_0422 asnS, asparaginyl-tRNA synthetase
MDIKDILLKPKSYDQSELTISGWVSYFRGNEKVCFVEINDGSTIKNLQVV
FKGFDFKLLENLKPGSAAVIKGKILHTPGKSQEVEMQALELVDYKKADED
YPIQNKEIKLETLREIPHLRHRTKVLRAVMLIRSTLAQEIHKYFIDKNFY
YMNSPIITSNDGEGAGETFEVYGSEIKHFFGKNNKATLGVTGQLHGESYA
VGFKKIYTFAPTFRAENSNTKKHLAEFWMVEPEVAFANLYDMINLAQDLL
KNVLEKTLEKNKFEFEFLSEFLNINLKERIELFTKSDLKIVDYRDAIKEL
EKHKDKFENKDIKFGLDLGTEHERYLVESIFKCPIALINFPKAFKAFYMH
QNDDGNTVAAFDLLIPQVGELIGGSQREVRYEKLKQRINELNISEKDFKW
YLDLRRFGDMGSSGFGLGFERLVVYATGIENIRDSIPYPRTVDNIKM
>MS53_0436 aspS, aspartyl-tRNA synthetase
MKFSKISNTSLDESYINKSVTLYGWVATKRKFGKISFVDLRDHSGIIQLV
FSEDIKLSKESVIKVTGVVSKRKDINPSLKTGTIEVLVSEYELLSSSKEL
PFEISEKISASEDLRMEYRFLDLRRESMQNAISLRSEVFFAIREFLNKEK
FLEIETPILAKATPEGARDFLVPTRSQNNFFALPQSPQLFKQLLMASGFE
KYYQIARCFRDEDSRKDRQPEFTQLDMEVSFLEVSAFQKLVENLFKYVFK
KVLNVDIQTPFQRLDFDTCIKDYGTDKPDLRFDLKIQDINNYFQEDNFEI
IKKQASKRMLFINEQITKKDFKALEEIAKKNSANILFYFVLENGKVLHSN
FANKAPRDVEKLIKDHNFKNGTCFIVANNFDNASKALGALRVELNSMFNY
AKNSYNFSWIINWPMFEFNEESQSYQAAHHPFTMFENTVEEFKTLSKNQI
KAKSYDLVLNGFELGSGSARIYSKEVQELIFESLGMDKKEQEEKFGFFLK
AFDYGLPPHCGIGLGLDRLLMILANKSTIRDVIAFPKNAKNKDIFTKAPS
EISSKQLSELFLELKK
>MS53_0407 atpA, ATP synthase alpha chain
MKNNFDDISAIIKDRIKNFDQKIDRSEVGKVISIGDGIALVSGLDKVENS
EVVIFDNDVYGLALNLEEEAVGVALFGNSNLISEGDSVRRSGQVISVPVG
EAMLSRVVDSLGKPIDGKGPIKSSKMAKIFKLAPGVMTRKEVNQPLETGI
IAIDSMIPVGKGQRELIIGDRQTGKTAIAIDTIINQKGKNVYCVYVAIGQ
KNSTVAQIVQKLNDTGSMDYTTVVVAGASESAPQQYIAPYTGVTIAEEFM
SQGKDVLVIYDDLSKHAIAYRTLSLLLRRPPGREAYPGDVFYLHSQLLER
AARLNKKYGGGSITAFPIIETQQGDISAYIPTNVISITDGQIFTKESLFN
SGQRPAVDVGFSVSRVGSAAQTKAMKSVVGSLKLELAQYNEMLAFAQFGS
DLDENTKAILEHGAKVYELIKQDQYSPISQADQAVILIGVKERIINIVPK
EWISEYRNQVIKYLQKDPDGKVIESNIINEGIISKENYAKLEQALVKICK
SIVSSIPNYDASMHKSLPEKYLETKEVDNV
>MS53_0159 atpA-2, ATP synthase alpha chain
MTTNNNPTISAIFDYVVEIKGQLDYHQNQIFYLKSNPNLKLLLISATKDK
AYCLASGTFNDFHINSEVVPQSHEFQVATSREFFGKIIDIQNNIYPHKAK
ASLNKSKYYSSLSTPFNNPKELLNYQPLKKQLLTGYVVVDLLIPIGRGQR
QLIIGDRKTGKTFLALNTIINQKNQGVKCIYVAIGQQHAQLTSTYQLLKE
NGALDHTIIINAPADSPYEQYLAPYVAMAHAENIAKDEDVLVIFDDLTTH
ANIYREIALLTNKPVGKEAFPGDMFFAHSRLLERSGRFAGKKSITALPIL
QTVDNDISSLIASNIISITDGQLVTNANIFQSGQLPAIDTELSVSRIGAA
VQEKNMAKTSKEIGKIYKAYKRQAKLSSLKYDLNDETNALIVDGQLVEGI
FSQKGVSFYNQKTIFLTSKLLAWGLLRNVSNIAEVLKFIEVLVETNQSFK
DAFDSIDGKNSENVDESLVRDYFAFALLQYAEYKNYNWKITLDRKFDQLT
KAQIMEIEARMENY
>MS53_0465 atpA-3, ATP synthase alpha chain
MENKLYISAVSDYVVEISGKSSFKQNELYHLANNKDAILMVISASEDKAF
CLIKLNQEDYKIGSEVVKATNSNQTIETTNDYFGKIIDIYGKILHQQEFI
NLNLINFLPQKSHIFNVNNHLMTYLPLEEQLNTGYSLIDLLIPIGKGQRE
LIIGDRKTGKSFIALNTIINQKDKNVKCIYVAIGQNQNEIANVYALLKEH
DAHKYTIVINAPSEKPYEQYLAPYIAMAHAENLSYENDVLIVFDDLTKHA
NIYREIALLINKPVGKEAFPGDMFYAHARLLERSGKFKNRKSITALPILQ
TVDNDITSLIASNIISITDGQIVTNSELFALNKYPAIDVNLSVSRIGSSV
QNKLMNNTAKTIGSLYKAFKKQAKLVAVKYDLNDDINSLMLSGEQIEKMF
NQKGITSYNEKDIFLVSKLIEWNLLNNLNDDDIHLAIRFLIAYEKENAEC
VKVINDLINNQVKDENLVKEYFVYLLAKFSLKYKLNWKIVAKKVFAIVDE
KTLDKVYKQLFGDK
>MS53_0411 atpB, ATP synthase A chain
MQEKNQNVILSNLWQWDQSQIISLILTVIIILVVSLIVFAKVTKVKPNQA
PTGVALVAEMYVTMVDDNSYNGTSGNFAKARPYLFTLITFLTVGNMMSFF
GLDPIATSYSVPLTLAIATWIGIFTVGIMYKKWSYLKEFVNPLDFVGKIP
PVISLGFRMYGNITGGGTVVVLMYLIFGYLWTLVFKNSEWFFFGSLITPL
FHFYFDVFDSLLQGYVFLTLTMVYWLNESGLDDVSTSQEEKQKLTFKEKM
AKMLAFSKKEKASQAIY
>MS53_0404 atpC, putative ATP synthase epsilon subunit
MAKLKLTITTPSAIFYDDLVDIVTLRVNLGYKGFLPNASEFFSNIEPGTL
TINYENSSDMIKCHIGSGLIYSNKESVNIITDDIVKIEDINLDALNKQKE
MLENRLKENLRESLLKQVEEKLENINSRIKAYNEFKK
>MS53_0405 atpD, ATP synthase beta chain
MLEKNKGKIIQILGPVVDVRFTTGKLPKLLNALRVELPTKEVFTFEVAQH
IGDDTVRCISMVSTNGLRRGLTVEDTGKAIMVPVGKQVLGRMFDVLGNPI
DELPLEEGGEKSSIHGPIPTYEQQKTTSEILETGIKVIDLLIPYAKGGKI
GLFGGAGVGKTVLVQELINNIATQHNGLSVFTGVGERTREGNDLYYEMKA
AGVLDKTALVFGQMNEPPGARMRVALTGLTMAEYFRDKQNQDVLLFIDNI
FRFTQAGSEVSALLGRIPSAVGYQPTLATEMGALQERITSTRSGSITSVQ
AVYVPADDLTDPAPATTFSHLDAKTVLDRNVAALGIYPAIDPLESSSRLL
DPLVVGQEHYKVAQDVINILQRFKELQDIIAILGMGELSEEDKKIVARAR
KIRNFLSQPFTVAEKFSGIKGSYVKLSDTIRSFKEILNGNLDDYPEDIFR
YAGSIDDVIARYKK
>MS53_0160 atpD-2, ATP synthase beta chain
MAKITKIWTDVVEVAFAKNEELPKINTILYSKETGSHLMVKKIVNDFELY
AVLISTMKPLYVGQDLQNTKKSFMVPVGEESKNHIFDVNGNSLTNPEAKL
KRVEMDSTIYPNNNFTTKPQILETGIKAIDFFIPVLSGAKIGLFGGAGVG
KTVLMKEVIFTLSKKDKKTTSIFIGAGERSREAIELYDELKFSNLMKNSI
IFVSRMNELAGSRMSIVPIGVTAAEYLRDTQKENVLLFIDNIFRFLQAGN
EMSASLDKKPSLGGYQATLNTDISYVENRIFTNENGTITSFQTVFLPMDD
LSDPSAVAIFKHLNGSLVLSREITAKNIFPAIDPLASSSDSVDERIIGKE
HYNAIVEAKKILQRYKELEDVILILGIDELDEEAKVVVKKALQLQNFFSQ
NFFMTEHFTHEKGVFVPLKETVNSVIRIINGEFLNVEPRKFLYIGSVDEI
DTTDARNFAKQSSTTEVAKA
>MS53_0464 atpD-3, ATP synthase beta chain
MSAKITKIWSDVVQVSFTNEALPAINTLLKTANNAYLIVKKVIDEKTLLA
VLVDSQDNLAIGQEIQVLNHSFHVPVGNLSKGHIYDILGNNLSSPEITNV
TKVEMNSTIKNNTNYTKKHQLLVTGIKAIDFFVPIFEGDKIGIFGGAGVG
KTVLMKEIIFNLSKQKENTSAIFIGSGERSREAIELYNDLSESNLMKNSV
MYVSRMNENPGARMSIVPVGITAAEYLRDNNKENVLLFIDNIFRFLQAGN
EVAASLDKKPSIGGYQATLNTEISQAEQRLFNNENGSITSFQTVFLPMDD
LSDPSAVAVFNHLNSSLVLSREISAKNIFPAFDPLVSSSNNVNPEFIGQR
HYNAILETKYILQKYKEIEDVMLILGFDELDDESKTIVKKALQLQKFFSQ
NFYMTEHFTFKSGVFVKLEDTISSVEKILKGEFLDLNPEKFSYIASVDDI
KI
>MS53_0410 atpE, ATP synthase C chain
MAEALSASSPVSGTVQTVVDGNTTTTTTTNTGLGVVAVGAGLAMIGAIGS
GLGQGYAAGKTVEAVGRNPEMISKIRATFIIGAGIAETASIYSFIVALLL
IFVGK
>MS53_0409 atpF, ATP synthase B chain
MGKVVTASDEIAKRFNNLFPSIPMMLATFIAFVIVFLLLFFFLYNPVKKM
IRKRQEFIQSQIDDSIKAKEDSLAKLSQAQAELIESHKQSVNIVNNAKSK
AQEILASYKNKAISDANRLIEETQIDLNERKKEFDKNSRILIAETATEIA
QRILKREISKSTQDEIIKDFLEDKTPIEDI
>MS53_0406 atpG, ATP synthase gamma chain
MSNLINIKNRINVVTNTRKITNAMQLVSTSKLHRIINLTKNIKAYQNLVE
TTFDNIVSKITQEELNEIFPPKQETDATLYIIVTSDIGLCGSYNSNVINE
LKKVIKPSDLVITLGTKGLNWIRVSKFKDQLYKAYVNLEDKLDYSIATEI
GNLNFELFAKNKISSCKIIYTKFVNNLIQEVSVKQLFPYDSSHLEIKKES
EQMEGDIEFEPSAEIILQRAFPLYVSSMIYVLVSLSKVSELASRRVAMES
ATDNADEIINDLNLEYNSKRQSVITQEITEIVAGAQATN
>MS53_0408 atpH, ATP synthase delta chain
MYVKVNPSSYSVAIYEIAKESNKIKTFHEQFSFVKKVIEKNPQLITFLKN
DEIALEKRFELIDEIFGSLEVDVKNSIKVALVRNMIFVLRKIIVDFLKIT
NYELGIKFAKVITAYPLSDSELEKIQKKLNEKTKKIVEISTEVDEKLLSG
YKIIFSNQLYERNYNNDLQKIKKTIIKGKEDEK
>MS53_0130 bcrA, ABC transporter ATP-binding protein
MKNILEVKSLQKVYSPNTGIFDINFSVEAGHFHSFIGENGAGKTTTIKSI
IGAYNSYSGEILIDGKNSKNPETKNIIGYVPEYAKFPKELTTFTYLQFLA
MLNGVSKSVAKEKITALLEKFNISDLKNKKPVNFSSGQKKKILLIQALIH
DPQLIILDEPTANLDPTARFELFTILNQLKSQGKTIFISSHVLSEIDKYT
DSFTLIHKGQIVYNGKKYKPLEKVFYEKVLSNK
>MS53_0388 cdd, cytidine deaminase
MLKKSYSPYSKFQVSAIAVDNNDNEYEGVNVENASFPCTVCAETLALSAS
VLRGSKPGTFKEIHILSSSDNYISPCGLCRQVMSEFMHDDAKIYQYSQNG
DYRLETLSEILKHPVRRDDIKSK
>MS53_0005 cdsA, phosphatidate cytidylyltransferase
MIMNIKNWTENKNSLFQQRILPAFIMVFFFFIFIGILRFAYFYSFSFSSE
VIISTRAISLLLMFGVAFWAMLELNKAFLENKYVSVIFAFAISAYTVFFN
GPIFSKYFVYSTEKFALSENYLSMFSVFYFNYWFWVKLVITSLLFLVLRI
VILSKSKVIVSGILLKLLLYFVANFVIWSFIYCVFIFSYMPSGFQNLIIF
TTIASFYDVGGFFGGKFLGKKIIKRPFSPFISPSKTWEGALVGLVFSIVF
VFVEIFLANVIEHNKFNLAQVILNVGSSSFNGKLFGTVLFFIVFAPVVSM
LGDLLFSLIKRVCLIKDFSKILKGHGGILDRIDGIASVFALWSFLMVILY
FLNYVG
>MS53_0393 cls, cardiolipin synthetase
MRKLFLKFNFRKILIFVLWISGTIAIFAGVSFAITRVNQNYVYFFIIFLY
LINLIFVIIMINSKSYSDSKFSWILFILILPIFGHIFYLIFGLKSKSNRF
QYLESIDKYEVNSYLDKATLNVKKTSDYEFHKLENFFKTKMLSCDFEFLD
TGNKFFENLFKELKKAKKSISIITFIIKPGVFADKFIEILKEKAQQGIKV
QWLIDDYGSILYKRKKINDLRKVGVEIYFINKIYWPVIWKKTFIRNHSKF
IIIDSKMVFNGGSNISDEYAGFSKRFGNLIDLNYKISGPYVNNYILNFAK
LWKFSSNTDIDIKESLFKDDSEKKYKNLALFCSENPFSPESKSEIYWTKL
MQMAKYNIKIATPYFSVTKTLFNQIVLTLKSGIDVEIYIPGLPDKKIPYE
VSLNELFKLKEYGLKIYIYSDHFVHTKMGLIDHKYAWSGSNNWDIRSMHM
QFETMEIFSGLDTKFIENLFEQYKSKSRLLDSQEYLKKTNPIKTFVLNWI
KPLI
>MS53_0143 cmk, cytidylate kinase
MIMELKVNIAIDGPSGVGKSTVSKLIAKKLNYTFINSGSIYRTIAYHVIK
NDIDINNEKDVISSLDSLEFSLSKNEELFYKGENITLILRSEQISISTPV
VSKIPEVREFVTSYIQKMTKGKKGFIIDGRDTTFKVMPHADVKIFLWATA
EERAQRRVDQNHQLGYNSNYDEVLYEIKKRDHQDMNREHDPLHKTEDSIL
IDCTNMKIDEVVNKIISLIK
>MS53_0396 comEB, deoxycytidylate deaminase fusion protein
MMKKNSKLNKAISWDDYFMGLAKLSALRSKDPSTQVGACIVNRQNHIIGM
GYNGMPNGEDELFPWESNSSDEKDNKYPYVMHAEVNAILNTSVMLQNSNA
TIYTSLFPCSNCAKIIVQSQIKELVYEDDKYHDTKDAEISRYILETGKVK
VRKHKTSVEFTLNFPKNDF
>MS53_0357 cysS, cysteinyl-tRNA synthetase
MLKIYVCGPTVYDELHIGNMRPILTFDLMLKAARYLKKDFIFIHNITDID
DKIIFKAKEQNISEKELAQKYSQKYLNHLKTFSVDTITKLEYVTKNLEYI
ESFLDKLYKRDNAYLIENSGLYFNVEKNLNNYGKISNQNLDDMHFDFDLN
SKLQKYNKADFALWKNTSEGIKFDSKFGQGRPGWHTECVALIEKNFGDSQ
LDIHGGGVDLIFPHHENENIQYQALYQKDITKKWLRSGQINLNNEKMSKS
LQNIISVDAFLENNSGNTLKFIFLMSSLTANINLNENLISDASNLDKKLI
KLSFLAKVNNLEIKPCDVSKEMEFLFELSFSKFMFEVNALLKNANKNDLE
ALNKLLFLFNTLGFSYNKLDFSSEIQTYKKWKAALELKDYKSADLLREDL
LKKNLI
>MS53_0019 def, putative polypeptide deformylase
MYQPSDVKIVSLPDKILRTKSKDVELPLSEENIELANRMIYHIEDSQKPF
STFRAGVGVAAIQYGIQKNVFYVKLTQNDNSVVFDDVLFNPIVTFKGKIL
TALAHGEGCLSVPDEIPNQEGLVSRSYEIKVQAYSYRKQKHLEFHLKGYL
AIVFQHELDHLNGKLFIDRINKKNPWKKPTKNIILI
>MS53_0446 deoA, pyrimidine-nucleoside phosphorylase
MRIVDLIEKKVNKKELTKEEIFFLIENYTKEFVPDYQMAAMLMAILFNSM
TYKEISYLTLAMLNSGKVYDFSDFDQVLVDKHSTGGIGDKTTLAVVPILA
SLGVYMPKLSGKGLGQTGGTIDKLESIPGLTTDISIEDFKAQLKEIKCVI
AAQSNEIVPADKKLYALRDVTSTVQSIPLIASSIMSKKLATGANIILLDV
KCGNGAFMKDLKSAKELAQTMINIGKELGVKVIVEITNMSRPIGKEIGNK
NEIIEAINMLSNKGPSDFSKLVFSSCEAILLEMGMVQTEDEARQKIALSI
RTYLALNKFYELVRYQGGNVEVLNDLKKFWNPKYTYEIKADKDGYLNVFN
AFTFGIVSMKLGAGRQTKEDKIDYEAGITLVKQTNEKVSKNEVIFKLHSS
NVIDSSLVEELKTAYKIQNNKVQNKIILERMQ
>MS53_0083 deoB, phosphopentomutase
MKKFNRIFMIVTDGLGIGPDRDQKAFKDAGANTIRSASVSEMFHIDNWKR
LGISNISQIHNHHPVKKPQAYVARIQEVSNGKDTLTGHWEMMGIKTLSPF
PTFTENGFPQELIDELSKAFDGKKIVGNKSASGTEIINEFAQEEKLNNSI
IVYTSMDSVLQICGHETWTGLDNLYRYAQAARDICSSRPEWNVGRIIARP
YTGDDGAYTRTFNRHDYAIKPKANILNKLKTKKVKTIAVGKINDIFVGQG
ITESIKSGSDEAGMDIVIDLASKKTKNEFVFLNLVQFDSHFGHRRDVHGY
ADNIAKFDVKLGKLLTVLNDDDLLIITSDHGNDPLYPGFNHTREFLPATI
YSKSFKSPKVLKDLEGLGTLGNIVAKNFGVDMVIETGEDIFDQLV
>MS53_0445 deoC, Deoxyribose-phosphate aldolase
MNFNQLIDHTYLKPEATKKNIDNLIMQGFEHNFFSVCVNSIWVKYVKEKI
KKLNSNLKITAVVGFPLGASITQAKAHEAKLAVEHGADEIDMVIAVGFLK
QKDYEYVLNDIKSVKKAIGNKVLKIIIETALLTKEEIKKATEIVLKSGAE
FIKTSTGFSYRGASLDDVVTMKSVIKDQKLEIKAAGGISTLEDMQKMHEA
GATRFGLSKSVEILKNQKVETKY
>MS53_0447 deoD, purine-nucleoside phosphorylase
MTPHITAQKDEIAKIVLMPGDPLRAKFIAETYLQDYKLVNTVRNMFIYTG
TYKGKKISIAGSGMGCPSIGIYSFELFKFYDVEKIIRIGSTGSYKKDLKN
YDLVLAKSAYSDSSAYKYNMLRKKSRLAFPSKELNEQIKKIAKSKKIKLN
LGRVHSSDIFYSQIPLEERISTSKAISVEMESYALFVNAEFLNKQAACLL
TVSDNLITHEVTSALERQNSFTKMMEIALEIK
>MS53_0140 dgk, deoxyguanosine kinase
MIVAVSGMISSGKSTLVKKLNSHYENNSLYLDEYKKDDEIFSTMLRWFLE
KRENINLSFDLYVLNHHIESLKEIYEEFNEKFTKDDYLFLDRFPAEHAIF
NKMDLVTNLNHKLAYDKALDNLLVNQIKPDLVLYLDIDFKTFQNRLTQRS
RSEEVDNFENNIDYWKNLHMFYKQYFLELCKKYQIKYQIIDTNNLDEGQV
LTKAISLIETFKNTKWK
>MS53_0320 dinP, DNA polymerase IV
MKPYLKNKPVAIARSSYKSLAVSVSYELKVKGAKAGMTRGDILKIEPNTI
FVSEDFSLYTNLSRKIFAYLQEKISHKILIASVDECYLDVNHLVNDEKKA
LNLAKYTQRKILEVFDIPITIGISTTKWYAKMTTNLNKPFGIGLTNKMNL
INILNLPIIDFYGIGKSLVEKLKTLKIYYIKDLYARNIEDLSLVEVFGTT
AYKYLDALKFDKYEEIIPEIKKSKVIGHESSFENINIPQEEVLQRLKEIV
ALVSNRLRYSSLVSNTINVKARIQSKKWFNKNKKIPQYCQEFKCFWKYAY
EIYQKNYENKKLNSIGFSVSNLKSEYDLEINLNLFEKPIENSKAIEIANQ
INSIIKVNKVTTLGRYKKELENKKEKEKIESTFNSFLGK
>MS53_0001 dnaA, chromosomal replication initiator protein
MQKVNLIKLKEDFDLFFINNENKKNFEEFFKNSTFALFEDKKLYIFSPLF
SKKSIQKFILENYQDLIFRFFKSKNFKLDNFYLIHSEKELNLLLQNSSRN
KVEKTQSIKFKNNDFGIKNKNYTFDNFFKSTFNELALEVLKNSLNETGEF
NNIYFLCGKSGSGKSHLLSAIANEAKKQNKSCVYIQPALFSNKITQVLFE
NNSLTKQELNNFFVNADVILFDDFDDYGEGKKKGTKNFILNIIENRINLN
KLTIIASKTEYKKLKSLFDEKLFNRLGSGIKVSIESPKLSERKSFLQFLN
PKLFEVLDEQSIEFILFNTSNSNWNLIQIVNNLKIRMKFLEGFQNKVEFI
KSLLDQDVKTKEEINIDLIISKVSKFFGISKKEIKSKSRKLSVSWARHIC
VYLDKKLLNKSLNEIGRDFNMDHSSVIYIIRKVNEKMKNLEKKSEINSII
NKIHEN
>MS53_0425 dnaB, replicative DNA helicase
MEKYNLKPENTTKHQNKELEEQLLSLIIDSKESQEFALSVIKKEYFFYTE
NQAIFQLIGEIIEKKERHKFTDLVDILRDLKLDEYKHISSRVTPEYINSL
YSTNLNTENLIPYIEELENLYIKRYFEAYFKEMSSTVKEKTFDVKTLMTD
LENLKSETREKSLQSKNFVEHGNVQMDVVIEVQEVIEGLNKHWGLTSSFK
NIDDIVQGFRPGQLVILAARPGIGKTALALNMAAHIARNVQDKDKNNKVL
FISLEMQKKELAKRVMSFTLNVDLKYLTNPKNIKKPREWKVPELVWSNNR
NNEFKKLNENLLYDDDVTGNLNDIIWKIKNFKKDNEDLAFVVVDYLQLVS
ATDISGNRQNEVSAISRSLKQLAIELNIPILALSQLSRNVESRENRRPQL
HDLRESGSIEQDADIVIFLSRKESYDKLSKVSKDGEVQKNAQSIRTEKGA
FVINTEVGIAKNRNGIIGTTNLAFYSNRVLFIDYNEYRPTNKFNKGRN
>MS53_0529 dnaE, DNA polymerase III alpha subunit
MNNKKPIYLHLKTEFSFLNSAIRLNKLFNLIESQKIEYLAITDKENLYAL
PYLLEFREKYKFKLIIGCEFELDNKLEVIILAKNLAGYKLINELIYQKSN
NNSINLSDLNSENIFVIDSDTNGYLKNKKSLEVELPNFFYNSKFQLENKD
NVVYAPVKKIIDKFENFTLNILDKIREEFKENNNFDDFYSEEEFNDLDEK
IYQNTLNLADQCFELEIDKEIKLPEFSSNSKEEIESKIKASERTKYLLLN
YDKDLVIERINYELSIIKEQNFVDYFLIIADALSWARKNKISIGPGRGSV
SGSLVAYVLEITDVNPLDFDLLFERFLNTKRVTYPDIDIDIQDDRRSEVL
DYIFEKYGQKRCALITTFSTLGAKSAIKDVGRMLGISNSEVNLVTKTIND
FDKNLTLESEYNKRNSKYKAIVSKYENLHEYATYIEGLYRQTGVHAAGIV
IANNDITNYFPINKVLDKYNQVQLSLENLEKYGLIKIDFLGLKNLTIVKN
IENLINPKLHFDNVINQNLNKFIDHKTFSILNDLKTEGIFQLESDGMKRA
ISQVKIDSFEDIYAIISLYRPGPSQYIPIYGKNKKDPSQIEKVHPIYDKI
VAPTFGIIVYQEQIMQIAQEVAGLSFSEADLLRRAISKKNSQELKSYKTK
FFEGGAKNNVSSDLLNRIYSNIEKFADYGFNKSHAVAYAVLALKLAFYKA
RYPFIFYKVLLDNSFSSQENTSKYVQEATKLKIKINAADINISSLNTVEE
NNNLYLSFLTIKGFGENSATKLIQERNRAGKFKNFFDAAIRLGMIGIKKA
TLSLLINANIFRSFGNINTLINSLEDVSNFVDLINKKVKKAFMTLDKSEQ
TDGKWISLYEDFAREEQFPNILDEVEISDKEIMDLETKAYGISLSVIDES
KVENEFSLNSLNENETRNFNVILEEFDVKLNTNSKKVKINDGKVSKFAFV
SDYSLSIFNKELLNKKINVTVTLKKSRSNFKYLLLEKWSL
>MS53_0453 dnaG, DNA primase
MLKISELKDLINQKLNIVSVISNFISLSKKGNNYIGLCPFHEDKNASLTT
NETKKIYKCFSCGEAGGIVEFIQKFKKISFMEALKIAATMANIDESEFSF
LNKEFKQNFTYDQIKIYDLLDFTNTFYKTNYLKSELARNYAKERKIDSPQ
IRQRFDIGFADNKTKEYLIENDYQLNELKNAGIINENFNSIINNRLTFGI
RNQDGKIVAFSGRDLTNNSSAKYVNSTENLVFKKSSILYNYHNAKDEIFN
KKEVYIVEGFMDVIAFYKAGIENVIAIMGVELSSAHINLLKGVKINLFLD
NDQAGKIATYKLIKKLANHNNVVSVIKNTYNKDADEILLSQGKEVLIKML
NENKVSAIDFAFNSLFEDFNLNKQKDFNNINEFCRKIDDTFGLAPPSIKN
YLTSLIKEKLNFDYKFKASFTPRSFSENKPVYKPKINEKNLLIKLKAEKR
NELLIMLLSNPDMVNYFFDDSLKWELLTQGTSDDFYSHYEKNISIKDKSK
SDQIKAGIVNFLHKKIYSELSKTYLVDEKQLLDLIKNYVDQNWDYWILKD
KENIDTINQIRRITRLLTMSYLDIQKPKRLNTSVFINKLQNIKSLAEACE
SDEKYIKYLKDKK
>MS53_0593 dnaJ, heat shock protein DnaJ
MSKRDYYEVLGVSKSASAAEIKTAYRKLAKQYHPDKLKDGTSDTKMQELN
QAYEVLSDENKRRKYDQYGHDAEKYGQGFGGFSGFEGFSGGDFSNFGGFE
DIFNMFTGKGSSRRNRPMQGDDLEKEIEISFIDSIVGTDLKIEAQKYNLC
LFCKGSGNDSSATMNTCSTCDGHGKIQRNKSSLFGSRTFVYEQCHSCNGS
GRVSSQKCKHCKGHKYQKEIKTIKINILPGTKNESVVKLSGYGSPGYNGG
PSGDLYIVIRVRPHKYYQRVENDLYLQLPVSFLDILKENTISIPTPWGEK
RIKLSKKYNSEKTIKVPNAGIKTSKGFNDLKLVLKVVMPDLDKKTTKELL
EATKNFKDKTSSDFVASVLKAK
>MS53_0351 dnaK, chaperone protein dnaK-heat shock protein 70
MAKEIVLGIDLGTTNSVVSIVEGKNPTVLENPNGKRTTPSVVAFKNGEII
VGDAAKRQVETNPDTIISIKRLMGTNKTVKANNKEYKPEEISAMILSYMK
DYAEKKLGQKVSKAVITVPAYFDNAEREATKNAGRIAGLEVLRIINEPTA
AALAFGLDKNKAMKVLVYDLGGGTFDVSVLDLEDGTFEVLSTSGDNHLGG
DDWDNEIVKWLTKEIKTKYSYDVSKDKYALARLKENAEKAKIDLSNQSVV
QINIPFLAMSANGPINVELSLKRSEFEAMTSHLLDRTRKPIEDALKEAKL
SANDIHEVLLVGGSTRMPAVQDMVKRTLGKEPNRSINPDEVVSIGAAIQG
GVLAGHIDDILLLDVTPLTLGIETLGGVATPLIPRNTTIPATKSQVFSTA
ADNQTEVTISVIQGERQMASDNKMLGRFNLTGIEAAPRGVPQIEVTFSID
VNGITKVSAKDMKTQKEQTITIENSSKLSEEEIQKFIKDAEANKEADAKR
KEEAETIVRAESLIDQVKKALEAQGDKADAKTKEESDKLIKELQDLIDKK
DIPTLKAKLEEVENMMKNFANFAQQANATKDQSSKDQEEVATVVEE
>MS53_0002 dnaN, DNA polymerase III beta subunit
MLFHINKKKIEEIIHTLINYTDSSDSFDSNKCFYIKINSDFLHVIANSNS
IAAQIKTKVDENKIRLEKKGEILINALMLKDVVSKLEGFITIQEKNNSIL
IYDVYSKFELSKKQTESFRKVEFDQHNNVFSVESKELKNVIKNASVSPSA
ANENTTDRRLKYINIKGKKEENKIVLYSTNFSRFSTDSLNVDNVNEFDFL
VDAKSLKKLLPQSAPKDINLFINEDRIGVFYDDIKIFLRVAKEKYLNVDS
LFKLSKYTEVLIEKSEFLSLIQKVYFLSSEQKKIYIELNNENQMKLNYEV
SEIGKSETISSSLTVNGPKVKVAFNYVYLHDALQTLNEGLVSAKFVLSND
DENKCTRIILKSTENDSNIQIIAALMF
>MS53_0055 dnaX, DNA polymerase III gamma and tau subunit
MKYKSLYRKYRPQNFHEIIGQDHIIQTLDNVISSEKIAHAFLFAGPKGTG
KTSTARVFAKALNCSHSEVRSQICESCPNQNSGDIIEMDAASNTGVDEIR
NLKENVDQLPFESKYKIYIIDEVHMLSKSAFNALLKTLEEPPSYVIFILA
TTDVQKVPITILSRVQSFNFRRISEKQIVAQLENILNKENISFEKEALML
IAQLSSGGLRDALTIAEQISNFENNNITKESVRKNFGIASNDEIIQVLND
LYSKNISDVLKKLNDLKLWGIDPFLFVLNLISLVKEYLLFRKTGDDSFLN
YYSEKELNDLKINDSFAYRVSSSLYDLLINVKRTEYPFEIIEVSFLKLLD
ENDFIAMQNEEKQFKQDFLSSIKELQKETKENKAKKEIKINLFENKTSSS
TKESSDTINIVNPFEIDLGYLGEDEKDEPKAQVKLAKEIDLNFATWAIFI
NKQKDKDLIKRHEFQLKDFWHSVKDSALQEFQYFKSEMIDRLQVAASSDS
YIVFNIKNDPASEKYKPYSPEKLKEITDSLNNNNYSYFLQNFSELAFGGY
KHIFFISSSLKNELMAAKKDLNENFENLAFDKIEKDNLKTENNLVFKKNL
EDLIFNKFG
>MS53_0431 efp, elongation factor EF-P
MIEVNKFKPGITFQDSGNIYVVLEATHSKQGRGQANVKAKAKNLRTGATT
ILSFTGGDKVEPAHIEKRKMNFLYSDDSNIYLMDSSDYSQIEIDLLKVEW
EMNFLKENSEVQVRMFQDEILDIELPANVDLKVTYAPDAVKGNTTTNPQK
KVTLETNFELETPMFIKENDVIIVSTETGKYVGKSK
>MS53_0142 engA, GTP-binding protein EngA
MIIMKNTIAIIGKPNVGKSTLFNRLNGRKISIVDDTPGVTRDRLYEVISW
LNKEIKIIDTGGIEIKNAPFQEQIQIQAKIAIEEADVIFFVFDGHSEISN
DDLFIMNILRKANKTVLALANKLEGNKDFDYSWYKLGVDIFPISALHGEG
LGEALDEACKHLFFEEKNLENNFKLSIIGKPNAGKSSLLNKLTNEYRSIV
SEIPGTTRDSVKSFLKIKDQNFEIIDTAGIMRKSKLVESVDHYALMRAMS
SLVESDLTLVVIDATIDELSHFDSRIIGYALEHNKPIVIVINKWDLVEKN
QNTMMQYEKKLREKMKFSSWMPVVFISAKSGSRIDKLIDTILQVRENLNR
EIKPNLLANLILEAQLIQPAISNKGGRLHIYYARKEKSKIPTFTFFVNNK
KYAHFSYMRFLEKQIRENFDFRGCPIVINLKNKSQIMQ
>MS53_0009 eno, enolase
MSAIKKIHAREVLDSRGNPTVQVEVYTELKGYGSAMVPSGASTGSREALE
LRDKGSKFESNWFGGKGVMQAVENVNKLIAPALIGFEVTDQRQVDLAMKA
LDGTKNKEKLGANAILGVSLAVARAAANELDLPLYKYLGGFNAHKLPLPM
LNVINGGEHASNTLDFQEFMVMPVGAKSFREALQMANFVFHNLAKLLKKH
GHGVQVGDEGGFAPNFKSHEEALDFLVEAIKLSGYKPATSGEKAVAIAMD
CASSELYKDGKYTFGKLKKAIEEKQPGFENLGKTKLVYTTDELIDYLDHL
VSKYPIVSIEDGLAESDWAGFEKLTKRLGHKLQVVGDDLTVTNTELLAKA
IERKAMNSILIKVNQIGSLTETFEAIQMAQMANMTAVVSHRSGETEDTTI
ADVAVAMNTGQIKTGSMSRTDRIAKYNRLLAIEEELSKASTFPKDVFYNL
KK
>MS53_0387 era, GTP-binding protein ERA
MVGRPNAGKSSLLNTILGYNLSIVTPVAQTTRNQITGVYTEGNLQIIFID
TPGIHKPKSLFGEHLNKEAFDTFSSVDLVLFLSPADEEVLKGDLFILEKL
KNVKNKVAVITKLDKVNSRPQLLKDKVNSLMEHDFKEIVATSIENEESID
SLVQLIEKYSYPGDFQYAEDDVTDKSVLFITKEIIRECAINNLSDELPHS
IYVEIENFEEDENFLLVEGIIYVTKDSQKGMLIGKNASMIKKIGQLARNK
ISSQFEKRVNLFLKVKVSKNWQKDPKILKKIGY
>MS53_0354 fba, fructose-bisphosphate aldolase
MPLTNAKEMLIKAKEGRYAVPHININNLEWAKAVLLAAQEVNSPLILATS
EGAVKYMGGFKTVANMVKGLVNDLNISIPVALHLDHGSYEGVKKALETDG
YSSVMFDGSHYKFAENYEKTKELLELAKTANCSFEAEVGTIGGEEDGIIG
SGELADAGEAKKMAELGIDVLAAGIGNVHGPYPENWKSLDFDKLKEIVSS
AKIGIVLHGGSGIPQKQIQKAISLGVTKINVNTELQQANHKALREFILSN
KDLEGKNFDPRKLYKPGFDAMQKTVKEKIHEFGSQNKA
>MS53_0021 ffh, signal recognition particle
MFNILEKRFQKAIEKYSKKTLLKEEDILEITREIKLALLEADVNLKVVKE
FISKVKEKALSSEIIGKLNPSQQMTKIFHDELVSILGGKIKEIKLDKKPT
VIMMCGLQGSGKTTTAAKLAFYLRKKKMAASPLLVAADIYRPAAIDQLVS
LAKSAQMDYFQMGINTPAEDIVKAALEQARDNKNDLIIIDTAGRLSIDEK
LMQELWNIKQIASPEEILFVADALSGQDIINVASAFHDKLKLSGSIITKL
DSDARGGAALSIRFILNLPIKFIGTGEKISNIDLFYPDRMADRILGMGDV
LSLIEKAQDVIDEDKAKNMMERMFSGNLNLDDFMEQIAQINKLGKFSKLL
KFMPGNLTNKISEDKIDSAEKKLKTYQILLSSMTIKERKNPKLLKQASRK
ERVIKGSGRSVQEFNRLLNDFDEMAKKMNEMSKKIKSGNLSGLSGMGMGG
LGGMF
>MS53_0524 fmt, methionyl-tRNA formyltransferase
MAGTPEFSVPIFKEIIKNFEVVAIVTQPDKPAKRGQNLQESPVKKLALKY
NLKLFQPEKISMIYEELKELDFDYMLTAAFGQYIPENILNLPKKFPLNIH
GSLLPKYRGAAPIQHALLNNETETGVQLIIMTKKMDAGDILKEAKIKIEE
SDISLTLFEKLSNLAAENIVSWIHDLDQNNYQRIIQDESKVTLASKLLKE
DSFLDKTKTKKENIAKIKAFALNPGARYINENNKLVKVYFATENKIKNAP
VFTCVDGDIFLNDYQIESKKRVTLK
>MS53_0397 folA, dihydrofolate reductase
MIKLIVALDPNNLIGKGDQMPWKIAEEFKHFKTTTLTHSLLFGRNTFLGL
PAKLENRTIYVLSKERVPRADYTLKTEQELFSLFAQFKNDDFNTLFIAGG
KTIYEKYYKFADELIISRVKKAYEGDVYLNLDLSHYSLTKVVDYSEFAVE
YYTKK
>MS53_0297 folD, methylenetetrahydrofolate dehydrogenase / methenyltetrahydrofolate cyclohydrolase
MKILSGREKAEQDLKQLKKELDELNLNRPIKLAIIQVGDKMESNRYVEQK
LKKAKEIGIEAKCFKFDENITQKRLLLAMDEINENWDGILIQLPLPKHLP
KEVILDAVPYEKDIDGLSHRNEFILYNEKNSDDKFFVPAAARAVLELIEH
HEINYKKKKVAVVGRSHLVGKPVAHILKRRGASVSTFDENTPIKLVASAD
IVIVAIGVPKYIKAENIKQGAIIIDVGTNYDQNDPSVIFGDVDHESVKTK
ASAITPVPGGVGPLTVVCLLKNLVEIYK
>MS53_0448 fpg, foramidopyrimidine DNA gycosylase
MPEYPEVTVVCQSLSKLLLGKKINNCELLSEKFAKNSSVKDFEEFFNNKT
FKKINNTGKFIEFIFDDKSRAIVHLRMEGKFFIRKTSDLEKYRFKHDHIY
FHLGNDETLAYNDSRGFGSFETISKENKLSVKEIKNLANLPKDVDIDYLY
KKLQNTTRSIKTILLDQKLVLGIGNIYADETLFASKIFPMEKAKNLSKAQ
LKTLMDNAQRIMDESIKLGGSTVHSYQSVNGIDGKFQQRLKVYGRAKLNC
LECGSFVKKVKLDFKQNGRGTSYCPNCQNEK
>MS53_0678 frr, ribosome releasing factor
MELEKYLDDFNKKTQKSIDHFVFEMSKISTGKANPQIVKKIKVMYYDNPT
ELDEIATIMVPEPQQLLIKPFDATSTKDIVKAILSANLGNFPMTDEGNQI
RITFPPMTSDRRKELVKSLSKFIEQAKVGVRNARQEIIKAIKSDAELSED
MQKNYVEKIELEVKKKIERISTLAKEKENDLNAF
>MS53_0614 ftsH, cell division protein FtsH
MEDRKMKQNIKRNWIWILIVMIVIGIILYFSIRNLFSTKVAEWSISELLN
NIERAKENTTDALYFKEITVNPFTNSITGVFNNTDNTSTSFVTYTNLDLL
RLSGVASDQGVISKIFTPEVFLTANNVSGSLKSVATPQPNPFLGILISSV
PVLILIFVMVWIYRSQVKMMNGQGGAFGGDKGTAQIIKSDKKFTDIAGNK
EPIEEISEVVDYLKNPGKYQQSGARMPHGILLGGPPGTGKTLLAKATAGE
ANVPFYFVSASSFVELFVGMGAKRVRQVISEARKNSPAIIFIDELDAIGR
TRGSGIGGGHDEREQTLNQLLVEMDGMKENSGLLFIAATNRTDVLDPALI
RPGRFDRIITVGLPDVKEREEILKLHAKGKRFESNVDFANIAKRTPGFSG
AQLENVINEAVLLSIREDTKVINLYQIDEAIDRVMSGPAKKSRTITKEEL
TMVAYHEAGHAVVGIKVPGGNKVQKITIIPRGNAGGYNLMMPENEKYNYS
KADLYATIASFMGGRAAEEIIYGDNKISTGAADDIKKATSIARRMVTQFG
MSDLGPIEYQSDEGSPFLGKALASNSSLSNQVNHEIELEIRKIIFTAKEQ
ATKIIKQNIELLELIKESLLKKETIVGEEIEYIAKHMKLPPEKIEEKDLS
KNSEDNNLDSLIEKTSKKE
>MS53_0145 ftsY, cell division protein FtsY
MAFFKKIINKLFHSNKENEIDEKKKKLKEKHLNLVLKSEKFQKYEKGLSQ
ASDFGKQLLELQNKHLELDEEYFENLEEILIMSDINVSLVDVIIEQIKKE
IRINKITDIKLIGEIIADKIFEIYTNNSIIDTSLDYKNNQTNVFFIVGVN
GSGKTTSIAKLANYYKSLDKKILIAAADTFRAGAVEQLRIWSEKIGCDIV
MPKKANADPSSVIYEAAKKAKDEAYDLLIIDTAGRLQNKVNLMNELKKMY
EVLKRFLPEAPNESLLVLDATNGQSGIMQAKVFKEVVNLSGIILTKMDGT
SKGGIVLSIKDELDLNVKLVGLGEKLDDLQEFDLELFIYQMTKSLLQENV
>MS53_0340 ftsZ, cell division protein
MYDNEAANVSKIKLCVIGVGGGGNNAVKMIQAAGFSNVNFIIANTDDQAL
SLNPCENKISLGKDTRGLGAGSDPEIGEKSARESVDEIEEALKGADVVLV
TAGLGGGTGTGAAPVIAEAAKKMGALTIGIVTTPFSYEGPKRKRIAKNGI
QELSKVVDSYIVLSNDKLAENFGDLPIEDSFQLANITLKNIILAFHDILY
RIGTINIDYADVVKILGGSGLAVVGIGQATGKDRATKAVEKAFEQNLYEY
PIKSANKILVNIQHDKKATLHEINTAIKKVHEILSQNRSDDQEEYDCIIG
QEAVETKDNAEVFKVSVIAGEAIIYTEEEVRRNPSLLNMDTSREAAKSFI
GDSIDRDKIVEAQDFPENEDFDKDFSQSFEEESPVRNSSAEAQAFHQNKD
EFDMWLMSSTQEVALEESQEEIRETFSKPEEFYQDYSQESFDNSQELVGD
DSGEFEAFQTEEVKTEDSGKYSFSSDSQDQSQTQTSTQESNFTWDLDESL
QEKTSTNEFPFGRKTHEASASTKEDEAEEFQEEDEEDKYSWF
>MS53_0047 fusA, elongation factor EF-G
MARDYDLKDYRNIGIMAHIDAGKTTTTERILYHTGKIHKIGETHDGVSQM
DWMEQEKERGITITSAATTAYWKNKRINIIDTPGHVDFTVEVERSLRVLD
GAVAVLDAQSGVEPQTETVWRQATNYKVPRIVYVNKMDKAGADFEAAVAS
VKSRLGGNAVAIQWPIGSESNFNGIIDLVTMTATTYNGESAEEEFPMEIP
TDLLDVAKAKRQELLEAAANFDEEVMMMVLEGADVDIDTFKNTIRKATLT
SEFFPVVCGTSFKNKGVKKMIDAVVDYLPSPLDIPPIKAYLNDQETDVVA
TDDGEFAALAFKVMTDPFVGSLTFFRVYRGVLEKGSYVYNSTKEQKERIG
RILQMHANNRVEIDECRAGDIAAAVGLKFTTTGDTLVGEKSPKVVLEKMV
FPEPVISQALEPESKAANEKLSLGLQKLSAEDPTFRTYTDEETGQTIISG
MGELHLDIIVDRLKREFGVKVKVGAPQVSYRETITKSAEVEGKHIKQSGG
KGQYGHVWLKFEPNHDQGFEFIDKIVGGKIPKEYIKPIQKGLEEKMAVGI
LAGYPMIDVKATLFDGSYHDVDSSELAYKIAASKALTKAKDLIGTVLLEP
IMDVSVVVPSDHMGDVIGDLSRRRGLISDQEQRNDGAVIVRAKVPLSEMF
GYSTELRSMTSGRGTYQMQFDHYEKCPKNISDEIIKKRNIQNKDEE
>MS53_0200 gap, glyceraldehyde-3-P dehydrogenase
MKKKIAINGFGRIGRLVLRRMLETSLTDKVEVVAVNDLTDAKTLAHLLKY
DTAFKKLQFSVEEKDSSLWVNGKEIKVFAEKDPSNLPWKDLGVDLVVEST
GFFTKKDLASKHLEAGAKKVLISAPAGSDLPTVVYNVNHKTLKSSDTVIS
AASCTTNCLAPVVKVLVEEFGLKSGYMTTVHSYTADQKLQDAPHKDLRRA
RAAAENIVPTSTGAAKAIGLVVPQASNVLDGIAIRVPTLTGSLVDLSVRL
EKSPSVEELNAAFKKAANESFKFETDEIVSSDIVNSHYGSVFDSKLTNFV
ESKDGRLYKLFAWYDNEMSYVSQLVRVLEYFVSL
>MS53_0270 gapA, glyceraldehyde 3-phosphate dehydrogenase
MKKKIAINGFGRIGRLVLRRMLETSLTDKVEVVAVNDLTDAKTLAHLLKY
DTAFKKLQFSVEEKDSSLWVNGKEIKVFAEKDPSNLPWKDLGVDLVVEST
GFFTKKDLASKHLEAGAKKVLISAPAGSDLPTVVYNVNHKTLKSSDTVIS
AASCTTNCLAPVVKVLVEEFGLKSGYMTTVHSYTADQKLQDAPHKDLRRA
RAAAENIVPTSTGAAKAIGLVVPQASNVLDGIAIRVPTLTGSLVDLSVRL
EKSPSVEELNAAFKKAANESFKFETDEIVSSDIVNSHYGSVFDSKLTNFV
ESKDGRLYKLFAWYDNEMSYVSQLVRVLEYFVSL
>MS53_0092 gatA, glutamyl-tRNA amidotransferase subunit A
MTKLKVKGNFNLALSELKSDKNNVVSYLYKDLPTFDGPLKDCVFTIKDVF
ATNDAPTQASSKILENFQPSYNAYPVELLINAGAKKVAKVHSDELALGGT
GLHSAYGIVKNPKDKSKQSGGSSSGSVASFSKNISFALGSDTGDSVRLPA
SFNGVVGFKPSYGAISRYGMFAYASSLDTVAYFTHNVHDAYELAKVLYQV
DKRDFTNVEVKLSENNKAKKPKSVLALDVSKYCEKYVADSYTKLLDELKK
QNVDIKLVEPNLDVLRSVRATYKIISFSEASSNLANLTGVAFGNREKGSS
WEEVMTNTRSKHLGKMVQERLVLGSYFLFDDNQKDLFLKAQKARRVIKNY
WESLINSYDVVIFPTFASVASDIKNPKSYDFMDYILTTSNLTGNPSLSIP
LGKHQNLDFNLSLDGKVYGDEALLQYGQFFEKLIRGIND
>MS53_0091 gatB, glutamyl-tRNA amidotransferase subunit B
MINFETVIGIEIHIELKTKTKMFSPVEINFNAESNTKANQIDLGYPGTLP
QVNKKAVKYAIMLAKALNMQIDSNLRFDRKHYFYPDLPKGYQITQFYHPI
GREGQIKLNNNGKEFEVNIERIHLEEDTARQHHKDNYSQLDYNRAGIPLI
EIVTHPVLRSSDEACLYVDAIRKVVQTLEISEGRLEIGSLRADINISIRP
LGSKSFSNKVEIKNLNSLKNIKLAIEEEIALQRAKFFANEEVLQQTKKID
EKTLKLQVLRTKTSTIDYRYFPEPNIPFIKLSKKFISSVKLKELPWEKEA
RYKSYNLNSIYLNSLLDDIHLANYFDSISYPDKDKLSKIFFAEVVSLANS
KEMKAYHLNIDPENITKAINLLDEEVISGKSLKKLIPLLVNFKSDIKKLV
KQNSLEQISDPNLISNIIKEIIKTNSELVKEYPTRQEKVLKFVLGKLMKD
TGGQVNPTVANEIAIKSLDEVFK
>MS53_0093 gatC, Asp-tRNAAsn/Glu-tRNAGln amidotransferase C subunit
MKKFSKKKFLEIAKVIMLEPNDELIEKIKIQWDDLLQDLKSLDKLDLKNA
EPLTHNNETYYEDFLREDEVVNFDDITKDNILKNAKEKDENYITFVKVVK
>MS53_0015 gcp, O-sialoglycoprotein endopeptidase
MWSISQIDIFKKYGGTIPEIASREHVKNIAILQNFLQEFIDLNKIDHIAY
TSEPGLIGCLQVGFLFASALSIALNKPLIKINHLDGHFFSGAIDNKEIKY
PALGLIVSGGHSQIIYAKNKFDFQIVGETLDDAIGECYDKVSSRLNLGFP
GGPIIDKIHASYKGKYLKLTKPKTSGEFDFSFSGIKTQVLNAFNNKKYES
IEQIAASFQEVAINYLIEKFKLAIDKFKPESILLGGGVSANKYLREKFKD
LHKNTIFPEIKYATDNGAMIAMCAYLRMKKNS
>MS53_0515 gidA, glucose inhibited division protein A
MNNNFDAIVIGAGHAGVEAAFALAKSNNKVALITFDLSKITMMPCNPSIG
GPAKGIITREIDALGGIQGYYSDLAMIQIKMLNDSKGPAVRAIRAQIDKE
KYSKLIREDLQKNSNITLIEAGVYEIKADKKVFKSVVLSTGEEIFAKVCV
LTTGTYMNSQILRGSSVTVSGPDGQKTTNKISESLKKLGFELQRFKTGTP
ARIYKSSIDFSKVEKEILDTNDLNFSNRSNKKLNQQVSCYLTYTNEKTHE
IILNNLDKSSMYSGLIKGTGPRYCPSIEDKVVRFSDRNRHQVFFEPETLD
ETIIYLNGLSTSMPEDIQMQFLKTIPGLENLKIQKYGYAIEYDALNSLDL
KHSLETKVIKNFFAAGQINGTSGYEEAAAQGLIAGINAALKLKNKKPLVL
KRSDAYIGVLIDDLVIKGTKEPYRMLTSRAEYRLLLRHDNSDYRLSKYGY
KLGLISKDEYSQIQKKYKNINSKINYLSKKYLSTNSNIAKKYNIKEATSY
LKLLLRPEINPKDILKNYKYQNELLIKIKLEGYIKKQKQDASRMKNLEKI
KIPNNINYDKVLNLASEAKDKLKIIKPETIAQAYRISGINPSDIQMLIFH
LKTYKKYDN
>MS53_0151 gidB, glucose inhibited division protein B
MDFEKYVSLIEEHNKNINLTGFSGESLWEEGILNSLLYMNSSTKDKSEIK
ILDIGSGVGFPAIPYALLRENNSIDIFEPIQKRVDFLNLVKQKLTLDKVN
IYKQRAEEFSQKNIYDVVVARAVGSVKTMLMAAFHLVALKGEMVLIKGPK
YKQEILEAQEILSKLKVEVIVDKFILNAKENFLVRIKKLRNCPKEFPYSW
KDIKKQS
>MS53_0023 glpQ, glycerophosphoryl diester phosphodiesterase
MNMENKYILGHRGYFDKAPENTKLAFDLALKHNFDGVELDIHLTKNNKIV
IIHDESILRTTGVDLEVYKNNYEDLKDYNYAFYFKNKVEKQSLMLLEDFL
DLYFDKFKIINIEIKTDKIHYLNIEKLLYVLVSEYLNFENKIVFSSFNFQ
SLILLKKINPNLKLGYLFDSMESLLRMEKDLILNTCNFLHPSWKLYLKNK
KELISYNLPLNLWTIRCFDKLKMFYKDSDINFLISNKKLPNSK
>MS53_0100 gltX, glutamyl-tRNA synthetase
MNKIRTRYAPSPTGFLHIGGARTALFCYLFAKHFNGDFIFRLEDTDVKRN
VEGGEASQLENLAWLGIIPDESPLKPNLKYGKYRQSEKLDRYKEVLDMLL
EKNLAYKAYDLPEELEAQKLESEQKGFASFRYDPSWLKISDEEKAKRDLN
NQFSYRIRMPKDKVFSWNDLVRGEISFSSNEISDWVIFKSDNYPTYNFAV
VVDDHDMQISHVLRGEEHIGNTPKQLALYDYLNWSSPQYGHLTIITDMGG
KKLSKRDLSLKQFIEDYKNEGYIPHAIFNFLALLGWTSEDAKEVMSKKEL
ISKFNPARLSKSPSKFDVNKMSWFSKIYMKNQSNEEVQSHLDFKDFNSNS
SWKEIFTSTFKESATTYLELQKALNNYLNPMSSELVLNEEELKVVKEFKA
NLKSFTVEEIQAAINLTASNLKLKGKALFMPIRKACTYLEHGPELAKAIY
LFGEKLITERLAKYEN
>MS53_0305 glyA, Serine hydroxymethyltransferase
MYKNLKLNDKYVQKAINSEFKRQRNFIELIASENYVSDDVLKAQGSVLTN
KYGEGYPYRRYYGSCENVDMVEQVAIDRLKEIFKVNYANVQPYSGSVANA
AAIASVVPNGGKIMGLSLKSGGHLTHGYKISFSGIFYNSITYEVGKNGKL
DYEEIKKIALAEKPDLIICGYSAYPRLIDFKKFREIADLCGAKLMADVAH
IAGLIAGGVHPSPVGYAHVITSTTHKTFRGARGGVIMTNDEEIAKKVDRW
VFPGYQGGPLFHAIAGKAIAFYEALQPSFKTYAENIVKNAKVFSEAFIKK
GVEVVSGGTDNHLLLINVKSSYNITGKEAENFLEKINITINKNSIPFDEL
PPLVTSGIRLGTAAMTSRNFTKWEELAEIIDYSLRNLEFLNSKSKAARDK
VKELKNRVLSFNKEFPILKKY
>MS53_0452 glyS, glycyl-tRNA synthetase
MNQNKMLELINHLKNAGFVFQGSEIYGGVANTWDYGPLGVLLKDNILNYW
KKFFVFSQNNIYMLDSKILLNSKVWEASGHVGNFNDPLIENKINNKRYRA
DKVIEELFPNENVAKMTHEQMQEFLQKNVTSYDNSKCAWSEIKKFNLMFE
TFQGVVDDKKKAIYLRPETAQGIFINFKNIQRAMRAKLPFGVAQVGKSFR
NEVTPGNFIFRTREFEQMELEFFFDEETPNSYFDELVNKSYDFMLKLGLS
KNNLKVRKHDQEELAHYSKATVDLEYNFPFGWGELMGIAHRGNFDLSTHS
KFSNEKLEYLDPNTNKKLIPSVIEPSVGLDRLMLAILCEAYSEEKVSESD
TRLVLKLDKKLSPYKVAILPLIKKFNPKANEIYSYLIDKNISVTFDESAS
IGKRYRRQDAIGTYYCLTVDEQSLEDNTVTLRDRDSMQQERINFKDILKF
L
>MS53_0123 gmk, guanylate kinase
MNKKKKSIVIFTGPSGVGKGTVEQLVFNYDELNLSLSCSATTRSPRGGET
NGIHYYFISKEEFKDRIKNKKFLEHSFHFDNYYGTLYSELDNIIARNKVP
FLEIETNGAKIIAQKMQKLKNPPYNLITIFLSPPSITDIYKRIKNRGTEN
AQTIKNRVNKAKEELLEAGNFKYVVYNDRPERAAQEIREILHKELDID
>MS53_0654 gpsA, glycerol-3-phosphate dehydrogenase
MTIIGSGAMASACGKVLFNNNHEVIIYGVNQQELKELSMGMNLKFFSKQT
KIPKFNTTSDLKLALDKTDYVLLAVPSKFMNQVYNQIITNLNSDVILINV
AKGFYPGTTLPLHSALEKMTEDNPKIKGVVSLIGPSHAEEIIKDCITLVC
SVSRDLELAQNVQSLFSNSYFRVYSQTDVIGAQIGSIFKNILAIANGILD
AKNYGINTKAALISRGIGEMKKYTLYSGGKLETLLGLTGIGDLIVTAFSR
YSRNFNFGYDFGKNGIKAFETSMTVEGLTALKDIYENVVSKKVIELPIIE
ALYNVVYKNRNFDKMLSKLLTRELKSE
>MS53_0379 greA, transcription elongation factor GreA
MEQEKIFLSQETLDKYKKEYEKLVKVDRVEIQNALKEARAQGDLSENAEY
DVARDKQAVVEARILELEGILDKAQLIKHKDENTISIGSKVTFLDLSTNK
EDEVTIMGIHDADPFNKKISNYSPLATAMMSKKEGDTVEVEGLEKYEIKI
ISVHNRD
>MS53_0352 grpE, heat shock protein GrpE
MLKRHKFNLKNGDVVTSSLKCYASDNLLEKYSKDIKLEIGKDEFLKGFDN
LLINHLKKFGLKKDFYILVKPNGANLEDDSLQNQSLKFEFSNFKVESKDK
QPEEAKKTCKNEEKLKELTEKIAKLEQNLAMEQYKNITEQMTFKNKVKEL
EASLSEKLQSALEEKTKHLESQFEDNKKFVLQKFLDALMDPFNNFVMATN
AGKNSDNEIVKNYCYGFDIVKKQFIDALERNSANIINPELNSKFDANWMQ
IIDTQEDASKEDETILRVARLGISLNNRLITPAQVVVVKNKK
>MS53_0317 gyrA, DNA gyrase subunit A
MIDNNKENSEYILDEDEFEEDQPELVFKQEIKKDEEEDDTEIPPQEEESY
RAQSKLIDEPTEGLTPVAIHDEVETSFLDYAMSVLVSRAIPDARDGLKPV
HRRILYDMSELGMTPGTQYKKSARIVGDVLGKYHPHGDSSVYNAMVRLAQ
DFSMRYPLVDGHGNFGSIDGDEPASMRYTEARMAKISTELLEGIKKNTVD
FVDNYDSTEKEPAVLPSRFPNLLVSGSIGIAVGMATSIPPHNLKETIDAV
IAYARNKDITVEELLQYIKGPDFPTGGVILGTKGILEAYKTGRGQIPLRS
EYEIVQLKNEKFRIIITKIPYNIRKSAIVESISKLDKENAVEGISDLRDE
SNRDGIRIVIDIKKGFNPEVVLNKLFKKSSLLTKFSVNMVALVNTQPKLL
TLKDVLDVYLEHQKEVLTRELNFDLKKAQDSIHILEGLLVATNNIDDVVA
LIKSSSSDEVASKKLIEKYSLSEEQAKAILNMRLGRLTGLSYSKMTNEIE
ELRKEIQRITSILDSEQELVNNVIADLEKIKEKYGDSRKTSIDASASSSI
NEEQLIPRKDIVITATVDGFVKRVNLEEYNLQNRGGMGSTGMKTWSGDAI
LSIIQTNTHVDLFLFSNLGKVYKLRAYKIQEADKKSKGNSFANLVELNKE
LNEKIIRILPVDSYESNLHLLTVTKKGIVKKTALDNFKKVRSNGIKAFKL
KDEEDELKDVILVTNSDLVLVANNHKNVVKFEASKIRSQARNSIGVQGMK
LDGKYEVQSISSSKEGEFVLTIGEFGFGKLTDHKEYSLTNRNAKGKTSIN
PAKAGNLVFAKFVNPTDELLIITAQGNTIRTQLDQVSVFSRNSKGVRIIK
LNEGDKIISVEVIKN
>MS53_0684 gyrB, DNA gyrase subunit B
MEDKNKVQNNAEYNADSIEVLEGLEAVRMRPGMYIGSKDKTGLHHLIWEI
VDNSVDEVLAGYADNIKITITKDGGVSVEDNGRGIPVDMHSKGKSALEIV
FTGLHAGGKFKSDAYKVSGGLHGVGASVVNGLSSYLGVWVKRNGNVYFAE
FKDGGKLEAPIKVIETTGDNKTGTKVLFYPDFTIMDKNEFDKNLIVDRIR
QTAYLNKNLRISLSDERDNSFVEFCYPNGILDFLTVITKSKNTLQNDELI
YTEGIYQDKTGDVKVEIAMRYMASAAKSNAVAYAYTNNIYNKEGGTHLNG
FFNGLTRIWNNYAQDKKFFKTQGEKFSREDLENNLFLIISIKHNNPEFEG
QTKHKLNSRNASPAVNKVFSEVFEKTLDQNPKFAEEVIKYLLDFKARRLK
DEKEKELQKKKGLGNSSLPGKLSDCSSKNAEESELYIVEGNSAGGSAKMG
RDRHFQAILPLKGKILNVEKKDIEKILKNDEILSLIAALGAGVGQDFNVN
KVRYQKVIIMTDADSDGSHIRVLLITFFFKLFRQLIEYGMLYIAQPPLYK
IESNKKVYYAYNEAQKEEILDSLDKSKKIMIQRYKGLGEMNADQLWETTM
DPKTRKMLQVQVSDAEKAMEVLNILMGEETEPRKEFIFENAKKVRDIDWI
>MS53_0182 hemK, Protoporphirogen oxidase HemK
MINELKREKRKYGLSENLTQKELNLLSKNYPIQKIIGHVEMLNVKIDLSY
KVLIPRYETEEVILKAFEYIKNDSSFKVLDLATGSGFIALAIKKKFSSAK
IYASDISKIALRQASKNAQINKLDIGLIHSNWFSNVNQKFNLIICNPPYI
GKYEELSESIKKYEPKKALYAKDDGFYFYKKIISQAPKYLQNEKLLIFEL
SALHLDKWNEIKNQKVKYNINSITFFNDIANLLRIAIIKFN
>MS53_0488 himA, bacterial nucleoid DNA-binding protein
MTKTEFIKAVSDKTGLTVGELNRVFDGFVYVLQEQLVAGEKVQLSNLGIF
DVATRAERTIKNHFTGKEQVVAAKKVVKYKPSKYLTDVVNE
>MS53_0437 hisS, histidyl-tRNA synthetase
MKYQRVKGTQDYGVEKAFLKDAVESLFLKEVRLHGFEYVELPTLEHAQLF
RSTVAQSDIGNKEMYEFLDKSQRELCLRPEMTANFVRAFVQNKWHAASAE
NKYAYVGKVFRYERPQKGRYREFTQAGVEFVGKADFFKDLYVITLVLRLL
AKLHIKYTLKLNYISNKETRKKYEETLHKYLLEYKDQLSESSQKRLETGN
VFRVLDDKEDSQKDFVKNAPKLSDFYSEEDKEYVKNIKRGLDTYHGLEYQ
FDEQVVRGLDYYDDLVFEVSIKDSKAAQDVIIGGGRYSNLIKDLEGPETS
SIGFAMGVDRVVDYLMDQEVYKEHLDKLETAHSENEYYFWAHPEASYKLN
FFVWFFNLQLNEHISSSLLFDYDSPNRNKAFEKAKKLNSKAFVTLEEDNS
LTVYDFKYGTKKDADLKEQYHHLDFTSLLDSRHFDNLFDSNLFKPSPKEL
MCMCSAFRNRFGDSKALLKFAKQFHYSEDDVYFSDQKIKKSKWKSAKS
>MS53_0173 hit, HIT-like protein
MEKSVFKKIIDRELPAEIIYEDDLVIAIMDAFPVSEGHFLVIPKSEKPNM
LTHNEEEMTYAFKVAYKLAKERLWDKGIKDFRLMINTGLKGKQTVFHTHI
HIVPYK
>MS53_0424 hlyC, hemolysin C
MGIGIKITIFIIIFILFLLSSIFSGSETAYSTIPATQIQELNDKKTRFGN
LIKKQLLRYNQILSTVLIANNLVNVASSVLTSFIIGSFFANDDDPLVLII
STLVVTPILVIFGEILPKLFAKKKPKLFLLLFSPFIEVLYYFFFVLTYPI
RKFSKQSDHTHSEDDIKKILELANSEGILDTKEKILAQKALDLNSTKINK
HYIRLKNVVYLDSSLSVNKALETFKETNYSRMPVKKDKNFIGIVLLKDLI
FSQNKSLLSLVKMVPSISIHSSLAKGLEIMKQNQIQMLFVTQNNSSNQVI
GIITLEDILEEVVGEIYDEYDQEEIKEIHEISWEKSLVKASTLMDAIFKQ
LELNLELLSDEEKEMSLYDFIVSKSEDNSFKTNLKIYLDNKKISFKVLKL
NQKNKVKTLVEIEKL
>MS53_0381 hpt, hypoxanthine-guaninephosphoribosyltransferases
MKKVLYSQEFIEEKIKACADFINQKYKDSKDLLVVGLLKGSVPFLASLIK
KLEVDFAIDFMTLSSYAGKSANTGNLKVIMDLDTDIKNRDVLIVEDIIDS
GVTLAKVEKMLKERNPKSLSIVTLMDKPHNREVNIKVDYACFLVENYFLV
GFGLDYKEKLRNLPYIGIMDEKFIDSNE
>MS53_0353 hrcA, heat-inducible transcription repressor
MKQLKKQHEEILKAVVGAYLTQKNEISSALLVKNYGIKFSPAKVRYLMTA
LEDEGLLVKETKSSGRKPTNKGLEYYAKFLSNAFDLKLINNLEKIFLNRK
DNIYNTIEEVTKELASLTGATFVTKFKDPNLILKSINLFEVSESLATIIL
VVSNGEVLSRKIDIPENKAIKISDLKIAMNIFQDNLIDCKLIDLEKRILL
LKDILAEKIIQYEDVIESYVKSILGIGIKSQIYGRENIILSRKIAREDVN
EILNILEKNSIWDALEKNSNDFEEIRISINSKGAFFSKRIDENNNLTEIS
VVAPNESDSNSIKSGIMLLTKIITNNINEKEKDKNERKHS
>MS53_0558 ileS, Ile-tRNA synthetase
MDFKKTLNMPSTKFDMKANLVEKEPLFRKKWLEDDIYQKVLKNNANNERF
VVHDGPPYANGDIHVGHALNKILKDIIVRYKSLQGYYSPFVPGWDTHGLP
IEHKMLTESKLDRDQITVELLRKKSRNYALKQIEHQKKQFQKLQLFSDFS
KIYITLDKSYEAKQLKVFKKLALDGLVYKGLKPIYWSPSSQSALAEAEVE
YETVTTNSIYVSFDVTKSTFNKVPVGSKLVVWTTTPWTLIANAAVAISFD
ITYLTVKYQDSLYVVAKNLFYNDLLEKFQWENYEVVDEFLGKEMPRNSIW
YKAPLLDFDAPVIATNYVLEDSGTGLVHSAPLFGEDDFSLTFDNDLKLIM
HISDTGHIENSQTKYDSLFYEEANKEIIKDLAEKVVHVYTYSHSYPHDWR
TKKPIIYRATPQWFVSIDKVRSKIVSELQNKVKTFPEWSKNRMISMIENR
GDWTISRQRTWGVPIIIFYDENEKPVINEEIFDHVIDLVANHGTDIWFSS
TVDELLPEKYRNRNWTKENDIMDVWFDSGVSSIAVDIDGGKTTLPFDVYL
EGNDQFRGWFNSSVINAVAYAGVSPYINLVSHGFALDGQGKKMSKSRNNV
VDPLDVIKKYGADILRLWVANSEYSSDVHISESILVQNSEIYRKIRNTVK
FLLGNLNNFKYDKDLKLTSIHHYINEELKSVKKEVLENYDKFRFINVIKV
LNRYVIDLSSFYFSVTKDILYIRKENDEERQMVLKNFYEILDFLMLALAP
IIPTTADEMYSYFNKENKKESLFLERLEKAGDVSFDEKVLEQFKEFFELR
DQVNILIENQIQNKVIKRSNELELVLPETASEFLKSLDLKTLLMVSKISY
GKTLQVVKFESEKCKRCWNHFASLNKEYEICDLCFSVLKDTLANA
>MS53_0578 infA, translation initiation factor IF-1
MAKDAIKLRAKVLEAYSMDDYLVELENKQQIKAKISGKMRVNRIRILPGD
LVDVELSSYDLTKGRITYRHK
>MS53_0686 infB, putative translation initiation factor IF-2
MSKKKTNRKNNIDDIKNQLQNAKTELKNGTFFFTGKMSIFEFANKTNLNA
NEIVKNFFLAGKLYNINHILEEEEIAQLCIENNFEFSKETKIDGTNFLDE
ISFEDKPEDLIKRAPIITIMGHVDHGKTSLIDKIRNSNITKSESSGITQH
TGAYQIVHKNQKITFIDTPGHEAFSAMRARGANVTDIVVLVVAADDGVMP
QTVEAIKHCKNANVPIIVFVNKMDKPNKDLDKLKGQLAENGVVIEEYGGS
VQTAYGSALKNEGIKELFDEILLLCEVLDLKANPKRFPIGTVIESRVDKR
IGALTTIIVQNGTLYKGDFLLVGSQYSKIRTLSDENGNAMDSIEPGCPAV
VTGFKIPPTAGSKFVGINDEKFAKRLASEKNYQEKINNLYSLSNSNNNSG
GKKVINVIIKSDTNGTAEAIKNQLEYLENDEAKIKVISSNVGDITENDLM
LAKASDSIIFTFNLKVLPTIRENLKVKKITLISHNVIYKIIEDCKLILDE
HVTPIYEEKKIGQAHVIKIFTYSKLGTIAGSMQDTGVVRLGAKVKVYRKN
KLIHEGFVQTLKRNLNEVKEVEKGKDFGTHLKDFNNIEVDDVLEFYEDVR
VN
>MS53_0606 infC, translation initiation factor IF-3
MQHNSKKPQPKHILNANIPYREVFVISEEGEKLGLYEKDKILQIAKEQGK
DLVLIATDPTPVVRILDYGKFKYISKKNQKEKKEKQSNVQNKEIRLTPFI
GKADLETKSKKAREYLLKGDRIKVSLKLRGREIARKELGFETLDKFYQTL
VDICDSSLDVKNPSERFLNINLLPNKQKIAKYLKDLKEKDKDKDLQNKDK
>MS53_0364 ksgA, dimethyladenosine transferase
MNHLDKNAKKSLGQNFLRDKNIINKIVNVFNIENEKVLEIGPGQGDLTKE
LLKKAKKVLAFEIDKSLIEHLKNEIKDLHFELRDQDFLNVNLNDDEFKDY
YVVANIPYYITSDILLKIYRSFWNFKGIVLMVQKEVAQRIVAQKNSKNYS
KLSISSQYLADVKIEFIVNKNSFIPAPKVDSAVISLKFKDNIDKENLEKM
LKFFLVCFANRRKKLTFTLNRNFNSTKVKLAYEKLNLSDNARIQELDVSQ
IVLLFTYLN
>MS53_0518 ktrA, putative potassium uptake protein KtrA
MKKNNSQSNAICVIGAGRFGSAVITQLIEIGKEVVAVDKSADNLKQFKDE
IDEVVILDAADIKALKAINIQRFETVVVAVANIDNIEIVSALLELKVANI
IARASTKRHARVLRQMGANIIVNPEQESGTRTAVIAANENFALYSEFLHE
LVDDFVIGFSDVKNSTIFDKPIKDLNFPAMGVTVVLVRRNGQTYQITGDF
VLKENDQVSIVGKIPSVNSVFQWLNSVN
>MS53_0519 ktrB, putative potassium uptake protein KtrB
MRLKRFRNFIKNKLYKVNNSVNRYKLSFNKTIYLFLAYFVIILIFSLILY
SPITQNETFAGQKITPLNYLDVVFTTSSAFSDTGLVIADSYNQWNIFGQA
LIATLIFSGGIGVFALKIFIINWIFRKTKITLTDMNLMQSERGGSGFRNP
TQVVITSVKFLIAVTIIFGFSLSFYFYFTDVKMTPGIKDYLGSNYISPKG
SWSLAFRFGFFHTISALNNAGFDIMSSNSIMPYYGAVELQICMIILLIIG
GIGYPVIFDIKLAIEHKIKGKKGRHRFSLFSKVTFVIYFLVFAIGTLLTF
LLETTSKDPHTYWNKIYVPDELMAEYNQYLSDSSLVPSSQLQYYLNNGQM
YGSVFQKSFGIVFINFSSRSAGFTSVVISDFSFPTVLLIGLEMIIGASPA
STGGGIRTTTFALFIMAIISMFRSRKDITLFKRQISKENTEMTFKVIALS
TILIIIGTFILSTSHSLYGGKLNNINLTGIFFNVASAFGTSGLSAGGISK
LNVASKIMLIIIMFVGQFGISSTLLVWKRKKNKESQFKYLEEELAIG
>MS53_0461 ldh, L-lactate dehydrogenase
MKKIIVIGMGNVGTTFVNIALARGLQANFVFVDKNEEICQAHVHDFQDMI
ALMPRNNSTFKVGTLLQEAKDADIVIVTASIPANKDFSDRLKLAEANSKL
MKSFGDQLKEAKFKGIVIVAANPCDVMASVFTYASNLPFKKVISTGTLLD
SARFKKFIAQKFNVNADSVQASILGEHGSSAIPLWSTVKIGDATLENLLK
SKKLKSNELNQILKQTIDEAFYIFSRKGNTQFGIGTSLYEITDAILNNKK
QVMNIGVKLPANYKNAGIYISIPVIVGKNGYEYLSVKPNFNNNELKQFEA
STSHMAKVHKDTLKLINIDMDFE
>MS53_0489 lepA, GTP-binding protein LepA
MQKNKIKTFSIIAHIDHGKSTLADRILELTNTVSKRELTNQFLDSMELEK
ERGISIKLNAVQLKYKDYIFQLIDTPGHVDFTYEVSRSLAASEGALLIVD
ATQGIQAQTLANVYLAIENKLEIIPVINKVDLPSADVDRVKQEIEDVIGI
PTNSAIEVSAKTGFGVDKLLDAIVEYVPSPLDADDLKPLKALIFDSYFDP
YRGVVLLIRIKEGKLKVGDKFMFMSRKHDESNTYHVIELGVKNPSETKKE
FLESGEVGWVSAAIRDAKEISVGDTITHIDNPAKEALPGYKKIKAVVFTG
FYPIDTKDYVQLKESLEKISLSDSSIVWEQETSKALGFGFRVGFLGLLHM
EILQERLDREYNVGIIATAPSVEYKIFKTNGEIEFVSNPTMMPDRSTIEK
IEEPYIEATVFIPNEYIGNLMELCQSKRGIYISLEALDDKRSKIVYELPL
SETILDFFDKMKSYTKGFASFEYELIGYKESDLVKVDILLNGEKVDAFSI
IAHKDKAYEHARELCIKLKDEIPRQNFEIPVQATIGGKIIARETIKAYRK
DVTAKLYGGDVTRKQKLLKKQKAGKKRMKKIGSIEVPQEAFLNILKTNTD
QKNKK
>MS53_0311 leuS, leucyl-tRNA synthetase
MYNFKEIEKKWQKYWIENNSFEPKNDFSMPKKYVLSMFPYPSGQLHMGHV
RNYTIGDAIARYYRKNNFNVLHPFGWDAFGLPAENAAIKNNIHPKKWTYE
NIETMNKVIKELGISFSWNRELATCDNDYTKWEQYIFLKFLENNLIYRKK
SLLNFCEQDNTVLANEQVIDNKCWRCDNEIQKKELETYYLKITKYANELL
ADLKLLENKWPSEVLKMQKNWIGKKKFFKTQFSFNGKTYDLYFENFSELK
SAKYLALSSKHDLVLDLIKEAKLRESDLEQINLIDKAYNNKDFSKKYLIN
LNLKANLPNQNLNLDLVVVDFLSNNSNVDSQLFNLENEKHKSYFDLFNLD
KSLANNSFDENNFTKEVKFNLKDWGISRQRYWGTPIPIVKCQKCGIVPEK
LENLPVLLPDDVVFNVSGNPLESNQKWIQTKCPNCNLDAQRETDTLDTFF
ESSWYFLRYTTPKDLRWNQIFDQAQLKYWNSVDEYIGGIEHAILHLLYAR
FFTKALVDLKLIDFKEPFSSLLTQGMVLKDGFKMSKSKGNVVAPTDMIEK
YGADATRLFILFATTPSKELEWSDLGLIGCFKFLTRLTDKVKFINKSGKF
EVHENLTKEQKLARYKLYLSLVKNKEIFEVKENEYAFNTLISWSMETLNE
YSNEEDSNLITEMFYVLTYVLEPFIPHLAWDISQKYFNLKNFKNQKIDLA
ALELNTMSIGITINGKLRGELQVQKNITKENIFLLAREKVAKWLENKEVI
KEIYIPSKLINFVIK
>MS53_0597 lgt, prolipoprotein diacylglyceryl transferase
MFKIGSYEFHLYSLMLMLGILCSILTIIFFWNRAKISSDILIVFIMITIP
TSLIGARLGFVFESLIYHPETLQVSKWYAIWNGGLSIQGGVLLAMIADVI
YAYRIRLKIDMRKVASIIIPTILIGQFVGRWGNYVNHEVYGKIDWDGHSV
LIFGKDFARNMYISDTYSASLGLQGAYRYPLFLYEALLNLAGYLLIVWVF
NLFGLFKPGVTSGMYLAWYGVVRLAMEPLRQEAFLFYSLLAIFFTLTGLV
IVVYYQFFNRVKYYKIKRKYYYDYLMVDLVKYNQWVQKTSYSALFYAVFS
FFQKNVTRKLIKK
>MS53_0282 licA, PTS system, lichenan-specific IIA component
MQKEKISVGYTNTSYKQGDLFIQEKTYNGMNHQLNLDELRNLDFVPELIS
HNHEQTVWKWIESKPLVLTDENIKKIAINFKKLHDSKCEFPKNNIAQRIK
NYLKILSEKNINIKEVNDFYNKVNLVLSNMDKSTPLHNDIYQSNLIWGKD
DKIYFVDWEYATMGDKHFDLAFFICAGHLDQRQEELLLKTYGNYSEEYLL
QHKVVIFYLIILWVNAQKVKHFDDKPYIEKMLKAEEKFQQRKAQNFS
>MS53_0567 lig, DNA ligase
MSNQQIKEKIISLNNYLKHLNHLYYDLDAPEVDDKTYDSLYNELLELEAK
YPSLVLEDSVTKIIGAFVSNKFKKTKHNKEMLSLDKAYKESEIFSFYENF
TQYKNLENFGFSLEPKIDGLSISIHYDNGKFIKAITRGDGTTGEDVSENV
FQIRDVPKQISYLKPLEVRGEIYMKKSTWKSLNEDIKNQYFQTNIEKIFS
YMQALPKSKSWSNLKIKTPIFFKNARNAAAGTLRQKDPKIVKSRNLSSLF
YEIVSPLEHNLKTQMEVLAFLKEQNFEVNEFQKLAKNDQEIMFEINEFSK
IKNNFEFDCDGFVIKFNLIDKWEQIGFTSKFPKWAIAYKYMLEEANTKIL
NIVAQVGRTGNITYIAQFMPVELNNTTVQNATLHNYEFIKKNNINIGDEI
TIIKSGEIIPKVISIYKKNTDSVFEKVLNCPSCNSLLEIPEGYVDQFCRN
ENCDEKKIQMLTFFVSKNCLNITNLSVQNIRIFYNHPVIQMREIQDIFLL
KNHVDEIKKIKFFAGKSQENKKINNILQSIEKAKDAYLRNVLAALGIKGI
GNIAANLLTNKITKLSDLNNLTDEDLLSIDTFGEKSIENLKEFLSSEKNQ
DLIKFLDENLNYLNSKKSSKLNNLNFAITGSLSISRDEFKKIILDNGGIF
SNSVSKNTSYLISNSKENSTKIKKALENNIKVITEEEFHNLLKEENA
>MS53_0382 lip3, triacylglycerol lipase
MIKYQYPYIFKNNNNFKNPVIFVHGFNSSPNCFSNFEMYWEKSNYYALAF
PGNNNLKLLSNHEASVYQYAELLVEFISNNDLKDVILIGHSMGGGTISLA
YKMRPDLIKKLIFLAPMNKTSLSLKDNYFDSYFPKTFQQYLKFIKNLYYD
PSFINDSSWLKEQEKLFNSQDYNNETITKLGKSLPNINLHNDIANAHLEI
KVPSLLVLGEKDGVIDRDLCLSYFKKQVKNIKTCWIPKTGHMMFNENFPA
FIKIVEDFILDE
>MS53_0312 lon, heat shock ATP-dependent protease
MQKKQTLNYVIVKTDEISFPFGYSEVLILEQDSIELLETTKFKFKNEDRL
VIVYAEDVYTEEVKFLQRGLYIKPLDAKEVMYQGEKALILTFKALHFFDI
QNFSYEMNQDEIMSANFLVDGNAKGTVGYEMVLSGHINNVEDVKENLMNE
FRQDQNKMNFFSIFETLVNNSNSFGISTNNQAGTAMLFKQNYGAKDEVKP
YDIEEIKALIDSKITQDNDPSEFLLNNFESLMTYFGFLDLNKFPHKWHLY
NSFDYGNFTRLINEVGNFIQTALKLEENITSEISKKLNNQQKEFMLREKR
KVIDDELAKLGKDTLQDDKDEYVKKLKNKTLKKMYPDSIKEIIRDETKRY
SEMMQASPEANLVKNYVEYLKKLPWRKVSKDRLDIKYAREVLEKYHYGIK
EVKERILEHLGVLINAQTYNKNYKNEVVSIDENYEIDLNLFKDKPSEKTV
FNNVPILALVGPPGTGKTTLAKAISEALNKKYVKISLGGVKDESEIRGHR
RTYVGAMPGKIVKGVAKAGVSNAVFLLDEIDKMASDHKGDPASAMLEVLD
PEQNAQFQDHYLEQEYDLSKIIFIATANYFQNIPEALIDRVEVIELDPYT
LNEKVQIAQKHLIPKVINEVYLDEKLFNIPEETLRFIINRYTREAGVRGL
KRILDKIARKIVIKRVLEPDLKSFDISLNNLEELLGVAPYKTDEDKHDEI
PGIATGLAYSTHGGSDLEIEVNVFKSEKGGIQLTGSLKDVMKESAQIALT
YVRSNAKYFGIHSFDFDKHTIHIHVPEGATPKDGPSAGVTFTTAIISALT
RLPVPNNYAMTGEITLQGKVLPIGGLKEKSFAAYWKKIKYVFIPHANIDN
LQKIPDEIKREITYIPVKRYDEIFQILFRDQKPENTITFN
>MS53_0060 lplA, lipoate-protein ligase A
MIIFKARSQSPYETLAFEEMLANDGELKEDVLFLYQHSNAVIIGKNQNAY
EEIKKDYIDKYDIKLARRLSGGGAVYQDLGNICFSFITTYNKKSGYDRFL
KPIIEYLNSLGLNAEFKGRNDILCNGAKISGNAQYIKGNKIVSHGTLLFD
ADLTKLANALTPAKIKFESKGIKSVAKRVTNIAKELNYSITVQDFIDDLI
KFFVTNYDAQYSELPVLRYKNKVQKIIERNSSRDWIYGKNPEFSVKNTKK
FNGGILTVKYNVVNNIVRDIVFEGDFLSLKPLDSLTANFINLVYDKEEFD
KVLSQIDLKFYFGTLEKEEILEVIFG
>MS53_0611 lysS, lysyl-tRNA synthetase
MKMSIKLTEQEQIRLSKLDTYKKLNINPFEKIEKNLNYVYSKDLKEKYSS
YSKEELESMDLYFDLYGRITSQRGPFIVIKDYFDKIQLYFNKKEHLDLAE
LVSNLDLGDIIHAHGKLSKTNTGELVVKIKTLKLLTKVLKPLPDKFHGLS
DIEEIYRHRYLDLISNEHSMEVFKKRSKIISLIRKYFDSNMYLEVETPFL
SNYISGAAAKPFKTFHNALSQEFTLRIATEIPLKKLLIGGIDRVYEMGRI
FRNEGIDTTHNPEFTTIEFYEAYSNLEKMMQRTEELFKLIAKELNLKTLQ
NKGEEINLEEPFKRVDMIDEVSKATGVDFRNVTLEKALELAKEHGVKLKK
YYTVGHIANELFEKLIEKTLVQPTFVMGHPIEISPLTYEASDPRYVERAE
LFINGKEYANMYTELSSPIEQLKRFEDQLNEKAQGNDESSDIDWDFIEAL
KYGMPPAGGCGIGIDRLVMLFTEKESIRDVLFFPTLKNKKSQG
>MS53_0579 map, methionyl aminopeptidase
MAIIKTQEEIQKISKSCQILAEVKSILYDFVRPGVSLKEIDQLAFKEIIK
RKAKPAFLGLYGFPATACISVNEELIHGIPSDYVLKDEDLLSIDLGCTYE
GYHSDSAFTMNVGKINEENIKLINVAKGAFEAGLKAIRKGATIGDISYAI
GKYIKKNNMYTPKEFCGHGIGKNLHEDPNVPNDGIPKKGMLLQDNMVICI
EPMITQSPGIKILKDGWTVVSKDKKKTSHYEHTVLIKNGKGIILTKGI
>MS53_0303 metG, methionyl-tRNA synthetase
MKKNFYITTPIYYASGNLHIGHLYTTTLAWVIRNYQKLLGNETKFLTGSD
EHGSKIAQKAKENNLSEIEFVNSVAAKFKELWNSYDINYDIFIRTTSENH
KKTAQKIFSYFYKNNYIYKNNYTGLYSVSAEEFLTKSQALEKNGKYYHPV
SHDELIEVSEESYFFKMSEFSPWLKKYFAENSNFLFPKKIENEILNNFIK
NGLQDLSVTRTNVSWAIPIKEDLNHTLYVWVDALSNYISALGYNPELDYD
SQSEDFKNFWENPNSKVVHLIGKEIARFHMIYWPIFLKALNLKQPTNIVA
HGWILANDGKMSKSKGNVVDPNELLLKFDKEQIKYFLASQIPMGNDGVFD
EKLLVDSINANIINSYGNLISRSLKMYANSFSVPLKYSKNTEKDFLEIEE
KILKSKVDFKKHMDLYLVDKAFEVARELASDLNKFIDIKMPWTLKDNLKE
LEKILIVLFNGIYALSCYYSIVFKNKTKEVAEVLKVTHFDLEKIDDFSKF
NETIFPDKYILYSRLKKD
>MS53_0610 metK, S-adenosylmethionine synthetase
MKKLFTSESVGRGHPDKICDQISDAILDAYLTWDPHSKVAVETMVSGNNV
FIAGEVKSKVTVDVIEIAKNVLRNIGYYSNNTSFITDIKSQSENIAMGVN
LQDSDDLGAGDQGFMFGYATNETSQYMPLGITLCNKIVSRAGMLIKNQEF
KDAKEDMKTQVTLDYSDPQNVKVDTIIFSCHHNEKYNETKFKNYIKTQIL
KPVLDEFNLELPERILINPTGKFVIGGPFSDTGLTGRKIIVDTYGGSARH
GGGAFSGKDATKLDRSGAYMARWIAKNLVAANIADKIEVQIAYSIGVAKP
VSVMVNTFGENKVPEDVVLDAILNNFELTPKGIIKSLNLNKPIYQKSSVY
GHFGREDFQFTWESLDKVEAIREFVISKGFNI
>MS53_0137 mglA, sugar ABC transporter ATP-binding protein
MKKEYAIEFENISKSFGNIKANSDISFKIQKGSIHAIIGENGAGKSTLMS
ILFGLYSPDSGVIKINGKKTFISNPNEATFLGIGMVHQHFKLVDVYTNLE
NIILGDEFTKKNTNLLNLTLSRQKIKALQETFLINFDLNKKTGNESVSVR
QKIEIMKMLYRDSDILIFDEPTAVLTQEEIQGLLKTFEIFKKQGKTIIFI
SHKLHEIKQIADNATVLRQGKVSAEFKVSSASVKDMAAAMVGSETLTIDN
PDKGKILGKDLIFEIKNLNLNGTKKLEDINLKIHSGEIMAIAGVEGNGQE
ELEKVISRMKKETSGEIKLKSTKLVKEKIKDFFKYKKFRIYLKSAFSLVF
LILFIMQISLWASSKAKELANLYLALGILFLGLFLFVAYYLSIEIYSYFK
IKNKYQKNAQEFINVNQLNTFEFSQIGFSYVSSDRHKHGLVLDFSLRNNT
FIRRTWDKLFNFFGVFKTKNIATQTSEIISNYDVRGANEGRSISRSLSGG
NQQKFIIGREMSSSYEFILIMNPTRGLDVGAINNIHQKILQAKKDKKAIL
LISYELDEILTLADTIAVISNGKIVAVKSSNELTKNQIGQYMAHSGSDHA
NKK
>MS53_0572 mgtA, cation-transporting P-type ATPase
MNMSENNKNSQGLTTAEAKTRNQTYGLNVLKKTKKPNVFLVFLSQFKDAM
VILLLIAAVVSLGIAIYNVSKNYVITREQNEVVALFISPFVIFLVVFLNS
LIGTYQSLKSYKAVKALEKNNELKAKVYRDGKIQVIPSSKVTVGDFLIVE
AGDYISADAKILKCYDFSVVESSLTGESNSVFKRVGKLASENIALGDRFN
QIFSGTYVSKGRALAEVYAIGENTQLGKISQMIKNQKELLTPLQKKLIHL
SKIFGYAGVALFLLTAILHVLLSALFSNDSLGFKNPKIYSDAFLIGISLA
VAAVPEGLVTFSTVLLAIGVSRVTKNKAIIRNLPSIEVLGSTTVICSDKT
GTMTQNKMQVVGFYDFTNPAATADKSMVGVGFFATNTATIRQEGDKLVEI
GDPTEIGILKYLTNHKFSQEMFWRSYSKLSTLEFDSERKMMSVLLQSLRD
RSLIVKGAPDVILKRSLNANRSHYEKIEEFISKGYRVLALAYKKWESPST
QLSVQDENNLTFLGLVALYDPPREEVASSILSAKNAGVKTIMITGDHIGT
AVSIAKNLGIYQTGDLAVSGAELASWDDKYLDSVINNVSVFARVNPSDKL
RIVSSLQRQNQVVAMTGDGINDAPALKKANIGIAMGQAGTDVAKEASGVV
LADDNYKTIVNSIRIGRETFDRIKLVITNLLVSSIAEVIIILLGLFIYRF
AFNRQIDGNEFIILSATQLLIVNLLAHGLPAIALGIVKQEENVMLRKPYK
TTDTIFSNGTFIVLLRQSLIIAFYSLLAYGVVGLFAIINDLKGKEFVRLC
SSAAFLTLGISSSLNTLNLMTKKNLVFANFNRYKWAILASLSSFLIVVFL
GFTPYLSEWIGNANVLSENYTALYGLIPLIFGFIPLFWEEIHKLFDQWWK
DPSIARPYFKKFKLAKKK
>MS53_0497 mgtE, Mg2+ transport protein
MKEEILNKIRAKEFIHIRNLTEDYPIADIAELISDFSLQDKILSLRILRK
DDAADLFAYFDIETQIEIAKSFSEDWAMKILQELQTNELANILEELPTNI
ASSILKLTPPEKRADINLILSFEDEQIGSIMQVDFLTLQPQWTVKKSISI
IRKKYKINPDISSDIYIIDGQGKLLGCTTISDVFLNNDSVLIENIYDPVK
SVFASDNKEDAAAIFTDQDRNTLPVIFQDERIVGIISSDDVIDVIQDEAT
EDMYKLAGISAASAEDSYIKNSIFKVVKSRIFWLIILMISSTISQFIIQK
FTDISSNVVTNLHLSISTGLIVGLIPIISGSAGNAGSQSSTTITRSAAIG
EISSKSLFKVLKKEFLVGLVIGAIMFFANVIRLIFYFLIFNEGSQVWTIA
LIIFASSLSLLIVILIAKIMGTIIPLLAIRWKRDPAVMSAPILATSTDAI
STLIFFGLNIGVLYLGSALNVFA
>MS53_0194 nagA, N-acetylglucosamine 6-P deacetylase
MSESGIIKSVNKGKCNIKDALDYSGHILMPNFIDSHTHGGYDFSFNDLKE
KNIQDKLNKYLAEIKKEGVGHVFATTVTASYSDIKKIASYFTEKYPKEFL
AWYLEGPYISKEKNGAHDENLIKNLSTKEVQFFSEVSKFIPVYLALASEY
SQNKKMLNQYHDQINFALGHSNDNNFDSKYLKDNKYKRVIHFLNAMSGFH
QRNKSLVNSVLEDTNRNYLIEIISDLTHVRSQTINFLYQSFDDSNIALVS
DSLPNKGSKNGIYKLNNLEVEKKDYLFYLRDSSTLAGSGMPYNLILKNFY
KATKCSFSELVKFSSYNVAKSLKSKTLGRIKINTKANFVLIDKDFNVKLH
YFDGEKAKLD
>MS53_0193 nagB, glucosamine-6-phosphate isomerase
MFKNKKDASLFLASFLVSLLEKSPQFNLGLATGDSPLDLYSFFAQKAKEK
NLVLSKIQTFNLDEYLNLDETSKKSYRYFMNENLFSKVGIDKSQTHFPLE
NNYDSYDELIDKKGGIDFQLLGIGTNGHIGFNEPGTPLESKTSIVDLAQS
TIDSNARFFANKDLVPRQAYSMGLSTILKAKEIALIAFGSSKCDVIKKLL
KLKDFDTSLPASALLKHNKVTLYLDLEAACDLL
>MS53_0195 nagC, N-acetylmannosamine kinase
MFALDIGGTSIKYGIIDFKYDILFSSSVKTKKEKMIFQVEKLILEAKKSY
DFDYVAISSAGVVDSNSNKITYTNSDYRVWTGFDFNIVARNTNTKIAMIN
DANAAALSELVSKKHDSFVSITLGTGLGAGIVYNGEIFQGKNFLGGEIGN
NLAFKNQKEKINEGLSFSRFNKKISQKFKIKSKTPSVYYPKLYKENQDFK
VLFNNYASKLAYWSFVIAIILNVDHVYIGGAFSFVDDFLFDKAKDIFISM
QDDSPYKISFSKASYKNNAGIIGATYFLKQKFNLA
>MS53_0198 nanA, acylneuraminate lyase
MFPAMVTPFTKDGKLHKAGVKEVVNFLVEKQKVDGIYITGSTGEFLLLSF
EDKKEVMKLVAEANAGRVTLIAQIGSLNIEETKELAKLAKELKYDAISAI
TPYYYNFSFNETHHYYEEISKAADIPMLIYYLPQLAGQKVSTDQFGKLLE
IKNVIGSKYGATDLFAFERLMSKYPDKLFMFAWDEALAMGLTMGAKGFIG
STYNVNAKGANAIIKAWEANDKEAVMKLTHTYNDYVLDLISKGLMQSLKA
IMRLHGVDAGYTRKPFWRYEDEEIKKHAEFITDKYLK
>MS53_0125 nfo, endonuclease IV
MIKLGSHVSFKKPNYLAGAAGESINNKANTMMIYLGAPQTTKRVEFELYK
KQEYLDFYAKDIPAEDIIVHAPYIINPANPTKAKFSCDFLIQEINRMNYI
NAKYLVLHPGAYTEFAPQEALDQLVKSLTHILSKTKDVVICIETMAGKGT
EIGINFEQISYLINKLNSDRIAICLDTCHLWDAGYNLKDYQSFKDELKKW
NLLKHVKVIHLNDSKNELSSHKDRHANIDQGHIGLETLAKFVHDKDFDNI
PIILETPYVDNKPIYDVEIQMLLNKKP
>MS53_0322 nifS, nitrogen fixation protein NifS
MMKKNLRANFPILKDIIYFDNSALVLKPLSAINALRDFYLKYSISSRTSD
TPIGVLVNSQIQSVREKVASLLDAKVSEIIFTSGTTESINYFVDMYGHNF
SEKDLIIVSGYNHAANLLPWINLSKKNKFKLIITENITREILKHQDKISL
ISLSVENNNFQSKEDYEFIVNYCKKYNVILVNDAAQSISHQKTSLNEYDV
IAFSFNKFYGPTGMGVLALKEKLIKKLSLSKFGGGSLAEVKKNKDFNFKN
NLTLFEPGTPNIANFFMADKSLDFFNEIGYEQTQEILNDLSLYLHEKLTE
VKNLVIYSSPGDNIALINFKNIPAQDVSDYLGSKNIYTIAGIFCSQYLRN
IQSQYSFVRISLGIYNNKKDIDKLISELKNVEGNYGIW
>MS53_0321 nifU, nitrogen fixation protein NifU
MIMDHYVNPRHFDKNILEKNVFYNNTCSDKLVVNATIEDKKLKDIKHYTQ
GCLICASSASIFIDQIQNKNLSEAFEINNLYKKLLDKNLLSDSELEKLGN
LWVFFNTKNHFNRLQCALMISKYIEKLEDESK
>MS53_0522 nox, NADH oxidase
MIVVGANHAGTSFLRTLKTVNPSAEVVAYDRNTNVSFLGCGIAVWVGGMF
KDPAGLFYSSPEVLTKEYGVKLHTQHDVVKIDRKSKKVVVKDLQTGREFE
DSYDKLVFAGGTWPIVPPFKGKDLKNVLLSKLFQHAEEIITKAKDPNVKN
VVVVGAGYIGVELVEAFHVRGKNVTLIDVQDRVVPNYFDPEFTDKMEENM
RKGGVNLRLGESVEEFTSKDGVHVSGVKTNKDSYDADLVLLCIGFRPQTA
VVEDVEKLPNGAIKVDEYQRSVSDENVYVIGDSASLKNVITNDYAHVALA
TNAVKTGIVAALHLAGMDVKFPGVVGTNAVSVFDCKYASTGFTKRLGEKN
GLENLAEVYFEDNDRPEFMAHYEKVACKIVYDTKTLKLVGAQVGSWGQDS
HAEIIYMLALAIQRGLTLPELALTDVFFLPHFNKPFNFVLVPVLRALGLK
YKA
>MS53_0401 nrdE, ribonucleoside-diphosphate reductase alpha chain
MKDNTNQFKAANEYLAYNAMSKLSEGKDSHDNDQKAIGAYMRVEILPKMM
QWENIHQRMQYLVENQYYEEEVVNNVTKAQLEELYQLIEKYNHRFPSFMG
VVKFFNSYCLKSFDGSKFLESYSERALMNALFLGGKDFESVKNILVEILS
GRFQPATPTFLNAGKKQRGEYVSCYLLRVEDNMESIARAVTTSLQLSKRG
GGVALSLTNLREFGAPIKQIQGQATGVIPVMKILEDSFSYANQLGQRQGA
GAVYLHAHHPDIMTFLDSKRENADEKIRIKSLSLGIVVPNITFELAKNNE
DMALFSPYDVEKVYGVPFSDIKVTEEYYNMLNNPKIRKTFVKARKFFQTV
AELHFESGYPYLLFDDTVNDRNPNAGRIVMSNLCSEIVQSSSLTEYDTDL
TVKKLGEDISCNLGSMNVDKLMNAGSDFGKSVFYAIKSLDHVSRGCDLSC
APSINHGNRNNRALGLGAMNLHGFFAVNEVYYDSPEALEFTNLFFYALAY
HAYKASNLLAKERNETYKNFKSSKYATGEYFDKYTKCKSDLYTAKLPKVI
ELFKKHNVTLPTQIDWSELVESIKKYGLANSHVLAVAPTGSISYLSSCTP
SLQPVVSPVEVRKEGKLGRVYSLAYKLDENNYKYYKDGAYELGPNPIIDI
VAQAQKHVDQAISLTLFMNDKATTRDLNKAYIRAFKAKCSSIYYVRIRQE
VLEDSEHIDWEKDGQSFECSSCTI
>MS53_0399 nrdF, ribonucleoside-diphosphate reductase beta chain
MISNNKYYNQSLSPLDYVKNNLQGVMRSVNWNFVNDPKDLEVWNRVTQNF
WLPEKIPVSNDLKSWNEMDKSWQELLVRTFTGLTLLDTIQATLGDIAQIP
NSLTDHEQVIYANFAFMVGVHARSYGTIFSTLSNSDDIEKAHEWVINNEK
LQARAKFLVPYYTSKDPLKSKIAAALMPGFLLYGGFYLPFYLSARGKLPN
TSDIIRLILRDKVLHNYYSGYKYRQKVEKLPKEKQAEYKEFTFKIMYELI
ELEKDFLRELYDGFGLADEAIAFSLYNAGKFLQNCGYESPFTPEETKISP
EVFAQLSARADENHDFFSGNGSSYVMGVSEETQDEDWEF
>MS53_0400 nrdI, NrdI protein
MIELKKPKGEKHIVYFSSETGNTKKFVDKLKINSSRIPIDLNASLEISQD
YVLFCPTYSGGFGEVKGSVPKQVIKFLNKKKNRDHCMAIVASGNTNFGDT
YGLAGNVLQAKLKVPLLHVFELLGTKHDEEVVHQKINQLWNNK
>MS53_0685 nusA, N-utilization substance protein A
MMAKKKEKDTFKNASNSKKWFLLLNSFSKNKEISNDEFIAMSQEVINHII
NRKLDPEAEVVFSVDNEKEEILLLNKNTEVVEDSEAAMYDELLGISYIGL
SKAKEVNKNAKVGDLISYPIEFNSFDQKNLVAMRNGFSAAIAEKAKNRLF
AKYHPLIGSKLMVQIASKHENGGFFLKLEDGTSAYLPKNSIIKSVELNPG
QKFDVFLNSVNIDAKGLYLEVTMTSPEQVRDVLFREIPEIANGDLIIRNI
QRIPGERSKVVVSLNPEKQSAHTHDLLGAMFGNKAQRINDVSKSLNNEKI
DVIRFAENPKDFIRNAMSPCPVVDVVKSKKGFYVIVRPEDVSLAIGSNGV
NVSLASKVTNNKIDVLSTEQAFQEKIYFQDNYVPVHYTPRERNKNNFKKQ
ARERASFGFDFGIEEFSKDVANFISKVELEDLLKEDKAQETKQTEVAKPA
TATSVKKPAKSTKLKTEAVDFNAYFDETNLKAGALSDEYSFVNKLDEYQQ
FENEFSGQSVEEEIKETQKQKVKKEKISAFSKNFKIDEDLLSYGLSKDLD
LSDLDDEKWKK
>MS53_0361 nusG, transcription antitermination protein
MQNSKFRWYLISTITGKEAVIVEALKNRIKSENIEQFFDFSATEDGPFKV
FKVPSITKTELNKKQKGLAYKVKWKNMFPGYIFVKADMQDLVWYIIRNTL
QVTGIIGSGGGGEKPTPVSQNQIRKSLEKEEEAKKLFEENKNLLNLKVGD
LVLITDGNWVGNEAVIEKIIVEDNMAEISFEDFNKKVEFKINLDWLTRIE
RN
>MS53_0168 obg, GTP-binding protein Obg
MAKFIDQVKIMLKAGKGGDGMISFRREAHVDKGGPDGGDGGTGGNIYFVA
DLGKNTLLSFYKNKFIIAEDGVKGGPKNLYGAKGKDTIVKVPLGTLVYKN
KKIVADVIKENHLYLVAKGGKGGRGNNKFKTSKNTAPRIAENGMPGEKYE
ANIVLKILSDVGLVGLPSCGKSTLINALSNAKAKVAEYEFTTLVPQLGLV
KYYDYSYTIADLPGLIKGASLGKGLGIQFLRHIERCKVVIHIVDFGSLDK
DPIQSYEAIQKELESYKLNLTQKPQLVVANKSDLANFKNNIEKFKAKYPN
IEIIEISALNYHNVENLKKIIWEFLEKTSHLQIKIEDDFETEVKEINYEP
DFVIQKMNQNHFKVTGKKIEELVLKIPINTFDNLMRFNNILKKIGVWEAL
IKRDIQKGDLVEIYQHKFEWEEEL
>MS53_0184 oppB, putative Oligopeptide transport system permease protein
MKAGLKACFLTKETQMKETKLKKPSSSSVMLEKIVPNYVTLDNRSLDEKK
WYVKLFNVESPLLKSTWRFTKIILEFFTIAFIVITITFFLINSVPGDTGV
ESGLSEAQKVAVRQQLGLDLPLFNRYLNYIRDLFRGDFGVSLSVFPRTSI
NDFIFDRLITSLYVGLWSVCLTVMIGVPIGVIVGKRPDGILDNITTVIIS
ILSSVPSLIFAILLLILGKNLNIPYIFDVNNFATYILPGFALSLGSIIVY
IKYIKTELNRELNSMHSKFCYLKGLSRSRFVWTHALKPSLFPIATFFPAV
VLGSFVGSIFIERIFTITGSGNILFSAITSKDYNIILFQVVFFSLLTILS
YTIRDILYELIDPRIRRKGGR
>MS53_0348 oppB-1, oligopeptide ABC transporter permease protein
MIKYLTQRVLLAIFTIFAIAIIVFFLVAYFAENPFVKEWENSGFKAEQAE
SVFQRSKDTYLIKPDTEFSRFEPLAWIDKKESVFVRFGYWVKSVFDSNQP
FGFVFNQNILSNADVKTIPAYFFRFLPYSLIITLPSFLISASLGIFLGII
AGYKRGKFFDWIVNLLSQFFVALPIFVTASVVILVLLSVFGTPPLFLLPR
DIEINGLSNTIASWASPIFVVVIGSLAGYITFVRNQVVTVLTSNYVLIAK
SKGLNQRQIFFKYVLRNISIPLAATLIPSYIGLLSGGVVIETYWRVPGVS
NVIVNAFPNGEINIIMFSTVFFTTLSVFTTIIVDISFVFLDPRIRYYSSS
TSLLFLFKQYLVRNKEKKLAQAKN
>MS53_0185 oppC, oligopeptide transport system permease protein
MSNKDAPNPLLKPFAYQQWKMVGNILEYRESAYLKTSLSPFKQFLNRYSK
SWSGVFGFVFLVAIFLFTFLFPLIWNDTSASNDAKDGYLQPFFKGHFLGT
TSRGNDFWTLIWHGLRYSLLLSLVVTLVEVFIGVTFGILMGHFEWFDKAF
TFFIKIFSVIPTIIILILVTIVINPTFWVIALALSLTGWTGMANQIRAQV
KRAKNFEWISASKVLATPTYKILLSYLPVIVPILVTQLVFTIPGVILSET
SLAFIGLSIPDAITLGTLINEGINTFSIYPRYVLIPASFLIVITTSVQLI
GSAIQTSLLKQR
>MS53_0347 oppC-1, oligopeptide transport system permease protein
MKLSSKEFNKKYNLNEKMLQNSLVRHVPKANLQFNNAAGKPKKLLNEILK
RYFSTWFFSLALVVFLAVLIFSIVISLTSKYSSSTSINNTSGLTYTLLDG
KTQIGTSNRTASLPPVFNPFVNLTLGSSGISQQVYNNSVTLWNSDSYFHG
LVYKTVFNPDNTSVRLEDGNLYVNAYSFYKADSISIILAQSQQRGLIAKD
LTQDQVLSYIEEIKRLNPQINLSTYLGTNSAGVDVWTSSWVGTWNAIRLA
VIVSFIQTMIGVFIGAYLGFHAGSLLDTIAMRIISIITSPPTLIWLLIAS
SIFGTSDLTLAITLIVVGWPGSVGITRLYIITVKDSDFIQASRLVGASKI
RLILRHALPAIVGKIANSFVASIPSIILSVSALAFLGFFKGNTANLGSIL
SSAPSEAGTNIWILVLPVGILLSISLSLQFIALGVHDSLDPKVIRGK
>MS53_0187 oppD, oligopeptide ABC transporter ATP-binding protein OppD
MMNKEFKGYSKLYDKPLKHENKNTYHELKDSFTHHKKVSKWKQVENNYKS
FLEKLRFAKKEFRIQDFIKNAKTEKVFGKDTVVAAEIEDIHLSFLNPANP
KEKNVVLRGTSLKIYEGYVHAIIGESGSGKSVITSLLYGLTGNNAVIDFG
KIKLFNNEVQDFTFTDWENRKIRGTIVSAVFQNPMSILDPTMKVGKQITE
GLLINKVVKTKMEAKKVALEYLKMTKINNPEKIMNAYPHELSGGMIQRIA
IASVMSLKPKILVMDEPTTALDPTVQALVLDIVREFQEKLKIAIVFITHD
LGVVASISDFISIMYAGQIVETGTKEEILEHPQHPYSWGLIMSMPDFNNS
EKLTTIRGSVPSSLNNIKGDAFAVRNDYALGVDLEVEPAMYQISDTHYVK
SALLDEKAPKYELPPLIKKMWQKYHQKLKELHQ
>MS53_0346 oppD-1, oligopeptide ABC transporter, ATP-binding protein
MVMNTKKQLLKARNLKVSFKLKKKNFLNIVRGVDLDIYPGEIVGLVGESG
SGKSVTSKALLSINENAFMSAKELWIDDINLLNLNKESKWVKIRGQKIGY
IPQDPLTSLNPTRKIGKQLLDSLNQNSEWKTKPLAEKKEYLIGLLKKFGI
RNAEQVFEMYPHLLSGGMKQRIVITMIVALKPLLIVADEPTTALDPTVQA
SVLKLFEDICREMKISIILISHNISVIAKVCDYIYVMYAGKIVEKGLKEE
IFTDPKHPYTWALISAIPENKEQRLYSIKGTPPDMSNLPVGDAFAPRNEY
ALEIDFLKEPPLFEVTKTHMLHHDYFTLIHQK
>MS53_0345 oppF-1, oligopeptide ABC transporter ATP-binding protein
MKAKAQENSKKILEISNLKKYFLNKNSVNKAVDNVSFSVYEGEIVGLIGE
SGSGKTSVARTITRFYENYNGFVTLDSKIISGNKISKKRLKHMRRNMQMI
FQDPMASVNGQNNVYSILKEPLVVNGVIQEKVKRVLKSWKQVKKNYFYTF
LELAKKLELKDKALINSLFEPFYTKWSNKFQELTDEDLNLEDLYNSFVAY
LEEKNKIYSELTNNLYSLSNQLIEKFEEKVKAFEEDKMDADKTRLKLALD
NYNKEKKLNRKNKAYFASLDTFKNTFKEFKDSFTNKKETKAIGKSILDSL
LSEVKNEAKLAKNSALSSANLKEYDFYIHLNQVYKFLYKLVKSNYAKLMY
FDFETGKTFRDNLLNYATTYFVSKSSDSSSWTNEKFKENFKFSLDEYLNN
SQKNKKQIDKDFAQNVKTFKSSLKKTFKNFFLKPDKNPEKLAKAKKNYEE
AQQNFDKELAKYIEKFELKIQRIKEKIKHQDSLSDSLKKVEKDLDSKFKE
LNAKYVELYKKQRILPLETKKNKTPSEARSLKNAKVELSAQESLVKERLK
SSKAFNLEQKYLNIDIDNINLLLGISKLDVFIKKHPYLEALNWLLYPYKV
LKIRALYIKSTIYKALEDVGLLKQFAYRYPHEFSGGQLQRIVIARALIIN
PKIIVADEPIASLDISIQAQIVNLLKDLCKKKNIGIIFIAHDLSMVEYIA
DKVQIMHLGKIVESGKTEKVYTSPLHPYTNTLFQSIPKISNANEKFQEIS
FDTKYLEEQKFPNATFLKEVEDNHYLFGTESQINKWSKKLKNVKKT
>MS53_0057 parC, topoisomerase IV subunit A
MSKKEIIEKIITKSVDKIMEERFETYSKYVISNRAIPDVRDGLKPVHRRI
LYSMYALGLDFDKKFKKSARIVGDVIGKYHPHGDTSVYNAMINLAQWWKM
NIPLLSMHGNIGSIDDDKQAAMRYTEVKLAKIANYIIGDIKKKTVKFIPN
FDDSETEPIVLPSMFPNLLVNGSRGIAIGMATEMPPHNLGEIIDACVYKI
KHPKASYSELSNFVLGPDFPTGGVIKGTKGIAEALENGRNEKNKIKLFCK
YEIYTKGKNKFIEITEIPYGVVKVKLVYEIDLIIQNKLIDGIIEIKDRSD
RDGINILITLDINSNEESILNYLFSKTQMQITYSYNNIVIDNNSPTLMNL
ENLISSYIAHIKNVKTLSLNYDLNKAKVRLEIINGFIKVSEITSQVIELI
RKTQGSKMGVVNNLIQVFNFTKLQAESIAELRLYKLSQTDKEIYLKEKVE
VKETINIIENLLNNEKEFNNFLINEIKAIKKEFSVPRKTQIEEKDFEVSY
NKLDLVKEEIINVSISKNGFIKRFSDKVLENNEWKNYALKEKDNLVFFSK
VNTVNFLLCFTNLGNYVIVAIYQIQEVKWKDLGNNINLFASDIRPDEEIV
SVIEVSDFEENLSVMLGTKQGYFKRVMLKDFLVSRFTKKYTAMPLNEDDY
LIKAKLTNLDSYLVAITENSIISKFSESEIMFYSTKARGSKAIYFSVGDK
LSNFTIASYGDEIFAFSSDLNYFYFNEADIVLTPKNIKGRNIFDKKYKLQ
NKNYLLFEDALATDFLYFKNTLNKLNQVKLNHLDKKKSAVLKHKFDNFES
VSLIKSLKKETINNSSKPKENPAQEEKQEPEKEVVVGRKKPVEIQGSLKD
LLTDYEEFTK
>MS53_0592 parE, topoisomerase IV subunit B
MPNNLYTAESIKKLKGLEAVRKRPGMYIGGADIHGLHHLVAEIVDNSIDE
ALAGYASEITVTLHSDLSVSVFDNGRGIPVEKVKGEFKTAVELVFTELHA
GGKFSSDSYKTSGGLHGVGSSVVNALSSKLEVIVSRNDKSYKTAFIQDSI
VEKTHEIPLQFKRGTLVKFWPDYKFFKDARLNFSTIAERLKESSFLVSNL
KITIIDEIKNHKEVYQSQKGLEEFLDFINGSKSVISKPVSYKETLKNIEV
EFAFQYSDDYSSIILSFVNNVKTIDGGSHEAGIKSAFVKVINDYAFKEAF
IKKQNIFDFEDIKEGLSLILSLKIPENLLEFVGQTKSKLGTTEARHIVEE
IATKKLEIWFLDNKKEAKNIVNKIKNAYEIRLEERKRRQENRKSKNILKE
KYILSDKLTPAMSKNPLEKELFLVEGDSAGGSAKSGRNRNFQAILPLRGK
VINSEKSKMLDILENTEIATIINSIGAGFGKDFDSSKAQYNKIIIMTDAD
TDGAHIQILLLTFFYRFMRKLIEDGKIYIALAPLYKVTYKSKNQYYYAWD
DSELKDILEKNAQSSYEIQRYKGLGEMNSDQLWETTMNPETRTLIKATIS
DAILAEKRVSTLMGDNVKIRKEWIDNNVNFSNDDDFLEQIN
>MS53_0544 pcrA, ATP-dependent helicase
MLDDLNEKQREAVEYFDSHLRIIAGAGTGKTKVLTRKILYLILEKKVDPS
KILAVTFTNKAAKEMKDRINSKYYDKQKVLFENVFTLHSFCAQVLRKYIN
LIGFSRNFPILDELDKKQVLQDLYVKNKITNHEVSYSNMAKYISWAKNNL
LDQKDLIAELEKQFSGDAVSKTIANVYQDYLNYMAEKGALDFDDLILHCK
TLLEMHPNVAAKIARYFNYILVDEFQDTSDLQFDILEKIIDKSSQLTIVG
DPDQTIYNWRGASVDLILNFENIFENSKTIVLDTNYRSTKKILASANKLI
KNNKNRFSKDLITNNDEGNDIEFYHAFNTEAEAQWVISKIKLLKKQKHQI
KNIVILYRSNYYSRAFEDALLGEGINYKIFNGYKFYQRTEIKDVLAFLKT
ILNKDSIALKRIINVPVRGIGPKTVEKIEAFAEKNKISLYDALFTHFKEL
PLGKEIILKKIYPFIKILRKYQLISEKYPLPVITQKLLEELNYLEQIKGN
QNENQNAIENVKELISVSMKNYFETNKEATAIDYLNQVSLLSTTGEDVEG
DDFVSLMTIHASKGLEFDNVFIVGLTEGVFPNYKHLEDAKENKHKTKTEL
NKGIEEERRLAYVAITRARKNLFVSDSRGSVYAPIIHEKQTSRFIREMGI
DFESFLVDKTSKFSRYLSEEENKNIKIIVGDAVSHTRFGEGIVQEVNDYD
IVVKFVHESAPLTIKKNHPSIKVLAR
>MS53_0272 pdhA, pyruvate dehydrogenase E1 component, alpha subunit
MSTKYKYLVDKDGKDVVMTDPSKLIRVLDVNGNLIDKKYKPQLTDKQLVE
GYKWMVLSRQQDTYMLQLQRQGRMLTFAPNLGEEALQVATAFALDKKKDW
FLPAFRSNATMLALGVPMVNQMLYWNGNERGSKIPEGVNVTPINIVIGTQ
ISQAAGVAFALKQNKTGGVALCFIGNGGTAEGEFYEGMNFASVRSWPAVF
CVNNNQWAISTPNHLESISSTIAAKAVAAAVPGVVVDGNDLLASYDVIKE
AVEFARKESRPVLVEFVTWRQGPHTTSDNPRVYRTETEEKKQEVWEPMHR
IEKYLLDRKLLTKKEIEKIWADSLEVAKKTYEESVKLNEATLDEVFDYTY
AELTPELKEQKQEALDFFKAHGGK
>MS53_0273 pdhB, pyruvate dehydrogenase E1 component, beta subunit
MMSDKKITVNNIEALNDALFTAMRKDPKTVLFGEDAGFEGGVFRATQGLQ
AEFGPERVFDTPIAEAAIAGVAVGAAMAGLHPIIEMQFQGFSYASFQQMF
THAARIRNRSRGRFTSPLVLRMPMGGGVRALEHHSEAIEALFAHIPGIKV
VMPAFPYDTKGLLLAAVNDPDPVVFLEPKKIYRAGKQEIPAGEYTVEIGK
ANVLKQGTDLTLVTYGAQVHAAIEAVQKLGDSVSVELIDLRTIKPLDLPT
VVESVKKTGRLLVVHEAVRSFSVSSELMAAVNERAFEYLKAPLARLTGYD
ITVPLAKGEVYHAISADKIVDKVKEVTSFKF
>MS53_0274 pdhC, dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex
MQVKSTPIARALAAKLGVDISQVKGSGFDGKVLYEDVKNFSPAAAATQPV
AASASATAAPQVGAYSEAVKPIRKAIAKAMTNSWSNVAYTNLVHRVNMTK
LWDLRSSIKDSLLKSEDVKITFLPFILKAVSVALKEFPLFSAKYNEAKST
LDFPGVVNLGFAVDTEAGLMVPVIKNANALSVLDLAREVSRLASAARNKT
IKPDDMKNAGFTVTNYGSVGSLWGVPVINYPELAILGVGAIQDEAFVEKG
TLVAGKAMYLTVAADHRWIDGADVGRFASRVKQLLESPELLGVY
>MS53_0275 pdhD, dihydrolipoamide dehydrogenase
MYTFKFADIGEGLHEGVVAEIYVKVGQQVKEGDNLFSVETDKVTSDIPSP
VSGTVTAIKMAQGDTIHVGQDIFVFDDGKGDAPVAEAPAPKAEGEEEAAS
VVGEVKVNNDLIDFSKMFSGQPAPKAEEVKPSAAPAPSAEDKTFDEGKKY
TGKVDESYDVIVVGSGPGGYLAAEEAGKAGLKTLIVEKKYWGGVCLNTGC
IPTKTLLKSADVISYLEHAADYGIVAEKAKIDFSKSWVKMHQRKADVVKK
ISSSVEMLMKMSKVTSVFGEAKFVGARALEVNGKVYEAKNVILATGSTAN
KLLKVPGFESGYKSGEILTSEEAINFDKKLPKKVTIVGGGVIGIEFANVF
AKAGSKVTVVQNGPVLLPGMDSDVSKLAKEMLEGMGVEVLLNANTLGYEK
KTLKVEVDSKTLSLKQDVVLTAIGRSANAINAAEVGVKLGERGEVLVDSL
QRTNVAGVYAIGDVTNQKMLAHVAYAHALVAVFHILGDKQKGSYHPKAVP
GCVYTSPEIAFIGMTEAEAKAQGRNVMTAKYSFANLGKAIASNKTKGLVK
LVVDKEFGEILGAWMVGENVTDYIAEVAMAMENEISVHEIAHTIHPHPTY
NEMIWEAARSASLTLTLAAMKK
>MS53_0154 pepA, leucyl aminopeptidase
MKIQYNQKNESDIVINFVFYDSKKIKDFIIKKNGYLTEDLENKIAYLYID
EKHANIDGLTKVIDSFASSIKRNYQINTESLTSHFDIYDALRILIMRLDF
HSSVLFKKSIDDLKEVKKFKPQISLIINTFDEKHVDNYVKKIKIISNSVK
SARFLQSMPENFLNSEQLAHYVAKDLKQIPEIQVTVFTKSNIEHLGMNLL
LSVNKGSTHEPRVVILEYNGDPESKQKTVFVGKGITFDTGGVNTKGYHTE
GMKYDMSGSVVAAFALKALAKLKAKVNAAAIMCITDNRSAGDASLPENVY
QSMSKKWVEVVDTDAEGRLVLADGIFYSASVLKATTIVDIATLTGSLKFA
LGETYSGVWSTSDEKWEKLKEASLTTFEKIWRMPLHEDYHKENKNSKVAD
LKNYSSKVPCDHNQAAMFLKEFTKGVDFIHCDIAYTAAKDQVAQGVLIPT
LVEFALNLKS
>MS53_0153 pepA-1, leucyl aminopeptidase
MKLNKVTNQRNSDMLLKAVFDSEKTKECKLLLKKQNQVTEFFSENTAKAY
LGSEEKYTYETLVKFVKQFVSSQARPYQVDVASFAKKAVKPRHVVKAFVD
AYNYANADLYSAKTNQKNSDEEKALSLLFVSNNPGEVSELELIYRKQTVL
SEAVNFARNLQILPPNIANSEYLAKKVENELSEYANLEVKVLDKEQIEDL
NMGLLLSVNRGSMYEPRVVVIEYNGNKESEEKTVMVGKGITFDSGGYSLK
PARSMLGMKFDMSGAAIVASVMMAVAEFKPKVNLSAVLCLTDNRVNGDAS
LPDSVWESMSGKTVEVNNTDAEGRLVMADGLTYAVRKLNATRLIDVATLT
GAILSALGTTYTGVWATSDQDWQSVLMASKVQDELVWRMPLDDEFSKEIK
KSLVADLKNTDLTGMGGSNSAAMFLKEFTENRKYVHFDIAGTAEQSGNPT
GVMVKTLVQLAINESIREMKK
>MS53_0350 pepF, oligoendopeptidase F
MKTKRFENRSSIPKKYKWDLDSILDGKSLQKHIDDYQKLFSRRIKAKDLK
FENLEAFIEDLKTLEKLLIVTNKISNYISNNLNANLVSEEIKKAANEFDF
LSKKLESEFGSEYNRLYKHKAKLKKWYLDPKLSFYRHSLDVLLESFKYKL
HDEVEEYIVKSSHGTISLESIFTTITDSEVVFEPALDSKHKKHVLNTANK
NELLKSNDSALRKDVYHKYLKGYLKHKESLALILFDHFKAITVEAKTRNY
KNTISMLLSEDKVDEKLLELLFEKTQKATKGSFVKYKQNLKKFYLAKFNS
KMQPWDSQRELLKLKNKYSIEEAQKLALSSLKPFGKEYTEKIKEAFREKW
IDYMPCKNKITGAYSIGASFGLDKKYILMNYNYSLDSVFTLVHELGHSMH
SYYSDKKQNIFNASYPIILAEIGSIYNELMLFDYLYENSKSKKEKFYLLQ
KFIDNFIDTVIKQTMWANYEFDLYSKIESGVAVNSFEYLSEIYYQNLVKY
SMSKSKPKKDEKLNISSVTIPHFYYYFYVYKYAIGQLVGINFYLQYKKGK
SSVIKNYIENFLSMGGSDFPLEILQKVGLNLYSEEFYKNGFDFIDSLIQK
WIKLGNSIFKK
>MS53_0500 pepO, endopeptidase O
MKPNLKDDFYGHLNYEWLEKEPIPADRSNIGSFSIISLEIEKLLVDLSYD
WATKAKELPEDKYVKEYVKLYSLVFDVEKRKKDGYAPAKKYLDEILALKN
FDDFQKLTLKNEYKYSFLPLEFGVSPDFVDSSHYAFWLGEPALVLPSVES
YSSPNATKQLEAWKKMVKTFCHDFGLDKDFSEKLVEKALKFDEALRKVVK
TSLEKADYVKFYNPTKPEEIFEKTKRFNTSEMVKSLTDKKVEVVSVTNPR
YLDHFSDLYSDDNFENYHAMFFVKNLVASALLLDEANRHVHFEFSKTMTG
VEKIKELKKYAYEFANGFFDIPFGTYYAKKYFGSEAKKDIEDMIKNMISI
YKSRLEKNTWMSKETIKKAIVKLNSLDVMIGWPEVFQPYFDHLKIDSSKS
LWENNVNIAKVMYDYNFSLYTQKVNNKEWKMSPALVNAYFNAFGNHIVFP
AAILKGEFYNLKNSRSENYGGIGAVIAHEISHAFDNNGARFDENGSLKNW
WTESDYKEFEKRTQKAIELFDGYQDVYGKVNGKLTVSENIADMGGFSCAL
EAAQKEKDFDAKKFFEKWASMWKAKYKKETALQLLDTDVHAPVKARANVN
LMNTDLFHETYQTSEKDKMYLAPEKRVKIW
>MS53_0149 pepP, XAA-PRO aminopeptidase
MDKTRLLKLLDLHKADALVSEALQTRLWYAKVETSDGYIVVEKDKATLFV
DNRYIEYAKKTAKNVEVKLLAGDNLKNFFKEKRFKKVLLEENYLTKQLTK
HLLSLMDLKEENVAWVHGQELRVVKSKEEVETLQEVVDLSLKSYDQLMAW
LRSKLDKKEKVTEKHAAAKLAYFMQINGCSKEGFDSIVATGKNAAEPHHH
PTDDVIEDNEILKVDFGGLYKGFCADITRTSFLGDRAKAKDPKVLEVLQI
VEEAAKAGRDAVRPGVLASDIDLVCRNYIKAKGYENYFLHSTGHGLGIDV
HELPVVSFRGETVLEPGMVITVEPGIYLEGLTGARIEDDVLVTETGRRVL
SRKDEN
>MS53_0296 pfk, 6-phosphofructokinase
MMKNIAILTSGGDSPGMNPAVVAIVKAAKANNINSYVVYEGYKGLVENNI
QSASELNINDYISRGGTFIYSARYPEFKDKEVRAKAIENLKTKNIEALIV
IGGDGSYMGAQKLHEEGVKTIGLPGTIDNDIKSSDFTIGYDTALNTIVSA
VDKIRDTANSHQRIMIVEVMGNQCGDLALYSGIATGAEIIATSSYTPTPE
EIANQALELTKQKNRRSVIIMVSEKRYNINQLAKLVEEKTKWATRANSLN
HIQRGGSPTAQERILASLLGFKAVEFLLDNKSGYALGIQNNDIVGVPILE
ALNMEPVAAKKTLEKTVKINKINKII
>MS53_0483 pgiB, glucose-6-phosphate isomerase
MSSSYLKLDFKLKNQVVPFESYQKQVSQIHNAVKSKSVEEKDWLGWLNLA
SDYNKEEYAKMEEKVAQWLKDKVEVVVVIGIGGSYLGAKTGYEFIFGKYS
IKKPQMELVFAGNDISAETLVAKLNYVKDKKFAINVISKSGTTLEPSIAF
REFRNLLEQKEVNSWEYIVATTDKQKGVLFELATAKKYTKFVIPDDVGGR
FSVLTAVGLFPFLCAGIDAKKVLEGARQMNKELFSENVMENAAYKYAVAR
HYLHKEKKYAVEIFVSYEPKLRYFAEWWKQLFAESEGKDGKGLWPSSAIF
STDLHSLGQMIQDGPKILFETVLTLENPAYDITFKDNVIDYDKLNYLSDK
KLSEVNNVAFNATMEAHSDEGNVPNISMLFKDFSEETLGALFMFFMRAVT
MSAYLLGVNPFNQPGVEVYKKNMFFLLGKK
>MS53_0114 pgk, phosphoglycerate kinase
MMKKTLNDLNLKNKTVLVRVDFNVPMKNGVVTSNKRIVAALPTIKKVLSE
NAKVVLMSHLGRVKSEEDKAKYNLELVAKELSKLLGKEVTFVNATRGKEL
EDAIAKLPHGEVLLMQNTRYEDLNDKAESKNSPELGKYWASLCDVFVNDA
FGTAHRAHASNVGVASNVKESCLGYLMEKEVSSLEKAVNSPAHPYVALIG
GAKVSDKIEVLENLVKIADKMLIGGGMAYTFKKALGQSIGHSLLEADKLD
FAKEFLAKYSDKVVLPIDNACSLEFSDVEPTFFEGDIPDNFDCLDIGPKT
MKLFEDALVGAKTVVWNGPMGVTEFKHYKQGTLAMCKAISKLENCFSIVG
GGDSVAAVEDLKMEDKFSHVSTGGGASLEFLQGLKLPGFEAIQEKN
>MS53_0656 pgm, 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
MNMKKVILVVIDGLGLRSEIHGNAFQMANTPFFDKLFSEYPNTLIQASGE
YVGLPDGQIGNSEVGHLNIGAGRVVYTGLSLINKALKDDKFKENQVFLNA
FNKVKENNSTLHLMGLLSPGGVHSLEAHLFEILKQAHNSGVENVAVHVFG
DGRDVAPKSIRESLEKLQELVDKYGYKIATISGRFYSMDRDKMFDRTEKA
YKAILGKSGNEFSSALEYLDLQYSQNITDEFLEPAKNSTLDSRYFLKDND
AVIFFNFRPDRARQLSHLILNSSLYDYQPSHLVKVSDFVSMMKYEGIKCN
IAYEEMLVNNPIGKVFEDANKTQLRVAETQKYAHVTYFMDGGVDVEYKNS
KRIMVDSLKVESYADTPQMSAEEITSQVISHAKDFDLTILNYANPDMVGH
TGVLESTLVALEVLDKQLSRLVKWAEKNKITVFITADHGNAEVMLDENNK
PVTKHTSSPVMLVTSDKSLKLKPGKLANIAPTVLDYMGMAKPKEMNENSL
LDK
>MS53_0106 pgmB, beta-phosphoglucomutase
MKAFIFDLDGVITDTAIFHYQAWKKILKEKFNLDYTLEEGEALKGLSREN
TLLEFLKLKSFSRKLSEQEIKEVCDEKNDFYKELLKSNLSVKNILPGIST
FVKKAKEANIKLAIASSSHNAPMILKSLELFNYFDYIVNPADVKVGKPNP
EIFLNAAKHFNLDPKECVGIEDAIAGARAIKAANMNLIAISQSISEEFDS
DFMLLKSTRELNFEKIMNYFSLK
>MS53_0494 pgsA, CDP-diacylglycerol--glycerol-3-phosphate3-phosph atidyltransferase
MTLFRIGLFVPLLIFILLAVYADVKNGYLIFNSLILVTFVLAMATDFLDG
YFARRWNVVSETGKLWDPLADKIITTTVLIYLAGVNFVPFWIVVLIVVRD
LLVDGHRVAMAQKNIEVSASIFGKIKTIVVSLGIVMVLMLNLIFVDLIQS
NISSGNVAGAKQYLPYINPNLRSYLGQALNTLSVPNVDMPNNDVLGTSEL
LHNFLNVNTVDLADNTKYILVTNLALLLGMLTSLLSGGIYLADFYRKNKS
>MS53_0308 pheS, phenylalanyl-tRNA synthetase alpha chain
MKLDLNEINNLEDLKKLKAKLNAADSEMSLLKEEIKKVSYEQKAFLGQKI
SKLKNKYQDFFEKCEEKIQKLKIQEKINNEFFDFSKLVNKPAKLHVITEI
ENRFRTWFLAHGYYESFSGEITDDFENFEILNIPQSHPARATHDSLYFNK
TKLLRTHNTGISINEILKSDKKEISTFAIGKVYRNDEDDATHSHQFTQLD
FVCVGKVGFSNLIWTLKSLLSYVLEEDIKIKLRPSYFPFTEPSVEVDVFY
KNRWIEILGAGMLHPNILKNKKNWSNESAFAAGIGLERIAMIKYGFNDIR
ELYSNDLRIIEKF
>MS53_0306 pheT, putative phenylalanyl-tRNA synthetase beta chain
MNKYLPEIKLDQSVTKALESLGFEVEFFEKFSSSKGLLFAKVLNVFDNPN
STKLQVVELDTKLGELTIQTTNKVLSKGDLTICYPVGSSYQGKEFQEVTM
QGYKSQGMLASFSEIGYDNSLLTDKDQILVLPKNFASLNDDASEKLELND
YIFELSITTNRNEINSYYFLAKELAAYYNTKFSCEFLDAKLKQSFESSFK
FEGNFLDKNYSFTLLEAKGKVSTSFEEKLLLAKHKIDSKFNPAVNLTNLV
LINLGIPIHVYDKAKLKSTKFSVGLYNGKVNLLGNKQVEVSDALAVFNGD
KVVSLAATMGLEESKVDLQTSEFIFEMASFPSKLIRNNAKEIKMNSNASN
LASKTITKYQVKLAHKFLFNYLKDLKLSNVVNDFELDKKVEINFDEEKLQ
RYSNGLPSSEFIKAFDKLKLLEFEFENQKIKVPLYRYDVSIFEDIIEELF
RFYNYDNFKEIPYIQIPGELKADNKNFKEKLKALGYSEARTFTLVNEKDS
KFDPLDLSDAIKLETFVSKEREFVRNSLAISLAEAVNNNKKKKINNVNLF
EVGMVNANLFYACLATTDKSFLELKQDFVSFFDNLNLEFKKPKNQFLHPN
YSAEIYLNDQKLGWIGKINPSFLDLDCLFVEFKYDLYFDDKFKKYEAPNL
DVLKSIDLTFELNNNEHLQKYLDKINSVAKVFEIKEIDDFKKETSHNVSL
RITAPSAEIDKLNSHFNKD
>MS53_0121 pknB, serine/threonine-protein kinase
MNDSNVYKKYEIISPLGEGGYANVFKIKSKFNNKYYALKYLNIQNKNSEF
ERFTNEAHLIKNLNTEYVPKIFEFYKDTKEAYMVLELINGSLVSEKLKAH
GRINVKDAVQIIKSIAYAVQEIHSHKIIHRDIKSDNIYITIDGKIKIIDF
GISIEDDVDQQRFTRESSVACSPFFMAPEIVNRNKPINKSVDIYAIGILF
YEMITGKVPFKGKTASETIKKHLSSEIPNPQSEVEEIPNSVVNIIYKALQ
KDPEKRYKNTLDLIFDLENSLNPKFLNQSLFNPKNLQEKKNFSWFIQSKF
FLVFIFSFIALCFIGIFVLLHFFGVY
>MS53_0097 plsC, 1-acyl-sn-glycerol-3-phosphate acyltransferase
MTLKKIVFALPWFFRVLKIRKMAKNYKSNPETYSEKFRYNYLLKLCEKIL
RIYNIDLEVIGYENIEKGYGFIVPNHKSGIDPIVLIAALKNPSQEEGAEN
KFATFISKEEQSKILIKAMSLIDVVLIKRNDLRNSYEGLINFGNYVKNKK
VYGVIFPEGTRVKGEALGEFKSGAFKIAKSNYLPIIPCAISNSADAFNSN
RKKRLKVTVSFLSPLKPQSFMILENEAISNRVKELISKELHKNAN
>MS53_0674 plsX, Fatty acid/phospholipid biosynthesis enzyme
MHIVFDINGNDKGPQAGYNAAYEFCLKNPNDKITLIGEISLLKQNENLEN
LFLIENNLKVATPKNIRENLKMPTSMNEAIDMVKNSKADAILSSGDSASY
VAGLTLTVGRIPNLSRPTFMPVANTINGQKLLILDVGSNTEVKPEYLYQW
ALIAKVFYQKMFNFSDPKVTILNIGSEAYKGPEFLLEAAKLISKDDSLNY
IGFSETREVLYGNYQIALIDGYGGNLVLKSYEGAFNTFKHLLKDGISKSF
RAKLGALLLKPAFENISKVLDYKKVGAAWVFGINTLAIKTHGASDKVSYL
YALEELKNGYKSNFLDVIRKTLKEN
>MS53_0004 polC, DNA polymerase III alpha subunit
MKEYKDVKVKSFANYFNLEFYENLIDIKLLDYSIDQNTKKINLSFELDSF
PTVNDFFAFIGNLDNIKDFKVFYSFSFLKINNTESWIEDFLKTACGYLKL
NELNSVNKVNNQFFYDEFSKSWKISLTKTANEIKVEKELLKLNKFLEKIG
IDIIYCFIDNKDSANNSDESDIESSVLNFVQNFQEEFETNSPSTFSKNKF
RKKQSREIQFFSIKELNENFSSLEKEQISVKGTIYKKELLFKNNNFEKHN
LFITDYDDAIKLIASKSSKVKNEFLDNLEVGKTFIFYCYVDTDQRGNKYI
QITKVNTSPDLREYSTDHQKIKRIEFNCKSKNNTLDGLLTPEEIVAEAKR
QGHSAVGISDYNSIFSFPEFYYAAKANNIKPIYGAGFAMLEDTNGAFLTE
FQNQDLITGRYVVFDIETTSLSAYHGEIIEFAATIIENKAVVDKVDIFIK
SKEKLSHFTTRLTSITNEMLDQKGIELKEALQKIYDVLNNNVAVAHNANF
DYNFLIEKFDQNNMQAPKCTFIDSLVVSRILFEHRDKHNLNEFCRNLSVN
YDTEKAHRALYDTEVLADAWIEATLKLKDIKQISNFQELSEYKSDALFSK
YFSLYINTVVKNQAGLKELFQLVSIANTKTFYGAPKIFWSTLKSFKNILV
GSNGVQGELFDILLLSSRQRVEKYIQKLDYIEIPHPDLFDSYLDRNQLTK
DQLLESLQILISLAKKHNKLIISTAEPRYRHKGDREIFKVLTSFPIRDKR
HFLWNYKAVKAGNYSVPNFYFLTTDEMLDAFSFLKDKSLIEDIVVNNAHK
LNNLIDENIEVIKTDLYPPSIKNSSELLKDLVYKNAKKKYGEVLPKLVQD
RIDKELIPIINYKFDVVYWISHILVKKANDDGYVVGSRGSVGSSLIANLI
NITEVNPLEPHYICDNCKHFEVVNNDKITSGYDLDDKNCPNCDSIMDKDG
HSIPFETFLGFKADKVPDIDLNFSGEYQIAIHNYTRELFGEDKTFRAGTV
SSIQYRKAFGFIKKYIEDTNTFYSNGFIDYLAEKCIDVKVTTGKHAGGIV
VLPENLDIEEFTPVNYASDGLEDKEWKTTHFKYDFLKENLLKLDLLGHSD
PTQIRFLEQATGLLSKNIPKKDKNLLKLFSSTEPMEIDPNDINGETTGAI
ALPEFGTKFTREIIKTSKPHLFADLISISGLSHGQNVWKNNAEDLILNEN
KTLNEIVCCRDDIMNYLIKKGVDASLSFKVTESVRKGKGVDSEDIKILST
YNIPDWFFDSMQKIKYMFPRAHAVAYVIMAWRMGYYKLYYPLEFYASFFS
VKCSKFDLSAMIDFSKDGYWKIKNKIEEIEKLIRTNNKKDNKKEEDILES
LNVALEMYSRGFTIQNIDIEKSDAYNWIIDKDSKSLIPPFSALDGIEAGA
IKIINARKERPFKTVLDFAKRSGVSSTIVEKLKELNVFKDLPESEQLSLF
G
>MS53_0508 potA, spermidine/putrescine ABC transporter ATP-binding protein
MNIGGFFLQNNTTKSVKNNNVIELIDIVKQFDEKLVLDNVNLNIKRGEFV
TLLGPSGSGKTTILRLIGGFEWATRGEIKFNGVDIKDLSPHKRNLSTIFQ
DYALFPHLNVEGNIMYGLKLKRVPKENVKKEHKNLLERKIKVWTEKAQRE
MKNLDKLQEEYENELKVLKPGTYKHQKRQTWLDDSDFKYSYWESYVLQKT
EEFKNKYFKRKLTKEEIDQTVDKIVNLVGLQNNKNKKITELSGGMKQRVA
LARSLIIEPEILLLDEPLSALDAKIREKMQVFLKQIQQELKLTFIFVTHD
QDEALELSDRIAVIREGKIEQYDTPKQIYDYPRNIWVAKFIGNSNIFNAK
FLKDSKVELLNKEFKTIHDEDEFAVDEEVDALIRPEDIDIVNQTQNTEHK
IKGKIVESIYRGSYYYIKVELKDSNYIFVETAKNFAVDETVYLSWTIDSI
HLMKKDPKWDYAKKDF
>MS53_0509 potB, spermidine/putrescine ABC transporter permease protein PotB
MLLIPFFVIAILLILLPIVLILVNSIAPRNNFDNWLLVKESNTWNIILRS
LKLGFIASIICLFIGIIYAYWVSKSKNKFFKIYALTLIISPLAIFTIARI
YSIKGLFLALFAGDPKSLNSEWFIVVGLVYLNLPLMIMPLYSVFKDMPKN
TVEASNDLGYSNFKTFFKVIIPYATKAILSGIAMIFLASATTFVVARKLL
PDGSQNQLIGELINEKINPGNPFDLSSGSALVIVVSAIFIGTYLLILIVP
KVIYHFKKGAVYE
>MS53_0510 potC, spermidine/putrescine transport system permease PotC
MSDFSNWKTILRSSYIYVILLAVYIPLFFGLVFSFNQETPKGEFNTTWTK
GTFENWRNLFDFGRDASAVNSFLLAFIVGFINVFLSLITVYALYRQKNKL
AKPAVLSNSNIPLVNPDNITAIGLVLVFGLFFGITATDSEGFFRVIVGHV
VMVIPYGISLSLPRSYKFNNNLFEASQDLGYSKLRSWFKTYFVYMLPSIL
MTFVVSFVFSIDDFIIARTVSNTSTLGTKLYEGAFQAWGLILGSIVLIIT
LVGNVIYTIINARKKK
>MS53_0148 ppa, inorganic pyrophosphatase
MKLKVVIEIPKGSNVKYEFNRKTNMLEVDRILREDFLYPCNYGFVPSTLD
WDGDELDVLVYSPEKFLPNSALNVRVIGAMKMVDDGETDTKLVAVHADDF
RLEHIKELKDLPLSFLVNLEAFFANYKNFKRVGITKVEGFESKEWALEEL
KECYELFEKYSSLPKDDFIKKMKEKHPEKYS
>MS53_0183 prfA, peptide chain release factor 1
MEKSIINSLLNIKEKYQDLKSQLNLPEIIADIKKYTKLSKEINSISEIVE
TFDEFLNLEENIKSSKELLDIETDAEVIMLAKEEISQAQSKQLELEEKLK
VLLLPKDKNDNKDVIVEIRGAAGGDEANIFAGDLYRMYTKWCQQNNMKLS
TLDLSPAVSGGFTLVTFSIQGEKAYSKLKFESGVHRVQRIPVTETKGRVH
TSTATVTVMPEIDDDIEIEIKKEDLRIDVFRSSGNGGQSVNTTDSAVRIT
HFPTGIVVSCQEGKSQIQNKDIAMRILKSKLYDLELQKKQSEESGYRKLA
GSGARSEKIRTYNYPQDRVTDHRIGYSTSLNYVMEGRLNPIIEELLLEEQ
KEKIAQAGI
>MS53_0492 proS, prolyl-tRNA synthetase
MKQLEKITPLEKDFAQWYTDVVTNGNLMNYGPAKGTIIYKPNSYGIWENI
QKTLNEVFKKHGVENIYAPLFIPESLFKIEKEHVQGFNPELATVTQVGNK
KLSEKLIVRPTSEVIFANLFKEDINSYNDLPKIYNQWANVVRWEKVTKPF
LRTREFLWQEGHTSHSSAEEARSFTVKMIKEYEKFLKNYLAIPVVSGKKT
CNEKFAGAVSTYTVEAMMKDGKALQTGTSHYLGQKFSRPYGISFKNKNNE
EDFVYQTSWGVSTRLLGAIIMVHGDNRGVIIPPKIAPIKVDILEILADKN
PEVSKVANKIYKELSKKLSVRLDASNKSPGFKASQSEIEGVPLRIEVGPR
DLENNCVTFVRRDTLEKTKVDLENVKKEVNNYLKLIQNNLYQAAKQRLEE
NTVYAYNYEDFKKHIVDNKFVVVPFCCVTKKEIEIKEETGATPRCILKKV
KPRGVKLECVCKSDGCCDDDKAIKYVVFARAY
>MS53_0122 prpC, protein phosphatase
MISLKSISITGAYRKKNDDRVSHFENDDFLVALVCDGMGGHLHGDIAAEE
TAKIFTNQFSKNFSYISFQETSLWLKNVVNLVKKRFKDLIKSDFSKERMG
TTLTGVLILKKIQKIIVFHIGDSRCYFYTKEKKLVQITQDHSYENKLLSA
GISLEEAKSNPKGRLLTSVLSLKNKITFNIYDLDQIDYAKVDKIILTSDG
AHEFISSEEFKAELKSSSSEKIVNSLVEIAQKNDSTDNISCIVIKLGE
>MS53_0150 prsA, ribose-phosphate pyrophosphokinase
MDNSNIILFGMDNCKVLAEEISKILNIKLTPIVKTTYQDGETMLVSENTV
RNRDVYIIASTSKNVNHSYMELFLFLDSLKRASAKNVTVALTYYGYARQD
RKVSGRQPIGAKLMANLLQKAGADRIISIDLHNPSIQGFFDIPVDDLKAQ
YPLALELKKTYSNNFTIVSPDHGGTVRARKFAELISDNLKICIIDKRRTG
ANQSEVMGILGEIKNQNAVIVDDIIDTGGTILKAAKALKNEGAKDVILVA
SHGLFTKGFEIFENDENIKEVLITNSVDNYENLSKFKKLKIVSLASFLSE
VISASVVGESISEIYKKWKEAITLFNNGIQK
>MS53_0653 pta, phosphate acetyltransferase
MNYELNLKSQVDALKSVKKIVLIDGDDQRALDAVRELKAQKNIEVLLLTE
KQENSSEFEFVNIFADEAKTKKYVEQYLELRKNKETLEQAEKAMASRPFH
AMMMLHNNEVDGVVGGLKFTTADILRAAFKVIGPKPGIKTISSIMVMHKE
EQQMVFSDISVNVSPNAQQLSEIATNAAEAAELLGFPNPKVAFLSFSTSG
SAVTEESKLVKEATDLFNASYAKTKAIGEVQLDAAIDLSVRKSKYKQDSY
DEKANLLVFPNLSAGNIGYKLVQRYGNFGAIGPIIVGTKKPVNDLSRGSS
VNDVVNTVLITALQSEGSK
>MS53_0616 pth, peptidyl-tRNA hydrolase
MKLIVGLGNPGDKYKFTRHNVGFLVIDLICQKLKITLDKEKTHGSYAKFE
DFIIAKPNTYMNLSGNFVLELANFFKIAPDDILVIHDEKDFELGKSAIKI
GGSGGSHNGVLDVINKLNTQNFKRLKIGIGQNQEMALKDYVLQRFSLEEF
SVLEPVLNQAADVCIQYSFNDIHYLMNKYNQKKKNGN
>MS53_0147 ptsG, PTS system, glucose-specific IIABC component
MSIAKLGSFFRSKKEKNSDNSGSGNARKILSKLSGAFMLPISVMAIAGLF
LGVGATVAEKAAGVAAVQKIGELLKILGDPVFGALPLLFAAAFVIAFTDE
AGVAVFAAIIGYLVFSAVQGVFITPVTSTVDGKEVIDGYVVLFEQGGRSA
KSLKQLVGSTLGIRSLQTSVFGGIVVGLVVQYLYNKFHTIQLPRVISFFG
GKRFVSLVTIPAMAVLAFVFLLFWPWVGIALNFLGEALNKTPVGVNSLIF
GYIERSLIPFGLHHVFYAPVWYTPAGGDLNAALQAFVSTNSLPLDLSLEG
AEGAAAAAGVSEGYANFVKLFQDVAKEPNGFQGDSTISLKLLGYGNTVAL
FSPTELVALKNPSSTIPTTLSWVGKTISQPVTVAGKTYYLYSNVPLFAFV
QYALNIKIGQYLDGKFGVMMLALPAAAAAMIFAAPKENRKVAAGTVVPAA
FTSLITGVTEPIEFTFLFLSPLLFWGFHSIMAAFSFMFANLLNVHIPMAF
SGGILDFVIYGVIPFQKGTQFWFPLLTGAAYMPVYFFVFYFWIKYKNLET
PGRGGNTKLFTRKDYEAKKDAKHSAEGMTSAKTVDPQAYAVVQAYGGTEN
ITAYNNCASRLRYDVKDVRKVNPEALKAAGAVAVKFEGSNHAQGIFGPVA
EQLNSKIKSQRDLIAAKEAEEKASSVRKLDQAPVVEKEVVKKETPVRKTT
VEQLTKPVSLYTPARGDLKPLEYLNDGVFSNKTMGDGFVVRFVSEKVGNV
YSPVDGVVTLVFPTKHAYGIETKEGVKLLVHIGIDTVNLNGQGFESFVKL
GQKVKAGDQLAKVDLPFLKRHKVKSDVITLVLPESKYKNFSVTLDTNEVP
KLGIRVGLVR
>MS53_0394 ptsH, phophocarrier protein HPr
MVTKEFKITDPIGLHARPATLIVSTANRFKSEASLHFNGKKANLKSIMNV
MALGVRTNDHITLEFSGDDEAQALEAVEKVMLDNKLV
>MS53_0523 ptsI, phosphoenolpyruvate-protein phosphatase
MLIKGIAASKGIAIAKVFKIEELPLDITQKTSNKDEELKLYDNARELVKT
KIQASAKLASSSEHAAIFEAHLNFLEDPSALEAIRNDINTNSYTAEYATK
SFYNNFAAIFESMDDTYMKERAADIRDVCKKLLYALNNIEETDLTQISEE
VIIVAEDLSPSQTVQLNKKYVKGFVTNIGGPTSHTAIMARSLGIPSVVGT
NSIMKHAQNGQLLALDGAKGEVLLNPSEAEIAEFKKQEQLYRDYLNKLKE
LKGKKSITTDGHEIEIEGNIGTPNDVESVLENDAQGIGLFRSEFLYMDNE
NWPTEDEQFLAYKKVIEQMNNQRVVIRTLDIGGDKTLKYYKFPEELNPFL
GFRAIRFCLQNEDVFKTQLKALIRASEFGRVSVMFPMITTLDEFLRAKNT
FEECYKEVSSANPKVAKREDIELGLMIETPAAAVLTEQFCKYADFVSIGT
NDLIQYSMASDRMNENVSYLYQPLNPSILKLVKMTIDGAHKYGKWAGMCG
EMAGDKRAFMILLGLGLDKFSMSASSVLSIRDLVRNTTFARAKEIANHAL
SLETETQVLEYLKSENLL
>MS53_0648 pyk, pyruvate kinase
MMYKETDKRTKLVATIGPSSDNYEMLKKLVQAGVTCVRANFSHGSYEEQK
NKFNLAKQVSKELNLPLSLMLDTKGPEIRVGKMKDGVQLIKQGTMLDILT
TEEAYKNLEGNSEQISVSYDMSLDLQVNDSVLLDDGKLSTKVVKVSKGLV
QVYVQNNHKLKTNKRINLPGVDFSLPFLSPKDVEDVKFGVQNGISYVAAS
FVNSAENVKQLRKVLVENGGEHIEIISKIESTLGIKNIDQIIEASDGIMV
ARGDLGLEVPYYEVPYYQKMIIRKCREAGKPVIVATQMLDSMENSPHPTR
AEVTDVYFAVELGADSTMLSGESANGGFPLEAVQTMTKISKRAEREFYSK
IYYPVHLEKIKEKLGSDLRSLIAYEIAKKTQGNEYKFAIVLSRTGKLLKK
VANYRPNTTIVGILDDEKLTNSFGIYSSVFTSLDSKELFSEIKKDHSKAI
LALKPFEYSKGDKFLVVENDSIKEYTVQ
>MS53_0677 pyrH, uridylate kinase smbA
MIKYKRILIKLSGEGFANKEKNLAIDFELVAKIASQLKIIIEKGVQVSIV
VGGGNFWRGVSAEKNGIPRNRADFIGMLATEMNALALQSGFEKAGLKARV
QSSINIDQKVAENYINEKTLKYLNNGEVVIFAGGTGRPYFTTDTAATLFA
AEIKAEVILMGKNKVDGVYDSDPKKNENAKHFSKITYDQILEKKLQVMDL
TATSMARDNNINLIVFNLLEDNSIIKALEGKITHTEVTR
>MS53_0082 rbfA, ribosome-binding factor A
MNEINLKRKESEILNLIANIVAFDLHNVNISDVVVMDVKLSNDLSHVKVF
VVVESNVQKTLIALNNSAPAVKRILSKTLTWRKVPTVTFVLDAHTAQTEK
IEKILQEIKND
>MS53_0561 recA, recombination protein
MGDKMIENKNIKSALNEIEKKFGKESIMVLRDIPNADVEVFSSGSILLDN
ALGINGLPKGKIIEIYGPESSGKTTLTLHAIAEVQKNGGIAAFIDAEHSI
DPQYAANIGVDIDNLILSQPDSGEQALEIVDILAKSGNVDLIVVDSVAAL
VPEAELNGEMKDQQIGAQARLMSKALRKITGNLNKNQTTIIFINQIREKV
GVIFGNPETTTGGRALKFYASIRIEVRKGSQITEGKDILGNEVKFKVVKN
KLSAPYKVTQSEILFSKGIDRYNELATIGIENKIFDKKGSWYYYKENNVA
QGKAALKTYIESNPEIISEIQDTLKSNKL
>MS53_0617 recD, exodeoxyribonuclease V, alpha subunit
MKDITQLVGKFTKIKAGGPEVGWGLYIFQSTDSLLRNCMVYITKKSVGSM
PTLFRNYKIDLVNNSNPNYKNSSKTLVAFTEFYEDQLTQEEKNKLLETIL
LKVKNLGKVKIERIIKNFGFDIFKHHSDIDALKEQTKDILTNLQIESLYE
YFQNHLDLIKSSFLNSKEISNFDIFIEQNKLSELKEFLVKKHPSNFDFLK
HYKVSDPYVWYNRNEFDNFALLDYFALKLNWGMSCDERINALTKFCFLEL
ITNNSTTVELRLLNSKIKEFIHEENSYWNGYPEDKNELEKTFKVVREIDG
KIYVALSIIYDKEKKIASFLKMLNSLNPIVLDSLPDSETKTLSEGQKSAY
ESFLKNNITIISGAPGTGKSHIIKHIHNTLKQNKYKNQKEYAILAPTGKA
SLSVSEKINAKVSTIHSFLQIEPSSEHTIKVKQINTEVKFLIIDEFSMVN
TYIFNLLIRACPNLIKLVLVGDVDQLPAIGPGNLLSDIVESKLFNVFYLD
KYFRSDSIEIFNHFNSIKTNSPPNFKDGIINYIKYLDSKYLSSVVDLFCE
IAKESGLDNLMLLSPMKVGDKGLDAINKKIQDLINPDSELVYSTKFGNKF
KINDRVIQQENRLDDDVYNGDIGFIRKKIGTKTQDIKILVEFKNNKLIKY
PLNEFLSQIKLAYGITVHKFQGSEIDNVIFAFADTHKRMLYKKLIYTGLS
RAKKQIWIVTNNKIDYPNLIKEIQNETPIYTNLKYILKGK
>MS53_0053 recR, putative recombination protein
MFNLSLIEEFITKIRKIPGISRKQAEKIVAWILYSKDDEIYELSNYFKKL
KDNISFCSFCNIPQENNNCYICNDTSRENKLLVVENPLIIEKLEKLSLFK
GKYFVFKNLVKNEKSLDKFYLDLSKLLKYCKNFEEVIFGISPTLEGEVTT
NLIRKEFEKFQINSSQLAIGIPIGASIDYMDEITLKFSIKNRQK
>MS53_0563 ribF, riboflavin kinase / FMN adenylyltransferase
MQDLIIYKFDQWTPQENDNYIIGAFEAFHLGHFQLYKKLLNNSGRKVIVT
FNNENLYKDANYFFQDNHSKYLNFAKLNIDCVVELDFQDIKNQSGQDFIN
KLTNNLPAKVIVGKDFRFGKNAKYKASDLSLINPNLQVEILEFYKFNNSK
ISTSELKQLVEFGDIKLLNSLLVYNYNFSGTLNIDASVELNPNLTPLHSG
IYLAKFVIKNFLYYGLFIKEFNKNCYIYIFDLDLDIKIEQTIDIEIFYNL
KLITKDESKYLNDDLIEMAKKLMLKFVN
>MS53_0318 rluB, ribosomal large subunit pseudouridine synthase B
MQKILSQAGVCSRREAEKLILEKKVKVNGQIATLGTKASFEDEILVNNKP
ITQREELVYFVLNKPKNTVCTLKDNFNRVKVTDLIDTDKKIFPVGRLDYD
TTGVLLLTNDGKLSNLLTHPSSEIKRIYRARISAPLTDKEMEILSKPVII
NNQRSTQEIYPADTKSYYVVLHQGSYHHVKKLFELVDKKVLDLNRVEFAN
ITVKNMQKGQYRRLTLHELKILKMLVNYKEN
>MS53_0094 rluC, ribosomal large subunit pseudouridine synthase C
MVSFKASKNDENRSLFKLICKYFPNLTIATIEKLFRKKEIKVNSKRITDK
KFVVSENDLVEVYGISESNLNLPQIKKVSFDFQIIYEDANILIIDKKENL
VIHGEDNSLDNQVLSYLKHKQIDSFKPSHVGRLDKETSGLIVYAKNYLTL
KQLNEKSFNFKKVYQFKSDFLSSSPLELKLYFYKDENNKTKISKTQKENS
KLAHSIFYCENNKKFAQIITGRKHQIRLSLAYLNKPIYGDKKYKGKKSTR
LMLHSYYLKFLNLEDNLKYLNKMEFYSNPKW
>MS53_0595 rluD, ribosomal large subunit pseudouridine synthase D
MLNLTVTYKDRIDKYIASNSSLSRADIQELIKSKAVFVNNGLVCKPSYIV
HPPQEIKIIRLLDKTPKIEAQNIKLDIIYEDDHLVIIDKPSGLIVHPSPT
HYENTLANGLLYHFKNNLSDTNGLLRPGIVHRIDKDTSGLLIVTKTNAVH
IKLAEMFKNHSIKRSYIAICDNFLTDKKLRINLPIGLDPKNPQKRKVTNI
KAKEAITNVELIKTFYHEKQPKSLVKCNLETGRTHQIRVHLAHINNPIYG
DNVYNKKIDDFNQRLHAYKLEFFHPMLEKQMTFYSKVPSEFNICEYDFEL
LKG
>MS53_0675 rncS, dsRNA-specific ribonuclease III
MEKDNQPSIEELKAFLQKNNIEYKNIDLFIEATTHKTYSKVNKNSKDYER
LEFLGDSLVGFLISDYCVREFSSLEPGELSRLRSKLVDKLALFKIAQKLK
VEQIIKTGPKKARNEVLSSSNVLSDVVEALIAAIYLDQGMQSAKDFIKSH
FYEIANKAQNKPNKDPKSELQEYFQTISAETVKYETIEIPNKRSFESKAW
HLNKIYGTGVGLSKKDAEKNAAANALSKLKT
>MS53_0619 rnhB, ribonuclease HII
MYRDEAEIKKIYDKSKFVFGIDEVGVGEFFTPLIATAVYVPKDKLEILKN
LGVKDSKLLSDEKIKKVFNDIKSHIQYASALISQKSYNILFTKFNANEIK
FLAHAEAINNLRKKVKKSELLIIDAYVNSDPSFNKYYEKIIVSYKDLYGF
SPWKEKIAILKKAESHYIEVAAASIVARYELLLQMQKMQEEFPKAKFNLA
SNKETLMLRDNFIKLYGKEKLPLVAKVVFKFKEDAKK
>MS53_0600 rnpA, ribonuclease P protein component
MKKQYRLRKNWEFDLVLKNKKFIANKYVIVYYKKASAFKVGITVPKKFAN
SVGRNYHKRQMKAIVHKMNLYNYPYEMVIIIRKNFINCNFLTKVIEIEKI
FTQFKQQNEKIK
>MS53_0119 rpe, ribulose-phosphate 3-epimerase
MKENRNKLVTPSILNVEKEKRIDYVNSLIDLGISWFHYDVMDAKFVENTA
IEVDEIIKISKKTKSHIKDVHLMVENPYEYVDKLKDYVDIFTFHYETIEN
DLDKFEEFLDLNKHNLRIGLAINPETDVERVFPFLEKLTLVLVMSVNPGK
GGQAFIESALDKIKKLKFERLNLRKNYEYLIQVDGGINNLTGPKCFKKGA
NLCVVGTFLVKSPTKETINSIFK
>MS53_0392 rpiB, ribose 5-phosphate isomerase B
MNKVIPLASDHAGFELKERLEKHFQALGYKIVDLGAKSNLDSDNNYALAG
HDLAHYMLENKCEFGIGICGTGLGISYALNRHNHIRAARVTSNEDAHLAK
LHNDANVLVFGARQVSFDQAKEMIENYINTTFEGGRHLKRINDIDRT
>MS53_0024 rpiR, transcriptional regulator
MKKQEKSQISHPILLNNSKLINSENKVLEFINGFQGEVFNYSIEDLAKLA
NVSTATVFRFVRKYGFKNFKEAIIFINKNLQKLNEKYPLSTSQDNNISTI
VAGNKYVLDNLYTNELQKIIEKAAQIIYNSKRILIHGAGSSKRMAETLVS
NLYKVSLNVIAHDDFHLFLPVLGNATTEDVCVLFSDNLNSPEAAFTIKQC
REKKVQIILITSKKKSNLITKNDVVILYEKITSKHLNIPLSSKWSQLLIA
DLLFENLLILDSNLREKLNNSIQIINKWKANL
>MS53_0623 rplA, 50S ribosomal protein L1
MAKKLSKNQQKVRALFDANQAYDLHEAIELAKKTSYTKFDASVDLAFKLN
LDVRKADQQLRGSVLLPKGTGKDVKVLVVTNNPEKQKLATEAKADFVLDA
AAFEQKLKEDDYNFDVIVADPAMMPILGKYGKKLGPKGLMPNPKTGTVTP
TPEKAVEELKKGKANYRTDKAGVVHSLIGKVSMPTESLVENAQTLISLIK
KLKPAAVKGTYMQNLTVSSSMGPGIKIKLEK
>MS53_0640 rplB, 50S ribosomal protein L2
MAIKHYKPTTNGRRNMTSLDYKHNLSGDKPTKSLLRILKNSAGRNNQGKI
TVRHHGGRVKRFYRLVDFKRNKDNIPAVVKTIEYDPNRSANICLLAYADG
EKRYIIAPKGIKVGQKVVSGEGADIIVGNSLPLSNIPEGTFIHNIEMQPG
GGAKLARSAGTSAQILGKDDNGKYVVVKLKSGETRRILARCRATVGMVGN
EEYSLVNVGKAGINRHRGIRPTVRGSVMNPVDHPHGGGEGKQPVGRKSPL
TPWGKIALGVKTRKTKKSSNKLILRRRKDAK
>MS53_0643 rplC, 50S ribosomal protein L3
MKGILGRKVGMTQIYSETGTAIPVTVIEVKPNVVTKVLTKQSNGYEAVQL
SVFDKREKLSNKPETGHFKKANTTPKRFVKEIRNMNGYELGQSVLVNIFS
VGELVDVSGTSKGKGFAGAIKRYNQHIGPKSHGGGGGSQPIRQTGSLGDI
SGNRVFKGMTMPGHLGSEKATLQNLEVVKVDLKENLLLVKGSVPGAKNSF
VVVKSAVKGLPAKAAVKLVDVKEVVLMNELVEKAKKLNVEVKVGMHSDEL
RPLIEQAELEAAKEKEGE
>MS53_0642 rplD, 50S ribosomal protein L4
MVKPQFNAQVDKRMLVEEVHQQAIFDSILSERASRRQGTHQVKNRAAVSG
SGKKPWKQKGTGRARHSSRRSPIWVGGGRAFGPQSVKNYSLKVNKKVKQL
AFRSALTMLVNDKAVLVEDFKMDKISTKDLSQKLKSLNVDKLRHVILVSE
NATVFKSSANLKNVTTLKAHSLNVETLVRADVLLVENESMKLLTERVLGS
N
>MS53_0631 rplE, 50S ribosomal protein L5
MMLKQKYKSEVVSALVKEFQYSSVMEVPRIEKIVVNMTAGKEVNNSKAIE
EVLNELTLITGQKPYQTVAKKSNAAWKLRKNMPMGGKVTLRKDRMWDFLE
KLITVAMPRIRDFRGANHKAFDKNGNFALGIKEEIIFPEIEFDKIRRNKG
LDVIVVTTAKTAKESKRLLELLGMPFDDKKHTKESAK
>MS53_0628 rplF, 50S ribosomal protein L6
MSRVGNRVLVVPAGVTVDISASNFVSVTGKLGKLERAFSPKVKITLQDNT
LTTQRLNEEKATKQLHGTTNALLANMLKGVSEGFQINLEIKGVGYKAELK
GNKLVVAAGYSHLVTLDIPSNVEVKVPKPVEISVKGIDKQAVGAFAAVVR
EIRKPNPYSGKGISYKGEKIRRKEGKTASK
>MS53_0426 rplI, 50S ribosomal protein L9
MKVILTKDSKYGKENAIIEVADGYAKNFLIPKGFAMAYSQDNLKIREQKL
SDLSALEHEKRSKARELQKQIEELSLMFTLDAAIDKAQNLHVHGSVSTKE
LKTKLLEHKIKLHDHAIQHVHLNVEGTHVVEVSLYKDIKAKLRVNLHINV
KK
>MS53_0420 rplJ, 50S ribosomal protein L10
MKESSLKLAKKVTVSEITNKISSAKAIAFAEYRGLTVAQLKEMRVEAKKV
GVELKVYKNRLFKLATDKLGYDLSSFLVGANIFAFSNDDDMSAAKLLVKF
AKKHKEFVVLKAGTFEGKVVDTQELKKVAALPSYEEALTILARSLMAPLQ
QLSLGLKLVSEQKSN
>MS53_0624 rplK, 50S ribosomal protein L11
MAKDVQKVAKLQFLAGKAKPGPSLAGVGVNMPEFTKAFNDATRDRGDEPV
PVQITVFKDKTFEFKLFTAPASYKIKQAAKIQSGSKNAKTTIAGTITLEQ
LKEIAEYKLPDLNTDDVNAAMAIVAGTAKQMGVLVEGYDDVAKAKQAAIE
AAKAESLAKAKKESLKSQEEELKASKGKAIDVNVIEKEREEKE
>MS53_0421 rplL, 50S ribosomal protein L7/L12
MAKLTKETFVESLKEMSIKEVMELVEAMKEEFGVDPAAAVAVAAAPGEAA
EAAKTSVKVVLKADNGKKVQIIKAVKDLLGGSLMDAKKIVDNLPAVVKEN
IKPEEAEPIRAALVEAGAEVSVE
>MS53_0076 rplM, 50S ribosomal protein L13
MRQTTIVNKENSNKKWFVVDAENQVLGRLASLVASVLRGKTKPTFTPNAD
MGDNVIIINAEKVKLTGKKEKNKVYYSHSGYPGGLKARTAEKLREEKPTA
LLEKAISGMIPHTKLGNQQRKNLYVYAGPEHKHQAQNPERLEVK
>MS53_0633 rplN, 50S ribosomal protein L14
MIFELSRANVADNSGAKQVGVIRVLGGSKKKVAEIGDVVICSVKKALPSG
DVKAGQVLKAVVVRTKRNTYRSNGSYIRFDDNAVVILKDDGTPVGTRVFG
PVAREIREKYPKIVSLALEVL
>MS53_0625 rplO, 50S ribosomal protein L15
MKLHNLKPTPNSRPEKHRKGRGHAAGKGKQAGKGQSGQNKRKGHRLGFEG
GQTPWFRRIGKRGFKNVNHVEYQVVNLSSLEERYSNNETVTLESLFERNL
IRRSVELRPVKVLAKGKLTKKLTLQVHSVSQAAREAVEKAGGKVEEL
>MS53_0636 rplP, 50S ribosomal protein L16
MLQPKRTKYRKPFLQSHDKRKAHKGNKVSFGSHGLQAVTSAWVDSRQIES
ARIAATRSLGREGNVIIRIFPHFSKTSKPIGVRMGSGKGSPEKWYTPVKV
NTVVFEIQGVSAERAKEALRLAGHKLPVKWKIIEKEGVN
>MS53_0573 rplQ, 50S ribosomal protein L17
MANPTQIYSRDSKWRRGVMRSLVSELLLHGRIQTTLTRAKEVRGHAEKLI
TKAKAQSLASRRHAASFLRPLVTKDNKTLLQELFDTIAPKYKDRPGGYTR
IYKLPKRDGDSTRMALIELV
>MS53_0627 rplR, 50S ribosomal protein L18
MSRNKARKVKQKRLRAKSELSRAASKPRLSVFKSHANFYAQLIDDQKRVT
LASVSSLKSGKYGGNVAAAKELGLLMGQKILDLKLETVAFDRNGYLYHGR
VKAFADAVREKGVKF
>MS53_0012 rplS, 50S ribosomal protein L19
MLELIEAPQLRTDLASFKTGDNVKVHLRIREGEKERIQIFEGLVIKKSES
GTREMFTVRKYSYGVGVERTFPTNSPSISQIEVLRSNKVRRKKLFYMRDR
KGKSARLKEIRTK
>MS53_0608 rplT, 50S ribosomal protein L20
MARVKGGTVTRARRKKWIKLAKGYFGHKSVGYKVAKQAVVKSWTYAFRDR
KQVKRNFRKLWIARINAAVRPHGLSYSQFINGLKKAEVLINRKMLSELAI
NQPQTFEKLVKLVQGK
>MS53_0551 rplU, 50S ribosomal protein L21
MLMFAIIETGGKQILVKEGDSIYVEKLEGQEKSEVKFDKVLAVNDVFGKP
YVTGAVVHGTIEKQGKAKKIVVYRHNPKSTHKRKLGHRQPYTLVKITKIK
GK
>MS53_0638 rplV, 50S ribosomal protein L22
MAQQAKAHVKMQRVSVSKAKLVANLFRGKDATLALGILHNTPQKSAKIFI
KLLNSAIANATNNHGMDASKLFVKEIHVNEGPTLKRFQPRSQGRAYEILK
RTSHFSIILEERA
>MS53_0641 rplW, 50S ribosomal protein L23
MELTRVIQAPIITEKTDRLLLDRKYTFKVDYFANKHQIKQAVETIFKVEV
VDVNTIKVGKKPKKLGRFAGFKSRYKKAIVTLAAGQRINYYPEDESDLKS
KAQFSEEKAIAKEAQSKKSKEVSDRVAQKLANKKQTATKTNENKKAPQTT
HRKVGSGS
>MS53_0632 rplx, 50S ribosomal protein L24
MKFKKNDEVIVIAGKDKGTVGRIEKILVKENKVIIKDVNMVTKHNKPSQQ
NQEGNLTSVEAPIHVSNVAYLVKKASKSSAAVYSKLGRVTNKDGKKVRLV
KKTKKEIQ
>MS53_0550 rpmA, 50S ribosomal protein L27
MATTKAGGSTKNGRDSHSKRLGAKLYDGQFAKAGAIIYRQRGTRVFPGVN
VQRSGDDTLFSLADGYVKYENKRNRKYVSVYPAK
>MS53_0066 rpmB, 50S ribosomal protein L28
MSRVDWFRGVGPMSGNTRSHAMNASRRKFNVNLQKVRVDFGSGKRTLRIS
TKTLKTWRKKGLI
>MS53_0635 rpmC, 50S ribosomal protein L29
MQFKEVKAKSVEELHKLVNDLKAELWTLEFRNSTGSLEQTHKIPQLRKDI
ARALTALKQKEMETK
>MS53_0477 rpmE, 50S ribosomal protein L31
MKKDLHPQYYSVAVKCETCKNEFTLKSTKKEFKIDVCSKCHPVYTGNRSQ
AKSTGMIEKFNRRLAKKDQQK
>MS53_0163 rpmF, 50S ribosomal protein L32
MAIVPKRKTSKQRKHKRNTHSALDAQNLVTCKNCTSMIEQHVTCYRCGFY
KGKKVAGYTCLNDRVQ
>MS53_0124 rpmG, 50S ribosomal protein L33
MAREGFTLECTSCKMQNYISKKNKKLHPEKVKLSKYCSKCSKHSVHKERK
>MS53_0601 rpmH, 50S ribosomal protein L34
MSKRTYQPNKRKHVKVHGFRSRMSTKNGRKILAARRAKGRKRLTVSDK
>MS53_0607 rpmI, 50S ribosomal protein L35
MKTKSALKKRVKVTATGKIKREQAFRSHLAQNKTKKQKRQSRKASFMKRS
DFKRFKFML
>MS53_0577 rpmJ, 50S ribosomal protein L36
MKVRSGVKKICKKCTIIKRKGVNRVICEIPKHKQRQG
>MS53_0574 rpoA, DNA-directed RNA polymerase subunit alpha
MEKLTKIKHRIIPAKDSQNNSYKKVLKIKGLERGFGNTLAVALRRILLSN
ITGIAPFCVRIEGVEHEFTALEKVSEDIVTILSNLKKVVLNYDEDYVKDN
QIIKLSLNANEDNRITSNHLTVTNAPRVEVQNKDVEIATLSKPGVLKLEM
FLRAGRGYVDFEDNKKFIEEKEKELKELSSLSKGAFIAMDSVFSPVVNVA
WKVTELNTASLKIEEQLELELETKLGVTPESAIKLACKILVAHFQTIGDL
TDLDSDEIFQSEKQSLEKEEDDMEIRLLNLSMRSQNALAKSGIKTLNELA
SYPIEKLKEIKNLGEKSREEIIRKLNEYGKLKN
>MS53_0485 rpoB, DNA-directed RNA polymerase beta subunit
MMQKDKKNYKLRKFGPITERRDYSITKHSLPVGDILATSKKSYQDFINKK
IEELLNEIYPIEASNKEASLEYEKKSVKFELPFKKAEHENLQIKTCKAKK
TNFSMKVYITLKKVVSQTGVVKKEKILLGEIPYITSSGSFIINGSEKVIV
SQLIRSPGAYFGVSVRNKQSEDLFNKLEILPRIGSWIEVSHKVTSANLDA
IKIKIDKNKNINIVTFLASFGLLADDIRYLFGKNEVLEETIRKNKTIDIT
EFSRQEIMDLCQEKIFRIIRKGDRISEESKRSLLSGMLFDKKRYNLSKTG
RYMLNNKLSLVERITNTYLAQKVVSHLGNTFDVGTYVTYEIAKEIQESFE
AKAKDNKSNLHLEKIPNINPDDVYYKINKDNKSLNKRINIARIKIWPTKR
AMDANETPSEVIGNDPKATEEHLLLSDIIAAISYYLNLTVGIGQDDDPDS
LMNKRIVSVGELLEGELRIALLKLEKATRERMGAKEPDKITAKNVTNNKL
ITNQMKTFFNTSKLAQFMDQINPLAEISNKRRVTSLGPGGLNRDTAQFEV
RDVHSTHYGRICPIETPEGPNIGLILNYAIYSTVNELGFLQTPYYKVNDG
VVDYNDVRYLTSYEEIGYAFAQSSVHVNDKNEIIDEQITIKKDYNYIIGS
PKDIDFLEVSSKQIVSVAAAAIPFLENNDANRALMGSNMQRQAVPLIEAE
APLVATGIEADIAKFSSYNIVANNDGEVIYVDGTKIQVRTAKKIDTYNLK
NFEKSNQGTIIQQKPIVKVGDHVKEGDLLVDGSSFKDGEMALGKNLLVGF
TTWNGYNFEDAIIINERLVKDDVLTSIYIEEQTIQFRISKSSEDIMTRDI
PNVSKYSMRNLDEFGIIKVGSEVVAGDVLVGRISPKGEENPSQEEKLLNA
IFNQRPQNYKDTSLKVKNGHNGTVIHVEVLSRENGDILEDGLDSIIKVYI
AQKRKIKVGDKMAGRHGNKGVISIILPEEDMPHLEDGTPLDIMLNPQGVP
SRMNIGQVLEMHLGMAAKKLGTKFVTPSFDGIKKETIEDLLQEANLDKSG
KQVVIDPITGEKFDNPISVGVIYMLKLNHMVDDKMHARSVGPYSLITQQP
LGGKSQNGGQRFGEMETWALESYGASNILQEILTYKSDDIYSRNLVYKAL
VNDSAIPNPGMPESFNVLSNELKGLLMKLGITETESNSDELIQHFDHLGV
EHE
>MS53_0484 rpoC, DNA-directed RNA polymerase beta chain
MSNTFSKNNVKKIKQISLSLATNEDVLSWSNGVVSKPETINYKTYKPEKD
GLFDEIIFGPVTDFKCPICFTKYKKSDENTICKRTTSCEKIQPKILPKIS
RRSRMGHIALNNPVVHFWFFKINHSTISKLLGLKVAGSNKPVTKSDLEKI
IYYKSHIVLETGGLKSLQKNTIIDINDAADIYAGALEEILEFNKDNKDGY
EEILDTLNDLKEYAASKTGQDYGIDFYEYNEIIEEYSQAKIGTGSKAIEY
LLKNIDLEKESKEIQDEIDTINDQNKYEISSSEALKRNKLYKRLAIIKSF
LKSGQKPENLLIYNLPVIPADLRPLVQLDGGRHSTSDINELYRRIIIRNN
RLEKWYESDAPVLIKQNEFRMLQEAVDALIDNSRKKPGPVTSKDGHPFKS
ISDALVGKKGRFRQNLLGKRVDYSGRSVIVVGPHLKMYQVGIPRDMAAKL
FEPWIINRIMKEEEGINSVKAAKKLVDSLNPIIWPYVEQVLENRPVLLNR
APTLHRLSIQAFQPVLIRGKAIKIHPLVTTAFNADFDGDQMAVHVPISKA
AVREAQELMLASKNILGPKDGEPIINPSQDIILGLYYLTIEKANQKNEGK
FYPSFNEMMLAYENKYINLATRVVLPVSALKKISILQKTDAPYIYSTVGK
FILNNAFPRDFDFVFGKRVTEKLTSTNEHGEEVVSLKTKIDTSEHDIKRY
VFNYGDNFTAKIKEADVNLPLNKKEIAKIVRNIYEKYVPIVNIEDISQVI
NKIDKTQLDNLHELCSELKDFNGNKLEDNRIHLELLVRLIKEEFLKIQDQ
YFAKDEESIFNHKYWELKHYTKLLERVWFRYSNYVSTVLDVIKDLGFKFS
TKSGITISMNDIVTSKTTKERIKKAEEETEALKDYFKKGYLTDDERYTLT
IKKWSDVKESIEKELKKVVDSNLDNPLFMMLSSGARGTYSNFTQLAGMRG
LMNNNTKILKADAENDRVVRSIVEIPVKSSFLDGLTAYEFYSSTHGARKG
LTDTALNTAKSGYLTRRLVEVAQGVVIREEDCGSDYGFVVKDIKDTKTNT
IIESLQERIEGRFTAVPIYDQNGKLIVKESELITPEIASEIVAKGITKVE
IRSVLSCHTRNGLCKKCYGKDLATNRIVNIGEAVGVIAAQSIGEPGTQLT
MRTFHTGGVAGGEDITGGFGRLIELIDAYDQPWGTPAEISRHYGKVKKIE
TQKNKKGKESGQFNISVEYFDEDGNKQTHQYLVKSSQRLRVKQGDEVVAG
QKLSEGPIVLNELLESVDTRAVQNYILKEVQKLYRLQGIAIADKYIEIII
RQMLSKISIIDPGDSSFYSGSLVDAFVYQKENGILLSQGKKPAYGVVKIK
GAKQTPLLSDSWLAAASYQETAKILVDASIAKRTDNLEGLKENIIIGYKI
PAGTNSNFEENGKYNLKEFSSYFPNKYDSTPELKLEEITDENIEEEFDYL
KENTISEEEFENLDDDTMYHLETSDEFEDESFGEDDFEYSEE
>MS53_0455 rpoD, DNA-directed RNA polymerase sigma factor
MDQLKKSKPHQKKWKVEEVLEFIERKKLDIEEEVVDELFDFFAQKNLFKA
DENIVSSEKDLKEEFEEELKAEKKSKSAKDLKLNFNADFDDDLLDEDDSP
LFDSDDDEEFDDDFIEDEEVDVNLEEYDHDEEDEEEDEKLEEDDELDFSL
VASDDDLDELDLDNFSPDEIDLQIDEENKKQDLSNKLTETTDIVKWYMRW
IGKYGKLLTPQEEKDLAEEMDKGGSRGKRARDLIIKRNLRLVVNAAKKYK
NRGLSFIDLVSEGNAGLLKAAQKFDIKKGFKFSTYATWWIRQSISRAVAD
QARIIRVPVHMVETINKIYKIEREIQQENGGEIIDEEIAARLGGKSKKYD
ASYIRYIRKINTSPISLDKQVGKENDSFFGDFVKDESIISPVEFADKEEL
ITKINYYVEKLLSEAEADLIKRYHGIGYDAKGNPVRSATLDEISKDFRGE
GKKISKERVRQIITKIYKKLRGYPEVVELFENFIKFKNED
>MS53_0413 rpsB, 30S ribosomal protein S2
MVSRDKLLEAGAYFGHKKQMWHPKMKEFIVPKRLNKNAHIIDIVKTQKYL
EFAYSLVEKLAAKGVSFIFVGTKRQAKKTVKEAAERTNSLYVSERWLGGT
LTNNSVIMKRVQKMNELDKKAEQGFKGYTKKEALLLQKQLDKLHQNLDGI
KNMRRLPQVMIVTDLVEDKIAIQEAKKKKIKIIGIVDTNVDPTVIDFGIP
ANDDSSKSINLIVNILADAIAKTQGKKQMYAYQPDDKIVLSNPHELKKSE
EASEVKAASTKEKLTEEASQ
>MS53_0637 rpsC, 30S ribosomal protein S3
MGQKVNPNGFRYGVTKAHNTTWFAHKATYGSKLVEDVKIYKFFDKFTRKF
QIGKVEIQRDLNNKVSVFLHTSKPAAILGENGTNIKNLTVALQKHLKNKK
LDVNLKVLTIKEPDLNARLLAEMIATKLENRESFRSAQKIAIRSALKAGA
KGIKTAVSGRLNGVDMARTEGYSEGEMKLHTLRQDVSYATATARTTYGAI
GVKVWVSLGEILQGDRTFHHASTKKN
>MS53_0478 rpsD, 30S ribosomal protein S4
MSRYTGPLFKKSRRFGYSILETNKEFSKGRKRTYAPGQHGNKRVKLSDYG
LHLYEKQKVKLVFGVSEKQLLKTYKKAVKSKEITGTVLLQLLESRLDNLV
YRAGFATTRRQARQLVNHGHFTIDGKKANIPSMQIKTGTTVVLKETSRKL
KLVQEALEMQPASAWVTRKDFQFTFYRVPERTEMHKDIKEALVVEFYAK
>MS53_0626 rpsE, 30S ribosomal protein S5
MVDIARVTKVVKGGRRFSFSAFVVIGNKKGTVGYGHGKANEVPDAIKKAI
KDAHNNLVEVPITKGTVPHEVTAKFLASKVLLKSAPKGKGLIASSRVRAV
VELAGYTDIVSKTYGSRSAQNVVKSVVKALLNLRTAKQIAEVRDKDVKDL
L
>MS53_0532 rpsF, 30S ribosomal protein S6
MKTKYEIMVLVGPKTSASTVESFLKSVFHDDFKKAEKLERTELAYEINKT
KHAQYFLVNLETERKNIAEFIRLSNINKEIWRHLVVNLDTEKGLNKVFKT
HRKFGHDFRDQRSHHGQAGEFRKREPQQKSKEQSEFSKEKKSFSKSVTKK
TVVSKPKETKEEK
>MS53_0048 rpsG, 30S ribosomal protein S7
MSRKKSAKVREVLADPIFNSVVVTKLINTIMLDGKKSIAQDILYSAFDLV
KEKTKKDPMQVFTQAVENITPQLEIRTRRIGGTNYQVPTEVSKRRKQALS
LRWLVQYARLRNDKSMDLRLANEIIDAANKTGGAIKKREDTHKMAEANKA
FAHFRW
>MS53_0629 rpsH, 30S ribosomal protein S8
MTDPISDLIVRIKNANQRKHKTVEIPHSNKKEAIVKLIKEEGYISSYSVE
GSKKTDKRLLVTLKYKGKQSAIVGIKRVSKPGLRVYVKSEEIPKVLSGYG
TCIMSTSKGLMTDKEARKANVGGEIIAFIW
>MS53_0077 rpsI, 30S ribosomal protein S9
MGRRKSSVARVIIRPGKGEFHINKRPAREYLTSDLYLKDANQPFVLTETF
QKFDTFVNVKGGGLNGQAGAIRLGIARALLHASPDYRTKLKAEGMLTRDA
RIKERKKPGLRAARRARQFSKR
>MS53_0644 rpsJ, 30S ribosomal protein S10
MKVFGFDHKVVDEAAKKLVSLAVATKNKFVGPIPMPTKREEVTILRSVHV
NKKSREQFESRTHQRLVVLENPSSELLDKLKRLELPAGVGLKFKEK
>MS53_0575 rpsK, 30S ribosomal protein S11
MARKAKKKNISSGVAHIHSSNQNTIITFTDEKGNVIAWSSSGKVGFKGTK
KKTSFAASEAAKDAAQMAKEHGISQVRVEMKGLGSGKDSARKQIEVWGIK
VTEIKDVTPIPHNGTRPPKRVLKRLRLKK
>MS53_0049 rpsL, 30S ribosomal protein S12
MPTTNQLVNRGRTSKVQKQNAPALSWSYNSLIKRSKKMPSPFKRGVCTRV
ATMTPKKPNSALRKFARVKLSNGMEVTAYIPGEKHNIQEHSVVLIRGGRV
KDLPGVRYHIVRGTQDVAGVNNRKQGRSLYGTKKDKK
>MS53_0576 rpsM, 30S ribosomal protein S13
MARILNIEIPNNKRVVISLTYIYGIGKSLASEICKKANVDENTKTAELTE
AQLSKLREVAKAYTTEGDLRREVTLNIKRYMEIKCYRGIRHRKGLPVRGQ
STQKNARTRKGPRKTVAGKKGK
>MS53_0630 rpsN, 30S ribosomal protein S14
MARKALIEKAKKHPKFSSRAYTRCELCGRPHSVLRKYKICRICFRNLAHE
GKIPGVKKASW
>MS53_0562 rpsO, 30S ribosomal protein S15
MISKQEKKLLVKKYGKNEKDTGNAFVQVALLTHDIEKLKPHFQANPKDFH
SRRGFLAKITQRKTLLAYLKKNDPETYLKCLEEFKLRK
>MS53_0010 rpsP, 30S ribosomal protein S16
MVKIRLKRMGSKFRPVYKIVVADARAPRDGKFIEALGHYNPSNKDFVLDS
EKTAKWLANGAKPTVTVWNLFKNNKLTESLKAKK
>MS53_0634 rpsQ, 30S ribosomal protein S17
MMTFENRNNRKTLTGKVVSAQKTQKTIIVEVDRYKKHLLYGKRFKKTKRY
AVHDEAQVAKVNDMVMIMETRPLSKTKHFRLYQVLSTASDVEKEAK
>MS53_0534 rpsR, 30S ribosomal protein S18
MAYNKRKKGYHNKKRTCHFCDNKLTYVDYKNVEDLKKFVNAVGSIKPKVA
TGNCAKHQRKVTLAVKRARLMALLPFAVARIRVHRSLVSAPASQNTKKVA
EKVEKEKAPAA
>MS53_0639 rpsS, 30S ribosomal protein S19
MARSLKKGPFADDHLLKKVQAIIDGKAPKKPIKTWSRRSTIFPDFVGLTF
AVHNGKQFIEVYVTDDMVGHKLGEFSPTRTFSGHGADKSKKK
>MS53_0071 rpsT, 30S ribosomal protein S20
MANIKSKIKNISRIETARVKNAAIKSRVKKAIRKAREAILENSPKAQELV
NKAHHEIGKAVSKGVMHLNKGARKSSRLDLFYNKTKTQ
>MS53_0417 rsuA, 16S rRNA uridine-516 pseudouridylate synthase and related Pseudouridylate synthase
MRIEKFIADSTLYTRNEIKKLISKGLVKVNDLIIKKSQSIDPKLDKIYLE
GILLEAREEFSYIMMNKPAGYICANFDWNKQVVFELLLDLEMNLKDFFTI
GRLDIDTEGLLIITNDGKLSHNLLSPKKHIPKTYYVELDKPLEKNIKELL
EKELLIDEIKYKKSILNNISNNKWEITIFEGKFHQIKIIFAHFGYKVTYL
KRIKMNNLSLDENLKPGEYKFLTKEELDLLKN
>MS53_0164 ruvA, holliday junction DNA helicase RuvA
MTLYKIGEIVYKNNNNIILESKGEGNLVTICDNSRYSKGEKLKLYLYEVK
NDYIQQTYGFKTFKERLLFTDLISIDKIGPKTAMLILDQNWELVANLIAE
GDWKEISKINYISDKSAKLICVELKDKWAKIIQNKEVKKFDDITNIKELK
QTLNKLGFKASDIDYAVNNISSTKELDLMVEESINLITTQMHANNQTT
>MS53_0165 ruvB, holliday junction DNA helicase RuvB
MGQKNLISTLKAMIESSKKQNKVLNHILFYGMPGMGKTSLAGIIANETKN
KIHFIQGSNLEKKSDLINILSVINENDIVFIDEIHSINKNIIEFLYSAME
DFVFDLIIGTESNAKALRMKIKPFTLIGATTKINEMAQPFKDRFGYIARF
VSYNAEDMKQIIRNSIKLLNINLGEEHFDFVASYSRNTPRIVNHLLERIN
DFAIVKNAGIIDKKIIKKTFKSLDLYEYGLTKDHVEYLQLLRDGFDSKPV
SLDTLSGVLIHPKEVLVNEIEPILLYLKLITKTSKGRMISSKGITYLLKE
KLIW
>MS53_0128 secA, preprotein translocase SecA subunit
MTFIYKAKFNKIIVTIWLRGKMAFFSKFLNIKSTEMRIAEKSLKRINDLE
KYVINNTDEELRSKTQFFKDLLKEGYKLEDIRDEVFAVAREATKRVLGKR
PYDVQILGGILLDLGSVAEMKTGEGKTITSIAPVYLNALSGKGAIVSTVN
EYLTERDAQEMGQVFNYLGLSVGINKAQMDPNLKRYAYSCDITYSVHSEL
GFDYLRDNMVSDMSEKVQRELNFCLIDEVDSILIDEAKTPLIISGGEAND
SSSYYSADQFVRTLNNDDFLVDEESKAVTLTASGIEKANSFFRIDDLYNI
EHSEKVHLIQNALRAHKVFKIDVEYIVKNNKIELVDAFTGRIMEGRSYSE
GLQQAIQAKEMVEIEPETQTLATITYQNFFRMFNKLCGMTGTGKTEEQEF
IDIYNMRVNVVPTNKPIAREDAPDLIFATAKDKWEAVGKEVERLYQKGQP
VLVGTAQIEDSEIIHRILIEKNVPHTVLNAKQDKALEAEIIAQAGVKGAV
TIATNMAGRGTDIKPSKEALELGGLYVLGTDKAESRRIDNQLRGRSGRQG
DVGISRFYISLEDQLIMRFANFEAFQEVYAKDAGKEITNKQLRFAFNNAQ
KKIEGFNYDSRKSVLNYDDVIRQQRDLIYSQRDLLLISNEFEEIIRRMIK
VFVKNLVAIEDHKLKSGAYDYQKLVDFLNKNIAVYIKHDFNVDEFKRIHD
NELVDKVNQMVNDIYNQWLANAIEKTDQAYIDNFKKQVLLKTLDDNWKKH
INKMDKLRSNVNLVQYSQKNPYQIYTDEGTKMFEDLIQTIAFESVLKVFS
SPLGEKSLITAEIKNDPLYQQVASTFEYNPYLSISEQEKQLLERYNNVKQ
RLNEVEQQNLQEQSYKDPASDNLENNPEPKTGSQSQSEHEMVLTPDTVID
PSIDTNQWFEEINIDDFINVTKKDSELESKEKEQEEVKNQETQPKENKPA
ETKVDATKNQENVSEELKAKEVATVVEEKPKKVSKAKSEKLKVAKKVKPK
DLESKEKPKSDKAKKSLAKKETQKPKKPKITSEVKIAKVEKTNKKAKAQD
KPKAKVTKAKETKPKTEVKADKVKTKTAKTSEAKAQKVEAENFVNKIVFP
KNKIDLKLEKIKLK
>MS53_0167 secD, Protein-export membrane protein SecD
MKQRLKNLFVLSNWKRFLISAITIVSTFIVIVLGSVFYISKDVNKSIDYG
GGIEVLVQVKKDDQNADKTLTEQVNKSLFDRLTGGTGLNGITVSSEGDGK
IRITKAGNVTNAQRDIFEKEISEKPILTVTDINLKPLFFDGSFTANGSLD
IGTPQNWVPPFALGAAKYVNQNGRDSVQLTLKNSDARLEWTKATDYLSKQ
SQPNNLVLMWLDIDKLLHIAKTQYPLEWKESGENLWNFVHVNNQAYTQIQ
DPVTNQPRLVANEFKKNVLDIQNKYLISVAQVNNPISTSEVIINGNFTNT
QAQELANRINFGLSDYSIDILSSVFLSSNLNDNAFQSAIIAGIVIFSLIS
IFMIVNYGLLGVLTTISIALYIYLTLLMFTVLRGEYSPVTIAALIIGIGI
SVDANVITYERLKKYVYSGDSLKKAFYSSNRLSLSSILDANITTIIIAFI
LFYFGTKDVRGYSITLTLSILFTLLVMLVFSRFLSYMLVNTGLFEKRLYL
LGLHKKYINHKTKLAKINENFNYYKNAKWFVLASLSFMVISLIVFASISG
ANKDIWAGLNRNIEFTGGINLNIATDRNTANTLSLAEANEIKKQIVESSQ
TFNIKNVNSIIDIQKANEQGTNYVINIRSQQDLSSIVNDIKNIATRVNPF
INVATFTVSSSEAAKLVQNAILATGIGFVGIVLYLLFRMNWTYSIAAIIA
LIHDFLMVLAFVVITRLQVSTIIVAAMLSIIGLSINDTVVTFDRIREKIK
FDYTGKILQKSDLKKIVNVAIADTIKRSIYTSFTTILAVSVILAFGNAIN
FTFNIVMLFGIAIGVYSSVFIASWVWAKLEYIRQKGIVKRKEKGFWEINN
PEEQTVNGINDFNY
>MS53_0581 secY, preprotein translocase secy subunit
MFSKINLFFYTFGSKLKNSWSNFWSSKEITKKIIFTLLIVSLYIVGTTIT
APFVRLNANISIADNSFLNTLNLIGGGGLTQFSIFALGISPFINASLIMM
ILQSRLFPMIYKLTQSGPQGRRKLNIATRILTFIIAYPQAVFLTKSLTAG
ERNSSFITLVSIDGFSVDLLVYFLLPMILISASLFALFLSEQITNKGVGN
GTSIIIMTGIAARLPFQMQNAFKIFVGDLSQSGTLVGILNFVTYIFIYLA
CLMVIGIFYNAERRIPIQQTGAGRSKALKEIGSLPIKLNPAGIMPIIFAM
LVLSLPTLIANILPNDNYSKQWINENLQFYKPLGFSLLIIITFVFSLLMG
IQQSKVDKIAEDFAKNGTFIPKVTPGEETQNYLVAIVFRLSFFSAFYLVI
IAGMQYVQIMTGILQPSIAFGGTSLMILVSVSIETISQLKARNKSKKLFK
AKSQTKKLILNRNNSKNKKDSYKGLLW
>MS53_0591 serS, seryl-tRNA synthetase
MLNIKYILENKELVRDKLISRNFDITIFDNFLSLAQERGKLMSSAQEQKS
KLTKLSKQFGIYKNDLEKLSLLKKEIEKVKSLETQLTNQANELNFKLDEI
LATIPNLPLDEIPFGKDENDNKVINVYEIGTKKDFEKPHYEIASELNMID
IPRAVKQSGSRFVIYKNEGSKLVRALINFMLDLHKQKGYDEFLTPYLVRS
EMLFGTGQLPKFKEDMFKVENSDLYLIPTAEITLTNYYNNEIVNLDKPFK
ACAYTECFRSEVGSSGKDTKGIIRQHQFKKVEIVKVTTKDDAIKEFNLML
EDAKNVLFKLEIPFREVLLSTGDMGFSSRKTIDLELWLPSESKYREVSSV
SYMGDFQARRAKIRYKNQDQKTEYAHTMNGSALAVDRLVAAIIEQYLDTD
GNLVIPKVLVPYMGMDKIYKK
>MS53_0028 sgaA, pentitol phosphotransferase enzyme II, A component
MNFLENLIENDSILLQQEASNWQEAIKLSTNLLEKAKIINQNYYLNILES
TAKYGPYYVIIDGFAMPHASGTSDSVFGNGFSLVTLKNPVVFENNVKVSV
LVCVAAIDGETHTKIAIPQLVAIFESPENIAKITSFQTKEQVIDFISKID
YTKYL
>MS53_0681 sgaA-1, PTS system, IIA component
MLSKLNFIDNLILNYSIALNQEANSWEEAIKAATDLLVKANAVSNLYYKK
IIESTKEFGPYYVIADNFAMPHAKSESDYVFDTAFSLVTFKNAISFDENK
KVKVMIYFASLNGEIHTKIAIPQIVAIFENHENVKKIANFQSKEKLIEFL
KSLDYKKYLQ
>MS53_0031 sgaE, sugar isomerase SgaE
MLLVKYNLVIHTWGNVSGITKDRKFMVIKPSGVSYEKLSWEDMVVTDLEN
NIYESKYNPSVDTPTHSLLYKENSQIKGIIHTHSINAVGFAQAGKEIPCY
GTTHADNFYGPIPCTKALSKKEIESNYEHNTGLKIIKHFKENNLDFKATP
AVLVKEHGPFAWSFKDPIDAVNIGLTLETVAKMALNTLLASWGKVTPAQN
ELIQKHYDRKHSKNATYGQRK
>MS53_0029 sgaH, 3-hexulose-6-phosphate synthase
MNKPLLQIALDFWEIQDAILAVKKAKKYIDVIEVGTILIASQGKKAIKAL
AEEFPDKIIVADGKIADAGKIFGKMFFENKARFTTCICAAEIPTIKDTME
IAKTFSPLNEVQMEMTNNFTWDQVQKWKEINVPQVVWHRSRDLQASGVKW
NQNDIDSVKKLANMGFKVTVTGGVTKEDIKLFKGIPIYIFIAGRTIYGAE
NPELAAKELKDEINKYW
>MS53_0026 sgaT-1, transport protein SgaT
MVKKKINVKALIGLIAVLVVFFLTAGITYAVRMGAYNDSFGAATTFFVDN
VLVGNFMGSVTILIGTVVFAGYLILGRSFTDSFSGMLKAMIGVIMLKIGA
GTLIGLARPIFSAISKLGTSVVPLDPYFVWNDSAAWLKNLNAGYEAWIAY
AMLLGFFVNIVMVMLRKYTNTHSIMLTGHVMFQQSAVVVPIVYFLLFYTQ
GLEVNSGQIFGIIIISSLLLGLYWSVGSSATIKGSDAITGNAGFCVGHQQ
MLGLSIAYGIGRFFGKKEDSAETKKISNKIKIFEDNIFTQTILIFILFLV
LILIAQFSSLPSNDPNTVNTIRFVNSDGAINPVYSQWNVDAKFWVINILL
GSMKIVASILVLQAGVRMFVTELQQSFQGISEKLVSGSVVAVDVAATYGF
SMNSVTYGFASGTIAQFVAVGILIGISKGTNGNFPIVIPLFITLFFNSGS
IGVFANASGGYKASIIVPAIFGFLEIFIIAFGIFALKSHAVAINSADSLP
FRTGFLGMFDWNFFFGLSLGVGSWAKPLAIIVFAIVLPLALVFVSQIVDS
NRQYKKTYLQKLFKINVNLLKTQENAA
>MS53_0683 sgaT-2, transport protein SgaT
MTSKIKLWKNSKLIKKAIIGITSFLVVLFLTALITYLIRIYEYENSFGEA
IAFFVNSVLIGNFMGSVTILIGSVVFGGYLVLGRSFSDSFLGMLKAMVGV
IMLKIRAPTLINLARSVFSALSNLGTSVITLNPYFVLNDSATWLKDFNAG
YEAWISYAMLLGFFVNILMVALRKFTNMHSIMLTGHVMFQQFAVVVPVVY
FLIFYQKNVAINIDQIIAIILISSLILGLYWSVGTIATIKGADKITNNAG
FAVGHQQMLGLSIAYGLGKFFGNVKDSAEVKKVSKKIKIFQDNIFTQSIL
ILILFTIMILIIQFSAIPAEKKDLVDKTRFINSNSQINKEFSEWNVDAQF
WVINIILGSIKIVTSILIIQTGIRMFVSELQQSFQGISEKLVPGAVMSVD
AAAMYGFSINSVTYGFIPGTIAQYLAVGVLVGLSKASGGVIPIAIPLFIT
LFFNSGSIGLYANASGGYKAAIIIPALFGFFEVLMIAFGIFALRAHAGAI
NSSDSFPFRTGFLGMFDWNFFFGLSLLVASWTKELSIIIFAFVIPILLVL
LSQIIDSNRQSKITFMQRLFKVKVNLLTK
>MS53_0030 sgaU, hexulose-6-phosphate isomerase
MLGIYEKAINEKFSLEEKIKIAKKANFDFMEFSVDETDKKLARLNWTKNQ
IKKVQLLLIENDFTFNSMTLSGLRKYPFGSHDPNIRKTSRNIIKKAILLA
KKLNIRTIQMAGYDVYYEKSDNQTLKYFYQNLKYALKLAAKYSVMLSFEV
MDTEFMGLNSRIMPWIEKLNSPYITIYPDLGNIYQWCKKENLEKEFLLAK
NKIVAFHFKDTLPGKFRDIEFGQGSVDFNYLLKIIKKHKLNQPMMIEMWS
KNNPEETFNQAVEKIAKARDFYYQKWNEVNKNK
>MS53_0040 sipS, signal peptidase I
MLFLFIFYFFLVKINGNSMLPLLKNGEWKLAFKYGPYNQKDIIIFEQNGV
NVVKMIVGKEGDKIIIKNNNLFINNNLITSLFMGNFGDDIELIVPKNHFF
VLGTNLNFSDDSRVFGFINSHQIIGKILF
>MS53_0549 smf, putative DNA processing protein
MNNILLYLSNKHKGDNYLIYKGLKDKEKLRKSEIDEITNIYLKNDIKFIS
IFDLNYPSSLFMVHYPPFVLYYKGNINLLNDLTKKRLYLVDEMNSEYSKE
ILSKNIRTLTENSILVTNSYASEKHLIDEFKNANASIIYIAKEGLNSSKF
DDINLENNLIISQYPIDDHPRKINFRQSNVLSAAIANSLVIFSSYKDSKV
NNLVSEFLNLGKDINCFPGSLDEKDGNNHLIQSGANLITQIQAVAK
>MS53_0480 smpB, SsrA-binding protein
MKIIATNKNAKRNYEILKTFEAGIKLEGWEVKSARASSVELKNAYCSIYK
DEVFLKESYFKKYMLLKVEETKNRKLLLHKKEILKIKQELQKNLSLIPTK
IYFNSNSLIKVELALGRGLKKYDKREKLKKEEVEKKLKKILKF
>MS53_0533 ssb, single stranded binding protein
MADLNKVILVGRVTNDFLLQKTKNNISYARNTIAVTRYTTSNTQRVSDFL
PFVAWRNQAEFLCKYVKKGDTILLEGKIQSNSYNNNEGTLVRSIDILVDN
VQILASKNYVNITNYGQNNYSQNKASYQANTYSDLNQSVNLSIEEKDISS
SAVFSRAETEEDDDSISANDFENITDDLNDDIDLDKGF
>MS53_0521 tdk, thymidine kinase
MRWKYDIGSLEVITGPMFAGKSNEIIRILNVNQIAGFKPLSFKPDFDTRW
SVNHIVSRTGSKMETINLKDPKDIWNHIKKDTQVIAFDEVHFFDMSIVAE
IQKLIEKKYKVIVSGLDMDYLGKPFEVVSQLCCLADKIKKLKAVCMNCHG
VANMTYRKVDNNERNLLGDSEYEARCRNCHKLR
>MS53_0505 thiI, thiamine biosynthesis protein
MYLSMYKKILIRYGELVLKGKNRTTFIKQLGSNIKEILNTEYEMEFDRMY
IPYSEENLKNLKYVFGISSFSPVIETNKNLEDIQSAITKLINKNASTFKI
AARRNDKSFELNSDQLNNLLGGFVLKNSHLKVNVKNPDQIFNIEIRKNSV
YVFDKSINGIGGIPVGISGKVLHLISGGFDSPVAAYLLMKRGFKVDFLTF
VTPPQTDETTIDKIKNLTKVLSRYQKESNLYVCDFSLISSYIEFTEFKSF
KIILMRRSFYRIASELAKQNEILMISNGENLAQVASQTNESMAVIGSSIK
NEILRPLLTYDKNEIINLSKVIETHDISILKSKEACELFAPKNPVTKPTE
AKTLRIESKLDELKTYEEIVLNQKMKKFAI
>MS53_0170 thrS, threonyl-tRNA synthetase
MMKANKELNHTTSHLLAAAVLKLFPETKLGFGPATSEGFYYDFEFKEPLS
DSELLKIEKMMKKLASRNLKMKQVSLSDYSFDNQPYKKELYNEFKSQNKE
VTFYTLADPLNKEKVFTDLCAGGHVEDTKHIKHFKLLSLAGAYWRGNSDN
IQLTRIYGTSWETKEELDEFLAILKDRKERDHRKIGKEMKLFTFNPLGGQ
GFPFWLEDGMHIHNEIRNLVLKMDKKYGFTEVLTPHFGEEKLYKISGHLD
HYKDDMFKPIVCENERLIPRPMTCPHHIILFGSEKRSYRDLPIRYSEQSQ
LYRYEKSGALTGLERVRSMLLTEGHLFVRKDQIAQEFKKMFELISDTLNA
FKIKINYVSLSLRDKADKEKYYANDQMWDAAEFELKKIIKELGIKYEEKI
GEAAFYGPKVDIQILTALNHEVTVSTIQLDFLLPQKFEISYTNSENNEEV
PVLIHRGLIGTYERFISILIEQTKGNLPFWLAPKQVTIIPVNENTDYEYA
KEVNDKLLALDIRSKVDFRNERLSKKVREAQISKSKFQVILGEAEKTNKT
ISYRRYGEEKTTTTTFEEFSKMLLELKASHE
>MS53_0398 thyA, thymidylate synthase
MKQYLHLLEHIKTSGTFKKDRTNIGTISLFGLQARYNLKEGFPLLTTKKM
AWKAICHELLWFLKGDTNIKYLVDNNVNIWNEWPYEIFKKSNDYQGESLK
EFSQKIKEDSSFAQKYGELGPVYGKQWRDFFGVDQISQVINDIKNNPTSR
RLIVSAWNVAQIDKMALPPCHAFFQFYVNDNNELSLHLYQRSGDMFLGVP
FNIASYSLLLSMVAQVTNLKVGEFIHTIGDAHIYSNHIDQVNTQLERAPY
KLPKLILNKNIKNIFDFTFEDIELENYISHETIKAKVAV
>MS53_0181 tktA, transketolase
MKHKNMHEKLVASMQAIALDSINKAKGGHIGMAIGAAPITATLFTKFLNI
NMQDPKWINRDRFILSAGHGSMSMYSVMHFLGMLSTEDMQAHKKLQSKTP
SHPEIDALDYVDATTGPLGQGVAMGVGMALSQKILASKFNKPNFELFNHD
VFVLHGDGCLQEGVALEAIQFAGTNKLDKLILIHDFNNVQIDSKASEVNN
INLINYFKSQNFKTFVVKIPNEKNLTKAIELAKASDKPSYIQVHTKIAKH
TPYQGTPKGHNGTLDEKQTLRFKRKLGLENKMPFVYDYDVFEYTKSFWEE
KEKNYQAWEELFNSYQKVHPQLARELFDLLKKEKHFDLSNLKFKQTNVAT
RNYVGEVLSYIDSNFEDFVVGSADLYAATKVGFSKQLDKNIKYGIREFSM
AAINNGINLDAAYKTIDSTFLAFADYMKPALRLGSLMELPAIHVFSHDSY
QVGGDGPTHQPFDQIPMLRAMSNFKVFRPCDESEVKHAFSYALNAKKDQV
AIITCRQNLKSLNLAPKNFTPAYVTQSVIGDFDLTLLATGSEVQLALEVA
EELKKHSIKAQVVSVMLLDELVNNENLALSLGLNKAPMYALEASSDSYWY
KLSKFNKLDGQFANGYGYSEDGDKVYKLKGFEAQSIAKNVLAFLKK
>MS53_0052 tmk, thymidylate kinase
MFITFEGLDGSGKTTVINELLKKLKDNFKFLDYVLTREPGGKDIKESEKI
REMILDSDLEFSPITEALLYTTSRRIHIDKVILPALAQNKIVFCDRYYDS
FYAYQGYGRNLGMEFTKTLTELAVGKTIPNLTFFFDISPFETRKRRSENN
LINDRLELEDLSFHNRVYEGYLEIIKNNKENRFVVVDATKPVNEIVDFIF
NYLVKHKDFVKFLK
>MS53_0531 topA, DNA topoisomerase I
MNKLVIVESPNKVKTIQKYLGNDYNVISCVGHIYKMKTSGPFGLGIDFEN
WEPLYEFDSTKKKVGKELKDSLKKAQMVYIATDPDREGESIGENLVSYLK
LNDNYKRVTYNEITKDAILKAFDNPHDLNWALINAQKSRRMLDRIIGFRL
SKLLQSKLQNAPSNASAGRVQSIALKLVIDREREILAFVPTKYWKLNAFL
LNENSLKAQYFNEENSSGQKEWIFESQIKEVKEFFEKLKDKKVKVTKINV
TEKKNKALVPFKQAAIYKRSPYSAAMTQSTLQKLYEGYGDGGLISYPRTD
STRLSQTFVNQAKKFIESKYGSDFVSSEVKGFTGDQDAHEAIRPTDLNLL
PENLEKLYPTISSNEVNLYKLIYEHTLKALIKPPVIKSKQYIYQVDKYLF
KNSFATVTFQGYYCVSAPEEKQEKDPNFEINQEVTVNNFAFEDLETKPTP
RYNDGSLIEALDDIKVGRPSTFASTVKIIKDRQYVEVLDSNAIKPTDFGM
IVLDKLVNNFPEIINEKYTAEVEGQLDLISENKLEKNQVMHDFYTKFNEL
YDQVASTMEKTRLEDNFLDEDCPDCSGKLLIRLNRKKQKFIGCKSFPNCT
YTRSYEDPDAKKRYYRNYKNTNKSN
>MS53_0486 tpiA, triosephosphate isomerase
MNKKLIVGNWKMNSTFSTTKEFLKEFQSLYSLNSKTYNQKATFAVATPFT
NLAALKDNDLNLKLAAQNMSFYEKGAYTGEVSADMLLDLNVSYVILGHSE
QRQYHAETDENVNKKARLALEKNLTPIVCVGETLEEYLAGKTKEVVKAQL
AASLKDLDVTKVIVAYEPIWAIGTGKVATAQIAQDVCKYIKELTSKQTVV
QYGGSVNAKNIFELSSQEDIDGFLVGGASLKATDFSDLMLNLK
>MS53_0368 tpx, thiol peroxidase
MKVKFGDKELTLNGLAPKHGDKVEAKGALAGSFDQVKFDNKGKMTVLSTF
PSIDTKVCDLQVGKLAHLSEKYTDFNFVSFSLDLPPALADYKANHPTGRV
EMYSDYFDKKTVSSLGMLINELQLATRAVFVLDKENKLVYSEVKDQVKDQ
VDFDALEEVLKKY
>MS53_0011 trmD, tRNA (guanine-N1)-methyltransferase
MMKINFLTLFPRYFEPLINESIIKKAVDKKILEFNVVDFRDFTKSKHRKV
DDEIYGGGHGLLLQVEPIDLALDSLENRGGYKILVTPQGKIFDQKMANKL
AKYDQITLISGRYEGFDERVTYLVDEEISIGDYVLTGGELPAMVIADSIC
RLVPGVIKKESVENDSFQNEGLLDYPQYTRPREYKNMKVPEVLFNGNHKE
ISEWKLKAQLEKTKKNRPDILERIKNEK
>MS53_0362 trmE, tRNA modification GTPase ThdF/TrmE
MNYQSYSDTICAISSGNNINQPISIIRISGKNAQSIVSKIFSGKVGENKT
ITYGFIKENSEIVDEVLVSWFLGEPQGDITVYNNYVGEPLIEINAHGGMI
VTNKILELLISNGARLAEPGEFTRRAFLNGKLDLSKADAIHNLIMSKTRL
QARNEASKLKGSASKVIKDLLKELSLLIGSIEVGIDYPEYIDDYEEDLKA
NSKEDINLTRINKLIARLEKIVKSSETALNYFEGIKLAIVGKPNVGKSSL
LNTMLKEDKAIVTNVAGTTRDIVEGIYYLDNFIFKIIDTAGIRKTRQEIE
KIGIERSYKAILDADIVLHLFDNLNSEDEFDLDIKKIVQENNKNYIKVVN
KSDLKSDIKWSDDFIKISAKNNDIKNLEDHLLKIYSGFDFNSEDIFATAR
QIKLFKESLEYAYAAREEIKNQLTYITAIVDLNNLFDTLQLIIGNSNRED
LLDEMFKNFCLGK
>MS53_0375 trmU, tRNA-(5-methylaminomethyl-2-thiouridylate)methyl transferase
MQNNKKTVVVGLSGGVDSSVAAYLLKKNYNVIGLFMRNWDSLINNDYLGN
REINNDICPQELDYKDAQEIARQLDIPLYRVDFVKEYWDYVFENFISEYK
KGRTPNPDILCNKYIKFDLFAKHAFNELKTDYIATGHYAKMKNGELYRAS
DKNKDQSYFLSQLSKEQLKKVLFPLENLTKDEIRKIAREQNLITAAKKDS
TGICFIGERKFAKFLQNYIPAKKGNVLDITNQKIVGEHSGCFYYTIGQRK
GLNLGGNKESYYVCGKNVAENIIYVAPSSRPEFLESNSLLASNLNLNTNN
FNKKNLSAKFRYRQEDSKVKVEFLENNFVKVYYDKAQAITPGQQVVFYDG
EKCIGGAVIEEIYLNDKKLTYL
>MS53_0169 trpS, tryptophanyl-tRNA synthetase
MQARLVSGIKPTGDLTLGNYLGAIKKFIKLQNNFESYIFVADLHALTDSQ
MSAKELKENRRKIIALYLASGLDPQKVNIFYQSDVLEHGFIQWLCLCETT
IGELNRMTQFKDKTEKFKQGNNTYKIPSGILAYPTLMAGDILLYNPEIVP
VGQDQTQHLELTRNIAERFNSKYKTKFNVPKPLLNEVGTKIMSLQNPDKK
MSKSEGSQKATIYLLEDPQSAYNKILKAVTDSENKVYLSDEKKGVKNLLN
IYAAINDLSLEEAAEKFRDSNYKEFKEAIAESVKALLENLQSKYNDYLKT
VDEIASSGASKAKKLAQKTILELKEKMGLN
>MS53_0565 truB, tRNA pseudouridine synthase B
MFYKINKPTNVFCNKYIRSWAKENNAEKIGQSGTLDPLASGLVIMATNSD
TKILQYVKNQPKVYLAKMEFNLFSNTLDSDGEVKKLNYKKVTLQKLEKAI
VKIKKQTYQMPPQFSSKKVKGKKALDLAYKNIAIKLKKQKIKIFSFELLE
FNFEKQYAVFEVSVSSGTYIRSIAKDLAKYCNSSAILTSLKRKSIDNIFL
NDLKENEFEKLNIKNLFNIKMHSLSIEDLNKLKNGQRVFLNYLNEKVFFI
VDKNSAKVLATGKIKNKYFYPKNVFVERIKNELQRQV
>MS53_0645 trxA, putative thioredoxin
MTRLKWAEAQELVKNNKDSDLLFLEFTTDWCGDCKMMKPVVTKLASSFSE
EDNIKFVNVDAEEAQLFRNPDSRWQVLKVPTHILLKGQEIVEKAYEYVPG
EVLKTWIEQRISK
>MS53_0596 trxB, thioredoxin reductase
MMQNEKYDLLIIGSGPAGLNAALYASRANLKVGFVEKGAPGGKLSTTSKV
ENWLGTKMIDGAALALEFFDHAQAYGAQYIYGEVASIKSHSLFDKEVLLK
DGKVLKAKTILIATGMVNRVPTFIKNIDSFLNRGVSFCAICDGPLYGKNP
TIVLGGGNSAVEESAYLSKIASEVHLVVKEASFRAEPSLVDDLKKLPNVH
IYMESEIKELRGESNLESAVIVDKNGVEKEIKVASFFPYIGFIPAADFAK
ELNILDDKGFIPTNESMETSVRGIFAAGDIRSKEIRQIITAASEGAMAAK
KISDLLNSSN
>MS53_0655 trxM, thioredoxin
MVHNTTKNSLPENFNSGLKVLVFHASWCGACKMLSPVLDRLAQEDSYEVF
KVNIDEDKAFAKELGVSSIPSVFVYKNGQVVANWVGYQPYEVMKKNLEAL
R
>MS53_0414 tsf, elongation factor EF-Ts
MSQNKLELIKELRQRTNSALGDVKKALEATDYNIEAAIKWLKENGIVKAA
KKSGRLASEGVVSAHGTPTQSLLLEVNSETDFVAQNEKFMTLVKNVTESV
FKAGASTLEEALQVKVSDSETVEQALTDATAVIGEKITLRRVLASKAKEG
HVLGTYLHANNRVAAVVEVTGSNSEVAKNVAMHLAAMNPEFVLVSDIPED
RMQEIKKAFEAPKDFDKKPAQIQERILSGWLDKQLGEVVLEKQPFVMEDS
LTVAKYLANANAKLVSAHRYEVGEGLEKVQSNFAEEVASMTK
>MS53_0667 tufA, Elongation factor Tu
MAKLDFDRSKEHVNVGTIGHVDHGKTTLTAAIATVLSKKGLSEARDYASI
DNAPEEKARGITINTSHIEYQTEKRHYAHVDCPGHADYVKNMITGAAQMD
GAILVVAATDGPMPQTREHILLSKQVGVPRMVVFLNKCDMVDDEEMIGLV
EMEIRDLLSEYGFDGDNAPIVRGSALKALEGDAVYEDKILELMNAVDTYI
ENPVKELDKPFLMAVEDVFTITGRGTVATGRVERGRLTLNEEVEIVGLKP
TKKTVVTGIEMFRKNLKEALAGDNAGLLLRGVNRDDVERGQVLAKPGSIV
PHTEFEAAIYVLKKEEGGRHTPFFKNYKPQFYFRTTDVTGGVEFEAGREM
VMPGENVNLKVKLISPIAVEEGTKFSIREGGRTVGAGSVTKIVK
>MS53_0622 tyrS, tyrosyl tRNA synthetase
MHKVLTELRDREILKDISNEEKFLSLPKNSGVYVGFDPTADSLHLGNYVQ
IVNLIRFKKHNWNALAVLGGATGMIGDPSFRSTERVLLSTEELLKNKNKI
KSQLESFGLKVFDNYEIYKDISFLDFLKNIGKLINVSYMLAKDSVKDRLA
QGLSFTEFSYQIIQGYDFLHLYQNQDIFVQYGGSDQWGNITTGIEMISKV
VGDNHKAIAITANLLTDSNGNKFGKSTGGGNLWLDAQKTKPFDMYQFLIN
QPDSEVEKLLKWLTFLEISEIKDLVNKHNKNPKDRLAQKALAYEVIKDIH
GKSAAENCTFLSEMLFNLSLDLSKVTLENMEFAYNQIESFEVEKGVNLVN
FLVENKILQSKRLAREFIASKSLKFNYEPIDEDFSVSSNYFEGKYATLHL
GKKKILICKVK
>MS53_0331 ugpA, ABC transporter, permease protein
MKKQSQGKKTISSTVLDKKIPTWKTLLILSPAIFLLILFTVIPLIFNIQT
SFTDRANRFTLQNYVTTFTDIRFAIGFRNSFIYGILVLPFVMIISLVISS
LIASLYRKYAKGIWQSVFFMPYITNSVAISLAFVQIFASNGILNQIIGGN
TPWLQTGNTQTFNALVALIINGVWGGLAFNILIFTTAMLGIDKNLYKSAA
IDGCGGIKTFFTITIPSIKGTINFLITLGIIGGIKVFPLALFQNSPTDAV
ANGASTIMIYVYIVTQIGNFQLAGAASLSLFIIGIIYSSVIRGGFFTIQL
SFTFLGERNVWVKVKNTDLLQSKKIKS
>MS53_0332 ugpE, ABC transporter permease protein
MKASAEKSSSIVKDSSFTGVLFSSVLKLISLCFFGVIILFPFFLMISLSL
FNDIESQNLANEFKLIPSFSKGPSFKNGALQDLPWKEVVQNTYTRAFSTG
YWNSLIITFLNVLVSVVLKVIVTMLMGYAFSLKNWRGKNVIWFFALALLV
LPEIALLSGQLQVVFRLKLNATYFGFVLTIALPFVASVFNAIMYKTAFEA
IPDRIKEVALVDGAVGHKYFLKIAAPMVLPTTLTVVILTALAAWNAYLWP
SLTSTGSTKDFQVLSVWLFKAGIDPDVQDSSANIQQNVKMAASIIAILPM
FLVYLLFRKRIMAAISRQGSTIKG
>MS53_0307 ung, uracil-DNA glycosylase
MKNSFLMVLQSEGKKPYFKNILSELERIGKDEVIYPAPPDIFAAFSDFEL
YETNLIFLGQDPYPNGHANGYAFSSNSEKTPMSLRNIFKELKKDYPEVLI
QSNNLKNWSRQKVLLLNIVLTVSKNKPDSHKNIGWESFTLKVVDLILGFN
KDCIIVALGNKARDFVSKLENPVKNLIFLSHPSPLSYNKSFKDSKLFLKI
NNLLKEQNKPEISWDIKGEYDLFT
>MS53_0309 upp, uracil phosphoribosyltransferase
MLKLVKHPLIEIKLSKLREKKTKIDEFRKNLNQISSLMAYEVLKKYKAKR
YQSKSVLDEKFKGKKLNKDILFVPILRAGLGMLDGFLEIASEARVGFYGL
SRDEKTLKPVCYLNKVPTLDPETFVVIIDPMLATGNSAIYVIDEMKKMGY
KNISFASLLTIQETLDKLQALHPDIDIYTASIDRELTSNGFISPGLGDAG
DKFFGT
>MS53_0022 uvrA, excinuclease ABC subunit A
MKNNEFITIKGARENNLKNVSLSLPRNKLIVFTGLSGSGKSSLAFNTIYE
EGRRRYVDSLSSYARMFLGGTKKPNVDSIEGLSPSISIEQKTVHNNPRST
VGTITEIFDYFRLLFARIGIPHCPTHKIKITGQSSKDILNEIYKQPENSK
LIIYSPVVDSQKGTHQNLLDSLIKENYLRVRINKQIYNLDEKITLNKNNK
YSIDIIVNRVVLNENNYNKIAESIEIATEKSDGIVIVENLDLNKEFMFSK
KHSCIHKDFSMPKIETRLFSFNAPYGMCEDCKGLGIQYKADFESIIPEMW
KTLEDGAIKYFENTVNSMNMEWQEFKIMLNHYKVPLDVPVDELKKEWIEY
IKYGTKVEDEKLSYSITSVNGNTVNRYGYIEGILDKIERMYYETSSDRTR
EYLNKFMGSFTCGSCKGARLNKNALAVWINGKNINDYIQLSISDCLIEIE
NLVEKHLTNQEKQISNLITKEIINRLTFLKNVGLTYLNLNRAAETLSGGE
AQRIRLATQIGSNLTGVLYVLDEPSIGLHQIDNQKLINALKKMVDLGNTL
IVVEHDEETMFAADYLVEIGPKAGLEGGEIVASGPLEEFIESKDSITAKY
LSGKESIEIPKSRRSGNGKVISILGASENNLKNIDVNIPLGKFIGVTGVS
GSGKSTLINEIFVRSWMQSENLMEGTRHKKAKFKGFKNLKLVDKIVSVNQ
NPIGKTPRSNPATYTSVFDDIRDIFANIEESKVRGYQKGRFSFNVPGGRC
EKCSGDGFIKIEMHFLPDVYVSCDDCDGKRYNKETLEIKYHFKNISDVLD
MSVDEALKFFENKIKITEKLKIMQEVGLGYIKLGQMSTTLSGGEAQRIKL
ATYLQKKPTGRTVYVLDEPTTGLHIHDVKKLLKILNRIVDNGDTVLVIEH
NLDVIKSCDYIIDLGPDGGVNGGKIVASGTPEQVAKIPHSYTGQFLKKIL
N
>MS53_0058 uvrB, excinuclease ABC subunit B
MKIFKLNSNFTPQGDQPKAINELVQGIKNNRKDQVLLGVTGSGKTFTIAN
VIKEFDRPAIILSHNKTLASQLYSELKAFFPENAVEYFISYFDYYRPEAY
KANTDTYIEKDSATNQQIEILRLSAYNSLLTRKDVIVVASVSAIYGALNP
EVYNKSFYNFYLNQKISVKDFIIKLTKNKYERNDLDVVPGRFAVKGDLVF
IAPADSETKMIRVSFSYDEIEEIAFVHPLEKTTIKKVSHYTLSPGDAYAT
DNSIYSTVIPQIQEELKERVKYYKDNNQILEATRINQRTNNDIDDMKEFG
HCKGIENYSMYLDGRTFGQRPYTILDYFPENSLMFIDESHMSLPQIRAMH
AGDRSRKNELVKYAFRLPSALENRPLTFDEFENSFSFNKIYISATPEAYE
INKTAGAVTTLYVRPTGLIDPEIFIYPKENQIERIYNIIMEQRKTGEKTL
VLTVTKRLAEEISNYFIDRKIKAAYIHSDHETFVRNEILRKLRMGTYEVV
IGINLLREGIDIPEVSKVIILDADSNGFLRNTKSLIQIVGRAARNANGQA
ILFADTITSAIKEMMEDNKIKRKIQMEYNQKYRIVPKTIIKPIRGAIYNE
NYENAMEILLKKSQKSKFSKNEKKALNSLIEDLEIQMKKAAKEYDYEEAI
RLRDMIHEIKQSQSNKGK
>MS53_0271 uvrC, excinuclease ABC subunit C
MDKKQELLSLLKNIPKKPGTYLWKDQFDNVIYVGKANNLHNRMNSYFKGN
INSFKTYAMFENIYSFDYFIADSPKAALILEKKYIDQYRPKYNIMLLDDK
QYPYLNIKIKDSLEIKQTYRVSKNSEFNIYYGPYPQSHLFKFVKILQRIF
LYNQGLLIKDKPKMYWIEKFNILKEILKFKNNDFNNLLKEKMIAAADNLN
FEAAIEYQKALEFISQFKEKQIIEISKYKNYDVFSFEEKNESIAIFYMLY
IYGVQNIFQRKIIENYDSLENIISNFLKEFYKNKALPDNIILDYKYKDLN
LDLDFKSKIIFPQKGINHDLIKLANENNNSGYESYLNQKIILEQHKLNLW
KNLASELFLDKLNSIFIFDNSHFNNSNPIGSCICYTKAEKNPHLYASFNH
EKEQKELKIKSDIEYMYHSVYKYLKRNHLFITKDDIFILDGSSMQIKFAQ
KAILDFNKDFNANLEIKLFGLVKDKNHKTNLMINSKDEIIKISSESFLFL
SKIQEEVDLFAKKRMQKNQINLTFKSRLIQIKGISYKTEEKLLKHFGTFA
NIYNASFEELQKVTNKSIAQKIKENLDIIARK
>MS53_0301 vacB, VACB-like ribonuclease II
MMNIDKIKLINYIKARKNVSFIELANYLKINRKDNKEFSAYLVSLIKRNK
IFKTFDSNYYVPELLRKQSGIIKVASKKQFAFLEFENEAQEKESVFVKFQ
DLNSALNNDEVIASIYKDHNEKNPTRQLLAVVDEIVQRNNQKIIGFIKKD
KNTIFFAPADGCFDKVKFELLNLSSKVKINDCVLCEIKKYDKNLVSLEIK
KVITNTSDPNVFVKAYLESTNIDLEFSAETLAESKLIPQEVDLNIKEKFQ
RKNLTSELIVTIDGESTKDFDDAINVKKLENGNFLLSVHIADVAHYVKEK
TNLDSEALKRGTSIYIANGVIPMLPSELSNGICSINPNVDRFALSCDIEI
DQHGNNVNYKIYKSVINSKFRLTYKQVQAFFDKDNNFLSLEQKKSSYVKE
LETMLTNAYELSLILHKYKEAQGYVDFEIPEPKIFLNEDGTVKEIKIHKR
VYSEILIEDFMVRTNEVVAKYLSDLKMPVLYRIHENPSEEKLQSLKTNLT
ALGINIKNINSITSSANDFSKFVYQTRNQRNDYFINLLFLRTMQKAIYSL
NNIGHFGLASEFYCHFTSPIRRYPDLLVHRILTMHLEGKSSQEILNHFDS
KLDSYAQLNSNSEQKAIEIERKVNDLKFAEFLKFQTGQKFKAQIVSVLNF
GIFVEFEFGGSGLIHKSNFFDGSYEANEMLTVFASETKSYKIGEYVDVVI
IATDLLEGKIDCVLESQYDAYKLNLTRKHEKPRNSK
>MS53_0298 valS, valyl-tRNA synthetase
MQKIYNHQNVEDGIESKWREKKYFIDHNLDKKPFSILLPPPNVTGKLHLG
HALDSYIPDTIIRFKKLSGYDVLWLPGMDHAGIATQSKVESELYKQNKLT
RHDLGKEKFLAEVWKWKEIHEKLFRQQWQTLGLALDYSNEAFTLSKEVNE
KVIKIFVELYNRGYIYKKNRAVSWDINLQTAISNIEVINKETPQKMYYIK
YFFENSSEYLTIATTRVETMLSDVAVIANPKDKRYKNLKIKFLIHPITKK
RLPLIFDEYVKIKFGSGLMKLSAHAEADIEIIEKLGLEVIETIDKNGYIN
APDYQWHKMERFEAREKMAQFLEENNYLIKAEDSISNVSYSDRSNSVIET
LMLPQWFIKMDHFRDLILKNLSSKEKIKFLPNRYKNNLKRWMNNVYDWNI
SRQLWWGHQIPAWYKDGKMKVQAESPGQGWVQDSDVLDTWFSSGIAAFSF
FKWENDDAFFKRYYPSSLMVSGYDLIFFWISRMIFLSLEFTNQRPFKEVF
MHGLIRDKDGRKMSKSLNNGIDPIEVVEKYGSDALRWFLITNTAPGMDIR
YNQEKIESAWKISNKLYNVALYISSMPDNNLEAKSSKLSEQSKWILNKLS
ALNKQIQKVFKTYDFSIIGVEIYQFIFTDLSSWYIELIKSLNIKNEAMYV
FKKILIMLHPFLPFTSDYLFNKLYNEELLEQSWPKFKRFKDSSEINLLID
AITKIRKYRDDNNISKKEKLYLCLKEKISKKNLNILLSLTNSEYKENKDF
LIVLDNNSIFIEISQEQKQKQKQELEKKIAFCQSEITRAQNILSNQSFIA
KAPKEKIKLEEDKLQRYKQELQIYLEELKWKY
>MS53_0268 vlhA, phase-variable hemagglutinin
MKNKKIKLLLAASAVAIAPAVIAISCGDQTPAPTPAPTPTPGNPNTDNPQ
NPNPGNPGTDNPQNPNTGNPGGGTVDPVETAKTEAKTAIDDSTELSDLVK
EALKRQVEATTTESAARDLKTKAEALVSAVKALSGSVTKAKAVKEDAEYS
KVTDTIKTTLEEKYTAATALLEGETKLKNLDASSNLDTTKATLESAKTAL
DAAVAAVKPELDFQKTKTSATAKVTELESLVNIALKAELQRQVNELTKDH
ATEATTMLANLTSLKESLESLQTLVSDGLKMQVDYPRNYYDADNKANFDA
ALLKASSVFPAFQWTTNSIIVPAPEGDALPNPRAWTKAREKSEFKLQNFV
MAPAQAAATTTAQTSPSAAATATVRVAMSEDAQAPQAPATPDLASTVSYL
KSLSDSLKAETDKLNGDTTENKTAYYKADTGRTLYWDGFMPKIVLEGFDK
TWGQNSENERKIRKWFDNAANWEGLSDQLTKKLGAERFKNVKLTYKEVTF
STNAVKTPTVTFTVAAKEGYTLDNSVNEISPLLLEFYITVMMKAQSSFLH
KELHLQQRQLVQRHLIMPQ
>MS53_0136 xylF, ABC transporter xylose-binding lipoprotein
MKKKFILPIIMTPIAATAIIATACGDQSEAQKPSGWIPKEERVAQIKTVD
LTSVKEEARSQKYVLITDKGDVHDKSFNQSSWEALNQLYDQTGAEVNFIQ
PSTENYTQAYNQALSQGYTVWILSGFTHSASLKSFIEQNYQTLVDRKIQI
IGIDFSLTGANALSKQYPYFFGLLFKFDQSAWIVGYATAKYLAYKYPNDA
DKRIVASFAGGDNVGTTRFNTGFAKGVLAYNQDPKNTVKVKHQFPVPLDS
GYETNEKMQTVITSVLSGQDGKTPTVVLPVAGPATGEVLNAYARSQANAD
KLVIGVDVDQSLSYPDKAGKFLTSITKNIAQAEYDIMTEILLSAKNSREN
KFLVGHDKSKTFTLEGTFAQGWAGFTKSHLTNAADRAKMDQFLTDAENLF
KSKSQAFVDYISDDSKATEGGQQSYTTVTDLLKAVTDLINQTNTTQQ
>MS53_0342 yabC, S-adenosyl-methyltransferase
MKNNHIPVLLNEVLDNLALKENGIYIDLTLGMGGHSKEILKRIPKGKLIA
FDKDDFAIKNASKTLSEVANNFEIIKSDFKDFKEELSNLGIYKVDGILAD
LGISSPQIDNAERGFSYLKNSALDMRMDQSQKLSAYDVVNLYPVEKLEYI
LKTYGEVKNYKYIASKIIEARPINTTLELANLIKSVTPQKLLKLKNPAKN
VFQAIRIEVNNELDSIHQMLSSVEDLLKVNASLLIISFHSLEDKIVKNYF
QELTKPKLPSKMPIQEDKFFATRRIYPSKQELNLNSRSKSAKLRILTKIK
D
>MS53_0663 ychF, GTP-binding protein YchF
MSLKAGIVGLPNVGKSTLFKALTKKQVESSNYAFTTIEPNISTVSVVDKR
LDEIAKIIKPNKIFYATFDFVDIAGLVKGASKGEGLGNKFLSNIREVDAI
IHVVRCFEDKNILHVSNSIDPIRDKEDINLELLLADLETVNNILNRVEKK
AKARDKFALLEKSISQRIKKALEENIPARELDFSDEEKNIINGYHLLSFK
PILYVANVKPEQLQNINSDEIFNKFKSSLKEYEKVVPICAQIESELIDLS
DEEKLEMLALYNISESGIESLTKKAFSLLQLETYFTAGVVEVRAWVYLKN
SLAPKCAGIIHSDFEKKFIKAEVISYKDFIEHGGEANARSAGKLRLEGKS
YVMQDGDICNFKFGK